kwr-20201231
false --12-31 1 30000000 P10Y P1Y P3Y P45Y P15Y P5Y P4Y P20Y 0.5 P7Y P1Y P2Y P3Y P5Y P3Y 0.13 3.1 2.3 108 1808 387.7 32.1 24.5 2.5 2 10000000 1 2.6 40 2.3 4.7 0.8 6.5 0.3 0.1 1.2 3 3.9 0.1 945 386.1 49906 65548 3.9 0.2 10 4.1 344.4 234.9 366 213.1 1 0.2 FY 0000081362 0.3 109.5 152.9 5.9 8/1/2024 1 9.1 22 0.6 7.3 20.3 0.2 8.3 21.9 0.5 963.2 719.8 534.6 176.6 174.4 60.8 5.3 5.4 4.7 1 1 10/1/2019 12/22/2020 3 us-gaap:Assets us-gaap:Liabilities 2028 2018 15.0 20.0 0000081362 2020-01-01 2020-12-31 0000081362 2020-06-30 0000081362 2019-12-31 0000081362 2018-12-31 0000081362 us-gaap:BuildingAndBuildingImprovementsMember srt:MinimumMember 2020-01-01 2020-12-31 0000081362 srt:MinimumMember us-gaap:MachineryAndEquipmentMember 2020-01-01 2020-12-31 0000081362 srt:MinimumMember us-gaap:SoftwareDevelopmentMember 2020-01-01 2020-12-31 0000081362 us-gaap:BuildingAndBuildingImprovementsMember srt:MaximumMember 2020-01-01 2020-12-31 0000081362 us-gaap:MachineryAndEquipmentMember srt:MaximumMember 2020-01-01 2020-12-31 0000081362 us-gaap:SoftwareDevelopmentMember srt:MaximumMember 2020-01-01 2020-12-31 0000081362 srt:MinimumMember 2020-01-01 2020-12-31 0000081362 srt:MaximumMember 2020-01-01 2020-12-31 0000081362 srt:MaximumMember us-gaap:EmployeeStockOptionMember 2020-01-01 2020-12-31 0000081362 srt:MinimumMember us-gaap:RestrictedStockMember 2020-01-01 2020-12-31 0000081362 srt:MinimumMember us-gaap:StockCompensationPlanMember 2020-01-01 2020-12-31 0000081362 srt:MaximumMember us-gaap:StockCompensationPlanMember 2020-01-01 2020-12-31 0000081362 srt:MaximumMember us-gaap:RestrictedStockUnitsRSUMember 2020-01-01 2020-12-31 0000081362 us-gaap:RestrictedStockMember 2019-12-31 0000081362 us-gaap:RestrictedStockUnitsRSUMember 2019-12-31 0000081362 2019-01-01 2019-12-31 0000081362 2018-01-01 2018-12-31 0000081362 2017-12-31 0000081362 kwr:InsuranceContractMember us-gaap:FairValueInputsLevel3Member 2019-01-01 2019-12-31 0000081362 us-gaap:FairValueInputsLevel3Member kwr:RealEstateFundMember 2019-01-01 2019-12-31 0000081362 us-gaap:FairValueInputsLevel3Member 2019-01-01 2019-12-31 0000081362 us-gaap:FairValueInputsLevel2Member 2019-12-31 0000081362 us-gaap:FairValueInputsLevel3Member 2019-12-31 0000081362 us-gaap:FairValueInputsLevel1Member 2019-12-31 0000081362 us-gaap:CommonStockMember 2017-12-31 0000081362 us-gaap:AdditionalPaidInCapitalMember 2017-12-31 0000081362 us-gaap:RetainedEarningsMember 2017-12-31 0000081362 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-12-31 0000081362 us-gaap:NoncontrollingInterestMember 2017-12-31 0000081362 us-gaap:CommonStockMember 2018-01-01 2018-12-31 0000081362 us-gaap:AdditionalPaidInCapitalMember 2018-01-01 2018-12-31 0000081362 us-gaap:RetainedEarningsMember 2018-01-01 2018-12-31 0000081362 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-01-01 2018-12-31 0000081362 us-gaap:NoncontrollingInterestMember 2018-01-01 2018-12-31 0000081362 kwr:StockOptionsCompensationExpenseMember 2019-01-01 2019-12-31 0000081362 kwr:StockOptionsCompensationExpenseMember 2018-01-01 2018-12-31 0000081362 kwr:NonvestedStockAwardsCompensationExpenseMember 2019-01-01 2019-12-31 0000081362 kwr:NonvestedStockAwardsCompensationExpenseMember 2018-01-01 2018-12-31 0000081362 kwr:EmployeeStockPurchasePlanCompensationExpenseMember 2019-01-01 2019-12-31 0000081362 kwr:EmployeeStockPurchasePlanCompensationExpenseMember 2018-01-01 2018-12-31 0000081362 kwr:MatchingStockContribution401KPlanCompensationExpenseMember 2019-01-01 2019-12-31 0000081362 kwr:MatchingStockContribution401KPlanCompensationExpenseMember 2018-01-01 2018-12-31 0000081362 kwr:DirectorsStockOwnershipPlanCompensationExpenseMember 2019-01-01 2019-12-31 0000081362 kwr:DirectorsStockOwnershipPlanCompensationExpenseMember 2018-01-01 2018-12-31 0000081362 us-gaap:AccumulatedTranslationAdjustmentMember 2017-12-31 0000081362 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2017-12-31 0000081362 us-gaap:AccumulatedTranslationAdjustmentMember 2018-01-01 2018-12-31 0000081362 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2018-01-01 2018-12-31 0000081362 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2017-12-31 0000081362 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2018-01-01 2018-12-31 0000081362 us-gaap:AccumulatedTranslationAdjustmentMember 2018-12-31 0000081362 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2018-12-31 0000081362 us-gaap:AccumulatedTranslationAdjustmentMember 2019-01-01 2019-12-31 0000081362 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-01-01 2019-12-31 0000081362 us-gaap:AccumulatedTranslationAdjustmentMember 2019-12-31 0000081362 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-12-31 0000081362 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2018-12-31 0000081362 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2019-01-01 2019-12-31 0000081362 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2019-12-31 0000081362 us-gaap:CustomerListsMember 2019-12-31 0000081362 us-gaap:OtherIntangibleAssetsMember 2019-12-31 0000081362 2020-12-31 0000081362 us-gaap:CommonStockMember 2019-01-01 2019-12-31 0000081362 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-12-31 0000081362 us-gaap:RetainedEarningsMember 2019-01-01 2019-12-31 0000081362 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-01-01 2019-12-31 0000081362 us-gaap:NoncontrollingInterestMember 2019-01-01 2019-12-31 0000081362 kwr:StockOptionsCompensationExpenseMember 2020-01-01 2020-12-31 0000081362 kwr:NonvestedStockAwardsCompensationExpenseMember 2020-01-01 2020-12-31 0000081362 kwr:EmployeeStockPurchasePlanCompensationExpenseMember 2020-01-01 2020-12-31 0000081362 kwr:MatchingStockContribution401KPlanCompensationExpenseMember 2020-01-01 2020-12-31 0000081362 kwr:DirectorsStockOwnershipPlanCompensationExpenseMember 2020-01-01 2020-12-31 0000081362 kwr:StockOptionsCompensationExpenseCYMember 2020-01-01 2020-12-31 0000081362 kwr:StockOptionsCompensationExpensePY1Member 2020-01-01 2020-12-31 0000081362 kwr:StockOptionsCompensationExpensePY2Member 2020-01-01 2020-12-31 0000081362 kwr:StockOptionsCompensationExpensePY3Member 2020-01-01 2020-12-31 0000081362 kwr:StockOptionsCompensationExpenseCYMember 2019-01-01 2019-12-31 0000081362 kwr:StockOptionsCompensationExpensePY1Member 2019-01-01 2019-12-31 0000081362 kwr:StockOptionsCompensationExpensePY2Member 2019-01-01 2019-12-31 0000081362 kwr:StockOptionsCompensationExpensePY3Member 2019-01-01 2019-12-31 0000081362 kwr:StockOptionsCompensationExpenseCYMember 2018-01-01 2018-12-31 0000081362 kwr:StockOptionsCompensationExpensePY1Member 2018-01-01 2018-12-31 0000081362 kwr:StockOptionsCompensationExpensePY2Member 2018-01-01 2018-12-31 0000081362 kwr:StockOptionsCompensationExpensePY3Member 2018-01-01 2018-12-31 0000081362 us-gaap:RestrictedStockMember 2020-12-31 0000081362 us-gaap:RestrictedStockMember 2020-01-01 2020-12-31 0000081362 us-gaap:RestrictedStockUnitsRSUMember 2020-12-31 0000081362 us-gaap:RestrictedStockUnitsRSUMember 2020-01-01 2020-12-31 0000081362 kwr:StockOptionsCompensationExpensePY1Member 2020-12-31 0000081362 kwr:StockOptionsCompensationExpensePY2Member 2020-12-31 0000081362 kwr:StockOptionsCompensationExpenseCYMember 2020-12-31 0000081362 kwr:TrademarksFormulationsandproducttechnologymemberMember 2019-12-31 0000081362 us-gaap:CustomerListsMember 2020-12-31 0000081362 kwr:TrademarksFormulationsandproducttechnologymemberMember 2020-12-31 0000081362 us-gaap:OtherIntangibleAssetsMember 2020-12-31 0000081362 us-gaap:FairValueInputsLevel1Member 2020-12-31 0000081362 us-gaap:FairValueInputsLevel2Member 2020-12-31 0000081362 us-gaap:FairValueInputsLevel3Member 2020-12-31 0000081362 us-gaap:AccumulatedTranslationAdjustmentMember 2020-12-31 0000081362 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-12-31 0000081362 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2020-12-31 0000081362 us-gaap:AccumulatedTranslationAdjustmentMember 2020-01-01 2020-12-31 0000081362 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-01-01 2020-12-31 0000081362 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2020-01-01 2020-12-31 0000081362 kwr:ShareRepurchaseProgramMember 2020-12-31 0000081362 srt:AsiaPacificMember kwr:EquityMethodInvesteeNameNipponQuakerJapanMember 2020-12-31 0000081362 us-gaap:FairValueInputsLevel3Member 2020-01-01 2020-12-31 0000081362 kwr:InsuranceContractMember us-gaap:FairValueInputsLevel3Member 2020-01-01 2020-12-31 0000081362 kwr:RealEstateFundMember us-gaap:FairValueInputsLevel3Member 2020-01-01 2020-12-31 0000081362 kwr:ExercisePriceRange3Member 2020-12-31 0000081362 kwr:ExercisePriceRange4Member 2020-12-31 0000081362 kwr:ExercisePriceRange5Member 2020-12-31 0000081362 kwr:ExercisePriceRange6Member 2020-12-31 0000081362 kwr:ExercisePriceRange7Member 2020-12-31 0000081362 kwr:ExercisePriceRange8Member 2020-12-31 0000081362 kwr:ExercisePriceRange3Member 2020-01-01 2020-12-31 0000081362 kwr:ExercisePriceRange4Member 2020-01-01 2020-12-31 0000081362 kwr:ExercisePriceRange5Member 2020-01-01 2020-12-31 0000081362 kwr:ExercisePriceRange6Member 2020-01-01 2020-12-31 0000081362 kwr:ExercisePriceRange7Member 2020-01-01 2020-12-31 0000081362 kwr:ExercisePriceRange8Member 2020-01-01 2020-12-31 0000081362 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2020-01-01 2020-12-31 0000081362 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-01-01 2019-12-31 0000081362 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0000081362 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0000081362 us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0000081362 us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0000081362 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2018-01-01 2018-12-31 0000081362 kwr:RealEstateFundMember us-gaap:FairValueInputsLevel3Member 2019-12-31 0000081362 us-gaap:CommonStockMember 2020-12-31 0000081362 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0000081362 us-gaap:RetainedEarningsMember 2020-12-31 0000081362 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0000081362 us-gaap:NoncontrollingInterestMember 2020-12-31 0000081362 us-gaap:RetainedEarningsMember 2020-01-01 2020-12-31 0000081362 us-gaap:NoncontrollingInterestMember 2020-01-01 2020-12-31 0000081362 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-12-31 0000081362 us-gaap:CommonStockMember 2020-01-01 2020-12-31 0000081362 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-12-31 0000081362 kwr:InsuranceContractMember us-gaap:FairValueInputsLevel3Member 2020-12-31 0000081362 kwr:RealEstateFundMember us-gaap:FairValueInputsLevel3Member 2020-12-31 0000081362 kwr:InsuranceContractMember us-gaap:FairValueInputsLevel3Member 2018-12-31 0000081362 kwr:InsuranceContractMember us-gaap:FairValueInputsLevel3Member 2019-12-31 0000081362 2021-01-31 0000081362 us-gaap:InterestRateSwapMember us-gaap:OtherNoncurrentLiabilitiesMember 2020-01-01 2020-12-31 0000081362 us-gaap:InterestRateSwapMember us-gaap:OtherNoncurrentLiabilitiesMember 2019-01-01 2019-12-31 0000081362 us-gaap:InterestRateSwapMember 2020-01-01 2020-12-31 0000081362 us-gaap:InterestRateSwapMember 2019-01-01 2019-12-31 0000081362 us-gaap:InterestExpenseMember 2020-01-01 2020-12-31 0000081362 us-gaap:InterestExpenseMember 2019-01-01 2019-12-31 0000081362 us-gaap:InterestExpenseMember 2018-01-01 2018-12-31 0000081362 srt:MaximumMember us-gaap:LandMember 2020-12-31 0000081362 us-gaap:SalesRevenueNetMember kwr:RollingLubricantsProductLineMember 2020-01-01 2020-12-31 0000081362 us-gaap:SalesRevenueNetMember kwr:RollingLubricantsProductLineMember 2019-01-01 2019-12-31 0000081362 us-gaap:SalesRevenueNetMember kwr:RollingLubricantsProductLineMember 2018-01-01 2018-12-31 0000081362 us-gaap:SalesRevenueNetMember kwr:MetalremovalfluidsLineMember 2020-01-01 2020-12-31 0000081362 us-gaap:SalesRevenueNetMember kwr:MetalremovalfluidsLineMember 2019-01-01 2019-12-31 0000081362 us-gaap:SalesRevenueNetMember kwr:MetalremovalfluidsLineMember 2018-01-01 2018-12-31 0000081362 us-gaap:SalesRevenueNetMember kwr:HydraulicFluidsProductLineMember 2020-01-01 2020-12-31 0000081362 us-gaap:SalesRevenueNetMember kwr:HydraulicFluidsProductLineMember 2019-01-01 2019-12-31 0000081362 us-gaap:SalesRevenueNetMember kwr:HydraulicFluidsProductLineMember 2018-01-01 2018-12-31 0000081362 us-gaap:EMEAMember us-gaap:ProductMember 2020-01-01 2020-12-31 0000081362 srt:AsiaPacificMember us-gaap:ProductMember 2020-01-01 2020-12-31 0000081362 us-gaap:EMEAMember us-gaap:ProductMember 2019-01-01 2019-12-31 0000081362 srt:AsiaPacificMember us-gaap:ProductMember 2019-01-01 2019-12-31 0000081362 us-gaap:EMEAMember us-gaap:ProductMember 2018-01-01 2018-12-31 0000081362 srt:AsiaPacificMember us-gaap:ProductMember 2018-01-01 2018-12-31 0000081362 kwr:CombinationAndOtherAcquisitionRelatedMember 2020-01-01 2020-12-31 0000081362 kwr:CombinationAndOtherAcquisitionRelatedMember 2019-01-01 2019-12-31 0000081362 srt:AsiaPacificMember kwr:EquityMethodInvesteeNameHoughtonKoreaMember 2020-12-31 0000081362 us-gaap:ForeignCountryMember 2020-12-31 0000081362 kwr:CombinationAndNormanHayMember 2020-12-31 0000081362 kwr:KoreaHoughtonCoporationMember 2019-12-31 0000081362 kwr:KoreaHoughtonCoporationMember 2020-12-31 0000081362 kwr:ExpirationInYearFiveMember 2020-01-01 2020-12-31 0000081362 kwr:ExpirationintwentyyearsmemberMember 2020-01-01 2020-12-31 0000081362 us-gaap:DomesticLineOfCreditMember 2020-12-31 0000081362 us-gaap:DomesticLineOfCreditMember 2019-12-31 0000081362 us-gaap:ForeignLineOfCreditMember 2020-12-31 0000081362 us-gaap:ForeignLineOfCreditMember 2019-12-31 0000081362 kwr:BankLinesOfCreditAndOtherDebtObligationsMember 2020-12-31 0000081362 kwr:BankLinesOfCreditAndOtherDebtObligationsMember 2019-12-31 0000081362 us-gaap:LineOfCreditMember 2020-12-31 0000081362 us-gaap:LineOfCreditMember 2019-12-31 0000081362 kwr:IndustrialDevelopmentBondsMember 2020-12-31 0000081362 kwr:IndustrialDevelopmentBondsMember 2019-12-31 0000081362 kwr:HoughtonMember 2019-08-01 2019-08-01 0000081362 kwr:HoughtonMember us-gaap:DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember kwr:CertainSteelAndAluminumRelatedProductLinesMember 2019-08-01 2019-08-01 0000081362 kwr:HoughtonMember 2019-08-01 0000081362 us-gaap:RevolvingCreditFacilityMember 2019-08-01 0000081362 us-gaap:DomesticLineOfCreditMember 2019-08-01 0000081362 us-gaap:ForeignLineOfCreditMember 2019-08-01 0000081362 kwr:HoughtonMember us-gaap:CustomerRelationshipsMember 2019-08-01 0000081362 kwr:HoughtonMember us-gaap:TrademarksMember 2019-08-01 0000081362 kwr:TrademarksFormulationsandproducttechnologymemberMember kwr:HoughtonMember 2019-08-01 0000081362 kwr:HoughtonMember us-gaap:CustomerRelationshipsMember srt:MinimumMember 2019-07-31 2019-08-01 0000081362 kwr:HoughtonMember srt:MaximumMember us-gaap:CustomerRelationshipsMember 2019-07-31 2019-08-01 0000081362 kwr:TrademarksFormulationsandproducttechnologymemberMember kwr:HoughtonMember 2019-07-31 2019-08-01 0000081362 kwr:HoughtonMember 2019-01-01 2019-12-31 0000081362 kwr:NormanHayMember 2019-10-01 2019-10-01 0000081362 kwr:NormanHayMember us-gaap:CustomerRelationshipsMember 2019-10-01 0000081362 kwr:NormanHayMember kwr:ProductTechnologyMember 2019-10-01 0000081362 kwr:NormanHayMember us-gaap:TrademarksMember 2019-10-01 0000081362 kwr:NormanHayMember us-gaap:NoncompeteAgreementsMember 2019-10-01 0000081362 kwr:NormanHayMember us-gaap:CustomerRelationshipsMember srt:MinimumMember 2019-10-01 2019-10-01 0000081362 kwr:NormanHayMember srt:MaximumMember us-gaap:CustomerRelationshipsMember 2019-10-01 2019-10-01 0000081362 kwr:NormanHayMember kwr:ProductTechnologyMember 2019-10-01 2019-10-01 0000081362 kwr:NormanHayMember us-gaap:TrademarksMember srt:MinimumMember 2019-10-01 2019-10-01 0000081362 kwr:NormanHayMember srt:MaximumMember us-gaap:TrademarksMember 2019-10-01 2019-10-01 0000081362 kwr:NormanHayMember srt:MinimumMember us-gaap:NoncompeteAgreementsMember 2019-10-01 2019-10-01 0000081362 kwr:NormanHayMember srt:MaximumMember us-gaap:NoncompeteAgreementsMember 2019-10-01 2019-10-01 0000081362 kwr:QhProgramMember 2020-01-01 2020-12-31 0000081362 kwr:QhProgramMember 2020-12-31 0000081362 us-gaap:PensionPlansDefinedBenefitMember 2020-01-01 2020-12-31 0000081362 us-gaap:PensionPlansDefinedBenefitMember 2019-01-01 2019-12-31 0000081362 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember us-gaap:EquitySecuritiesMember 2020-12-31 0000081362 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember us-gaap:DebtSecuritiesMember 2020-12-31 0000081362 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember us-gaap:EquitySecuritiesMember 2019-12-31 0000081362 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember us-gaap:DebtSecuritiesMember 2019-12-31 0000081362 kwr:RealEstateFundMember us-gaap:FairValueInputsLevel3Member 2018-12-31 0000081362 us-gaap:FairValueInputsLevel3Member 2018-12-31 0000081362 us-gaap:PensionPlansDefinedBenefitMember us-gaap:OtherLiabilitiesMember kwr:ClevelandBakersAndTeamstersPensionFundMember 2020-01-01 2020-12-31 0000081362 us-gaap:PensionPlansDefinedBenefitMember kwr:ClevelandBakersAndTeamstersPensionFundMember 2019-01-01 0000081362 us-gaap:PensionPlansDefinedBenefitMember kwr:ClevelandBakersAndTeamstersPensionFundMember 2019-12-31 0000081362 us-gaap:PensionPlansDefinedBenefitMember kwr:ClevelandBakersAndTeamstersPensionFundMember 2020-01-01 2020-12-31 0000081362 us-gaap:PensionPlansDefinedBenefitMember kwr:ClevelandBakersAndTeamstersPensionFundMember 2020-12-31 0000081362 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2020-12-31 0000081362 us-gaap:InterestRateSwapMember kwr:OtherLiabilitiesCurrentMember 2019-11-30 0000081362 us-gaap:PensionPlansDefinedBenefitMember country:US 2020-01-01 2020-12-31 0000081362 us-gaap:PensionPlansDefinedBenefitMember country:US 2019-01-01 2019-12-31 0000081362 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember country:US 2020-01-01 2020-12-31 0000081362 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember country:US 2019-01-01 2019-12-31 0000081362 us-gaap:PensionPlansDefinedBenefitMember country:US 2020-12-31 0000081362 us-gaap:PensionPlansDefinedBenefitMember country:US 2019-12-31 0000081362 us-gaap:PensionPlansDefinedBenefitMember us-gaap:EquitySecuritiesMember country:US 2020-12-31 0000081362 us-gaap:PensionPlansDefinedBenefitMember us-gaap:DebtSecuritiesMember country:US 2020-12-31 0000081362 us-gaap:PensionPlansDefinedBenefitMember us-gaap:EquitySecuritiesMember country:US 2019-12-31 0000081362 us-gaap:PensionPlansDefinedBenefitMember us-gaap:DebtSecuritiesMember country:US 2019-12-31 0000081362 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember country:US 2020-12-31 0000081362 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember country:US 2019-12-31 0000081362 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember country:US 2018-01-01 2018-12-31 0000081362 us-gaap:PensionPlansDefinedBenefitMember country:US 2018-01-01 2018-12-31 0000081362 country:US us-gaap:SupplementalEmployeeRetirementPlanDefinedBenefitMember 2020-01-01 2020-12-31 0000081362 country:US us-gaap:SupplementalEmployeeRetirementPlanDefinedBenefitMember 2019-01-01 2019-12-31 0000081362 us-gaap:LineOfCreditMember 2020-01-01 2020-12-31 0000081362 us-gaap:EmployeeStockOptionMember 2020-01-01 2020-12-31 0000081362 country:US us-gaap:SupplementalEmployeeRetirementPlanDefinedBenefitMember 2018-01-01 2018-12-31 0000081362 srt:SubsidiariesMember 2020-12-31 0000081362 srt:SubsidiariesMember 2020-01-01 2020-12-31 0000081362 srt:SubsidiariesMember 2019-01-01 2019-12-31 0000081362 srt:SubsidiariesMember 2018-01-01 2018-12-31 0000081362 srt:AmericasMember 2020-01-01 2020-12-31 0000081362 us-gaap:EMEAMember 2020-01-01 2020-12-31 0000081362 srt:AsiaPacificMember 2020-01-01 2020-12-31 0000081362 srt:AmericasMember 2019-01-01 2019-12-31 0000081362 us-gaap:EMEAMember 2019-01-01 2019-12-31 0000081362 srt:AsiaPacificMember 2019-01-01 2019-12-31 0000081362 srt:AmericasMember 2018-01-01 2018-12-31 0000081362 us-gaap:EMEAMember 2018-01-01 2018-12-31 0000081362 srt:AsiaPacificMember 2018-01-01 2018-12-31 0000081362 srt:AmericasMember us-gaap:IntersegmentEliminationMember 2020-01-01 2020-12-31 0000081362 us-gaap:EMEAMember us-gaap:IntersegmentEliminationMember 2020-01-01 2020-12-31 0000081362 srt:AsiaPacificMember us-gaap:IntersegmentEliminationMember 2020-01-01 2020-12-31 0000081362 srt:AmericasMember us-gaap:IntersegmentEliminationMember 2019-01-01 2019-12-31 0000081362 us-gaap:EMEAMember us-gaap:IntersegmentEliminationMember 2019-01-01 2019-12-31 0000081362 srt:AsiaPacificMember us-gaap:IntersegmentEliminationMember 2019-01-01 2019-12-31 0000081362 srt:AmericasMember us-gaap:IntersegmentEliminationMember 2018-01-01 2018-12-31 0000081362 us-gaap:EMEAMember us-gaap:IntersegmentEliminationMember 2018-01-01 2018-12-31 0000081362 srt:AsiaPacificMember us-gaap:IntersegmentEliminationMember 2018-01-01 2018-12-31 0000081362 us-gaap:NonUsMember 2020-01-01 2020-12-31 0000081362 us-gaap:NonUsMember 2019-01-01 2019-12-31 0000081362 us-gaap:NonUsMember 2018-01-01 2018-12-31 0000081362 srt:AmericasMember 2020-12-31 0000081362 us-gaap:EMEAMember 2020-12-31 0000081362 srt:AsiaPacificMember 2020-12-31 0000081362 srt:AmericasMember 2019-12-31 0000081362 us-gaap:EMEAMember 2019-12-31 0000081362 srt:AsiaPacificMember 2019-12-31 0000081362 srt:AmericasMember 2018-12-31 0000081362 us-gaap:EMEAMember 2018-12-31 0000081362 srt:AsiaPacificMember 2018-12-31 0000081362 us-gaap:NonUsMember 2020-12-31 0000081362 us-gaap:NonUsMember 2019-12-31 0000081362 us-gaap:NonUsMember 2018-12-31 0000081362 srt:MaximumMember 2020-12-31 0000081362 srt:AmericasMember kwr:EquityMethodInvesteeNameKelkoPanamaMember 2020-12-31 0000081362 srt:AmericasMember kwr:EquityMethodInvesteeNamePrimexMember 2020-12-31 0000081362 srt:AmericasMember kwr:EquityMethodInvesteeNameKelkoVenezuelaMember 2020-12-31 0000081362 us-gaap:PensionPlansDefinedBenefitMember country:US kwr:OtherMember 2019-12-31 0000081362 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember kwr:OtherMember 2019-12-31 0000081362 us-gaap:PensionPlansDefinedBenefitMember country:US kwr:OtherMember 2020-12-31 0000081362 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember kwr:OtherMember 2020-12-31 0000081362 us-gaap:FairValueInputsLevel3Member kwr:OtherAlternativeInvestmentsMember 2018-12-31 0000081362 us-gaap:FairValueInputsLevel3Member kwr:OtherAlternativeInvestmentsMember 2019-12-31 0000081362 us-gaap:FairValueInputsLevel3Member kwr:OtherAlternativeInvestmentsMember 2020-12-31 0000081362 us-gaap:FairValueInputsLevel3Member kwr:OtherAlternativeInvestmentsMember 2020-01-01 2020-12-31 0000081362 us-gaap:FairValueInputsLevel3Member kwr:OtherAlternativeInvestmentsMember 2019-01-01 2019-12-31 0000081362 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2017-12-31 0000081362 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2018-12-31 0000081362 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2019-12-31 0000081362 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2020-12-31 0000081362 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2018-01-01 2018-12-31 0000081362 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2019-01-01 2019-12-31 0000081362 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2020-01-01 2020-12-31 0000081362 kwr:KoreaHoughtonCoporationMember 2020-01-01 2020-12-31 0000081362 kwr:EquityMethodInvesteeNameNipponQuakerJapanMember 2020-01-01 2020-12-31 0000081362 kwr:EquityMethodInvesteeNameKelkoPanamaMember 2020-01-01 2020-12-31 0000081362 kwr:EquityMethodInvesteeNameKelkoVenezuelaMember 2020-01-01 2020-12-31 0000081362 kwr:EquityMethodInvesteeNamePrimexMember 2020-01-01 2020-12-31 0000081362 kwr:KoreaHoughtonCoporationMember 2019-01-01 2019-12-31 0000081362 kwr:EquityMethodInvesteeNameNipponQuakerJapanMember 2019-01-01 2019-12-31 0000081362 kwr:EquityMethodInvesteeNameKelkoPanamaMember 2019-01-01 2019-12-31 0000081362 kwr:EquityMethodInvesteeNameKelkoVenezuelaMember 2019-01-01 2019-12-31 0000081362 kwr:EquityMethodInvesteeNamePrimexMember 2019-01-01 2019-12-31 0000081362 kwr:KoreaHoughtonCoporationMember 2018-01-01 2018-12-31 0000081362 kwr:EquityMethodInvesteeNameNipponQuakerJapanMember 2018-01-01 2018-12-31 0000081362 kwr:EquityMethodInvesteeNameKelkoPanamaMember 2018-01-01 2018-12-31 0000081362 kwr:EquityMethodInvesteeNameKelkoVenezuelaMember 2018-01-01 2018-12-31 0000081362 kwr:EquityMethodInvesteeNamePrimexMember 2018-01-01 2018-12-31 0000081362 us-gaap:CommonStockMember srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2017-12-31 0000081362 us-gaap:AdditionalPaidInCapitalMember srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2017-12-31 0000081362 us-gaap:RetainedEarningsMember srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2017-12-31 0000081362 us-gaap:AccumulatedOtherComprehensiveIncomeMember srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2017-12-31 0000081362 us-gaap:NoncontrollingInterestMember srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2017-12-31 0000081362 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2017-12-31 0000081362 us-gaap:CommonStockMember srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember 2017-12-31 0000081362 us-gaap:AdditionalPaidInCapitalMember srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember 2017-12-31 0000081362 us-gaap:RetainedEarningsMember srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember 2017-12-31 0000081362 us-gaap:AccumulatedOtherComprehensiveIncomeMember srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember 2017-12-31 0000081362 us-gaap:NoncontrollingInterestMember srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember 2017-12-31 0000081362 srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember 2017-12-31 0000081362 kwr:NormanHayMember 2020-01-01 2020-12-31 0000081362 kwr:CoralChemicalCompanyMember 2020-01-01 2020-12-31 0000081362 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2020-01-01 2020-12-31 0000081362 us-gaap:AssetsTotalMember srt:SubsidiariesMember 2020-01-01 2020-12-31 0000081362 us-gaap:SalesRevenueNetMember srt:SubsidiariesMember 2020-01-01 2020-12-31 0000081362 kwr:HoughtonMember srt:ScenarioPreviouslyReportedMember 2019-08-01 0000081362 kwr:HoughtonMember srt:RestatementAdjustmentMember 2019-08-01 0000081362 kwr:HoughtonMember srt:ScenarioPreviouslyReportedMember 2019-08-01 2019-08-01 0000081362 kwr:HoughtonMember srt:RestatementAdjustmentMember 2019-08-01 2019-08-01 0000081362 kwr:NormanHayMember srt:ScenarioPreviouslyReportedMember 2019-10-01 0000081362 kwr:NormanHayMember srt:RestatementAdjustmentMember 2019-10-01 0000081362 kwr:NormanHayMember 2019-10-01 0000081362 kwr:NormanHayMember srt:ScenarioPreviouslyReportedMember 2019-10-01 2019-10-01 0000081362 kwr:NormanHayMember srt:RestatementAdjustmentMember 2019-10-01 2019-10-01 0000081362 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember us-gaap:AccountingStandardsUpdate201613Member 2020-01-01 0000081362 srt:AmericasMember kwr:MetalsMember us-gaap:OperatingSegmentsMember 2020-01-01 2020-12-31 0000081362 us-gaap:EMEAMember kwr:MetalsMember us-gaap:OperatingSegmentsMember 2020-01-01 2020-12-31 0000081362 srt:AsiaPacificMember kwr:MetalsMember us-gaap:OperatingSegmentsMember 2020-01-01 2020-12-31 0000081362 srt:AmericasMember kwr:MetalworkingMember us-gaap:OperatingSegmentsMember 2020-01-01 2020-12-31 0000081362 us-gaap:EMEAMember kwr:MetalworkingMember us-gaap:OperatingSegmentsMember 2020-01-01 2020-12-31 0000081362 srt:AsiaPacificMember kwr:MetalworkingMember us-gaap:OperatingSegmentsMember 2020-01-01 2020-12-31 0000081362 srt:AmericasMember us-gaap:ProductMember us-gaap:OperatingSegmentsMember 2020-01-01 2020-12-31 0000081362 us-gaap:EMEAMember us-gaap:ProductMember us-gaap:OperatingSegmentsMember 2020-01-01 2020-12-31 0000081362 srt:AsiaPacificMember us-gaap:ProductMember us-gaap:OperatingSegmentsMember 2020-01-01 2020-12-31 0000081362 us-gaap:ProductMember us-gaap:OperatingSegmentsMember 2020-01-01 2020-12-31 0000081362 kwr:MetalsMember us-gaap:OperatingSegmentsMember 2020-01-01 2020-12-31 0000081362 kwr:MetalworkingMember us-gaap:OperatingSegmentsMember 2020-01-01 2020-12-31 0000081362 srt:AmericasMember us-gaap:OperatingSegmentsMember kwr:GlobalSpecialtyBusinessesMember 2020-01-01 2020-12-31 0000081362 us-gaap:EMEAMember us-gaap:OperatingSegmentsMember kwr:GlobalSpecialtyBusinessesMember 2020-01-01 2020-12-31 0000081362 srt:AsiaPacificMember us-gaap:OperatingSegmentsMember kwr:GlobalSpecialtyBusinessesMember 2020-01-01 2020-12-31 0000081362 us-gaap:OperatingSegmentsMember kwr:GlobalSpecialtyBusinessesMember 2020-01-01 2020-12-31 0000081362 srt:AmericasMember us-gaap:OperatingSegmentsMember 2020-01-01 2020-12-31 0000081362 us-gaap:EMEAMember us-gaap:OperatingSegmentsMember 2020-01-01 2020-12-31 0000081362 srt:AsiaPacificMember us-gaap:OperatingSegmentsMember 2020-01-01 2020-12-31 0000081362 us-gaap:OperatingSegmentsMember 2020-01-01 2020-12-31 0000081362 srt:AmericasMember us-gaap:TransferredAtPointInTimeMember us-gaap:OperatingSegmentsMember 2020-01-01 2020-12-31 0000081362 us-gaap:EMEAMember us-gaap:TransferredAtPointInTimeMember us-gaap:OperatingSegmentsMember 2020-01-01 2020-12-31 0000081362 srt:AsiaPacificMember us-gaap:TransferredAtPointInTimeMember us-gaap:OperatingSegmentsMember 2020-01-01 2020-12-31 0000081362 srt:AmericasMember us-gaap:TransferredOverTimeMember us-gaap:OperatingSegmentsMember 2020-01-01 2020-12-31 0000081362 us-gaap:EMEAMember us-gaap:TransferredOverTimeMember us-gaap:OperatingSegmentsMember 2020-01-01 2020-12-31 0000081362 srt:AsiaPacificMember us-gaap:TransferredOverTimeMember us-gaap:OperatingSegmentsMember 2020-01-01 2020-12-31 0000081362 us-gaap:TransferredAtPointInTimeMember us-gaap:OperatingSegmentsMember 2020-01-01 2020-12-31 0000081362 us-gaap:TransferredOverTimeMember us-gaap:OperatingSegmentsMember 2020-01-01 2020-12-31 0000081362 srt:AmericasMember us-gaap:TransferredAtPointInTimeMember us-gaap:OperatingSegmentsMember 2019-01-01 2019-12-31 0000081362 us-gaap:EMEAMember us-gaap:TransferredAtPointInTimeMember us-gaap:OperatingSegmentsMember 2019-01-01 2019-12-31 0000081362 srt:AsiaPacificMember us-gaap:TransferredAtPointInTimeMember us-gaap:OperatingSegmentsMember 2019-01-01 2019-12-31 0000081362 srt:AmericasMember us-gaap:TransferredOverTimeMember us-gaap:OperatingSegmentsMember 2019-01-01 2019-12-31 0000081362 us-gaap:EMEAMember us-gaap:TransferredOverTimeMember us-gaap:OperatingSegmentsMember 2019-01-01 2019-12-31 0000081362 srt:AsiaPacificMember us-gaap:TransferredOverTimeMember us-gaap:OperatingSegmentsMember 2019-01-01 2019-12-31 0000081362 us-gaap:TransferredAtPointInTimeMember us-gaap:OperatingSegmentsMember 2019-01-01 2019-12-31 0000081362 us-gaap:TransferredOverTimeMember us-gaap:OperatingSegmentsMember 2019-01-01 2019-12-31 0000081362 srt:AmericasMember us-gaap:OperatingSegmentsMember 2019-01-01 2019-12-31 0000081362 us-gaap:EMEAMember us-gaap:OperatingSegmentsMember 2019-01-01 2019-12-31 0000081362 srt:AsiaPacificMember us-gaap:OperatingSegmentsMember 2019-01-01 2019-12-31 0000081362 us-gaap:OperatingSegmentsMember 2019-01-01 2019-12-31 0000081362 srt:AmericasMember kwr:MetalsMember us-gaap:OperatingSegmentsMember 2019-01-01 2019-12-31 0000081362 us-gaap:EMEAMember kwr:MetalsMember us-gaap:OperatingSegmentsMember 2019-01-01 2019-12-31 0000081362 srt:AsiaPacificMember kwr:MetalsMember us-gaap:OperatingSegmentsMember 2019-01-01 2019-12-31 0000081362 srt:AmericasMember kwr:MetalworkingMember us-gaap:OperatingSegmentsMember 2019-01-01 2019-12-31 0000081362 us-gaap:EMEAMember kwr:MetalworkingMember us-gaap:OperatingSegmentsMember 2019-01-01 2019-12-31 0000081362 srt:AsiaPacificMember kwr:MetalworkingMember us-gaap:OperatingSegmentsMember 2019-01-01 2019-12-31 0000081362 srt:AmericasMember us-gaap:ProductMember us-gaap:OperatingSegmentsMember 2019-01-01 2019-12-31 0000081362 us-gaap:EMEAMember us-gaap:ProductMember us-gaap:OperatingSegmentsMember 2019-01-01 2019-12-31 0000081362 srt:AsiaPacificMember us-gaap:ProductMember us-gaap:OperatingSegmentsMember 2019-01-01 2019-12-31 0000081362 kwr:MetalsMember us-gaap:OperatingSegmentsMember 2019-01-01 2019-12-31 0000081362 kwr:MetalworkingMember us-gaap:OperatingSegmentsMember 2019-01-01 2019-12-31 0000081362 us-gaap:ProductMember us-gaap:OperatingSegmentsMember 2019-01-01 2019-12-31 0000081362 srt:AmericasMember us-gaap:OperatingSegmentsMember kwr:GlobalSpecialtyBusinessesMember 2019-01-01 2019-12-31 0000081362 us-gaap:EMEAMember us-gaap:OperatingSegmentsMember kwr:GlobalSpecialtyBusinessesMember 2019-01-01 2019-12-31 0000081362 srt:AsiaPacificMember us-gaap:OperatingSegmentsMember kwr:GlobalSpecialtyBusinessesMember 2019-01-01 2019-12-31 0000081362 us-gaap:OperatingSegmentsMember kwr:GlobalSpecialtyBusinessesMember 2019-01-01 2019-12-31 0000081362 srt:AmericasMember kwr:MetalsMember us-gaap:OperatingSegmentsMember 2018-01-01 2018-12-31 0000081362 us-gaap:EMEAMember kwr:MetalsMember us-gaap:OperatingSegmentsMember 2018-01-01 2018-12-31 0000081362 srt:AsiaPacificMember kwr:MetalsMember us-gaap:OperatingSegmentsMember 2018-01-01 2018-12-31 0000081362 srt:AmericasMember kwr:MetalworkingMember us-gaap:OperatingSegmentsMember 2018-01-01 2018-12-31 0000081362 us-gaap:EMEAMember kwr:MetalworkingMember us-gaap:OperatingSegmentsMember 2018-01-01 2018-12-31 0000081362 srt:AsiaPacificMember kwr:MetalworkingMember us-gaap:OperatingSegmentsMember 2018-01-01 2018-12-31 0000081362 kwr:MetalsMember us-gaap:OperatingSegmentsMember 2018-01-01 2018-12-31 0000081362 kwr:MetalworkingMember us-gaap:OperatingSegmentsMember 2018-01-01 2018-12-31 0000081362 srt:AmericasMember us-gaap:ProductMember us-gaap:OperatingSegmentsMember 2018-01-01 2018-12-31 0000081362 us-gaap:EMEAMember us-gaap:ProductMember us-gaap:OperatingSegmentsMember 2018-01-01 2018-12-31 0000081362 srt:AsiaPacificMember us-gaap:ProductMember us-gaap:OperatingSegmentsMember 2018-01-01 2018-12-31 0000081362 us-gaap:ProductMember us-gaap:OperatingSegmentsMember 2018-01-01 2018-12-31 0000081362 srt:AmericasMember us-gaap:OperatingSegmentsMember kwr:GlobalSpecialtyBusinessesMember 2018-01-01 2018-12-31 0000081362 us-gaap:EMEAMember us-gaap:OperatingSegmentsMember kwr:GlobalSpecialtyBusinessesMember 2018-01-01 2018-12-31 0000081362 srt:AsiaPacificMember us-gaap:OperatingSegmentsMember kwr:GlobalSpecialtyBusinessesMember 2018-01-01 2018-12-31 0000081362 us-gaap:OperatingSegmentsMember kwr:GlobalSpecialtyBusinessesMember 2018-01-01 2018-12-31 0000081362 srt:AmericasMember us-gaap:OperatingSegmentsMember 2018-01-01 2018-12-31 0000081362 us-gaap:EMEAMember us-gaap:OperatingSegmentsMember 2018-01-01 2018-12-31 0000081362 srt:AsiaPacificMember us-gaap:OperatingSegmentsMember 2018-01-01 2018-12-31 0000081362 us-gaap:OperatingSegmentsMember 2018-01-01 2018-12-31 0000081362 srt:AmericasMember us-gaap:TransferredAtPointInTimeMember us-gaap:OperatingSegmentsMember 2018-01-01 2018-12-31 0000081362 us-gaap:EMEAMember us-gaap:TransferredAtPointInTimeMember us-gaap:OperatingSegmentsMember 2018-01-01 2018-12-31 0000081362 srt:AsiaPacificMember us-gaap:TransferredAtPointInTimeMember us-gaap:OperatingSegmentsMember 2018-01-01 2018-12-31 0000081362 srt:AmericasMember us-gaap:TransferredOverTimeMember us-gaap:OperatingSegmentsMember 2018-01-01 2018-12-31 0000081362 us-gaap:EMEAMember us-gaap:TransferredOverTimeMember us-gaap:OperatingSegmentsMember 2018-01-01 2018-12-31 0000081362 srt:AsiaPacificMember us-gaap:TransferredOverTimeMember us-gaap:OperatingSegmentsMember 2018-01-01 2018-12-31 0000081362 us-gaap:TransferredAtPointInTimeMember us-gaap:OperatingSegmentsMember 2018-01-01 2018-12-31 0000081362 us-gaap:TransferredOverTimeMember us-gaap:OperatingSegmentsMember 2018-01-01 2018-12-31 0000081362 kwr:QhProgramMember 2018-12-31 0000081362 kwr:QhProgramMember 2019-01-01 2019-12-31 0000081362 kwr:QhProgramMember 2019-12-31 0000081362 2017-01-01 2017-12-31 0000081362 srt:AmericasMember us-gaap:OperatingSegmentsMember 2018-12-31 0000081362 us-gaap:EMEAMember us-gaap:OperatingSegmentsMember 2018-12-31 0000081362 srt:AsiaPacificMember us-gaap:OperatingSegmentsMember 2018-12-31 0000081362 srt:AmericasMember us-gaap:OperatingSegmentsMember 2019-12-31 0000081362 us-gaap:EMEAMember us-gaap:OperatingSegmentsMember 2019-12-31 0000081362 srt:AsiaPacificMember us-gaap:OperatingSegmentsMember 2019-12-31 0000081362 srt:AmericasMember us-gaap:OperatingSegmentsMember 2020-12-31 0000081362 us-gaap:EMEAMember us-gaap:OperatingSegmentsMember 2020-12-31 0000081362 srt:AsiaPacificMember us-gaap:OperatingSegmentsMember 2020-12-31 0000081362 us-gaap:OperatingSegmentsMember kwr:GlobalSpecialtyBusinessesMember 2018-12-31 0000081362 us-gaap:OperatingSegmentsMember kwr:GlobalSpecialtyBusinessesMember 2019-12-31 0000081362 us-gaap:OperatingSegmentsMember kwr:GlobalSpecialtyBusinessesMember 2020-12-31 0000081362 us-gaap:CorporateBondSecuritiesMember 2018-12-31 0000081362 us-gaap:PensionPlansDefinedBenefitMember 2018-01-01 2018-12-31 0000081362 us-gaap:CashAndCashEquivalentsMember country:US us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel12And3Member 2020-12-31 0000081362 us-gaap:FairValueInputsLevel1Member us-gaap:CashAndCashEquivalentsMember country:US us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0000081362 us-gaap:FairValueInputsLevel2Member us-gaap:CashAndCashEquivalentsMember country:US us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0000081362 us-gaap:FairValueInputsLevel3Member us-gaap:CashAndCashEquivalentsMember country:US us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0000081362 country:US kwr:PooledSeparateAccountsMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel12And3Member 2020-12-31 0000081362 us-gaap:FairValueInputsLevel1Member country:US kwr:PooledSeparateAccountsMember us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0000081362 us-gaap:FairValueInputsLevel2Member country:US kwr:PooledSeparateAccountsMember us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0000081362 us-gaap:FairValueInputsLevel3Member country:US kwr:PooledSeparateAccountsMember us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0000081362 kwr:RealEstateFundMember country:US us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel12And3Member 2020-12-31 0000081362 us-gaap:FairValueInputsLevel1Member kwr:RealEstateFundMember country:US us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0000081362 us-gaap:FairValueInputsLevel2Member kwr:RealEstateFundMember country:US us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0000081362 us-gaap:FairValueInputsLevel3Member kwr:RealEstateFundMember country:US us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0000081362 country:US us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel12And3Member 2020-12-31 0000081362 us-gaap:FairValueInputsLevel1Member country:US us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0000081362 us-gaap:FairValueInputsLevel2Member country:US us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0000081362 us-gaap:FairValueInputsLevel3Member country:US us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0000081362 kwr:CommingledFundsMember country:US us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0000081362 country:US us-gaap:FairValueMeasurementsRecurringMember kwr:PooledSeparateAccountsMeasuredAtNavMember 2020-12-31 0000081362 country:US us-gaap:FairValueMeasurementsRecurringMember kwr:PensionAssetsAtNAVMember 2020-12-31 0000081362 us-gaap:CashAndCashEquivalentsMember country:US us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel12And3Member 2019-12-31 0000081362 us-gaap:FairValueInputsLevel1Member us-gaap:CashAndCashEquivalentsMember country:US us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000081362 us-gaap:FairValueInputsLevel2Member us-gaap:CashAndCashEquivalentsMember country:US us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000081362 us-gaap:FairValueInputsLevel3Member us-gaap:CashAndCashEquivalentsMember country:US us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000081362 country:US kwr:PooledSeparateAccountsMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel12And3Member 2019-12-31 0000081362 us-gaap:FairValueInputsLevel1Member country:US kwr:PooledSeparateAccountsMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000081362 us-gaap:FairValueInputsLevel2Member country:US kwr:PooledSeparateAccountsMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000081362 us-gaap:FairValueInputsLevel3Member country:US kwr:PooledSeparateAccountsMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000081362 kwr:RealEstateFundMember country:US us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel12And3Member 2019-12-31 0000081362 us-gaap:FairValueInputsLevel1Member kwr:RealEstateFundMember country:US us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000081362 us-gaap:FairValueInputsLevel2Member kwr:RealEstateFundMember country:US us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000081362 us-gaap:FairValueInputsLevel3Member kwr:RealEstateFundMember country:US us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000081362 kwr:CommingledFundsMember country:US us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000081362 country:US us-gaap:FairValueMeasurementsRecurringMember kwr:PooledSeparateAccountsMeasuredAtNavMember 2019-12-31 0000081362 country:US us-gaap:FairValueMeasurementsRecurringMember kwr:PensionAssetsAtNAVMember 2019-12-31 0000081362 country:US us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel12And3Member 2019-12-31 0000081362 us-gaap:FairValueInputsLevel1Member country:US us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000081362 us-gaap:FairValueInputsLevel2Member country:US us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000081362 us-gaap:FairValueInputsLevel3Member country:US us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000081362 us-gaap:ForeignPlanMember us-gaap:CashAndCashEquivalentsMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel12And3Member 2020-12-31 0000081362 us-gaap:FairValueInputsLevel1Member us-gaap:ForeignPlanMember us-gaap:CashAndCashEquivalentsMember us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0000081362 us-gaap:FairValueInputsLevel2Member us-gaap:ForeignPlanMember us-gaap:CashAndCashEquivalentsMember us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0000081362 us-gaap:FairValueInputsLevel3Member us-gaap:ForeignPlanMember us-gaap:CashAndCashEquivalentsMember us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0000081362 kwr:InsuranceContractMember us-gaap:ForeignPlanMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel12And3Member 2020-12-31 0000081362 us-gaap:FairValueInputsLevel1Member kwr:InsuranceContractMember us-gaap:ForeignPlanMember us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0000081362 us-gaap:FairValueInputsLevel2Member kwr:InsuranceContractMember us-gaap:ForeignPlanMember us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0000081362 us-gaap:FairValueInputsLevel3Member kwr:InsuranceContractMember us-gaap:ForeignPlanMember us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0000081362 us-gaap:ForeignPlanMember kwr:EquityFundsDiversifiedMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel12And3Member 2020-12-31 0000081362 us-gaap:FairValueInputsLevel1Member us-gaap:ForeignPlanMember kwr:EquityFundsDiversifiedMember us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0000081362 us-gaap:FairValueInputsLevel2Member us-gaap:ForeignPlanMember kwr:EquityFundsDiversifiedMember us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0000081362 us-gaap:FairValueInputsLevel3Member us-gaap:ForeignPlanMember kwr:EquityFundsDiversifiedMember us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0000081362 us-gaap:ForeignPlanMember us-gaap:FixedIncomeFundsMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel12And3Member 2020-12-31 0000081362 us-gaap:FairValueInputsLevel1Member us-gaap:ForeignPlanMember us-gaap:FixedIncomeFundsMember us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0000081362 us-gaap:FairValueInputsLevel2Member us-gaap:ForeignPlanMember us-gaap:FixedIncomeFundsMember us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0000081362 us-gaap:FairValueInputsLevel3Member us-gaap:ForeignPlanMember us-gaap:FixedIncomeFundsMember us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0000081362 us-gaap:ForeignPlanMember kwr:DomesticAndForeignGovernmentDebtSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel12And3Member 2020-12-31 0000081362 us-gaap:FairValueInputsLevel1Member us-gaap:ForeignPlanMember kwr:DomesticAndForeignGovernmentDebtSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0000081362 us-gaap:FairValueInputsLevel2Member us-gaap:ForeignPlanMember kwr:DomesticAndForeignGovernmentDebtSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0000081362 us-gaap:FairValueInputsLevel3Member us-gaap:ForeignPlanMember kwr:DomesticAndForeignGovernmentDebtSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0000081362 kwr:RealEstateFundMember us-gaap:ForeignPlanMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel12And3Member 2020-12-31 0000081362 us-gaap:FairValueInputsLevel1Member kwr:RealEstateFundMember us-gaap:ForeignPlanMember us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0000081362 us-gaap:FairValueInputsLevel2Member kwr:RealEstateFundMember us-gaap:ForeignPlanMember us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0000081362 us-gaap:FairValueInputsLevel3Member kwr:RealEstateFundMember us-gaap:ForeignPlanMember us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0000081362 us-gaap:ForeignPlanMember kwr:OtherAlternativeInvestmentsMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel12And3Member 2020-12-31 0000081362 us-gaap:FairValueInputsLevel1Member us-gaap:ForeignPlanMember kwr:OtherAlternativeInvestmentsMember us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0000081362 us-gaap:FairValueInputsLevel2Member us-gaap:ForeignPlanMember kwr:OtherAlternativeInvestmentsMember us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0000081362 us-gaap:FairValueInputsLevel3Member us-gaap:ForeignPlanMember kwr:OtherAlternativeInvestmentsMember us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0000081362 us-gaap:ForeignPlanMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel12And3Member 2020-12-31 0000081362 us-gaap:FairValueInputsLevel1Member us-gaap:ForeignPlanMember us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0000081362 us-gaap:FairValueInputsLevel2Member us-gaap:ForeignPlanMember us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0000081362 us-gaap:FairValueInputsLevel3Member us-gaap:ForeignPlanMember us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0000081362 us-gaap:ForeignPlanMember kwr:CommingledFundsMember us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0000081362 us-gaap:ForeignPlanMember us-gaap:FairValueMeasurementsRecurringMember kwr:DiversifiedInvestmentFundRegisteredInvestmentCompaniesMember 2020-12-31 0000081362 us-gaap:ForeignPlanMember us-gaap:FairValueMeasurementsRecurringMember kwr:PensionAssetsAtNAVMember 2020-12-31 0000081362 us-gaap:ForeignPlanMember us-gaap:CashAndCashEquivalentsMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel12And3Member 2019-12-31 0000081362 us-gaap:FairValueInputsLevel1Member us-gaap:ForeignPlanMember us-gaap:CashAndCashEquivalentsMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000081362 us-gaap:FairValueInputsLevel2Member us-gaap:ForeignPlanMember us-gaap:CashAndCashEquivalentsMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000081362 us-gaap:FairValueInputsLevel3Member us-gaap:ForeignPlanMember us-gaap:CashAndCashEquivalentsMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000081362 kwr:InsuranceContractMember us-gaap:ForeignPlanMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel12And3Member 2019-12-31 0000081362 us-gaap:FairValueInputsLevel1Member kwr:InsuranceContractMember us-gaap:ForeignPlanMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000081362 us-gaap:FairValueInputsLevel2Member kwr:InsuranceContractMember us-gaap:ForeignPlanMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000081362 us-gaap:FairValueInputsLevel3Member kwr:InsuranceContractMember us-gaap:ForeignPlanMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000081362 us-gaap:ForeignPlanMember kwr:EquityFundsDiversifiedMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel12And3Member 2019-12-31 0000081362 us-gaap:FairValueInputsLevel1Member us-gaap:ForeignPlanMember kwr:EquityFundsDiversifiedMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000081362 us-gaap:FairValueInputsLevel2Member us-gaap:ForeignPlanMember kwr:EquityFundsDiversifiedMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000081362 us-gaap:FairValueInputsLevel3Member us-gaap:ForeignPlanMember kwr:EquityFundsDiversifiedMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000081362 us-gaap:ForeignPlanMember us-gaap:FixedIncomeFundsMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel12And3Member 2019-12-31 0000081362 us-gaap:FairValueInputsLevel1Member us-gaap:ForeignPlanMember us-gaap:FixedIncomeFundsMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000081362 us-gaap:FairValueInputsLevel2Member us-gaap:ForeignPlanMember us-gaap:FixedIncomeFundsMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000081362 us-gaap:FairValueInputsLevel3Member us-gaap:ForeignPlanMember us-gaap:FixedIncomeFundsMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000081362 us-gaap:ForeignPlanMember kwr:DomesticAndForeignGovernmentDebtSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel12And3Member 2019-12-31 0000081362 us-gaap:FairValueInputsLevel1Member us-gaap:ForeignPlanMember kwr:DomesticAndForeignGovernmentDebtSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000081362 us-gaap:FairValueInputsLevel2Member us-gaap:ForeignPlanMember kwr:DomesticAndForeignGovernmentDebtSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000081362 us-gaap:FairValueInputsLevel3Member us-gaap:ForeignPlanMember kwr:DomesticAndForeignGovernmentDebtSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000081362 kwr:RealEstateFundMember us-gaap:ForeignPlanMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel12And3Member 2019-12-31 0000081362 us-gaap:FairValueInputsLevel1Member kwr:RealEstateFundMember us-gaap:ForeignPlanMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000081362 us-gaap:FairValueInputsLevel2Member kwr:RealEstateFundMember us-gaap:ForeignPlanMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000081362 us-gaap:FairValueInputsLevel3Member kwr:RealEstateFundMember us-gaap:ForeignPlanMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000081362 us-gaap:ForeignPlanMember kwr:OtherAlternativeInvestmentsMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel12And3Member 2019-12-31 0000081362 us-gaap:FairValueInputsLevel1Member us-gaap:ForeignPlanMember kwr:OtherAlternativeInvestmentsMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000081362 us-gaap:FairValueInputsLevel2Member us-gaap:ForeignPlanMember kwr:OtherAlternativeInvestmentsMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000081362 us-gaap:FairValueInputsLevel3Member us-gaap:ForeignPlanMember kwr:OtherAlternativeInvestmentsMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000081362 us-gaap:ForeignPlanMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel12And3Member 2019-12-31 0000081362 us-gaap:FairValueInputsLevel1Member us-gaap:ForeignPlanMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000081362 us-gaap:FairValueInputsLevel2Member us-gaap:ForeignPlanMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000081362 us-gaap:FairValueInputsLevel3Member us-gaap:ForeignPlanMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000081362 us-gaap:ForeignPlanMember kwr:CommingledFundsMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000081362 us-gaap:ForeignPlanMember us-gaap:FairValueMeasurementsRecurringMember kwr:DiversifiedInvestmentFundRegisteredInvestmentCompaniesMember 2019-12-31 0000081362 us-gaap:ForeignPlanMember us-gaap:FairValueMeasurementsRecurringMember kwr:PensionAssetsAtNAVMember 2019-12-31 0000081362 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel12And3Member 2020-12-31 0000081362 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0000081362 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0000081362 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0000081362 us-gaap:FairValueMeasurementsRecurringMember kwr:PensionAssetsAtNAVMember 2020-12-31 0000081362 us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0000081362 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel12And3Member 2019-12-31 0000081362 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000081362 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000081362 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000081362 us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000081362 us-gaap:FairValueMeasurementsRecurringMember kwr:PensionAssetsAtNAVMember 2019-12-31 0000081362 kwr:HoughtonMember 2020-01-01 2020-12-31 0000081362 kwr:CoralChemicalCompanyMember srt:ScenarioPreviouslyReportedMember 2020-12-22 0000081362 kwr:CoralChemicalCompanyMember srt:ScenarioPreviouslyReportedMember 2020-12-22 2020-12-22 0000081362 kwr:CoralChemicalCompanyMember 2020-12-22 2020-12-22 0000081362 kwr:CoralChemicalCompanyMember 2020-12-22 0000081362 us-gaap:CustomerRelationshipsMember kwr:CoralChemicalCompanyMember 2020-12-22 0000081362 kwr:ProductTechnologyMember kwr:CoralChemicalCompanyMember 2020-12-22 0000081362 kwr:CoralChemicalCompanyMember kwr:TrademarksandformulationsMember 2020-12-22 0000081362 srt:MinimumMember us-gaap:CustomerRelationshipsMember kwr:CoralChemicalCompanyMember 2020-12-22 2020-12-22 0000081362 srt:MaximumMember us-gaap:CustomerRelationshipsMember kwr:CoralChemicalCompanyMember 2020-12-22 2020-12-22 0000081362 srt:MinimumMember kwr:ProductTechnologyMember kwr:CoralChemicalCompanyMember 2020-12-22 2020-12-22 0000081362 srt:MaximumMember kwr:ProductTechnologyMember kwr:CoralChemicalCompanyMember 2020-12-22 2020-12-22 0000081362 kwr:CoralChemicalCompanyMember kwr:TrademarksandformulationsMember 2020-12-22 2020-12-22 0000081362 kwr:NormanHayMember 2020-01-01 2020-03-31 0000081362 kwr:TinplatingsolutionsMember 2020-01-01 2020-12-31 0000081362 kwr:TelnordicMember 2020-04-01 2020-06-30 0000081362 kwr:TelnordicMember 2020-06-30 0000081362 kwr:SouthAfricaEquityAffiliateMember 2020-03-31 0000081362 kwr:SouthAfricaEquityAffiliateMember 2020-01-01 2020-03-31 0000081362 kwr:MiningnorthamericatrademarksformulationsandproducttechnologyMember 2018-03-01 2018-03-31 0000081362 kwr:MiningnorthamericatrademarksformulationsandproducttechnologyMember 2019-01-01 2019-03-31 0000081362 kwr:GlobalSpecialtyBusinessesMember 2018-01-01 2018-12-31 0000081362 kwr:GlobalSpecialtyBusinessesMember 2019-01-01 2019-12-31 0000081362 kwr:GlobalSpecialtyBusinessesMember 2020-01-01 2020-12-31 0000081362 kwr:GlobalSpecialtyBusinessesMember 2018-12-31 0000081362 kwr:GlobalSpecialtyBusinessesMember 2019-12-31 0000081362 kwr:GlobalSpecialtyBusinessesMember 2020-12-31 0000081362 us-gaap:IntersegmentEliminationMember kwr:GlobalSpecialtyBusinessesMember 2018-01-01 2018-12-31 0000081362 us-gaap:IntersegmentEliminationMember kwr:GlobalSpecialtyBusinessesMember 2019-01-01 2019-12-31 0000081362 us-gaap:IntersegmentEliminationMember kwr:GlobalSpecialtyBusinessesMember 2020-01-01 2020-12-31 0000081362 kwr:DefinedContributionPlanMember 2020-01-01 2020-12-31 0000081362 kwr:PerformanceIncentiveStockUnitsMember 2020-01-01 2020-12-31 0000081362 kwr:PerformanceIncentiveStockUnitsMember 2020-12-31 0000081362 kwr:PerformanceIncentiveStockUnitsMember 2018-01-01 2018-12-31 0000081362 us-gaap:StockCompensationPlanMember 2018-01-01 2018-12-31 0000081362 kwr:PerformanceIncentiveStockUnitsMember 2019-01-01 2019-12-31 0000081362 us-gaap:StockCompensationPlanMember 2019-01-01 2019-12-31 0000081362 us-gaap:StockCompensationPlanMember 2020-01-01 2020-12-31 0000081362 kwr:CombinationAndOtherAcquisitionRelatedMember 2018-01-01 2018-12-31 0000081362 kwr:HoughtonMember 2018-01-01 2018-12-31 0000081362 us-gaap:ForeignPlanMember 2020-01-01 2020-12-31 0000081362 country:US 2020-01-01 2020-12-31 0000081362 us-gaap:ForeignPlanMember 2020-12-31 0000081362 country:US 2020-12-31 0000081362 country:US 2019-12-31 0000081362 us-gaap:ForeignPlanMember 2019-12-31 0000081362 country:US 2018-12-31 0000081362 us-gaap:ForeignPlanMember 2018-12-31 0000081362 us-gaap:ForeignPlanMember 2019-01-01 2019-12-31 0000081362 country:US 2019-01-01 2019-12-31 0000081362 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember us-gaap:ForeignPlanMember 2018-12-31 0000081362 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember us-gaap:ForeignPlanMember 2019-01-01 2019-12-31 0000081362 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember us-gaap:ForeignPlanMember 2019-12-31 0000081362 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember us-gaap:ForeignPlanMember 2020-01-01 2020-12-31 0000081362 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember us-gaap:ForeignPlanMember 2020-12-31 0000081362 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2018-12-31 0000081362 srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember 2018-12-31 0000081362 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2019-12-31 0000081362 srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember 2019-12-31 0000081362 us-gaap:CommonStockMember 2018-12-31 0000081362 us-gaap:CommonStockMember srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2018-12-31 0000081362 us-gaap:CommonStockMember srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember 2018-12-31 0000081362 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0000081362 us-gaap:AdditionalPaidInCapitalMember srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2018-12-31 0000081362 us-gaap:AdditionalPaidInCapitalMember srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember 2018-12-31 0000081362 us-gaap:RetainedEarningsMember 2018-12-31 0000081362 us-gaap:RetainedEarningsMember srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2018-12-31 0000081362 us-gaap:RetainedEarningsMember srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember 2018-12-31 0000081362 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-12-31 0000081362 us-gaap:AccumulatedOtherComprehensiveIncomeMember srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2018-12-31 0000081362 us-gaap:AccumulatedOtherComprehensiveIncomeMember srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember 2018-12-31 0000081362 us-gaap:NoncontrollingInterestMember 2018-12-31 0000081362 us-gaap:NoncontrollingInterestMember srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2018-12-31 0000081362 us-gaap:NoncontrollingInterestMember srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember 2018-12-31 0000081362 us-gaap:CommonStockMember 2019-12-31 0000081362 us-gaap:CommonStockMember srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2019-12-31 0000081362 us-gaap:CommonStockMember srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember 2019-12-31 0000081362 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0000081362 us-gaap:AdditionalPaidInCapitalMember srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2019-12-31 0000081362 us-gaap:AdditionalPaidInCapitalMember srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember 2019-12-31 0000081362 us-gaap:RetainedEarningsMember 2019-12-31 0000081362 us-gaap:RetainedEarningsMember srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2019-12-31 0000081362 us-gaap:RetainedEarningsMember srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember 2019-12-31 0000081362 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0000081362 us-gaap:AccumulatedOtherComprehensiveIncomeMember srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2019-12-31 0000081362 us-gaap:AccumulatedOtherComprehensiveIncomeMember srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember 2019-12-31 0000081362 us-gaap:NoncontrollingInterestMember 2019-12-31 0000081362 us-gaap:NoncontrollingInterestMember srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2019-12-31 0000081362 us-gaap:NoncontrollingInterestMember srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember 2019-12-31 0000081362 country:US 2018-01-01 2018-12-31 0000081362 us-gaap:ForeignPlanMember 2018-01-01 2018-12-31 0000081362 us-gaap:CorporateBondSecuritiesMember 2020-12-31 0000081362 us-gaap:CorporateBondSecuritiesMember 2020-01-01 2020-12-31 0000081362 us-gaap:CorporateBondSecuritiesMember 2018-01-01 2018-12-31 0000081362 us-gaap:RevolvingCreditFacilityMember 2020-12-31 0000081362 us-gaap:ForeignCountryMember country:IT 2020-01-01 2020-12-31 0000081362 us-gaap:ForeignCountryMember country:BR 2020-01-01 2020-12-31 0000081362 us-gaap:ForeignCountryMember country:MX 2020-01-01 2020-12-31 0000081362 us-gaap:ForeignCountryMember country:NL 2020-01-01 2020-12-31 0000081362 us-gaap:ForeignCountryMember country:CN 2020-01-01 2020-12-31 0000081362 us-gaap:ForeignCountryMember country:ES 2020-01-01 2020-12-31 0000081362 us-gaap:ForeignCountryMember country:DE 2020-01-01 2020-12-31 0000081362 us-gaap:ForeignCountryMember country:GB 2020-01-01 2020-12-31 0000081362 us-gaap:ForeignCountryMember country:CA 2020-01-01 2020-12-31 0000081362 us-gaap:ForeignCountryMember country:IN 2020-01-01 2020-12-31 0000081362 us-gaap:InternalRevenueServiceIRSMember 2020-01-01 2020-12-31 0000081362 us-gaap:StateAndLocalJurisdictionMember 2020-01-01 2020-12-31 0000081362 us-gaap:ForeignCountryMember country:IT 2020-12-31 0000081362 us-gaap:ForeignCountryMember kwr:HoughtonMember country:IT 2020-12-31 0000081362 us-gaap:ForeignCountryMember kwr:HoughtonMember country:DE 2020-12-31 0000081362 kwr:EquityMethodInvesteeNameKelkoVenezuelaMember 2019-12-31 0000081362 us-gaap:RevolvingCreditFacilityMember us-gaap:LetterOfCreditMember 2020-12-31 0000081362 us-gaap:LineOfCreditMember us-gaap:LetterOfCreditMember 2020-12-31 0000081362 kwr:CombinationMember 2019-01-01 2019-12-31 0000081362 srt:MaximumMember kwr:AcpMember 2020-12-31 0000081362 srt:MinimumMember kwr:AcpMember 2020-12-31 0000081362 srt:MaximumMember kwr:AsbestosClaimsMember 2020-12-31 0000081362 kwr:AsbestosClaimsMember 2005-01-01 2005-12-31 0000081362 kwr:AsbestosClaimsMember 2007-01-01 2007-12-31 0000081362 2007-01-01 2007-12-31 0000081362 srt:MaximumMember kwr:HoughtonEnvironmentalMattersMember 2020-12-31 0000081362 srt:MinimumMember kwr:HoughtonEnvironmentalMattersMember 2020-12-31 0000081362 kwr:HoughtonEnvironmentalMattersMember 2020-12-31 0000081362 kwr:HoughtonEnvironmentalMattersMember 2019-12-31 0000081362 srt:MinimumMember 2020-12-31 0000081362 kwr:ForeignconsumptiontaxMember 2020-12-31 0000081362 kwr:ForeignconsumptiontaxMember 2020-01-01 2020-12-31 0000081362 srt:MaximumMember kwr:ForeignconsumptiontaxMember 2020-12-31 0000081362 srt:MinimumMember kwr:ForeignconsumptiontaxMember 2020-12-31 0000081362 kwr:KelkoQuakerChemicalSaMember 2020-12-31 0000081362 kwr:KelkoQuakerChemicalSaMember 2019-12-31 0000081362 us-gaap:LineOfCreditMember 2019-08-01 2019-08-01 0000081362 us-gaap:SalesRevenueNetMember kwr:CustomerConcentrationRiskTopFiveMember 2020-01-01 2020-12-31 0000081362 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2020-01-01 2020-12-31 0000081362 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember country:US 2018-12-31 0000081362 us-gaap:PensionPlansDefinedBenefitMember 2018-12-31 0000081362 us-gaap:PensionPlansDefinedBenefitMember country:US 2018-12-31 0000081362 us-gaap:PensionPlansDefinedBenefitMember us-gaap:ForeignPlanMember 2018-12-31 0000081362 us-gaap:DefinedBenefitPlanEquitySecuritiesMember kwr:CommingledFundsMember 2020-12-31 0000081362 us-gaap:FixedIncomeSecuritiesMember kwr:CommingledFundsMember 2020-12-31 0000081362 us-gaap:OtherDebtSecuritiesMember kwr:CommingledFundsMember 2020-12-31 0000081362 us-gaap:OtherDebtSecuritiesMember kwr:DiversifiedInvestmentFundRegisteredInvestmentCompaniesMember 2020-12-31 0000081362 us-gaap:FixedIncomeSecuritiesMember kwr:DiversifiedInvestmentFundRegisteredInvestmentCompaniesMember 2020-12-31 0000081362 us-gaap:DefinedBenefitPlanEquitySecuritiesMember kwr:DiversifiedInvestmentFundRegisteredInvestmentCompaniesMember 2020-12-31 0000081362 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2018-01-01 2018-12-31 0000081362 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2019-01-01 2019-12-31 iso4217:DKK iso4217:GBP iso4217:USD iso4217:ZAR xbrli:pure xbrli:shares iso4217:USD xbrli:shares dummy:People
 
 
 
 
 
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
 
FORM
10-K
 
ANNUAL REPORT PURSUANT TO
 
SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
 
ACT OF 1934
 
For the fiscal year ended
December 31, 2020
or
 
TRANSITION REPORT PURSUANT TO
 
SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
 
ACT OF 1934
For the transition period from
 
to
 
Commission file number
001-12019
 
 
QUAKER CHEMICAL CORPORATION
(Exact name of Registrant as specified in its charter)
 
 
 
 
A
Pennsylvania
 
Corporation
 
No.
23-0993790
(State or other jurisdiction of incorporation or organization)
 
(I.R.S. Employer Identification No.)
 
 
 
 
901 E. Hector Street
,
Conshohocken
,
Pennsylvania
 
19428-2380
(Address of principal executive offices)
 
(Zip Code)
 
Registrant’s telephone number, including area code: (
610
)
832-4000
 
Securities registered pursuant to Section 12(b) of the Act:
 
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, $1 par value
KWR
New York Stock Exchange
 
Securities registered pursuant to Section 12(g) of the Act:
None
 
 
 
Indicate by check mark if the Registrant is a well-known seasoned issuer, as defined in Rule
 
405 of the Securities Act.
 
Yes
 
 
No
 
 
Indicate by check mark if the Registrant is not required to file reports
 
pursuant to Section 13 or Section 15(d) of the Act.
 
Yes
 
 
No
 
 
Indicate by check mark whether the Registrant (1) has filed all reports
 
required to be filed by Section 13 or 15(d) of the Securities Exchange
 
Act of 1934 during the
preceding 12 months (or for such shorter period that the registrant was required
 
to file such reports), and (2) has been subject to such filing requirements
 
for the past 90
days.
 
Yes
 
 
No
 
 
Indicate by check mark whether the Registrant has submitted electronically
 
every Interactive Data File required to be submitted pursuant to Rule 405
 
of Regulation S-
T (
§
 
232.405 of this chapter) during the preceding 12 months (or for
 
such shorter period that the Registrant was required to submit such
 
files).
 
Yes
 
 
No
 
 
Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging
growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2
 
of the
Exchange Act.
 
 
 
Large accelerated filer
 
 
Accelerated filer
 
 
 
Non-accelerated filer
 
Smaller reporting company
 
Emerging growth company
 
If an emerging growth company, indicate by check mark if the Registrant has elected not to use the extended transition period
 
for complying with any new or revised
financial accounting standards provided pursuant to Section 13 (a) of the
 
Exchange Act.
 
 
Indicate by check mark whether the registrant has filed a report on and
 
attestation to its management’s assessment of the effectiveness of its internal control over
financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15
 
U.S.C. 7262(b)) by the registered public accounting firm that prepared or
 
issued its audit
report.
 
Yes
 
 
No
 
 
Indicate by check mark whether the Registrant is a shell company (as defined
 
in Rule 12b-2 of the Act).
 
Yes
 
 
No
 
 
State the aggregate market value of the voting and non-voting common equity
 
held by non-affiliates computed by reference to the price at which the common
 
equity
was last sold as of the last business day of the Registrant’s most recently completed second fiscal quarter. (The aggregate market value is
 
computed by reference to the last
reported sale on the New York Stock Exchange on June 30, 2020): $
3,273,904,147
Indicate the number of shares outstanding of each of the Registrant’s classes of common stock, as of the
 
latest practicable date:
17,853,700
 
shares of Common Stock,
$1.00 Par Value, as of January 31, 2021.
DOCUMENTS INCORPORATED BY REFERENCE
Portions of the Registrant’s definitive Proxy Statement relating to the 2021 Annual Meeting of Shareholders
 
are incorporated by reference into Part III.
 
 
 
 
1
QUAKER CHEMICAL CORPORATION
 
Table of
 
Contents
 
Page
 
Part I
Item 1.
Business.
2
Item 1A.
Risk Factors.
7
Item 1B.
Unresolved Staff Comments.
19
Item 2.
Properties.
19
Item 3.
Legal Proceedings.
19
Item 4.
Mine Safety Disclosures.
19
Item 4(a).
Information about our Executive Officers.
20
Part II
Item 5.
 
Market for Registrant's Common Equity,
 
Related Stockholder Matters and Issuer Purchases of Equity Securities.
22
Item 6.
Selected Financial Data.
23
Item 7.
 
Management’s Discussion and
 
Analysis of Financial Condition and Results of Operations.
24
Item 7A.
 
Quantitative and Qualitative Disclosures About Market Risk.
41
Item 8.
Financial Statements and Supplementary Data.
43
Item 9.
Changes in and Disagreements With Accountants
 
on Accounting and Financial Disclosure.
100
Item 9A.
 
Controls and Procedures.
100
Item 9B.
Other Information.
102
Part III
Item 10.
Directors, Executive Officers and Corporate
 
Governance.
103
Item 11.
Executive Compensation.
103
Item 12.
Security Ownership of Certain Beneficial Owners and Management
 
and Related Stockholder Matters.
103
Item 13.
Certain Relationships and Related Transactions,
 
and Director Independence.
103
Item 14.
Principal Accountant Fees and Services.
103
Part IV
Item 15.
Exhibits and Financial Statement Schedules.
104
Item 16.
Form 10-K Summary.
107
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2
PART
 
I
As used in this Annual Report on Form 10-K (the “Report”),
 
the terms “Quaker Houghton”, the “Company”, “we”,
 
and “our”
refer to Quaker Chemical Corporation (doing business as Quaker
 
Houghton), its subsidiaries, and associated companies, unless the
context otherwise requires.
 
The term Legacy Quaker refers to the Company prior to
 
the closing of its combination with Houghton
International, Inc. (“Houghton”) (herein referred
 
to as the “Combination”) on August 1, 2019.
 
Throughout the Report, all figures
presented, unless otherwise stated, reflect the results of
 
operations of the combined company for the year ended
 
December 31, 2020;
and for the year ended December 31, 2019, the results of
 
Legacy Quaker plus five months of Houghton’s
 
operations post-closing of
the Combination on August 1, 2019; and for the year
 
ended December 31, 2018, the results of only Legacy Quaker.
Item 1.
 
Business.
 
General Description
The Company was organized in 1918, incorporated
 
as a Pennsylvania business corporation in 1930,
 
and in August 2019
completed
 
the Combination with Houghton to form Quaker Houghton.
 
Quaker Houghton is a global leader in industrial process
fluids.
 
With a presence around the world,
 
including operations in over 25 countries, the Company’s
 
customers include thousands of
the world’s most advanced
 
and specialized steel, aluminum, automotive, aerospace,
 
offshore, can, mining, and metalworking
companies. Quaker Houghton develops, produces, and
 
markets a broad range of formulated chemical specialty
 
products and offers
chemical management services (which we refer to as “Fluidcare
TM
”) for various heavy industrial and manufacturing applications
throughout its four segments: Americas; Europe, Middle
 
East and Africa (“EMEA”); Asia/Pacific; and Global Specialty
 
Businesses.
The major product lines of Quaker Houghton include
 
metal removal fluids, cleaning fluids, corrosion inhibitors, metal
 
drawing
and forming fluids, die cast mold releases, heat treatment
 
and quenchants, metal forging fluids, hydraulic fluids,
 
specialty greases,
offshore sub-sea energy control fluids,
 
rolling lubricants, rod and wire drawing fluids and surface treatme
 
nt chemicals.
 
The following
are the respective contributions to consolidated net sales of
 
each of our principal product lines representing more than 10% of
consolidated net sales for
 
any of the past three years based on the Company’s
 
current product line segmentation:
2020
2019
2018
Metal removal fluids
23.9
%
19.9
%
15.4
%
Rolling lubricants
21.8
%
21.9
%
25.5
%
Hydraulic fluids
13.3
%
13.0
%
13.0
%
Houghton Combination
On August 1, 2019, the Company completed the Combination
 
and acquired all of the issued and outstanding shares of
 
Houghton
from Gulf Houghton Lubricants, Ltd. (“Gulf”) and certain other
 
selling shareholders in exchange for a combination of cash and
 
shares
of the Company’s common
 
stock in accordance with the share purchase agreement dated
 
April 4, 2017 (the “Share Purchase
Agreement”).
 
The shares were bought for an aggregate purchase consideration
 
consisting of: (i) $170.8 million in cash; (ii) the
issuance of approximately 4.3 million shares of the
 
Company’s common stock, $1.00
 
par value per share, comprising 24.5% of the
common stock outstanding upon the closing of the Combination;
 
and (iii) the Company’s refinancing
 
of Houghton’s net indebtedness
as of the closing of the Combination of approximately
 
$702.6 million.
 
Houghton is a leading global provider of specialty chemicals and
 
technical services for metalworking and other industrial
applications, and, the combination with Legacy Quaker
 
created a leading global supplier of industrial process fluids.
 
The
Combination expanded the Company’s
 
addressable metalworking, metals and industrial end markets, including
 
steel, aluminum,
aerospace, defense, transportation-original equipment
 
manufacturer (“OEM”), transportation-components, offshore
 
sub-sea energy,
architectural aluminum, construction, tube and pipe,
 
can and container, mining, specialty coatings
 
and specialty greases.
 
The
Combination also strengthened the product portfolio of the
 
combined Company.
 
Notable Recent Acquisition Activity
In December 2020, the Company completed its acquisition
 
of Coral Chemical Company (“Coral”), a privately held,
 
U.S.-based
provider of metal finishing fluid solutions, for approximately
 
$53 million, net of cash acquired.
 
Coral provides technical expertise and
product solutions for pre-treatment, metalworking and wastewater
 
treatment applications to the beverage can and general industrial
end markets.
 
In February 2021, the Company acquired certain assets related to
 
tin-plating solutions primarily for steel end markets for
approximately $25 million.
Impact of COVID-19
During 2020, the global outbreak of COVID-19 and
 
subsequent pandemic negatively impacted all locations where
 
the Company
does business.
 
Although the Company has now operated during several
 
quarters in this COVID-19 environment, the full extent of
 
the
pandemic and related business impacts remains
 
uncertain and volatile, and therefore the full extent to which
 
COVID-19 may impact
the Company’s future
 
results of operations or financial condition is uncertain.
 
The pandemic has disrupted the operations of the
Company and its suppliers and customers and, as a result,
 
the Company experienced volume declines and lower net sales during
 
2020
as further described in Item 7 of this Report.
 
The initial impact was at its China subsidiaries in the first quarter
 
of 2020 and beginning
 
3
in late March continued throughout 2020 in the rest of
 
the business as the pandemic led to a global economic slowdown.
 
Management
continues to monitor the impact of the COVID-19
 
pandemic on the Company,
 
the overall specialty chemical industry and the
economies and markets in which the Company operates.
 
 
Sales Revenue
A substantial portion of the Company’s
 
sales worldwide are made directly through its own employees
 
and its Fluidcare programs,
with the balance sold through distributors and agents.
 
The Company’s employees typically
 
visit the plants of customers regularly,
work on site, and through training and experience,
 
identify production needs which can be resolved or otherwise addressed
 
either by
utilizing the Company’s
 
existing products or by applying new formulations developed
 
in its laboratories.
 
The Company recognizes revenue in an amount that
 
reflects the consideration that the Company expects to receive
 
in exchange
for the goods or services transferred to its customers.
 
To do this, the Company
 
applies a five-step model that requires the Company
to: (i) identify the contract with a customer; (ii) identify
 
the performance obligations in the contract; (iii) determine the
 
transaction
price; (iv) allocate the transaction price to the performance
 
obligations in the contract; and (v) recognize revenue when
 
,
 
or as, the
Company satisfies a performance obligation.
As part of the Company’s
 
Fluidcare business, certain third-party product sales to customers are
 
managed by the Company.
 
Where
the Company acts as principal, revenues are recognized
 
on a gross reporting basis at the selling price negotiated
 
with its customers.
 
Where the Company acts as an agent, revenue is recognized on
 
a net reporting basis at the amount of the administrative fee earned
 
by
the Company for ordering the goods.
 
The Company transferred third-party products under arrangements resulting
 
in net reporting of
$42.5 million,
 
$48.0 million and $47.1 million for the years ended December
 
31, 2020,
 
2019 and 2018,
 
respectively.
Competition
The specialty chemical industry comprises a number
 
of companies similar in size to the Company,
 
as well as companies larger
and smaller than Quaker Houghton.
 
The Company cannot readily determine its precise position in
 
every industry it serves.
 
However,
the Company estimates it holds a leading global position
 
in the market for industrial process fluids including significant
 
global
positions in the markets for process fluids in portions of
 
the automotive and industrial markets, and a leading position in
 
the market for
process fluids to produce sheet steel and aluminum.
 
The offerings of many of the Company’s
 
competitors differ from those of Quaker
Houghton; some offer a broad portfolio of
 
fluids, including general lubricants, while others have more
 
specialized product ranges.
 
All
competitors provide different levels of technical
 
services to individual customers.
 
Competition in the industry is based primarily on
the ability to supply products that meet the needs of the
 
customer and provide technical services and laboratory assistance
 
to the
customer, and to a lesser extent, on
 
price.
Major Customers and Markets
In 2020,
 
Quaker Houghton’s five largest
 
customers (each composed of multiple subsidiaries or divisions
 
with semi-autonomous
purchasing authority) accounted for approximately
 
10% of consolidated net sales, with its largest customer
 
accounting for
approximately 3% of consolidated net sales.
 
A significant portion of the Company’s
 
revenues are realized from the sale of process
fluids and services to manufacturers of steel, aluminum,
 
automobiles, aircraft, industrial equipment, and durable goods and,
 
therefore,
Quaker
 
Houghton is subject to the same business cycles as those experienced
 
by these manufacturers and their customers.
 
The
Company’s financial performance
 
is generally correlated to the volume of global production
 
within the industries it serves, rather than
directly related to the financial performance of its customers.
 
Furthermore, steel and aluminum customers typically have limited
manufacturing locations compared to metalworking
 
customers and generally use higher volumes of products at a single
 
location.
Raw Materials
 
Quaker Houghton uses approximately 3,000 raw materials,
 
including animal fats, vegetable oils, mineral oils, oleochemicals,
ethylene, solvents, surfactant agents, various chemical compounds
 
that act as additives to our base formulations, and a wide variety
 
of
other organic and inorganic compounds
 
and various derivatives of the foregoing.
 
The price of mineral oil and its derivatives can be
affected by the price of crude oil and industry
 
refining capacity.
 
Animal fat and vegetable oil prices, as well as the prices of
 
other raw
materials, are impacted by their own unique supply
 
and demand factors, and by biodiesel consumption which
 
is affected by the price
of crude oil.
 
Accordingly, significant fluctuations
 
in the price of crude oil can have a material impact on
 
the cost of these raw
materials.
 
In addition, many of the raw materials used by Quaker
 
Houghton are commodity chemicals which can experience
significant price volatility.
 
Accordingly, the
 
Company’s earnings could be
 
affected by market changes in raw material prices.
 
Reference is made to the disclosure contained in Item 7A
 
of this Report.
Patents and Trademarks
Quaker Houghton has a limited number of patents and patent
 
applications including patents issued, applied for,
 
or acquired in the
U.S. and in various foreign countries, some of which may
 
prove to be material to its business, with the earliest patent expiry
 
in 2021.
 
The Company principally relies on its proprietary formulae
 
and its applications know-how and experience to meet
 
customer needs.
 
Quaker Houghton products are identified by numerous trademarks
 
that are registered throughout its marketing area.
 
4
Research and Development—Laboratories
The Company maintains approximately thirty separate laboratory
 
facilities worldwide that are primarily devoted to applied
research and development.
 
In addition, the Company maintains quality control labs at
 
each of its manufacturing facilities.
 
Quaker
Houghton research and development is directed primarily
 
toward applied technology since the nature of the Company’s
 
business
requires continual modification and improvement of formulations
 
to provide specialty chemicals to satisfy customer requirements.
 
If
problems are encountered which cannot be resolved
 
by local laboratories, the problem is referred to one of our ten principal
laboratories, located in Conshohocken, Pennsylvania; Valley
 
Forge, Pennsylvania; Aurora, Illinois; Santa Fe Springs,
 
California;
Uithoorn, the Netherlands; Coventry,
 
United Kingdom; Dortmund, Germany; Barcelona, Spain; Turin,
 
Italy or Qingpu, China.
Research and development costs are expensed as incurred.
 
Research and development expenses during the years ended
December 31, 2020,
 
2019 and 2018 were $40.0 million,
 
$32.1 million and $24.5 million, respectively.
Regulatory Matters
In order to facilitate compliance with applicable federal,
 
state, and local statutes and regulations relating to occupational
 
health
and safety and protection of the environment, the Company
 
has an ongoing program of site assessment for the
 
purpose of identifying
capital expenditures or other actions that may be
 
necessary to comply with such requirements.
 
The program includes periodic
inspections of each facility by the Company and/or independent
 
experts, as well as ongoing inspections and training by on-site
personnel.
 
Such inspections address operational matters, record keeping, reporting
 
requirements and capital improvements.
 
Capital
expenditures directed solely or primarily to regulatory
 
compliance amounted to approximately $3.7
 
million, $4.4 million and $1.5
million during the years ended December 31, 2020,
 
2019 and 2018,
 
respectively.
Company Segmentation
The Company’s operating
 
segments, which are consistent with its reportable segments,
 
reflect the structure of the Company’s
internal organization, the method by which
 
the Company’s resources are allocated
 
and the manner by which the Company and the
chief operating decision maker assess performance.
 
The Company’s reportable segments
 
are: (i) Americas; (ii) EMEA; (iii)
Asia/Pacific; and (iv) Global Specialty Businesses.
 
See Note 4 of Notes to Consolidated Financial Statements in Item
 
8 of this Report,
incorporated herein by this reference.
Non-U.S. Activities
Since significant revenues and earnings are generated by
 
non-U.S. operations, the Company’s
 
financial results are affected by
currency fluctuations, particularly between the U.S.
 
dollar and the euro, the British pound sterling, the Brazilian
 
real, the Mexican
peso, the Chinese renminbi and the Indian rupee,
 
and the impact of those currency fluctuations on the underlying economies.
 
Incorporated by reference is (i) the foreign exchange
 
risk information contained in Item 7A of this Report, (ii)
 
the geographic
information in Note 4 of Notes to Consolidated Financial
 
Statements included in Item 8 of this Report, and (iii) information
 
regarding
risks attendant to foreign operations included in Item
 
1A of this Report.
Number of Employees
On December 31, 2020, Quaker Houghton had approximately
 
4,200 full-time employees globally of whom approximately 900
were employed by the parent company and its U.S. subsidiaries,
 
and approximately 3,300 were employed by its non
 
-U.S. subsidiaries.
 
Associated companies of Quaker Houghton (in which
 
it owns 50% or less and has significant influence) employed
 
approximately 600
people on December 31, 2020.
Core Values
Quaker Houghton considers its employees as its greatest strength
 
in differentiating our business and strengthening our
 
market
positions.
 
We have established
 
core values that are inclusive of embracing diversity and
 
creating a culture where we learn from and
are inspired by the many cultures, backgrounds and knowledge
 
of our team members.
 
The Company’s goal is to have
 
an organization
that is inclusive of all its people and is representative
 
of the communities in which we operate.
The Company’s core
 
values are (i) live safe; (ii) act with integrity; (iii) drive results;
 
(iv) exceed customer expectations; (v)
embrace diversity; and (vi) do great things together.
 
Our core values embody who we are as a company,
 
guide our decisions and
inspire us.
 
Our commitment to these values, in words and actions, builds
 
a safer, stronger Quaker Houghton
 
,
 
and these values guide
the Company’s internal
 
conduct and its relationship with the outside world.
 
By fostering a culture and environment that exemplifies
our core values, we gain, as a company,
 
unique perspectives, backgrounds and varying experiences
 
to ensure continued long-term
success.
 
The Company respects and values all of its employees and
 
believes inclusion, diversity and equality are essential pillars to
drive the Company’s
 
success.
 
Workplace
 
Safety
We are committed
 
to maintaining a strong safety culture and to emphasizing
 
the importance of our employees’ role in identifying,
mitigating and communicating safety risks.
 
We maintain policies
 
and operational practices that communicate a culture
 
where all
levels of employees are responsible for safety.
 
We believe that
 
the achievement of superior safety performance is both
 
an important
short-term and long-term strategic goal in managing our
 
operations.
 
We emphasize
 
ten “lifesaving” rules which make a significant
 
5
difference in preventing serious injuries and
 
fatalities.
 
We also require
 
all employees to regularly complete safety training.
 
Additionally, our
 
senior management team is closely involved in our safety programs
 
and conducts regular reviews of safety
performance metrics and reviews the Company’s
 
safety performance during Company-wide meetings.
Talent
 
Management and Retention
Maintaining a robust pipeline of talent is crucial to
 
our
 
continued success and is a key aspect of succession planning efforts
 
across
the organization.
 
Our leadership and human resources teams are responsible for
 
attracting and retaining top talent by facilitating an
environment where employees want to show up to work
 
and do great things together.
 
To achieve sustained high
 
performance,
management invests in the development, safety,
 
and wellbeing of our employees.
 
Additionally, we regularly
 
evaluate our
compensation and benefits package,
 
including health and wellness benefits, paid-time off policies,
 
monetary compensation, and
educational reimbursements,
 
to ensure that our total compensation and benefits packages are aligned
 
with our business strategy,
organizational culture, and diversity and inclusion
 
philosophy while ensuring that we remain competitive in
 
the markets we serve
while following local and statutory wage and benefits
 
laws and guidelines.
 
Sustainability Report
The Company publishes annual sustainability reports which
 
are available free of charge on its corporate
 
website under “Investors
- Commitment to Sustainability - Sustainability Report.”
 
The Company’s 2019 Sustainability Report
 
reflects the most recent available
data on a variety of topics, including
 
specific information relating to: (i) the Company’s
 
environmental footprint and climate change
initiatives;
 
(ii) the Company’s diversity
 
initiatives;
 
(iii) certain safety metrics; and (iv) training courses our
 
employees completed.
Information included in these sustainability reports is not intended
 
to be incorporated into this Report.
Quaker Houghton on the Internet
Financial results, news and other information about
 
Quaker Houghton can be accessed from the Company’s
 
website at
https://www.quakerhoughton.com
 
.
 
This site includes important information on the Company’s
 
locations, products and services,
financial reports, news releases and career opportunities.
 
The Company’s periodi
 
c
 
and current reports on Forms 10-K, 10-Q, 8-K, and
other filings, including exhibits and supplemental
 
schedules filed therewith, and amendments to those reports, filed with
 
the Securities
and Exchange Commission (“SEC”) are available on
 
the Company’s website, free of
 
charge, as soon as reasonably practicable after
they are electronically filed with or furnished to the SEC.
 
Information contained on, or that may be accessed through,
 
the Company’s
website is not incorporated by reference in this Report and,
 
accordingly, you
 
should not consider that information part of this Report.
Factors that May Affect Our Future
 
Results
(Cautionary Statements under the Private Securities Litigation
 
Reform Act of 1995)
Certain information included in this Report and other
 
materials filed or to be filed by Quaker Chemical Corporation
 
with the SEC
(as well as information included in oral statements or other
 
written statements made or to be made by us) contain
 
or may contain
forward-looking statements within the meaning of Section
 
27A of the Securities Act of 1933, as amended, and Section
 
21E of the
Securities Exchange Act of 1934, as amended.
 
These statements can be identified by the fact that they do
 
not relate strictly to
historical or current facts.
 
We have based
 
these forward-looking statements, including statements regarding
 
the potential effects of the
COVID-19 pandemic on the Company’s
 
business, results of operation, and financial condition, and our expectations
 
that we will
maintain sufficient liquidity and remediate any
 
of our material weaknesses in internal control over financial
 
reporting on our current
expectations about future events.
These forward-looking statements include statements with respect
 
to our beliefs, plans, objectives, goals, expectations,
anticipations, intentions, financial condition, results of operations,
 
future performance, and business, including:
 
 
the potential benefits of the Combination and other acquisitions;
 
 
the impacts on our business as a result of the COVID-19
 
pandemic and any projected global economic rebound
 
or
anticipated positive results due to Company actions taken
 
in response to the pandemic;
 
 
our current and future results and plans; and
 
 
statements that include the words “may,”
 
“could,” “should,” “would,” “believe,” “expect,” “anticipate,” “estimate,”
“intend,” “plan” or similar expressions.
Such statements include information relating to current and
 
future business activities, operational matters, capital spending,
 
and
financing sources.
 
From time to time, forward-looking statements are also included in
 
the Company’s other periodic
 
reports on Forms
10-K, 10-Q and 8-K, press releases, and other materials released
 
to, or statements made to, the public.
Any or all of the forward-looking statements in this Report,
 
in the Company’s Annual
 
Report to Shareholders for 2020 and in any
other public statements we make may turn out to be wrong.
 
This can occur as a result of inaccurate assumptions
 
or as a consequence
of known or unknown risks and uncertainties.
 
Many factors discussed in this Report will be important in determining
 
our future
performance.
 
Consequently, actual results may
 
differ materially from those that might be anticipated
 
from our forward-looking
statements.
 
 
6
We undertake
 
no obligation to publicly update any forward-looking statements,
 
whether as a result of new information, future
events or otherwise.
 
However, any further disclosures made
 
on related subjects in the Company’s
 
subsequent reports on Forms 10-K,
10-Q, 8-K and other related filings should be consulted.
 
A major risk is that demand for the Company’s
 
products and services is
largely derived from the demand for our customers’
 
products, which subjects the Company to uncertainties related
 
to downturns in a
customer’s business and unanticipated customer
 
production shutdowns.
 
Other major risks and uncertainties include, but are not
limited to, the primary and secondary impacts of the COVID-19
 
pandemic including actions taken in response to the pandemic by
various governments, which could exacerbate some
 
or all of the other risks and uncertainties faced by the Company,
 
including the
potential for significant increases in raw material costs, supply
 
chain disruptions, customer financial instability,
 
worldwide economic
and political disruptions, foreign currency fluctuations,
 
significant changes in applicable tax rates and regulations,
 
future terrorist
attacks and other acts of violence, each of which
 
is discussed in greater detail in Item 1A of this Report.
 
Furthermore, the Company is
subject to the same business cycles as those experienced
 
by our customers in the steel, automobile, aircraft, industrial
 
equipment, and
durable goods industries.
 
The ultimate significance of COVID-19 impacts on our business will depend
 
on, among other things, the
extent and duration of the pandemic, the severity of the
 
disease and the number of people infected with the
 
virus, the continued
uncertainty regarding availability,
 
administration and long-term efficacy of a
 
vaccine, or other treatments, including on new strands or
mutations of the virus, the longer term effects on
 
the economy, including
 
the resulting market volatility,
 
and the measures taken by
governmental authorities and other
 
third parties restricting day-to-day life and business operations
 
and the length of time that such
measures remain in place, as well as laws and other governmental
 
programs implemented to address the pandemic or assist impacted
businesses, such as fiscal stimulus and other legislation
 
designed to deliver monetary aid and other relief.
 
Other factors could also
adversely affect us, including those related to
 
the Combination and other acquisitions and the integration of
 
the acquired businesses.
 
Our forward-looking statements are subject to risks, uncertainties
 
and assumptions about the Company and its operations
 
that are
subject to change based on various important factors,
 
some of which are beyond our control.
 
These risks, uncertainties, and possibly
inaccurate assumptions relevant to our business could
 
cause our actual results to differ materially from expected
 
and historical results.
 
Therefore, we caution you not to place undue reliance
 
on our forward-looking statements.
 
For more information regarding these
risks and uncertainties as well as certain additional
 
risks that we face, refer to the Risk Factors section in Item
 
1A of this Report, and
in our quarterly and other reports filed from time
 
to time with the SEC.
 
This discussion is provided as permitted by the Private
Securities Litigation Reform Act of 1995.
 
 
7
Item 1A.
 
Risk Factors.
There are many factors that may affect our
 
business and results of operations, including the following
 
risks relating to: (1) the
demand for our products and services and our ability
 
to grow our customer base; (2) our business operations, including
 
internal and
external factors that may impact our operational
 
continuity; (3) our international operations; (4) our supply chain
 
;
 
(5) domestic and
foreign taxation and government regulation and oversight;
 
and (6) more general risk factors that may impact our business.
Risks Related to the Demand for our Products
 
and Services and our Customer Base
 
Changes to the industries and markets that we serve could
 
have a material adverse effect on our liquidity,
 
financial position and
results of operations.
As a leader in industrial process fluids, the Company
 
is subject to the same business cycles as those experienced by our
 
customers
that participate in the steel, automobile, aircraft, industrial
 
equipment, aerospace, aluminum and durable goods industries.
 
Because
demand for our products and services is largely
 
derived from the global demand for their products, we are subject
 
to uncertainties
related to downturns in our customers’ businesses and unanticipated
 
shutdowns or curtailments of our customers’ production,
including as a result of adverse changes affecting
 
national, regional and global economies or increased competitive
 
pressure within our
customers’
 
industries.
 
For example, our business was adversely affected by the
 
production slowdown of the Boeing 737 Max aircraft
that occurred in 2020.
 
Our customers may experience deterioration of their businesses, cash
 
flow shortages and difficulty obtaining
financing, leading them to delay or cancel plans to purchase
 
products, and they may not be able to fulfill their obligations
 
in a timely
fashion.
 
We have limited ability to
 
adjust our costs contemporaneously with changes in sales; thus,
 
a significant sudden downturn in
sales due to reductions in global production within the industries we
 
serve and/or weak end-user markets could have a
 
material
adverse effect on our liquidity,
 
financial position and results of operations.
 
Further, our suppliers and other business partners
 
may
experience similar conditions, which could impact their
 
ability to fulfill their obligations to us and also result in material
 
adverse
effects on our liquidity,
 
financial position and results of operations.
Changes in competition in the industries and markets we serve
 
could have a material adverse effect on our liquidity,
 
financial
position and results of operations.
The specialty chemical industry is highly competitive
 
and there are many companies with significant financial resources
 
and/or
customer relationships that compete with us to provide
 
similar products and services.
 
Some competitors may be able to offer more
favorable or flexible pricing and service terms or,
 
due to their larger size or greater access to resources,
 
may be better able to adapt to
changes in conditions in our industries, fluctuations
 
in the costs of raw materials or changes in global economic conditions,
 
potentially
resulting in reduced profitability and/or a loss of market
 
share for us.
 
The pricing decisions of our competitors could lead us to
decrease our prices which could negatively affect
 
our margins and profitability.
 
In addition, our competitors could potentially
consolidate their businesses to gain scale to better position
 
their product offerings, which could have a negative
 
impact on our
profitability and market share.
 
Competition in our industry historically has also been
 
based on the ability to provide products that
meet the needs of the customer and render technical
 
services and laboratory assistance, which our competitors may be
 
able to
accomplish more effectively than we are
 
able to do.
 
Further, in connection with obtaining regulatory
 
approval of the Combination, we
divested certain of Houghton’s products
 
and related assets to a competitor which they may use to compete
 
with us in certain areas
where we continue to sell those products.
 
If we are unsuccessful with differentiating ourselves, it could
 
have a material adverse effect
on our liquidity,
 
financial position and results of operations and we could lose
 
market share to our competitors.
Loss of a significant customer,
 
bankruptcy of a major customer,
 
or the closure of or significant reduction in production at a
customer site could have a material adverse effect
 
on our liquidity, financial position and
 
results of operations.
During 2020, the Company’s
 
top five largest customers (each composed of multiple
 
subsidiaries or divisions with semi-
autonomous purchasing authority) together accounted
 
for approximately 10% of our consolidated net sales, with the
 
largest customer
accounting for approximately 3% of our consolidated
 
net sales.
 
The loss of a significant customer could have a material adverse
 
effect
on our liquidity,
 
financial position and results of operations.
 
Also, a significant portion of our revenues is derived from
 
sales to
customers in the cyclical steel, aerospace, aluminum
 
and automotive industries where bankruptcies have occurred
 
in the past and
where companies have periodically experienced financial
 
difficulties.
 
If a significant customer experiences financial difficulties
 
or
files for bankruptcy protection, we may be unable to collect
 
on our receivables, and customer manufacturing sites may
 
be closed or
contracts voided.
 
The bankruptcy of a major customer could therefore have a material
 
adverse effect on our liquidity,
 
financial
position and results of operations.
 
Also, some of our customers, primarily in the steel, aluminum
 
and aerospace industries, often have
fewer manufacturing locations compared to other metalworking
 
customers and generally use higher volumes of products at
 
a single
location.
 
The loss, closure or significant reduction in production at one or more
 
of these locations or other major sites of a significant
customer could have a material adverse effect
 
on our business.
We may not
 
be able to timely develop, manufacture and gain market acceptance
 
of new and enhanced products required to
maintain or expand our business, which could adversely affect
 
our competitive position and our liquidity, financial
 
position and
results of operations.
We believe that
 
our continued success depends on our ability to continuously
 
develop and manufacture new products and product
enhancements on a timely and cost-effective
 
basis in response to customer demands for higher performance
 
process chemicals and
other product offerings.
 
Our competitors may develop new products or enhancements to
 
their products that offer performance,
 
 
8
features and lower prices that may render our products less competitive
 
or obsolete, and we may lose business and/or significant
market share.
 
The development and commercialization of new products requires
 
significant expenditures over an extended period of
time, and some products that we seek to develop may
 
fail to gain traction or never become profitable.
 
In any event, ongoing
investments in research and development for the future
 
do not yield an immediate beneficial impact on our operating
 
results and
therefore could result in higher costs without a proportional
 
increase in revenues.
 
In addition, our customers use our specialty chemicals for
 
a broad range of applications.
 
Changes in our customers’ products or
processes or changes in regulatory,
 
legislative or industry requirements may lead our customers to reduce
 
consumption of the specialty
chemicals that we produce or make them unnecessary
 
or less attractive.
 
Customers may also adopt alternative materials or processes
that do not require our products.
 
An example of such evolving customer demands and
 
industry trends is the movement towards light
weighting of materials and electric vehicles.
 
Should a customer decide to use a different material due
 
to price, performance or other
considerations, we may not be able to supply a product that
 
meets the customer’s new requirements.
 
Consequently, it is important
 
that
we develop new products to replace the products that
 
mature and decline in use.
 
Despite our efforts, we may not be able to develop
and introduce products incorporating new technologies in a
 
timely manner that will satisfy our customers’ future needs or achieve
market acceptance.
 
Moreover, new products may have
 
lower margins than the products they replace.
 
Our business, results of
operations, cash flows and margins could
 
be materially adversely affected if we are unable to manage
 
successfully the maturation or
obsolescence of our existing products and the introduction
 
of new products.
Risks Related to Business Operations, Including Internal
 
and External Factors that May Impact Our Operational
 
Continuity
Our ability to profitably operate our consolidated company
 
as anticipated requires us to effectively complete
 
the integration of our
consolidated operations.
 
An inability to appropriately capitalize on growth, including organic
 
growth and future acquisitions,
could adversely affect our liquidity,
 
financial position and results of operations.
Completing the integration of the combined Quaker Houghton
 
presents the Company with significant risks, which may affect
 
our
ability to achieve expected cost synergies or
 
expand our combined business into new markets and geographies.
 
These risks include,
among others:
 
the diversion of management time and focus from operating
 
our business to address challenges that may arise in the
continued integration of Houghton;
 
the transition of further operations and customers of Houghton
 
to the combined business, including across different
 
cultures
and languages, and the need to address the particular economic,
 
currency, political, and
 
regulatory risks associated with
specific countries;
 
the failure to realize anticipated operational or financial
 
synergies;
 
delays in the implementation or remediation of controls, procedures,
 
and policies at Houghton;
 
possible liabilities for activities of Houghton before the acquisition,
 
such as possible violations of laws, commercial disputes,
tax liabilities (as discussed in Note 26 of Notes to Consolidated
 
Financial Statements included in Item 8 of this Report),
 
and
other known and unknown liabilities that may not be sufficiently
 
protected against in the Share Purchase Agreement.
In addition to the Combination, we have completed several
 
other acquisitions over the past several years as discussed
 
in Note 2 of
the Notes to the Consolidated Financial Statements included in
 
Item 8 of this Report.
 
Acquired companies may have significant latent
liabilities that may not be discovered before they are acquired
 
and may not be reflected in the price we pay.
 
Acquisitions also could
have a dilutive effect on our financial results and
 
while they generally result in goodwill, goodwill could be impaired
 
in the future
resulting in a charge to earnings.
 
Our ability to implement our growth strategy may be
 
limited by our ability to identify appropriate acquisition
 
or joint
 
venture
candidates, our financial resources, including available
 
cash and borrowing capacity,
 
and our ability to negotiate and complete suitable
arrangements.
 
Further, the success of our growth
 
depends on our ability to navigate risks similar to those listed above
 
and
successfully integrate acquisitions, including, but not
 
limited to, our ability to:
 
successfully execute the integration or consolidation
 
of the acquired or additional business into existing processes and
operations;
 
develop or modify financial reporting, information
 
systems and other related financial tools to ensure overall financial
integrity and adequacy of internal control procedures;
 
identify and take advantage of potential synergies,
 
including cost reduction opportunities, while retaining
 
legacy business and
other related attributes;
 
 
adequately address challenges arising from the increased scope,
 
geographic diversity and complexity of our operations; and
 
further penetrate existing, and expand into new,
 
markets with the product capabilities acquired in acquisitions.
If we fail to successfully integrate acquisitions into our
 
existing business, our financial condition and results of operations
 
could
be adversely affected.
 
We may fail
 
to obtain the benefits we anticipate from the Combination
 
or our other recently completed or
 
9
future acquisitions or joint ventures and we may not
 
create the appropriate infrastructure to support such additional
 
growth from
organic or acquired businesses, which could
 
also have a material adverse effect on our liquidity,
 
financial position and results of
operations.
Gulf and its wholly-owned subsidiary,
 
QH Hungary Holdings Limited, have a significant minority stake in the Company
 
and the
contractual ability to nominate certain directors of the Company,
 
which may enable them to influence the direction of our business
and significant corporate decisions.
 
As a result of the Combination, Gulf and its wholly
 
-owned subsidiary, QH Hungary
 
Holdings Limited (together, the
 
“Gulf
Affiliates”), have become our largest shareholders.
 
Subject to certain restrictions over timing and amount of sales in the
 
shareholders
agreement they have entered into with the Company,
 
if they were to make available for sale a portion of their shares,
 
that portion
could represent a significant amount of common
 
stock of the Company being sold which could have an adverse impact
 
on the
Company’s stock price.
In addition, the Gulf Affiliates currently have
 
the right to designate three individuals for election to our board
 
of directors (the
“Board”) and this right, together with their share ownership,
 
gives them substantial influence over our business, including
 
over matters
submitted to a vote of our shareholders, including the election
 
of directors, amendment of our organizational documents,
 
acquisitions
or other business combinations involving the Company,
 
and potentially the ability to prevent extraordinary transactions such
 
as a
takeover attempt or business combination.
 
The concentration of ownership of our shares held by the Gulf
 
Affiliates may make some
future actions more difficult without their support.
 
The Gulf Affiliates, however,
 
among other provisions in the shareholders
agreement, have agreed that for so long as any of their designees
 
are on the Board, and for six months thereafter,
 
they will vote all
Quaker Houghton shares consistent with the recommendations of
 
the Board for each director nominee as reflected in each proxy
statement of the Company,
 
including in support
 
of any Quaker Houghton directors nominated for election or
 
re-election to the Board
(except as would conflict with their rights to designees on
 
the Board).
 
Nevertheless, the interests of Gulf may conflict with our
interests or the interests of our other shareholders, though
 
we are not aware of any such existing conflicts of interest at this time.
Failure to comply with any material provision of our principal
 
credit facility or other debt agreements could have a material
adverse effect on our liquidity,
 
financial position and results of operations.
 
We significantly
 
increased our level of indebtedness in connection with
 
the closing of the Combination.
 
Our principal credit
facility requires the Company to comply with certain
 
provisions and covenants, and, while we do not currently
 
consider these
provisions and covenants to be overly restrictive, they
 
could become more difficult to comply with as business or
 
financial conditions
change.
 
We will also be subject
 
to interest rate risk due to the variable interest rates within the
 
credit facility and if interest rates rise
significantly, these
 
interest costs would increase as well.
Our principal credit facility contains provisions that
 
are customary for facilities of its type, including affirmative
 
and negative
covenants, financial covenants and events of default,
 
including restrictions on (a) the incurrence of additional
 
indebtedness, (b)
investments in and acquisitions of other businesses, lines of
 
business and divisions, (c) the making of dividends or capital stock
purchases and (d) dispositions of assets.
 
We may declare
 
dividends and make share repurchases in annual amounts not
 
exceeding the
greater of $50 million annually and 20% of consolidated
 
EBITDA (earnings before interest, taxes, depreciation and
 
amortization) if
we are otherwise in compliance with the credit facility
 
and we may also distribute certain other amounts to our shareholders if
 
we
satisfy a consolidated net leverage ratio.
 
Other financial covenants contained in our principal credit
 
facility include a consolidated
interest coverage test and a consolidated net leverage
 
test.
 
Customary events of default in the credit facility include,
 
among others,
defaults for non-payment, breach of representations and warranties,
 
non-performance of covenants, cross-defaults, insolvency,
 
and a
change of control of the Company in certain circumstances.
 
If we are unable to comply with the financial and
 
other provisions of our
principal facility,
 
we could become in default.
 
The occurrence of an event of default under the credit facility
 
could result in all loans
and other obligations becoming immediately due and payable and
 
the facility being terminated.
 
In addition, deterioration in the
Company’s results of
 
operations or financial position could significantly increase
 
borrowing costs.
Changes to the LIBOR calculation method or the replacement
 
of LIBOR may have adverse consequences for the Company
 
that
cannot yet reasonably be predicted.
 
The Company’s principal
 
credit facility permits interest on certain borrowings to be calculated based
 
on LIBOR.
 
The LIBOR
benchmark has been subject of national, international,
 
and other regulatory guidance and proposals for reform and is currently
expected to be discontinued after 2021.
 
The transition away from LIBOR presents various risks and challenges,
 
including with
respect to our borrowings and hedging arrangements that
 
rely on the LIBOR benchmark.
 
Further, the overall financial market
 
may be
disrupted as a result of the phase-out or replacement of
 
LIBOR.
 
Various
 
parties are working on industry wide and company specific
transition plans related to derivatives and cash markets exposed
 
to LIBOR.
 
The U.S. Federal Reserve, in conjunction with the
Alternative Reference Rates Committee, a steering
 
committee comprised of large U.S. financial institutions,
 
is considering replacing
LIBOR with the Secured Overnight Financing Rate (“SOFR”),
 
a new index calculated using short-term repurchase agreements,
backed by Treasury securities.
 
At this time, the future of LIBOR remains uncertain.
 
It is not possible to predict whether SOFR will
attain market traction as a LIBOR replacement or to
 
predict any other reforms to LIBOR that may be enacted.
 
The potential effect of
the phase-out or replacement of LIBOR on the Company’s
 
financial position or results of operations cannot yet be predicted,
 
but we
do not believe it would have a material adverse impact
 
on the financial results of the Company.
 
 
10
Risks Related to our International Operations
 
Our global presence subjects us to political and economic
 
risks that could adversely affect our business, liquidity,
 
financial
position and results of operations.
A significant portion of our revenues and earnings are generated
 
by non-U.S. operations.
 
Our success as a global business will
depend, in part, upon our ability to succeed across different
 
legal, regulatory, economic,
 
social and political conditions by developing,
implementing and maintaining policies and strategies that
 
are effective in all of the locations where we do
 
business.
 
Risks inherent in
our global operations include:
 
increased transportation and logistics costs, or transportation
 
may be restricted;
 
increased cost or decreased availability of raw materials;
 
trade protection measures including import and export
 
controls, trade embargoes, and trade sanctions between
 
countries or
regions we serve that could result in our losing access to customers
 
and suppliers in those countries or regions;
 
unexpected adverse changes in export duties, quotas and
 
tariffs and difficulties in obtaining export licenses;
 
 
termination or substantial modification of international
 
trade agreements that may adversely affect our access to
 
raw
materials and to markets for our products;
 
our agreements with counterparties in countries outside
 
the U.S. may be difficult for us to enforce
 
and related receivables
may take longer or be difficult for us to collect;
 
 
difficulties of staffing and managing
 
dispersed international operations;
 
 
less protective foreign intellectual property laws, and
 
more generally, legal
 
systems that may be less developed and
predictable than those in the U.S.;
 
limitations on ownership or participation in local enterprises as well
 
as the potential for expropriation or nationalization
 
of
enterprises;
 
the impact of widespread public health crises, such as the
 
COVID-19 pandemic;
 
 
instability in or adverse changes to the economic, political
 
,
 
social, legal or regulatory conditions in a country or region where
we do business, including hyperinflationary conditions or
 
as a result of terrorist activities; and
 
complex and dynamic local tax regulations, including
 
changes in foreign laws and tax rates or U.S. laws and tax
 
rates with
respect to foreign income that may unexpectedly increase
 
the rate at which our income is taxed, impose new and additional
taxes on remittances, repatriation or other payments by
 
subsidiaries, or cause the loss of previously recorded tax benefits.
The current global geopolitical and trade environment
 
creates the potential for increased escalation of domestic and international
tariffs and retaliatory trade policies.
 
Further changes in U.S. trade policy and additional
 
retaliatory actions by U.S. trade partners
could result in a worsening of economic conditions.
 
If we are unable to successfully manage these and other
 
risks associated with our
international businesses, the risks could have a material
 
adverse effect on our business, results of operations
 
or financial condition.
Additionally, on
 
January 31, 2020, the United Kingdom’s
 
(“U.K.”) ended its membership in the European Union (“EU”)
(commonly referred to as “Brexit”).
 
The U.K. and the EU entered into a trade and cooperation agreement
 
effective January 1, 2021,
but uncertainty remains regarding its implications and
 
implementation,
 
and whether any new trade agreements with other countries or
territories will be agreed upon and implemented and how any
 
such agreements may impact our business.
 
The long-term economic,
legal, political and social implications of Brexit, including
 
regarding data protection in the U.K. and the free movement
 
of goods,
services, and people between the U.K., the EU, and
 
elsewhere, also remains unclear.
 
Brexit has caused and could cause further
disruptions to, and create uncertainty surrounding, our
 
business in the U.K. and EU, including affecting our
 
relationships with our
existing and future customers, suppliers and employees.
 
Brexit could lead to legal uncertainty and potentially divergent
 
national laws
and regulations as the U.K. determines which EU laws to
 
replace or replicate.
 
Brexit could also lead to calls for similar referendums
in other European jurisdictions which could cause increased
 
economic volatility in the European and global markets.
 
Uncertainty
around these and related issues could lead to adverse
 
effects on the economy of the U.K. or in the other economies
 
in which we
operate.
 
There can be no assurance that any or all of these events will not
 
have a material adverse effect on our business operations,
results of operations and financial condition.
 
The scope of our international operations subjects us to risks from
 
currency fluctuations that could adversely affect
 
our liquidity,
financial position and results of operations.
Our non-U.S. operations generate significant revenues
 
and earnings.
 
Fluctuations in foreign currency exchange rates may affect
product demand and may adversely affect the
 
profitability in U.S. dollars of the products and services we provide
 
in international
markets where payment for our products and services is made
 
in the local currency.
 
Our financial results are affected by currency
fluctuations, particularly between the U.S. dollar and
 
the euro, the Brazilian real, the Mexican peso, the Chinese renminbi,
 
and the
Indian rupee, and the impact of those currency fluctuations
 
on the underlying economies.
 
During the past three years, sales by our
 
 
11
non-U.S. subsidiaries, which use their local currencies as their
 
functional currency,
 
accounted for approximately 60% to 70% of our
consolidated net sales.
 
We generally do
 
not use financial instruments that expose us to significant risk
 
involving foreign currency
transaction; however, the relative size
 
of our non-U.S. activities has a significant impact on reported
 
operating results and our net
assets.
 
Therefore, as exchange rates change, our results can
 
be materially affected.
 
Incorporated by reference is the foreign exchange
risk information contained in Item 7A of this Report
 
and the geographic information in Note 4 of Notes to Consolidated
 
Financial
Statements included in Item 8 of this Report.
 
Also, we occasionally source inventory in a different
 
country than that of the intended sale.
 
This practice can give rise to foreign
exchange risk.
 
We seek to mitigate this
 
risk through local sourcing of raw materials in the majority
 
of our locations.
Risks Relating to Our Supply Chain
 
If we are unable to obtain price increases or contract concessions sufficient
 
to offset increases in the costs of raw materials,
 
this
could result in a loss of sales, gross profit, and/or market
 
share and could have a material adverse effect
 
on our liquidity, financial
position and results of operations.
 
Conversely, if we fail to adjust prices in a
 
declining raw material cost environment, we could
lose sales, gross profit, and/or market share which could have
 
a material adverse effect on our liquidity,
 
financial position and
results of operations.
 
Quaker Houghton uses approximately 3,000 different
 
raw materials, including animal fats, vegetable oils, mineral oils,
oleochemicals, ethylene, solvents, surfactant agents, various
 
chemical compounds that act as additives to our base formulations,
 
and a
wide variety of other organic and inorganic
 
compounds, and various derivatives of the foregoing.
 
The price of mineral oils and their
derivatives can be affected by the price of
 
crude oil and industry refining capacity.
 
Animal fat and vegetable oil prices, as well as the
prices of other raw materials, are impacted by their
 
own specific supply and demand factors, as well as by biodiesel
 
consumption
which is also affected by the price of crude
 
oil.
 
Accordingly, significant
 
fluctuations in the price of crude oil in the past have had and
are expected to continue to have a material impact on the
 
cost of our raw materials.
 
In addition, many of the raw materials we use are
commodity chemicals, which can experience significant
 
price volatility.
We generally
 
attempt to pass through changes in the prices of raw materials to
 
our customers, but we may be unable to do so (or
may be delayed in doing so).
 
In addition, raising prices we charge to
 
our customers in order to offset increases in the
 
prices we pay
for raw materials could cause us to suffer
 
a loss of sales volumes.
 
Although we have been successful in the past in recovering
 
a
substantial amount of raw material cost increases while retaining
 
our customers, there can be no assurance that we will be able to
continue to offset higher raw material costs or
 
retain customers in the future.
 
A significant change in margin or the loss of customers
due to pricing actions could result in a material adverse
 
effect on our liquidity,
 
financial position, and results of operations.
Lack of availability of raw materials and issues associated with sourcing
 
from single suppliers and suppliers in volatile economic
environments could have a material adverse effect
 
on our liquidity, financial position, and
 
results of operations.
 
The specialty chemical industry periodically experiences
 
supply shortages for certain raw materials.
 
In addition, we source some
materials from a single supplier or from suppliers in
 
jurisdictions that have experienced political or economic
 
instability.
 
Even if we
have multiple suppliers of a particular raw material, there
 
are occasionally shortages.
 
Any significant disruption in supply could affect
our ability to obtain raw materials or satisfactory substitutes or
 
could increase the cost of such raw materials or substitutes, which
could have a material adverse effect on our
 
liquidity, financial position and
 
results of operations.
 
In addition, certain raw materials
that we use are subject to various regulatory laws, and
 
a change in our ability to legally use such raw materials may impact the
products or services we are able to offer which
 
could negatively affect our ability to compete and could
 
adversely affect our liquidity,
financial position and results of operations.
Loss of a significant manufacturing facility or disruptions within
 
our supply chain or in transportation could have a
 
material
adverse effect on our liquidity,
 
financial position and results of operations.
Our manufacturing facilities are located throughout
 
the world.
 
While we have some redundant capabilities, if one of our facilities
is forced to shut down or curtail operations because of damage
 
or other factors, including natural disasters, labor difficulties
 
or
widespread public health crises, such as the ongoing
 
COVID-19 pandemic, we may not be able to timely supply
 
our customers.
 
This
could result in a loss of sales over an extended period
 
or permanently.
 
While the Company seeks to mitigate this risk through business
continuity and contingency planning and other measures,
 
the loss of production in any one region over an extended period of time
could have a material adverse effect on our
 
liquidity, financial position and
 
results of operations.
 
In addition, the coronavirus
pandemic has caused and may in the future cause significant
 
travel disruptions, quarantines and/or closures, which could result
 
in
disruptions to our manufacturing and production operations
 
at our facilities, as well as those of our suppliers and customers.
 
Any
losses due to these events may not be covered by our existing
 
insurance policies or may be subject to certain deductibles.
We could
 
be similarly adversely affected by disruptions
 
to our supply chain and transportation network.
 
The Company relies
heavily on railroads, ships, and over-the-road shipping methods to
 
transport raw materials to its manufacturing facilities and to
transport finished products to customers.
 
The costs of transporting our products could be negatively
 
affected by factors outside of our
control, including shipping container shortages or global
 
imbalances in shipping capabilities, rail service interruptions or rate
increases, extreme weather events, tariffs,
 
rising fuel costs and capacity constraints.
 
Significant delays or increased costs affecting our
supply chain could materially affect our financial
 
condition and results of operations.
 
Disruptions at our suppliers could lead to short
 
 
12
term or longer term increases in raw material or energy
 
costs and/or reduced availability of materials or energy,
 
potentially affecting
our financial condition and results of operations.
Risks Relating to Domestic and Foreign Taxation
 
and Government Regulation and Oversight
 
Changes in tax laws could result in fluctuations in our effective
 
tax rate and have a material effect on our liquidity,
 
financial
position and results of operation.
 
We pay income
 
taxes in the U.S. and various foreign jurisdictions.
 
Our effective tax rate is derived from a combination
 
of local
tax rates and tax attributes applicable to our operations in
 
the various countries, states and other jurisdictions in which we
 
operate.
 
Our effective tax rate and respective tax liabilities could
 
therefore be materially affected by changes in
 
the mix of earnings in countries
with differing statutory tax rates, changes in tax
 
rates, expiration or lapses of tax credits or incentives, changes
 
in uncertain tax
positions, changes in the valuation of deferred tax
 
assets and liabilities, or changes in tax laws or in how they are
 
interpreted or
enforced, including matters such as transfer pricing.
 
One example is the impact of the U.S. Tax
 
Cuts and Jobs Act, enacted in the U.S.
in 2017 (“U.S. Tax
 
Reform”).
 
We have made
 
various interpretations and assumptions with regard to uncertainties
 
and ambiguities in
the application of certain provisions of U.S. Tax
 
Reform which could turn out to be incorrect.
 
In addition, we are regularly under
audit by tax authorities, and the final decisions of
 
such audits could materially affect our current tax estimates and
 
tax positions.
 
See
Note 10 and Note 26 of Notes to Consolidated Financial
 
Statements in Item 8 of this Report for a discussion of certain
 
income and
non-income tax audits and inspections.
 
Any of these factors or similar tax-related risks could cause our
 
effective tax rate and tax-
related payments,
 
including any such payments related to tax liabilities of businesses we have
 
acquired, to significantly differ from
previous periods and current or future expectations
 
which could have a material effect on our liquidity,
 
financial position and results
of operations.
 
Pending and future legal proceedings including environmental
 
matters could have a material adverse effect on
 
our liquidity,
financial position, and results of operations, as well as our reputation
 
in the markets it serves.
The Company and its subsidiaries are routinely party
 
to proceedings, cases, and requests for information from, and negotiations
with, various claimants and federal and state agencies relating
 
to various legal matters, including tax and environmental
 
matters.
 
See
Note 10 and Note 26 of Notes to Consolidated Financial
 
Statements in Item 8 of this Report, which describes uncertain
 
tax positions
and tax audits and inspections, as well as certain information
 
concerning pending asbestos-related litigation against
 
an inactive
subsidiary, amounts
 
accrued associated with certain environmental, non-capital remediation
 
costs and other potential commitments or
contingencies.
 
An adverse result in one or more pending or ongoing matters
 
or any potential future matter of a similar nature could
materially and adversely affect our liquidity,
 
financial position, and results of operations, as well as our reputation
 
in the markets we
serve.
 
Failure to comply with the complex global regulatory
 
environment in which we operate could have an adverse impact
 
on our
reputation and/or a material adverse effect
 
on our liquidity, financial position and
 
results of operations.
 
 
We are subject
 
to government regulation in all of the jurisdictions in which
 
we conduct our business.
 
Changes in the regulatory
environments
 
in which we operate, particularly,
 
but not limited to, the U.S., Mexico, Brazil, China, India, Thailand,
 
Australia, the
U.K. and the EU, could lead to heightened regulatory compliance
 
costs and scrutiny, could
 
adversely impact our ability to continue
selling certain products in the U.S. or foreign markets,
 
and/or could otherwise increase the cost of doing business.
 
While we seek to
mitigate these risks through a variety of actions,
 
including receiving Responsible Care Certification, ongoing
 
employee training,
 
and
employing a comprehensive environmental, health and
 
safety program, there is no guarantee these actions will prevent all potential
regulatory compliance issues.
 
For instance, failure to comply with the EU’s
 
Registration, Evaluation, Authorization and Restriction of
Chemicals (“REACH”) regulations or other similar laws and
 
regulations could result in our inability to sell certain
 
products or we
could incur fines, ongoing monitoring obligations or other
 
future business consequences, which could have a material adverse
 
effect
on our liquidity,
 
financial position and results of operations.
 
In addition, the U.S. Toxic
 
Substances Control Act (“TSCA”) requires
chemicals to be assessed against a risk-based safety standard
 
and that unreasonable risks identified during risk
 
evaluation be
eliminated.
 
This regulation and other pending initiatives at the U.S. state
 
level, as well as initiatives in Canada, Asia and other
regions, could potentially require toxicological testing
 
and risk assessments of a wide variety of chemicals, including chemicals
 
used
or produced by us.
 
These assessments may result in heightened concerns about
 
the chemicals involved and additional requirements
being placed on their production, handling, labeling
 
or use.
 
These concerns and additional requirements could also
 
increase the cost
incurred by our customers to use our chemical products
 
and otherwise limit their use which could lead to a
 
decrease in demand for
these products.
 
A decrease in demand due to these issues could have an adverse
 
impact on our business and results of operation.
 
 
Further, we are subject to the
 
U.S. Foreign Corrupt Practices Act (the “FCPA”),
 
the U.K. Bribery Act and other anti-bribery,
 
anti-
corruption and anti-money laundering laws in jurisdictions around
 
the world.
 
The FCPA, the
 
U.K. Bribery Act and similar laws
generally prohibit companies and their officers,
 
directors, employees and third-party intermediaries, business partners
 
and agents,
from making improper payments or providing other improper
 
items of value to government officials or other
 
persons.
 
While we have
policies and procedures and internal controls designed
 
to address compliance with such laws, we cannot guarantee that
 
our employees
and third-party intermediaries, business partners and
 
agents will not take, or be alleged to have taken, actions in violation of
 
such
policies and laws for which we may be ultimately held
 
responsible.
 
Detecting, investigating and resolving actual or alleged violations
can be extensive and require a significant diversion of
 
time, resources and attention from senior management.
 
Any violation of the
FCPA, the U.K.
 
Bribery Act or other applicable anti-bribery,
 
anti-corruption and anti-money laundering laws could
 
result in
 
13
whistleblower complaints, adverse media coverage,
 
investigations, loss of export privileges, and criminal or
 
civil sanctions, penalties
and fines, any of which could adversely affect
 
our business and financial condition.
 
The shipment of goods, services and technology
 
across international borders subjects us to extensive trade laws and
 
regulations.
Our import activities are governed by the unique customs
 
laws and regulations in each of the countries where we operate.
 
Moreover,
many countries, including the U.S., control the export and
 
re-export of certain goods, services and technology and impose related
export record-keeping and reporting obligations.
 
Governments may also impose economic sanctions against certain
 
countries, persons
and entities that may restrict or prohibit transactions
 
involving such countries, persons and entities, which may limit
 
or prevent our
conduct of business in certain jurisdictions.
 
The laws and regulations concerning import activity,
 
export record-keeping and reporting, export control and
 
economic sanctions
are complex and constantly changing.
 
These laws and regulations can cause delays in shipments and
 
unscheduled operational
downtime.
 
Moreover, any failure to comply with applicable
 
legal and regulatory trading obligations could result in
 
criminal and civil
penalties and sanctions such as fines, imprisonment,
 
debarment from governmental
 
contracts, seizure of shipments and loss of import
and export privileges.
 
In addition, investigations by governmental authorities as well
 
as legal, social, economic and political issues in
these countries could have a material adverse effect
 
on our business, results of operations and financial condition.
 
We are also subject
to the risks that our employees, joint venture partners
 
and agents outside of the U.S. may fail to comply with
 
other applicable laws.
Uncertainty related to environmental regulation and industry standards
 
relating to, as well as physical risks of, climate change and
biodiversity loss, could impact our results of operations and
 
financial position.
 
Increased public and stakeholder awareness and concern
 
regarding global climate change, biodiversity
 
loss, and other
environmental risks may result in more extensive international,
 
regional and/or federal requirements or industry standards to reduce
 
or
mitigate the effects of these changes.
 
These regulations could mandate even more restrictive standards
 
or industry standards than the
voluntary goals that we have established or require changes
 
to be adopted on a more accelerated time frame.
 
There continues to be a
lack of consistent climate legislation, which
 
creates economic and regulatory uncertainty.
 
For example, the new U.S. presidential
administration has issued Executive Orders seeking to
 
adopt new regulations and policies to address climate change and
 
to suspend,
revise, or rescind prior agency actions that are identified
 
as conflicting with the administration’s
 
climate policies.
 
The new
presidential administration also announced that in February
 
2021, the U.S. will formally re-join the Paris Agreement.
 
The Paris
Agreement requires countries to review and “represent
 
a progression” in their intended nationally determined contributions
 
which set
greenhouse gas emission reduction goals every five
 
years.
 
Though we are closely following developments in this area
 
and changes in
the regulatory landscape in the U.S., we cannot predict
 
how or when those challenges may ultimately impact our business.
 
While
certain climate change initiatives may result in new
 
business opportunities for us in the area of alternative
 
fuel technologies and
emissions control, compliance with these initiatives may also result
 
in additional costs to us including, among other things, increased
production costs, additional taxes, reduced emission allowances
 
or additional restrictions on production or operations.
 
In addition, the potential physical impacts of climate change
 
and biodiversity loss are highly uncertain and
 
will be particular to the
circumstances developing in various geographical regions.
 
These may include extreme weather events and long-term
 
changes in
temperature levels and water availability as well as damaged ecosystems.
 
The physical risks of climate change and biodiversity loss
may impact our facilities, our customers and suppliers, and
 
the availability and costs of materials and natural resources, sources
 
and
supply of energy,
 
product demand and manufacturing.
 
In particular, climate change serves as a risk multiplier
 
increasing both the
frequency and severity of natural disasters that may affect
 
our business operations.
 
If environmental laws or regulations or industry standards
 
are either changed or adopted and impose significant operational
restrictions and compliance requirements upon us or
 
our products, or our operations are disrupted due to physical impacts of
 
climate
change or biodiversity loss, our business, capital expenditures,
 
results of operations, financial condition and competitive
 
position could
be negatively impacted.
We are subject to
 
stringent labor and employment laws in many jurisdictions in which
 
we operate, and our relationship with our
employees could deteriorate which could adversely impact
 
our operations.
 
A majority of our full-time employees are employed outside
 
the U.S.
 
In many jurisdictions where we operate, labor and
employment laws grant significant job protection to certain
 
employees including rights on termination of employment.
 
In addition, in
certain countries our employees are represented by
 
works councils or are governed by collective bargaining
 
agreements.
 
We are often
required to consult with and seek the consent or advice of
 
works councils or labor unions.
 
These regulations and laws, together with
our obligations to seek consent or consult with the relevant
 
unions or works councils, could have a significant impact
 
on our flexibility
in managing costs and responding to market changes.
 
While the Company believes it has generally positive relations with its labor
unions and employees, there is no guarantee the Company
 
will be able to successfully negotiate new or renew labor
 
agreements
without work stoppages, labor difficulties or
 
unfavorable terms.
 
If we were to experience any extended interruption of operations
 
at
any of our facilities because of strikes or other work stoppages,
 
our results of operations and financial condition could be
 
materially
and adversely affected.
 
 
14
We may be
 
unable to adequately protect our proprietary rights and trade brands,
 
which may limit our ability to compete in our
markets and could adversely affect our liquidity,
 
financial position and results of operations.
 
 
We have a
 
limited number of patents and patent applications, including
 
patents issued, applied for, or acquired
 
in the U.S. and in
various foreign countries, some of which are material
 
to our business.
 
However, we rely principally on our
 
proprietary formulae and
the applications know-how and experience to meet
 
customer needs.
 
Also, our products are identified by trademarks that are registered
throughout our marketing area.
 
Despite our efforts to protect our proprietary information
 
through patent and trademark filings, and
the use of appropriate trade secret protections, it is possible
 
that competitors or other unauthorized third parties may obtain, copy,
 
use,
disclose or replicate our formulae, products, and proces
 
ses.
 
Similarly, third
 
parties may assert claims against us and our customers
and distributors alleging our products infringe upon
 
third-party intellectual property rights.
 
In addition, the laws and/or judicial
systems of foreign countries in which we design, manufacture,
 
market and sell our products may afford little or
 
no effective protection
of our proprietary technology or trade brands.
 
Also, security over our global information technology structure
 
is subject to increasing
risks associated with cyber-crime and other related cyber-security
 
threats.
 
These potential risks to our proprietary information, trade
brands and other intellectual property could subject us to
 
increased competition and a failure to protect, defend or enforce our
intellectual property rights could negatively impact
 
our liquidity, financial position
 
and results of operations.
General Risk Factors
Our business could be adversely affected
 
by environmental, health and safety laws and regulations or by
 
potential product, service
or other related liability claims.
 
The development, manufacture and sale of specialty
 
chemical products and other related services involve inherent
 
exposure to
potential product liability claims, service level claims, product
 
recalls and related adverse publicity.
 
Some customers have and may in
the future require us to represent that our products conform
 
to certain product specifications provided by them.
 
Any failure to comply
with such specifications could result in claims or legal
 
action against us.
 
Any of the foregoing potential product or service risks could
also result in substantial and unexpected expenditures
 
and affect customer confidence in our products and
 
services, which could have a
material adverse effect on our liquidity,
 
financial position and results of operations.
In addition, our business is subject to hazards associated
 
with the manufacturing, handling, use, storage, and transportation
 
of
chemical materials and products, including historical operations
 
at our current and former facilities.
 
These potential hazards could
cause personal injury and loss of life, severe damage
 
to, or destruction of, property or equipment and environmental contamination
 
or
other environmental damage, which could have an adverse
 
effect on our business, financial condition or results
 
of operations.
 
In the
jurisdictions in which we operate, we are subject to numerous U.S.
 
and non-U.S. national, federal, state and local environmental,
health and safety laws and regulations, including those
 
governing the discharge of pollutants into the air and
 
water, the management
and disposal of hazardous substances and wastes and the
 
cleanup of contaminated properties.
 
We currently
 
use, and in the past have
used, hazardous substances at many of our facilities, and
 
we have in the past been, and may in the future be, subject
 
to claims relating
to exposure to hazardous materials.
 
We also have
 
generated, and continue to generate, hazardous wastes at a number
 
of our facilities.
Liabilities associated with the investigation and
 
cleanup of hazardous substances, as well as personal injury,
 
property damages or
natural resource damages arising from the release of,
 
or exposure to, such hazardous substances, may be imposed in many situations
without regard to violations of laws or regulations
 
or other fault, and may also be imposed jointly and severally (so
 
that a responsible
party
 
may be held liable for more than its share of the losses involved,
 
or even the entire loss).
 
These liabilities may also be imposed
on many different entities, including, for
 
example, current and prior property owners or operators, as well as entities
 
that arranged for
the disposal of the hazardous substances.
 
The liabilities may be material and can be difficult to identify
 
or quantify.
 
In addition, the
occurrence of disruptions, shutdowns or other material
 
operating problems at our facilities or those of our customers
 
due to any of
these risks could adversely affect our reputation
 
and have a material adverse effect on our operations
 
as a whole, including our results
of operations and cash flows, both during and after the
 
period of operational difficulties.
 
Further, some of the raw materials we handle
 
are subject to government regulation.
 
These regulations affect the manufacturing
processes, handling, uses and applications of our products.
 
In addition, our production facilities and a number of our distribution
centers require numerous operating permits.
 
Due to the nature of these requirements and changes in our operations,
 
our operations
may exceed limits under permits or we may not have
 
the proper permits to conduct our operations.
 
Ongoing compliance with environmental laws, regulations
 
and permits that impact registration/approval requirements,
transportation and storage of raw materials and finished
 
products, and storage and disposal of wastes could require
 
us to make changes
in manufacturing processes or product formulations and
 
could have a material adverse effect on our results
 
of operations.
 
We may
incur substantial costs, including fines, damages, criminal
 
or civil sanctions and remediation costs, or experience
 
interruptions in our
operations, including as a result of revocation, non-renewal
 
or modification of the Company’s
 
operating permits and revocation of the
Company’s product
 
registrations, for violations arising under these laws or permit
 
requirements.
 
Any such revocation, modification or
non-renewal may require the Company to cease or limit
 
the manufacture and sale of its products at one or more of its facilities, which
may limit or prevent the Company’s
 
ability to meet product demand or build new facilities and
 
may have a material adverse effect on
the Company’s business, financial
 
position, results of operations and cash flows.
 
Additional information may arise in the future
concerning the nature or extent of our liability with
 
respect to identified sites, and additional sites may be identified
 
for which we are
alleged to be liable, that could cause us to materially increase
 
our environmental accrual or the upper range of the
 
costs we believe we
could reasonably incur for such matters.
 
Increased compliance costs may not affect competitors
 
in the same way that they affect us
 
15
due to differences in product formulations,
 
manufacturing locations or other factors, and we could be at a competitive
 
disadvantage,
which might adversely affect our financial performance.
We could be
 
subject to indemnity claims and liable for other payments relating to
 
properties or businesses we have divested.
 
In connection with the sale of certain properties and
 
businesses, we agreed to indemnify the purchasers of such
 
properties for
certain types of matters, such as certain breaches of representations
 
and warranties, taxes and certain environmental matters.
 
With
respect to environmental matters, the discovery of
 
contamination arising from properties that we have divested may
 
expose us to
indemnity obligations under the sale agreements with
 
the buyers of such properties or cleanup obligations and
 
other damages
 
under
applicable environmental laws, even if we were not
 
aware of the contamination.
 
We may not have
 
insurance coverage for such
indemnity obligations.
 
Further, we cannot predict the nature of
 
and the amount
 
of any indemnity or other obligations we may have to
the applicable purchaser.
 
These payments may be costly and may adversely affect
 
our financial condition and results of operations.
Our insurance may not fully cover all potential exposures.
We maintain
 
product, property,
 
business interruption, casualty,
 
and other general liability insurance, but this may not cover
 
all
risks associated with the hazards of our business and these
 
coverages are subject to limitations, including deductibles
 
and coverage
limits.
 
We may incur
 
losses beyond the limits, or outside the coverage, of our insurance
 
policies, including liabilities for
environmental remediation.
 
In addition, from time to time, various types of insurance
 
for companies in the specialty chemical
industry have not been available on commercially acceptable
 
terms and, in some cases, have not been available at all.
 
We are
potentially at additional risk if one or more of our
 
insurance carriers fail.
 
Additionally, severe disruptions
 
in the domestic and global
financial
 
markets could adversely impact the ratings and survival
 
of some of our insurers.
 
Future downgrades in the ratings of enough
insurers could adversely impact both the availability of
 
appropriate insurance coverage and its cost.
 
In the future, we may not be able
to obtain coverage at current levels, if at all, and our
 
premiums may increase significantly on coverage that
 
we maintain.
Impairment evaluations of goodwill, intangible assets, investments or other
 
long-lived assets could result in a reduction in our
recorded asset values which could have a material
 
adverse effect on our financial position and results of
 
operation.
We perform
 
reviews of goodwill and indefinite-lived intangible assets on
 
an annual basis, or more frequently if triggering events
indicate a possible impairment.
 
We test goodwill
 
at the reporting unit level by comparing the carrying value of
 
the net assets of the
reporting unit, including goodwill, to the reporting unit's fair
 
value.
 
Similarly, we test indefinite
 
-lived intangible assets by comparing
the fair value of the assets to their carrying values.
 
If the carrying values of goodwill or indefinite-lived intangible
 
assets exceed their
fair value, the goodwill or indefinite-lived intangible assets would
 
be considered impaired.
 
In addition, we perform a review of a
definite-lived intangible asset or other long-lived
 
asset when changes in circumstances or events indicate a possible
 
impairment.
 
If
any impairment or related charge is warranted,
 
then our financial position and results of operations could be
 
materially affected. See
Note 16 of Notes to Consolidated Financial Statements included
 
in Item 8 of this Report.
Disruption of critical information systems or material breaches
 
in the security of our systems could adversely affect
 
our business
and our customer relationships, and subject us to fines or other
 
regulatory actions.
We rely on
 
information technology systems to obtain, process, analyze, manage,
 
transmit, and store electronic information in our
day-to-day operations.
 
We also rely
 
on our technology infrastructure in all aspects of our business, including
 
to interact with
customers and suppliers, fulfill orders and bill, collect
 
and make payments, ship products, provide support to customers,
 
and fulfill
contractual obligations.
 
Our information technology systems are subject to potential
 
disruptions, including significant network or
power outages, cyberattacks, computer viruses, other malicious codes,
 
and/or unauthorized access attempts, any of which, if
successful, could result in data leaks or otherwise compromise
 
our confidential or proprietary information and disrupt
 
our operations.
Security breaches could result in unauthorized disclosure
 
of confidential information or personal data belonging to
 
our employees,
partners, customers or suppliers for which we may
 
incur liability.
 
Cybersecurity incidents, such as these, are becoming
 
more
sophisticated and frequent, and there can be no assurance
 
that our protective measures will prevent security breaches that could
 
have a
significant impact on our business, reputation and financial
 
results.
 
We are subject
 
to the data privacy and protection laws and regulations adopted
 
by federal, state and foreign legislatures and
governmental agencies in various countries in which we
 
operate, including the EU General Data Protection Regulation.
 
Implementing
and complying with these laws and regulations may
 
be more costly or take longer than we anticipate, or could
 
otherwise affect our
business operations.
 
Breaches, cyber incidents and disruptions, or failure to
 
comply with laws and regulations related to information security or
privacy could result in legal claims or proceedings against us
 
by governmental entities or individuals, significant
 
fines, penalties or
judgements, disruption of our operations, remediation
 
requirements, changes to our business practices, and damage
 
to our reputation.
Therefore, a failure to monitor, mainta
 
in or protect our information technology systems and data
 
integrity effectively or to anticipate,
plan for and recover from significant disruptions to
 
these systems could have a material adverse effect on our
 
business, results of
operations or financial condition.
 
 
16
Our business depends on attracting and retaining qualified
 
management and other key personnel.
Due to the specialized and technical nature of our business, our
 
future performance is dependent on our ability to attract, develop
and retain qualified management, commercial, technical,
 
and other key personnel. Competition for such personnel is intense,
 
and we
may be unable to continue to attract or retain such personnel.
 
In an effort to mitigate such risks, the Company
 
utilizes retention
bonuses, offers competitive pay and maintains continuous
 
succession planning, including for our senior executive officers.
 
However,
there can be no assurance that these mitigating factors
 
will be adequate to attract or retain qualified management or other key
personnel.
 
Failure to retain key employees could also adversely affect
 
our ability to complete the integration of the Combination.
Increasing scrutiny and changing expectations from
 
stakeholders with respect to our environmental, social and governance
(“ESG”) practices may impose additional costs on us or expose
 
us to new or additional risks.
Companies across all industries are facing increasing
 
scrutiny from stakeholders related to their ESG practices.
 
Investor
advocacy groups, certain institutional investors, investment
 
funds, and other influential investors are also increasingly focused on
 
ESG
practices and in recent years have placed increasing
 
importance on the implications and social cost of their investments.
 
Regardless of
the industry, investors’
 
increased focus and activism related to ESG and similar matters
 
may impact access to capital, as investors may
decide to reallocate capital or to not commit capital as a
 
result of their assessment of a company’s
 
ESG practices.
 
We face pressures
 
from certain stakeholders to prioritize and promote
 
sustainable practices and reduce our carbon footprint. Our
stakeholders may pressure us to implement ESG procedures
 
or standards beyond those we have in place in order
 
to continue engaging
with us, to remain invested in us, or before they will make
 
further investments in us.
 
Additionally, we may
 
face reputational
challenges in the event our ESG procedures or standards do
 
not meet the standards set by certain constituencies.
 
We have adopted
certain practices as highlighted in the Company’s
 
Sustainability Report, including with respect to environmental stewardship.
 
Further, as we work to align
 
with the recommendations of the Financial Stability Board’s
 
Task Force on
 
Climate-related Financial
Disclosures and the Sustainability Accounting Standards
 
Board, we continue to expand our disclosures in these areas.
 
This is
consistent with our commitment to executing on a
 
strategy that reflects the economic, social, and environmental
 
impact we have on
the world while advancing and complementing our
 
business strategy.
 
Our disclosures on these matters and standards we set for
ourselves or a failure to meet these standards, may
 
influence our reputation and the value of our brand.
 
It is possible that our
stakeholders might not be satisfied with our ESG efforts
 
or the speed of their adoption.
 
If we do not meet our stakeholders’
expectations, our business and/or our ability to access
 
capital could be harmed.
 
Any harm to our reputation resulting from setting
these standards or our failure or perceived failure to meet
 
such standards could adversely affect our business, financial
 
performance,
and growth.
 
Additionally, adverse
 
effects upon our customers’ industries related to
 
the worldwide social and political environment, including
uncertainty or instability resulting from climate change
 
or biodiversity loss, changes in political leadership and environmental
 
policies,
changes in geopolitical-social views toward fossil fuels and
 
renewable energy,
 
concern about the environmental impact of climate
change or biodiversity loss, and investors’ expectation
 
s
 
regarding ESG matters, may also adversely affect
 
demand for our services.
Any long-term material adverse effect on
 
our customers or their industries could have a significant financial
 
and operational adverse
impact on our business.
Terrorist
 
attacks, other acts of violence or war,
 
natural disasters, widespread public health crises or other uncommon
 
global events
may affect the markets in which we operate and
 
our profitability which could adversely affect our liquidity,
 
financial position and
results of operations.
 
Terrorist attacks,
 
other acts of violence or war, natural
 
disasters, widespread public health crises, including the
 
ongoing COVID-
19 pandemic, or other uncommon global events may negatively
 
affect our operations.
 
There can be no assurance that there will not be
terrorist attacks against the U.S. or other locations where we
 
do business.
 
Also, other uncommon global events such as earthquakes,
hurricanes, fires and tsunamis cannot be predicted.
 
Terrorist attacks,
 
other acts of violence or armed conflicts, and natural disasters, which
 
may be amplified by ongoing global
climate change and biodiversity loss, may directly
 
impact our physical facilities and/or those of our suppliers or customers.
 
In
addition, terrorist attacks or natural disasters may disrupt
 
the global insurance and reinsurance industries with the result
 
that we may
not be able to obtain insurance at historical terms and
 
levels, if at all, for all of our facilities.
 
In addition, available insurance coverage
may not be sufficient to cover all of the damage
 
incurred or, if available, may be prohibitively
 
expensive.
 
Widespread public health
crises could also disrupt operations of the Company,
 
its suppliers and customers which could have a material adverse
 
impact on our
results of operations.
For example, refer to “The COVID-19 pandemic and its impact
 
on business and economic conditions have negatively affected
 
our
business, results of operations and financial condi
 
tion and the extent and duration of those effects is uncertain,”
 
included in this “Risk
Factors” section.
 
The consequences of terrorist attacks, other acts of violence
 
or armed conflicts, natural disasters, widespread public
health crises or other uncommon global events can
 
be unpredictable, and we may not be able to foresee or
 
effectively plan for these
events, resulting in a material adverse effect
 
on our business, results of operations or financial condition.
 
 
17
The COVID-19 pandemic and its impact on business and economic
 
conditions have negatively affected our business, results
 
of
operations and financial condition and the extent and
 
duration of those effects is uncertain.
 
The COVID-19 pandemic that began in the first quarter
 
of 2020 and the resulting impacts significantly disrupted the global
economy and financial markets and adversely affected
 
the Company’s operations as well as those
 
of its suppliers and customers.
 
The
pandemic and its impacts adversely affected
 
the Company’s results of operations
 
and financial condition in 2020 and the adverse
effects have continued into 2021.
 
The Company initially experienced disruptions as a result of COVID-19
 
at its China subsidiaries
and subsequently throughout the rest of the business due
 
to the global economic slowdown that ensued and continues.
 
We have
experienced, and may experience in the future, temporary
 
site or facility closures at our own facilities or those of our
 
customers in
response to illness or government mandates in some of
 
the jurisdictions in which we operate.
 
Even in facilities that are not closed, we
could be affected by reductions in employee
 
availability and productivity,
 
changes in operating procedures, and increased costs.
 
The
Company anticipates that its future results of operations may
 
continue to be adversely impacted by COVID-19 until
 
effective vaccines
have been widely administered.
 
In particular, the spread of COVID-19
 
and efforts to contain the virus have:
 
reduced the demand for our products and services as many
 
customers have reduced production levels;
 
 
driven declines in volume and net sales across all reportable
 
segments;
 
 
required us to adjust certain of our facility operating procedures
 
and to take steps to reduce costs and preserve liquidity;
 
and
 
negatively affected the estimated fair value of
 
certain of the Company’s reporting
 
units or other indefinite-lived or long-lived
assets, namely the Company’s
 
Houghton and Fluidcare trademarks and tradename indefinite-lived
 
intangible assets, such that
their estimated fair values were less than their carrying
 
values and required adjustments.
These effects are likely to increase or become
 
exacerbated the longer the crisis continues,
 
and the pandemic in the future could
(or, in some instances, could further):
 
 
limit the availability and reduce the productivity of our
 
employees;
 
 
challenge our financial reporting systems and processes, internal
 
control over financial reporting, and disclosure controls and
procedures, including our ability to ensure that information
 
required to be disclosed in our reports under the Exchange Act is
recorded, processed, summarized and reported within the
 
time periods specified in the SEC’s rules
 
and forms,
 
and that such
information is accumulated and communicated to our
 
management, including our chief executive officer
 
and chief financial
officer, to allow for timely
 
decisions regarding required disclosure;
 
 
present challenges as a result of travel restrictions and remote work
 
arrangements, including, as further described in Item 9A
of this Report, impacting the planning, execution and timing
 
of the Company’s remediation
 
and integration plan activities,
including the implementation of new or enhanced business process
 
and information technology general controls, as
necessary,
 
as well as impacting the timing of the Company’s
 
on-going enterprise resource planning system implementations
 
;
 
 
increase our costs as a result of emergency
 
measures that we may take or that may be imposed on us by regulatory
authorities;
 
 
cause a delay in customer payments or cause a deterioration
 
of the credit quality of other counterparties that could
 
result in
credit losses or force both customer and supplier bankruptcies;
 
 
cause delays and disruptions in the availability of and timely
 
delivery of materials and components used in our operations;
 
cause us to breach covenants in our existing credit
 
facility, including
 
covenants regarding our consolidated interest coverage
ratio and consolidated net leverage ratio, or increase our
 
cost of capital or make additional capital, including the refinancing
of our existing credit facility,
 
more difficult or available only on terms less favorable
 
to us;
 
 
impact our liquidity position and cost of and ability to access funds
 
from financial institutions and capital markets;
 
 
negatively affect the estimated fair values of the
 
Company’s reporting units or other
 
indefinite-lived or long-lived assets; and
 
cause other risks to impact us, including the other risks described
 
in this “Risk Factors” section.
Although we have implemented business continuity
 
and emergency response plans as well as health and
 
safety measures to
permit us to continue to provide services and products to customers
 
and support our operations, there can be no assurance that the
continued spread of COVID-19 and efforts to
 
contain the virus (including, but not limited to, voluntary and
 
mandatory quarantines,
restrictions on travel, limiting gatherings of people, reduced
 
operations and extended closures of
 
many businesses and institutions)
will not further impact our business, results of operations
 
and financial condition.
 
However, given the unprecedented
 
and continually
evolving developments with respect to this pandemic,
 
the Company cannot, as of the date of this Report, reasonably
 
estimate the full
extent of the impact to its future results of operations or
 
to the ability of it or its customers to resume more normal operations.
 
A
further prolonged outbreak or resurgence
 
and period of continued restrictions on day-to-day life and business operations
 
would likely
result in volume declines and lower net sales into 2021
 
periods as well.
 
 
 
18
The ultimate significance of COVID-19 impacts on our
 
business will depend on, among other things, the extent and
 
duration of
the pandemic, the severity of the disease and the number
 
of people infected with the virus, the development and continued uncertainty
regarding availability,
 
administration and long-term efficacy of a vaccine or
 
other treatments, including on new strains or mutations of
the virus, the longer-term effects on the
 
economy, including market
 
volatility, and the
 
measures taken by governmental authorities and
other third parties restricting day-to-day life and the
 
length of time that such measures remain in place, as well as laws and
 
other
governmental programs implemented to address the pandemic or
 
assist impacted businesses, such as fiscal stimulus and other
legislation designed to deliver monetary aid and other relief.
Epidemic diseases could negatively affect various
 
aspects of our business, make it more difficult to
 
meet our obligations to our
customers, and could result in reduced demand from
 
our customers.
 
These could have a material adverse effect
 
on our business,
financial condition, results of operations, or cash flows.
 
Our business could be adversely affected
 
by the effects of a widespread outbreak of
 
contagious disease, similar to the COVID-19
impacts described above.
 
A significant outbreak of contagious diseases in the human population
 
could result in a widespread health
crisis that could adversely affect the economies and
 
financial markets of many countries, resulting in an economic
 
downturn that could
affect demand for our products and likely
 
impact our operating results.
 
To the extent that
 
the Company’s customers and
 
suppliers are
materially and adversely impacted by a widespread
 
outbreak of contagious disease, this could reduce the availability,
 
or result in
delays, of materials or supplies to or from the Company,
 
which in turn could materially interrupt the Company’s
 
business operations.
We have identified
 
material weaknesses in our internal control over financial reporting
 
that could, if not remediated, result in
material misstatements in our financial statements and in the
 
inability of our independent registered public accounting
 
firm to
provide an unqualified audit opinion which could have a material
 
adverse effect on us.
As a public company,
 
we are required to comply with the SEC’s rules
 
implementing Sections 302 and 404 of the Sarbanes-Oxley
Act of 2002, or the Sarbanes-Oxley Act, which require
 
management to certify financial and other information in our quarterly
 
and
annual reports and provide an annual management report on
 
the effectiveness of controls over financial reporting.
As disclosed under “Item 9A. Controls and Procedures”
 
of this Report, during the course of preparing our audited financial
statements for the Company’s
 
annual report on Form 10-K (the “2019 Form 10-K”), we,
 
in conjunction with our independent
registered public accounting firm, identified certain
 
material weaknesses as of December 31, 2019.
 
A material weakness is a
deficiency, or combination
 
of deficiencies, in internal control over financial reporting,
 
such that there is a reasonable possibility that a
material misstatement of annual or interim financial
 
statements will not be prevented or detected on a timely
 
basis.
 
We identified
 
certain deficiencies in our application of the principles associated
 
with the criteria set forth by the Committee of
Sponsoring Organizations of the Treadway
 
Commission in Internal Control—Integrated Framework (2013)
 
that management
concluded constituted a material weakness.
 
We did not
 
design and maintain effective controls in response
 
to the risks of material
misstatement.
 
Specifically, changes
 
to existing controls or the implementation of new controls
 
were not sufficient to respond to
changes to the risks of material misstatement in financial
 
reporting as a result of becoming a larger,
 
more complex global organization
due to the Combination.
 
This material weakness also contributed to an additional material
 
weakness as we did not design and
maintain effective controls over the review
 
of pricing, quantity and customer data to verify that revenue
 
recognized was complete and
accurate.
During 2020, management began developing its full remediation
 
plan and executing
 
what will be a multi-step remediation process
to completely and fully remediate its identified material weaknesses
 
as further described in Item 9A of this Report. However,
 
the
Company has not yet remediated the previously identified
 
material weakness over
 
the review of pricing, quantity and customer data to
verify that revenue recognized was complete and
 
accurate as of December 31, 2020, and as a result, the Company
 
also did not
remediate the previously identified material weakness related
 
to risk assessment.
 
Until the remediation plans are deemed effective,
 
we
cannot assure you that our actions will adequately remediate
 
these material weaknesses or that additional material weaknesses in
 
our
internal controls will not be identified in the future.
 
Although the Company expects to be able to remedy these material
 
weaknesses
during 2021, it may be unable to do so due to the impact
 
of the COVID-19 pandemic or for other reasons, in which case we
 
would
continue to be subject to the risk that a material misstatement
 
of annual or interim financial statements will not be prevented
 
or
detected on a timely basis.
 
Any failure to identify and correct material weaknesses in a
 
timely manner could have a material adverse
effect on the financial condition of the Company.
As a result of these material weaknesses, management
 
determined that both our disclosure controls and procedures and
 
internal
control over financial reporting were not effective
 
as of December 31, 2020 and our independent registered public
 
accounting firm
likewise issued an opinion indicating that we had not maintained
 
effective internal control over financial reporting
 
as of December 31,
2020.
 
 
 
19
Because these control deficiencies could have resulted
 
in misstatements of interim or annual consolidated financial statements
 
and
disclosures that could have resulted in a material misstatement
 
that would not be prevented or detected, we performed additional
analysis and procedures to ensure that our consolidated
 
financial statements presented in this Annual Report on Form 10-K were
prepared in accordance with GAAP and fairly reflected
 
our financial position and results of operations as of and
 
for the year ended
December 31, 2020.
 
Subsequently, notwithstanding
 
these material weaknesses, the Company has concluded that
 
these control
deficiencies did not result in a misstatement to the related
 
balances and disclosures for the year ended December
 
31, 2020.
Our management,
 
including our chief executive officer and chief financial
 
officer, does not expect that
 
our internal control over
financial reporting will prevent all errors and all fraud.
 
A control system, no matter how well designed and operated,
 
can provide only
reasonable, not absolute, assurance that the control
 
system’s objectives will be met.
 
Further, the design of a control system must
reflect the fact that there are resource constraints,
 
and the benefits of controls must be considered relative
 
to their costs.
 
Controls can
be circumvented by the individual acts of some persons,
 
by collusion of two or more people, or by management override
 
of the
controls.
 
Over time, controls may become inadequate because of changes in
 
circumstances or deterioration in the degree of
compliance with policies or procedures may occur.
 
Because of the inherent limitations in a cost-effective
 
control system,
misstatements due to error or fraud may occur and may
 
not be detected.
Item 1B.
 
Unresolved Staff Comments.
 
None.
Item 2.
 
Properties.
 
Quaker Houghton’s corporate
 
headquarters and a laboratory facility are located in
 
its Americas segment’s Conshohocken,
Pennsylvania location.
 
The Company’s other principal
 
facilities in its America’s segment
 
are located in Detroit, Michigan;
Middletown, Ohio; Dayton, Ohio; Strongsville, Ohio;
 
Carrollton, Georgia; Zion, Illinois; Waterloo,
 
Ontario; Monterrey, N.L.,
Mexico; Rio de Janeiro, Brazil and Sao Paulo, Brazil.
 
The Company’s EMEA segment
 
has principal facilities in Uithoorn, The
Netherlands; Manchester, U.K.; Dortmund,
 
Germany; Barcelona, Spain; Navarra, Spain; Karlshamn, Sweden;
 
Tradate, Italy; and
Turin, Italy.
 
The Company’s Asia/Pacific segment
 
operates out of its principal facilities located in Qingpu,
 
China; Songjiang, China;
Kolkata, India; Rayong, Thailand; Sydney,
 
Australia; and Moorabbin, Australia.
 
The Company’s Global Specialty
 
Businesses
segment operates out of its principal facilities in Aurora,
 
Illinois; Santa Fe Springs, California; Batavia, New York;
 
Zion, Illinois; and
Coventry, U.K..
 
With the exception of the Conshohocken,
 
Santa Fe Springs, Aurora, Karlshamn, Rayong, Coventry,
 
and Sydney
sites, which are leased, the remaining principal facilities are
 
owned by the Company and, as of December 31,
 
2020, were mortgage
free.
 
Quaker Houghton also leases sales, laboratory,
 
manufacturing, and warehouse facilities in other locations.
 
Quaker Houghton’s principal
 
facilities consist of various manufacturing, administrative,
 
warehouse, and laboratory buildings.
 
Substantially all of the buildings are of fire-resistant construction
 
and are equipped with sprinkler systems.
 
The Company has a
program to identify needed capital improvements that
 
are implemented as management considers necessary or desirable.
 
Most
locations have raw material storage tanks, ranging from
 
1 to 200 at each location with capacities ranging from 1,000
 
to 82,000 gallons,
and processing or manufacturing vessels ranging in capacity
 
from 8 to 29,000 gallons.
Each of Quaker’s non-U.S. associated companies
 
(in which it owns a 50% or less interest and has significant
 
influence) owns or
leases a plant and/or sales facilities in various locations
 
,
 
with the exception of Primex, Ltd.
Item 3.
 
Legal Proceedings.
 
The Company is a party to proceedings, cases, and requests for
 
information from, and negotiations with, various claimants and
Federal and state agencies relating to various matters, including
 
environmental matters.
 
For information concerning pending asbestos-
related litigation against an inactive subsidiary,
 
certain environmental non-capital remediation costs and other
 
legal-related matters,
reference is made to Note 26 of Notes to Consolidated
 
Financial Statements, included in Item 8 of this Report, which
 
is incorporated
herein by this reference.
 
The Company is a party to other litigation which management currently
 
believes will not have a material
adverse effect on the Company’s
 
results of operations, cash flow or financial condition.
Item 4.
 
Mine Safety Disclosures.
 
Not Applicable.
 
 
 
20
Item 4(a).
 
Information about our
 
Executive Officers.
 
Set forth below is information regarding the executive
 
officers of the Company,
 
each of whom have been employed by the
Company or by Houghton for at least five years, including
 
the respective positions and offices with the Company
 
(or Houghton) held
by each over the respective periods indicated.
 
Each of the executive officers, with the exception
 
of Mr. Hostetter,
 
is appointed
annually to a one-year term.
 
Mr. Hostetter is considered
 
an executive officer in his capacity as principal accounting
 
officer for
purposes of this Item.
Name, Age, and Present
Position with the Company
 
Business Experience During the Past Five
Years
 
and Period Served as an Officer
 
 
Michael F. Barry,
 
62
Chairman of the Board, Chief Executive
Officer,
 
President and Director
 
Mr. Barry,
 
who has been employed by the Company since 1998, has served
 
as
Chairman of the Board since May 2009, in addition
 
to his position as Chief
Executive Officer and President held since October
 
2008.
 
He served as interim
Chief Financial Officer from October through November
 
2015.
 
He served as Senior
Vice President and Managing
 
Director – North America from January 2006 to
October 2008.
 
He served as Senior Vice President
 
and Global Industry Leader –
Metalworking and Coatings from July through December
 
2005.
 
He served as Vice
President and Global Industry Leader – Industrial Metalworking
 
and Coatings from
January 2004 through June 2005 and Vice
 
President and Chief Financial Officer
from 1998 to August 2004.
 
Joseph A. Berquist, 49
Senior Vice President,
 
Global Specialty
Businesses and Chief Strategy Officer
Mr. Berquist, who has
 
been employed by the Company since 1997, has served as
Senior Vice President,
 
Global Specialty Businesses and Chief Strategy Officer
 
since
August 2019.
 
He served as Vice President and
 
Managing Director – North America
from April 2010 until July 2019.
Jeewat Bijlani, 44
Senior Vice President,
 
Managing Director - Americas
Mr. Bijlani has served as Senior
 
Vice President, Managing
 
Director - Americas
since he joined the Company in August 2019.
 
Prior to joining the Company,
 
Mr.
Bijlani served as President, Americas and Global Strategic
 
Businesses of Houghton
from March 2015 until July 2019.
 
Prior to that role, he served as Senior Vice
President M&A, Business Development and Strategic Planning
 
to execute
Houghton’s growth initiatives
 
with key customers and in business segments from
December 2011 to March 2015.
 
Prior to joining Houghton, Mr. Bijlani
 
served as a
Director in the Private Equity Group at Celerant Consulting
 
from March 2006 to
November 2011 where he led
 
strategic and business transformation engagements in
the Chemicals and Manufacturing sector.
 
Mary Dean Hall, 63
Senior Vice President,
 
Chief Financial Officer
and Treasurer
 
Ms. Hall, who has been employed by the Company since
 
November 2015, has
served as Senior Vice
 
President, Chief Financial Officer and Treasurer
 
since August
2019.
 
She served as Vice President,
 
Chief Financial Officer and Treasurer
 
from
November 2015 until July 2019.
 
Prior to joining the Company,
 
Ms. Hall served as
the Vice President and
 
Treasurer of Eastman Chemical Company
 
from April 2009
until October 2015.
 
Prior to that role, she held various senior-level financial
positions of increasing responsibility with Eastman from
 
1995 through 2009,
including Treasurer,
 
Vice President and Controller,
 
and Vice President, Finance.
 
Shane W.
 
Hostetter, 39
Vice President, Finance
 
and Chief
 
Accounting Officer
Mr. Hostetter,
 
who has been employed by the Company since July 2011,
 
has served
as Vice President, Finance
 
and Chief Accounting Officer since August
 
2019.
 
He
served as Global Controller and Principal Accounting Officer
 
from September 2014
until July 2019.
Kym Johnson, 50
Senior Vice President,
 
Chief Human
Resources Officer
Ms. Johnson has served as Senior Vice
 
President, Chief Human Resources Officer
since she joined the Company in August 2019.
 
Prior to joining the Company,
Ms. Johnson served as Senior Vice
 
President Global Human Resources of Houghton
from June 2015 until July 2019.
 
Prior to joining Houghton, she served as Vice
President, Human Resources and Chief Human Resources Officer
 
of FMC
Corporation from July 2013 to October 2014. Prior
 
to that role, she held various
senior-level human resources roles with FMC from July 1992
 
to October 2014,
including Director, Global Talent
 
Management and HR Director, Asia Pacific.
 
 
 
21
Name, Age, and Present
Position with the Company
 
Business Experience During the Past Five
Years
 
and Period Served as an Officer
Dieter Laininger, 57
Senior Vice President,
 
Managing
Director - Asia / Pacific
 
Mr. Laininger,
 
who has been employed by the Company since 1991, has served
 
as
Senior Vice Present, Managing
 
Director – Asia / Pacific since August 2019.
 
He
served as Vice President
 
and Managing Director – Asia / Pacific from April 2018
until July 2019, in addition to his role as Vice
 
President and Managing Director -
South America, a position he assumed in January
 
2013 and held until July 2019.
 
Mr. Laininger also served
 
as Vice President and Global
 
Leader – Primary Metals, a
position which he assumed in June 2011
 
and held until July 2019.
 
Wilbert Platzer,
 
59
Senior Vice President,
 
Global Operations,
Environmental Health & Safety (“EHS”) and
Procurement
Mr. Platzer,
 
who has been employed by the Company since 1995, has served
 
as
Senior Vice President,
 
Global Operations, EHS and Procurement since August
2019.
 
He served as Vice President,
 
Global Operations, EHS and Procurement from
April 2018 until July 2019.
 
He served as Vice President and
 
Managing Director –
EMEA from January 2006 through March 2018.
 
Dr. David Slinkman, 56
Senior Vice President,
 
Chief Technology
Officer
Dr. Slinkman
 
has served
 
as Senior
 
Vice President,
 
Chief Technology
 
Officer since
he joined
 
the Company
 
in August 2019.
 
Prior to joining
 
the Company,
Dr. Slinkman
 
served as
 
Vice President
 
of Technology
 
of Houghton
 
from March
2012 until
 
July 2019.
 
Prior to joining
 
Houghton, Dr.
 
Slinkman served
 
as Global
Technology
 
Leader of
 
Nalco Chemical
 
Company from
 
2008 until
 
2012.
 
Prior to
that role,
 
he held various
 
positions
 
with Nalco
 
from December
 
1990 until
 
2008
including
 
Manager,
 
Research and
 
Development
 
for the finishing
 
technologies
group, which
 
encompassed
 
both metal
 
working fluids
 
and surface
 
treatment
products,
 
and Technical
 
Director
 
for the paper
 
chemicals
 
group.
Adrian Steeples, 60
Senior Vice President,
 
Managing
Director – EMEA
Mr. Steeples, who has been
 
employed by the Company since 2010, has served as
Senior Vice President,
 
Managing Director – EMEA since August 2019.
 
He served
as Vice President and Managing
 
Director – EMEA from April 2018 until July 2019.
He served as Vice President
 
and Managing Director - Asia/Pacific from July 2013
through March 2018.
 
Robert T. Traub,
 
56
Senior Vice President,
 
General Counsel and
Corporate Secretary
Mr. Traub,
 
who has been employed by the Company since 2000, has served
 
as
Senior Vice President,
 
General Counsel and Corporate Secretary since August 2019.
 
He served as Vice President,
 
General Counsel and Corporate Secretary from April
2015 until July 2019.
 
He served as the Corporation’s
 
General Counsel from March
2012 through March 2015.
 
He has also served
 
as Director of Global Corporate
Compliance since January 2009.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
22
PART
 
II
 
Item 5.
 
Market for Registrant’s Common
 
Equity, Related Stockholder Matters and
 
Issuer Purchases of Equity Securities.
 
The Company’s common
 
stock is listed on the New York
 
Stock Exchange (“NYSE”) under the trading symbol KWR.
 
Our Board
declared cash dividends that totaled $1.56 per share
 
of outstanding common stock or $27.8 million during
 
the year ended December
31, 2020 and $1.525 per share of outstanding common
 
stock or $23.7 million during the year ended December
 
31, 2019.
 
In February
and May 2020, our Board declared quarterly cash dividends
 
of $0.385 per share of outstanding common stock, payable
 
to shareholders
of record in April 2020 and July 2020, respectively.
 
Subsequently, our Board
 
declared quarterly dividends of $0.395 per share of
outstanding common stock in September and November
 
2020, respectively, payable
 
to shareholders of record in October 2020 and
January 2021, respectively.
 
We currently
 
expect to continue to pay comparable cash dividends on a quarterly
 
basis in the future.
 
Future declaration of dividends and the establishment of future
 
record dates and payment dates are subject to the final
 
determination of
our Board, and will be based on our future financial condition,
 
results of operations, capital requirements, capital expenditure
requirements, contractual restrictions, anticipated cash
 
needs, business prospects, provisions of applicable law and other
 
factors our
Board may deem relevant.
There are no restrictions that the Company believes are
 
likely to materially limit the payment of future dividends.
 
However,
under the Credit Facility there are certain restrictions, including
 
a limit on dividends paid not to exceed the greater of $50.0
 
million
annually and 20% of consolidated EBITDA so long as there
 
is no default under the Credit Facility.
 
Reference is made to the
“Liquidity and Capital Resources” disclosure contained
 
in Item 7 of this Report.
As of January 15, 2021,
 
17,853,463 shares of Quaker common stock were issued
 
and outstanding and were held by 712
shareholders of record.
 
Each share of common stock is entitled to one vote per share.
Reference is made to the information in Item 12
 
of this Report under the caption “Equity Compensation
 
Plans,” which is
incorporated herein by this reference.
The following table sets forth information concerning
 
shares of the Company’s
 
common stock acquired by the Company during
the fourth quarter of 2020 for the period covered by
 
this report:
Issuer Purchases of Equity Securities
(c)
(d)
Total
 
Number of
 
Approximate Dollar
(a)
(b)
Shares Purchased
Value of
 
Shares that
Total
 
Number
 
Average
as part of Publicly
May Yet
 
be
of Shares
Price Paid
Announced Plans
 
Purchased Under the
Period
Purchased (1)
Per Share (2)
or Programs
Plans or Programs (3)
October 1 - October 31, 2020
$
$
86,865,026
 
November 1 - November 30, 2020
$
$
86,865,026
 
December 1 - December 31, 2020
$
$
86,865,026
 
Total
$
$
86,865,026
 
(1)
 
The Company did not acquire any shares of the Company’s
 
common stock from employees during the fourth quarter
 
of 2020.
 
All shares that would be acquired from employees are related
 
to the surrender of Quaker Chemical Corporation shares in
payment of the exercise price of employee stock options
 
exercised or for the payment of taxes upon exercise of
 
employee
stock options or the vesting of restricted stock.
 
(2)
 
The Company did not acquire any shares of the Company’s
 
common stock from employees during the fourth quarter
 
of 2020.
 
The price that would be paid for shares acquired from employees
 
pursuant to employee benefit and share-based compensation
plans is based on the closing price of the Company’s
 
common stock on the date of exercise or vesting as
 
specified by the plan
pursuant to which the applicable option or restricted stock
 
was granted.
 
(3)
 
On May 6, 2015, the Board of Directors of the Company
 
approved, and the Company announced, a share repurchase
program, pursuant to which the Company is authorized
 
to repurchase up to $100,000,000 of Quaker Chemical Corporation
common stock (the “2015 Share Repurchase Program”).
 
The 2015 Share Repurchase Program has no expiration date.
 
There
were no shares acquired by the Company pursuant
 
to the 2015 Share Repurchase Program during the quarter ended
December 31, 2020.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
https://cdn.kscope.io/4584db1655b25ad637edbfbb73b0ac5a-kwr-20201231p24i0.gif
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
23
Stock Performance Graph:
 
The following graph
 
compares the cumulative
 
total return (assuming
 
reinvestment of dividends)
 
from
December 31, 2015 to December 31,
 
2020 for (i) Quaker’s common stock,
 
(ii) the S&P MidCap 400 Index (the
 
“MidCap Index”), (iii)
the S&P 400
 
Materials Group Index
 
(the “Materials 400
 
Group Index”) and
 
(iv) the S&P
 
600 Materials Group
 
Index (the “Materials
600 Group Index”).
 
The graph assumes the investment
 
of $100 on December
 
31, 2015 in each of
 
Quaker’s common stock,
 
the stocks
comprising the
 
MidCap Index and
 
the Materials Group
 
Index, respectively.
 
The comparison of
 
the Materials 400
 
Group Index was
added in 2020 to provide a closer comparison to the
 
MidCap Index comparison.
 
 
12/31/2015
12/31/2016
12/31/2017
12/31/2018
12/31/2019
12/31/2020
Quaker
$
100.00
$
168.15
$
200.14
$
237.98
$
222.13
$
345.21
MidCap Index
100.00
120.74
140.35
124.80
157.49
179.00
Materials 400 Group Index
100.00
137.25
166.82
132.84
160.57
177.66
Materials 600 Group Index
100.00
154.70
170.04
132.20
159.40
195.55
Item 6.
 
Selected Financial Data.
 
The Company has omitted the table for selected
 
financial data pursuant to the SEC Final Rule Release Nos. 33
 
-10890, which
among other revisions, amends certain disclosure requirements required
 
by Regulation S-K relating to selected financial data (Item
301) and supplementary financial information (Item 302).
 
The Company has early adopted the guidance on an Item-by-Item
 
basis and
eliminated Items 301 and 302 in its consolidated financial
 
statements.
 
 
 
24
Item 7.
 
Management’s Discussion and Analysis
 
of Financial Condition and Results of Operations.
 
As used in this Annual Report on Form 10-K (the “Report”),
 
the terms “Quaker Houghton”, the “Company”, “we”,
 
and “our”
refer to Quaker Chemical Corporation (doing business as Quaker
 
Houghton), its subsidiaries, and associated companies, unless the
context otherwise requires.
 
The term Legacy Quaker refers to the Company prior to
 
the closing of its combination with Houghton
International, Inc. (“Houghton”) (herein referred
 
to as the “Combination”) on August 1, 2019.
 
Throughout the Report, all figures
presented, unless otherwise stated, reflect the results of
 
operations of the combined company for the year ended
 
December 31, 2020,
for the year ended December 31, 2019 includes the
 
result of Legacy Quaker plus five months of Houghton’s
 
operations post-closing of
the Combination on August 1, 2019, and for the year ended
 
December 31, 2018, the results only of Legacy Quaker.
Executive Summary
Quaker Houghton is a global leader in industrial process
 
fluids.
 
With a presence around the world,
 
including operations in over
25 countries, our customers include thousands of the world’s
 
most advanced and specialized steel, aluminum, automotive, aerospace,
offshore, can, mining, and metalworking
 
companies.
 
Our high-performing, innovative and sustainable solutions are
 
backed by best-
in-class technology,
 
deep process knowledge, and customized services.
 
Quaker Houghton is headquartered in Conshohocken,
Pennsylvania, located near Philadelphia in the U.S.
Overall, the Company’s
 
2020 performance, like most other companies in the
 
world, was negatively impacted by the COVID-19
pandemic and its impact on the global economy,
 
including
 
most of the Company’s
 
customers.
 
However, the Company’s
 
acquisition
activity in late 2019, including the Houghton Combination
 
and the Norman Hay acquisition, drove a 25% increase in 2020 net
 
sales to
$1,417.7
 
million compared to $1,133.5 million in 2019.
 
Excluding net sales from acquisitions, current year net
 
sales would have
declined approximately 11% primarily
 
due to a 9% decrease in sales volumes associated with the negative
 
impacts of COVID-19 on
global production levels throughout each of the Company’s
 
segments.
 
Similar to net sales, the Company’s
 
gross profit and selling,
general and administrative expenses (“SG&A”) also increased
 
due to the full year inclusion of Houghton and Norman
 
Hay, but both
also benefited from the realization of cost savings associated with
 
synergies achieved with the Combination as well
 
as the impact of
cost saving measures put in place to help offset
 
the impacts of COVID-19.
 
The Company’s 2020 reported operating
 
income of $59.4
million increased compared to $46.1 million in 2019.
 
Excluding all one-time costs and other non-core items that largely
 
related to the
Combination and Norman Hay in each period, the Company’s
 
non-GAAP operating income of $134.0 million
 
increased 10%
compared to $122.0 million in 2019, primarily due to
 
the net sales increases and cost synergies and savings
 
mentioned above.
 
Further
details of the Company’s
 
consolidated operating performance are discussed in the Company’s
 
Consolidated Operations Review,
 
in the
Operations section of this Item, below.
The Company’s net income
 
and earnings per diluted share of $39.7 million and $2.22 in
 
2020, respectively, increased
 
compared
to $31.6 million and $2.08 per diluted share, respectively,
 
in 2019.
 
Excluding all one-time costs and other non-core items that largely
related to the Combination and Norman Hay in each
 
period, the Company’s current
 
year non-GAAP net income and non-GAAP
earnings per diluted share were $85.2 million and $4.78,
 
respectively, compared
 
to $88.7 million and $5.83, respectively,
 
in 2019.
 
The increase in the Company’s current
 
year reported earnings drove a 28% higher adjusted EBITDA of
 
$222.0 million compared to
$173.1 million in 2019, primarily due to the Houghton
 
and Norman Hay acquisitions as well as the benefit of costs savings
 
associated
with the Combination,
 
partially offset by the negative impacts of COVID-19.
 
See the Non-GAAP Measures section of this Item,
below.
The Company’s 2020
 
operating performance in each of its four reportable segments: (i)
 
Americas; (ii) Europe, Middle East and
Africa (“EMEA”); (iii) Asia/Pacific; and (iv) Global Specialty
 
Businesses, reflect similar drivers to that of its consolidated
performance.
 
Each segment’s net sales benefited
 
from a full year of Houghton and the Company’s
 
Global Specialty Businesses
segment also benefited from a full year of Norman Hay.
 
Without the inclusion of Houghton and
 
Norman Hay, net sales would
 
have
been lower in all segments compared to the prior year,
 
primarily driven by declines in volume primarily due to the
 
negative impacts of
COVID-19 on the Company’s
 
end markets.
 
As reported, all of the Company’s
 
segment operating earnings were higher compared to
2019 because of the inclusion of a full year of Houghton and
 
Norman Hay as well as cost synergies achieved
 
with the Combination
and other cost savings actions taken due to COVID-19,
 
partially offset by the negative impacts of COVID-19
 
on global sales volumes.
 
Additional details of each segment’s
 
operating performance are further discussed in the Company’s
 
reportable segments review,
 
in the
Operations section of this Item, below.
 
The Company generated net operating cash flow of $178.4
 
million in 2020 compared to $82.4 million in 2019.
 
The 117%
increase in net operating cash flow year-over
 
-year was primarily driven by the inclusion of a full year of earnings
 
from Houghton and
Norman Hay, as well as
 
higher operating cash flow due to changes in working
 
capital.
 
The key drivers of the Company’s
 
operating
cash flow
 
and overall liquidity are further discussed in the Company’s
 
Liquidity and Capital Resources section of this Item, below
 
.
 
Overall, the Company’s
 
2020 results reflect the fact that the negative impacts of COVID-19
 
were partially offset by the positive
impacts of a full year of Houghton and Norman Hay performance
 
,
 
Combination synergies and cost savings actions
 
.
 
The Company’s
performance showed a good quarterly growth trend across the
 
globe beginning after the second quarter of 2020, during
 
which the
impacts of COVID-19 were most severe, indicating
 
a gradual improvement in the Company’s
 
end markets and continued market share
gains.
 
Despite these challenges, the Company was able to generate significant
 
net operating cash flow in 2020, continue to pay its
regular dividends, pay down its debt above its required commitments
 
,
 
and continue to execute its integration plans for the
Combination.
 
 
25
The global economic slowdown and other impacts due
 
to COVID-19 posed an unprecedented challenge in 2020, but the
Company successfully navigated this downturn, demonstrating
 
its ability to respond quickly to changing market conditions and
 
deliver
on the benefits it anticipated from the Combination
 
with Houghton.
 
In 2020, the Company continued to service and supply its
customers despite very difficult economic
 
conditions, it continued to gain share in the market, it completed
 
a significant part of the
integration activities, and realized $58 million of cost
 
synergies which exceeded the original estimate of $35
 
million.
 
The Company
also made recent bolt-on acquisitions which are expected
 
to contribute towards earnings growth in 2021 and, even with those
acquisitions, the Company reduced its net debt by
 
12% or $94 million during 2020.
 
As the Company looks forward, it
 
expects some
short-term headwinds from higher raw material costs and
 
lower than expected volumes in the automotive market due
 
to the
semiconductor shortage.
 
However, the Company expects 2021
 
to result in a step change in its profitability from 2020 as the Company
completes its integration cost synergies, continues
 
to take further share in the marketplace, benefits from a projected
 
gradual rebound
in demand, and sees the positive impact of its recent acquisit
 
ions.
Impact of COVID-19
 
In early 2020, the global outbreak of COVID-19
 
negatively impacted all locations where the Company
 
does business.
 
Although
the Company has now operated during several quarters
 
in this COVID-19 environment, the full extent of the outbreak
 
and related
business impacts remains
 
uncertain and volatile, and therefore the full extent to which COVID-19
 
may impact the Company’s future
results of operations or financial condition is uncertain.
 
This outbreak has significantly disrupted the operations
 
of the Company and
those of its suppliers and customers.
 
The Company has experienced significant volume declines and
 
lower net sales as further
described in this section, initially at its China subsidiaries in the
 
first quarter of 2020 and, beginning in late March continued
throughout the rest of its business due to the global economic
 
slowdown brought on by COVID-19.
 
Management continues to
monitor the impact that the COVID-19 pandemic is having
 
on the Company,
 
the overall specialty chemical industry and the
economies and markets in which the Company operates.
 
 
Given the speed and frequency of the continuously evolving developments
 
with respect to this pandemic, the Company cannot, as
of the date of this Report, reasonably estimate the
 
magnitude or the full extent of the impact to its future results of
 
operations or to the
ability of it or its customers to resume more normal
 
operations, even as certain restrictions are lifted.
 
The prolonged pandemic and a
resurgence of the outbreak, and continued
 
restrictions on day-to-day life and business operations may result
 
in volume declines and
lower net sales in future periods as compared to pre-COVID-19
 
levels.
 
To the extent that the Company’s
 
customers and suppliers
continue to be significantly and adversely impacted by
 
COVID-19, this could reduce the availability,
 
or result in delays, of materials
or supplies to or from the Company,
 
which in turn could significantly interrupt the Company’s
 
business operations.
 
Given this
ongoing uncertainty,
 
the Company cautions that its future results of operations could be significantly
 
adversely impacted by COVID-
19.
 
Further, management continues to
 
evaluate how COVID-19-related circumstances, such as remote
 
work arrangements, illness or
staffing shortages and travel restrictions have affected
 
financial reporting processes and systems, internal control
 
over financial
reporting, and disclosure controls and procedures.
 
While the circumstances have presented and are expected
 
to continue to present
challenges, and have necessitated additional time
 
and resources to be deployed to sufficiently address the
 
challenges brought on by the
pandemic, at this time, except as otherwise noted in
 
Item 9A of this Report, management does not believe that
 
COVID-19 has had a
material impact on financial reporting processes, internal
 
controls over financial reporting, or disclosure controls and procedures.
 
For
additional information regarding the potential impact of COVID-19,
 
see Item 1A of Part I of this Report.
 
The Company’s top
 
priority is, and especially during this pandemic remains, to protect the health
 
and safety of its employees and
customers, while working to ensure business continuity
 
to meet customers’ needs:
 
 
Our People
 
– The Company has taken steps to protect the health and wellbeing
 
of its people in affected areas through various
actions, including enabling work at home where needed and
 
possible, and employing social distancing standards,
implementing travel restrictions where applicable, enhancing
 
onsite hygiene practices, and instituting visitation restrictions
 
at
the Company’s facilities.
 
The Company does not expect that it will incur material
 
expenses implementing health and safety
policies for employees, contractors, and customers.
 
 
 
Our Operations
 
– Currently, all of
 
the Company’s 31 production
 
facilities worldwide are open and operating and are deemed
as essential businesses in the jurisdictions where they are
 
operating.
 
The Company believes that to date it has been able to
meet the needs of all its customers across the globe
 
despite the current economic challenges.
 
 
 
Our Business Conditions
 
– The Company’s second
 
half of 2020 showed solid improvement over the first half,
 
which was
consistent with expectations that April and May would
 
be the worst months of the year and that the Company
 
would show
gradual quarterly improvement sequentially throughout
 
the remainder of the year.
 
However, demand still remained lower
than pre-COVID-19 levels as many customers maintained
 
reduced production levels through the end of 2020.
 
Excluding
Houghton and Norman Hay net sales, all four of the Company’s
 
reportable segments showed declines in net sales due to
COVID-19 during 2020 compared to the prior year,
 
with the Americas and EMEA being the most impacted and
 
Asia/Pacific
being the least impacted.
 
The Company currently expects that the impact from COVID-19
 
will gradually improve each
quarter in 2021 subject to the effective containment
 
of the virus and successful distribution of a vaccine.
 
However, the
incidence of reported cases of COVID-19 appears to
 
be again increasing in several geographies where we have
 
significant
 
26
operations and it remains highly uncertain as to how long
 
the global pandemic and related economic challenges will last and
when our customers’ businesses will recover.
 
 
 
Our Actions
 
– The Company took various actions to temporarily conserve
 
cash and reduce costs during 2020.
 
Some of these
actions during 2020 included eliminating all discretionary
 
expenditures, delaying or freezing salary increases where legally
permitted, reducing executives’ salaries for a period of
 
time, lowering 2020 planned capital expenditures by approximately
30%, and accelerating and fine-tuning the Company’s
 
integration plans.
 
These temporary initiatives were designed and
implemented so that the Company could successfully manage through
 
the challenging COVID-19 situation while continuing
to protect the health of its employees, meet customers’ needs,
 
maintain the Company’s
 
long-term competitive advantages and
above-market growth, and enable it to continue to
 
effectively integrate Houghton.
 
While the actions taken in 2020 to protect
our workforce, to continue to serve our customers with excellence
 
and to conserve cash and reduce costs, have been effective
thus far, further actions to respond
 
to the pandemic and its effects may be necessary as conditions
 
continue to evolve.
 
Critical Accounting Policies and Estimates
Quaker Houghton’s discussion
 
and analysis of its financial condition and results of operations
 
are based upon its consolidated
financial statements which have been prepared in accordance with
 
accounting principles generally accepted in the United States (“U.S.
GAAP”).
 
The preparation of these financial statements requires the Company
 
to make estimates and judgments that affect the
reported amounts of assets, liabilities, revenues and expenses, and
 
related disclosure of contingent assets and liabilities.
 
On an
ongoing basis, the Company evaluates its estimates, including
 
those related to customer sales incentives, product returns, bad
 
debts,
inventories, property,
 
plant and equipment (“PP&E”), investments, goodwill, intangible
 
assets, income taxes, business combinations,
restructuring, incentive compensation plans (including
 
equity-based compensation), pensions and other postretirement benefits,
contingencies and litigation.
 
Quaker Houghton bases its estimates on historical experience
 
and on various other assumptions that are
believed to be reasonable under such circumstances, the
 
results of which form the basis for making judgments about the
 
carrying
values of assets and liabilities that are not readily apparent
 
from other sources.
 
However, actual results may differ
 
from these
estimates under different assumptions or
 
conditions.
Quaker Houghton believes the following critical accounting
 
policies describe the more significant judgments and
 
estimates used
in the preparation of its consolidated financial statements:
Accounts receivable and inventory exposures:
 
Quaker Houghton establishes allowances for doubtful accounts
 
for estimated
losses resulting from the inability of its customers to
 
make required payments.
 
If the financial condition of the Company’s
 
customers
were to deteriorate, resulting in an impairment of their
 
ability to make payments, additional allowances may be required.
 
As part of
our terms of trade, we may custom manufacture products
 
for certain large customers and/or may ship products
 
on a consignment basis.
Further, a significant portion of our
 
revenue is derived from sales to customers in industries where
 
companies have experienced past
financial difficulties.
 
If a significant customer bankruptcy occurs, then we must judge
 
the amount of proceeds, if any,
 
that may
ultimately be received through the bankruptcy or liquidation
 
process.
 
These matters may increase the Company’s
 
exposure should a
bankruptcy occur, and may require
 
a write down or a disposal of certain inventory as well as the failure
 
to collect receivables.
 
Reserves for customers filing for bankruptcy protection
 
are established based on a percentage of the amount of receivables
 
outstanding
at the bankruptcy filing date.
 
However, initially establishing
 
this reserve and the amount thereof is dependent on the Company’s
evaluation of likely proceeds to be received from the
 
bankruptcy process, which could result in the Company
 
recognizing minimal or
no reserve at the date of bankruptcy.
 
We generally reserve
 
for large and/or financially distressed customers on
 
a specific review basis,
while a general reserve is maintained for other customers
 
based on historical experience.
 
The Company’s consolidated
 
allowance for
doubtful accounts was $13.1 million and $11.7
 
million as of December 31, 2020 and 2019, respectively.
 
The Company recorded
expense to increase its provision for doubtful accounts by
 
$3.6 million, $1.9 million and $0.5 million for the years
 
ended December
31, 2020, 2019 and 2018, respectively.
 
Changing the amount of expense recorded to the Company’s
 
provisions by 10% would have
increased or decreased the Company’s
 
pre-tax earnings by $0.4 million, $0.2 million and $0.1 million
 
for the years ended December
31, 2020,
 
2019 and 2018,
 
respectively.
 
See Note 13 of Notes to Consolidated Financial Statements in Item
 
8 of this Report.
Environmental and litigation reserves:
 
Accruals for environmental and litigation matters are
 
recorded when it is probable that a
liability has been incurred and the amount of the liability
 
can be reasonably estimated.
 
Environmental costs and remediation costs are
capitalized if the costs extend the life, increase the
 
capacity or improve the safety or efficiency of the property
 
from the date acquired
or constructed, and/or mitigate or prevent contamination
 
in the future.
 
Estimates for accruals for environmental matters are based on a
variety of potential technical solutions, governmental regulations
 
and other factors, and are subject to a wide range of potential
 
costs
for remediation and other actions.
 
A considerable amount of judgment is required in determining
 
the most likely estimate within the
range of total costs, and the factors determining this judgment
 
may vary over time.
 
Similarly, reserves for
 
litigation and similar
matters are based on a range of potential outcomes and
 
require considerable judgment in determining the
 
most probable outcome.
 
If
no amount within the range is considered more probable
 
than any other amount, the Company accrues the lowest amount
 
in that range
in accordance with generally accepted accounting principles.
 
See Note 26 of Notes to Consolidated Financial Statements in
 
Item 8 of
this Report.
 
27
Realizability of equity investments:
 
The Company holds equity investments in various foreign
 
companies where it has the
ability to influence, but not control, the operations of the
 
entity and its future results.
 
The Company would record an impairment
charge to an investment if it concluded that a
 
decline in value that was other than temporary occurred.
 
Adverse
 
changes in market
conditions, poor operating results of underlying investments,
 
devaluation of foreign currencies or other events or circumstances
 
could
result in losses or an inability to recover the carrying value
 
of the investments, potentially leading to an impairment charge
 
in the
future.
 
The carrying amount of the Company’s
 
equity investments as of December 31, 2020 was $95.8 million,
 
which included four
investments: $19.4 million for a 32% interest in Primex, Ltd.
 
(Barbados); $7.8 million for a 50%
 
interest in Nippon Quaker Chemical,
Ltd. (Japan); $0.3 million for a 50% interest in Kelko
 
Quaker Chemical, S.A. (Panama); and $68.3 million for a 50% interest
 
in Korea
Houghton Corporation (Korea).
 
The Company also has a 50% interest in a Venezuelan
 
affiliate, Kelko Quaker Chemical, S.A
(Venezuela).
 
Due to heightened foreign exchange controls, deteriorating
 
economic circumstances and other restrictions in Venezuela,
during the third quarter of 2018 the Company concluded that it no
 
longer had significant
 
influence over this affiliate.
 
Prior to this
determination, the Company historically accounted
 
for this affiliate under the equity method.
 
As of December 31, 2020 and 2019, the
Company had no remaining carrying value for its investment
 
in Venezuela.
 
See Note 17 of Notes to Consolidated Financial
Statements in Item 8 of this Report.
Tax
 
exposures, uncertain tax positions and valuation
 
allowances:
 
Quaker Houghton records expenses and liabilities for taxes
based on estimates of amounts that will be determined as deductible
 
in tax returns filed in various jurisdictions.
 
The filed tax returns
are subject to audit, which often occur
 
several years subsequent to the date of the financial statements.
 
Disputes or disagreements may
arise during audits over the timing or validity of certain
 
items or deductions, which may not be resolved for extended
 
periods of time.
 
The Company also evaluates uncertain tax positions on
 
all income tax positions taken on previously filed tax returns or
 
expected to be
taken on a future tax return in accordance with FIN 48,
 
which prescribes the recognition threshold and measurement attributes
 
for
financial statement recognition and measurement of tax
 
positions taken or expected to be taken on a tax return
 
and, also, whether the
benefits of tax positions are probable or if they will be more
 
likely than not to be sustained upon audit based upon the
 
technical merits
of the tax position.
 
For tax positions that are determined to be more likely than not to
 
be sustained upon audit, the Company
recognizes the largest amount of benefit that
 
is greater than 50% likely of being realized upon ultimate
 
settlement in the financial
statements.
 
For tax positions that are not determined to be more
 
likely than not sustained upon audit, the Company does not recognize
any portion of the benefit in its financial statements.
 
In addition, the Company’s
 
continuing practice is to recognize interest and/or
penalties related to income tax matters in income tax expense.
 
Also, the Company nets its liability for unrecognized tax benefits
against deferred tax assets related to net operating
 
losses or other tax credit carryforward on the basis that the uncertain
 
tax position is
settled for the presumed amount at the balance sheet
 
date.
Quaker Houghton also records valuation allowances
 
when necessary to reduce its deferred tax assets to the amount
 
that is more
likely than not to be realized.
 
While the Company has considered future taxable income
 
and assesses the need for a valuation
allowance, in the event Quaker Houghton were
 
to determine that it would be able to realize its deferred tax assets in the future
 
in
excess of its net recorded amount, an adjustment to
 
the deferred tax asset would increase income in the period
 
such determination was
made.
 
Likewise, should the Company determine that it would not be able
 
to realize all or part of its net deferred tax assets in the
future, an adjustment to the deferred tax asset would be
 
charged to income in the period such determination was made.
 
Both
determinations could have a material impact on the Company’s
 
financial statements.
In 2017, the U.S. government enacted comprehensive
 
tax legislation commonly referred to as “U.S. Tax
 
Reform”
 
which
implemented significant changes, particularly impacting
 
taxation for non-U.S. earnings and dividends from certain
 
foreign
subsidiaries.
 
Based on interpretations and assumptions the Company
 
believes to be reasonable with regard to various uncertainties
and ambiguities in the application of certain provisions
 
of U.S. Tax Reform
 
and subsequent to numerous temporary regulations,
notices, and other formal guidance published by the Internal Revenue
 
Service (“I.R.S.”), U.S. Treasury,
 
and various state taxing
authorities in 2018, the Company completed its accounting
 
for the tax effects of U.S. Tax
 
Reform as of December 22, 2018.
 
It is
possible that the I.R.S. could issue subsequent guidance
 
or take positions on audit that differ from the Company’s
 
interpretations and
assumptions.
 
The Company currently believes that subsequent guidance
 
or interpretations made by the I.R.S. will not be materially
different from the Company’s
 
application of the provisions of U.S. Tax
 
Reform and would not have a material adverse effect on
 
the
Company’s tax liabilities,
 
earnings, or financial condition.
Pursuant to U.S. Tax
 
Reform, the Company recorded a $15.5 million transition
 
tax liability for U.S. income taxes on the
undistributed earnings of non-U.S. subsidiaries.
 
As of December 31, 2020, $7.0 million in installment have
 
been paid with the
remaining $8.5 million to be paid through installments
 
in future years.
 
However, the Company may also be subject
 
to other taxes,
such as withholding taxes and dividend distribution
 
taxes, if these undistributed earnings are ultimately remitted to
 
the U.S.
 
As of
December 31, 2020,
 
the Company has a deferred tax liability of $5.9 million, which
 
primarily represents the estimate of the non-U.S.
taxes the Company will incur to remit certain previously taxed
 
earnings to the U.S.
 
It is the Company’s current
 
intention to reinvest
its future undistributed earnings of non-U.S. subsidiaries
 
to support working capital needs and certain other growth
 
initiatives outside
of the U.S.
 
The amount of such undistributed earnings at December 31, 2020
 
was approximately $322.6 million.
 
Any tax liability
which might result from ultimate remittance of these
 
earnings is expected to be substantially offset by foreign
 
tax credits (subject to
certain limitations).
 
It is currently impractical to estimate any such incremental
 
tax expense.
 
See Note 10 of Notes to Consolidated
Financial Statements in Item 8 of this Report.
 
28
Goodwill and other intangible assets:
 
The Company accounts for business combinations und
 
er the acquisition method of
accounting.
 
This method requires the recording of acquired assets, including
 
separately identifiable intangible assets, at their
acquisition date fair values.
 
Any excess of the purchase price over the estimated fair value of
 
the identifiable net assets acquired is
recorded as goodwill.
 
The determination of the estimated fair value of assets acquired
 
requires management’s judgment
 
and often
involves the use of significant estimates and assumptions,
 
including assumptions with respect to future cash inflows
 
and outflows,
discount rates, royalty rates, asset lives and market multiples, among
 
other items.
 
When necessary, the Company
 
consults with
external advisors to help determine fair value.
 
For non-observable market values, the Company may determine
 
fair value using
acceptable valuation principles, including the excess earnings,
 
relief from royalty,
 
lost profit or cost methods.
The Company amortizes definite-lived intangible assets on
 
a straight-line basis over their useful lives.
 
Goodwill and intangible
assets that have indefinite lives are not amortized and are
 
required to be assessed at least annually for impairment.
 
The Company
completes its annual goodwill and indefinite lived intangible
 
asset impairment test during the fourth quarter of each
 
year, or more
frequently if triggering events indicate a possible impairment.
 
In completing a quantitative impairment test, the Company compares
the reporting units’ or indefinite lived intangible assets fair
 
value to their carrying value, primarily based on future discounted
 
cash
flows, in order to determine if an impairment charge
 
is warranted.
 
The estimates of future discounted cash flows involve considerable
management judgment and are based upon certain significant
 
assumptions.
 
These assumptions include the weighted average cost of
capital (“WACC”)
 
as well as projected revenue growth rates and operating
 
income, which result in estimated EBITDA and EBITDA
margins.
 
As of March 31, 2020, the Company evaluated the initial impact
 
of COVID-19 on the Company’s
 
operations, as well as the
volatility and uncertainty in the economic outlook as a
 
result of COVID-19, to determine if this indicated it was more likely
 
than not
that the carrying value of any of the Company’s
 
indefinite-lived or long-lived assets was not recoverable.
 
The Company considered
the negative effect of COVID-19 on the Company’s
 
operations and, at the time, the impact it expected to have
 
on its full year 2020
results in evaluating if a triggering event was present for
 
one or more of the Company indefinite-lived or long-lived
 
assets and, also,
the Company took into consideration the carrying value
 
and estimated fair value for each of its assets.
 
The Company concluded that
the impact of COVID-19 did not represent a triggering
 
event as of March 31, 2020 with regards to any of the Company’s
 
indefinite-
lived and long-lived assets, except for the Company’s
 
Houghton and Fluidcare trademarks
 
and tradename indefinite-lived intangible
assets.
 
Given the relatively short period of time between the
 
fair value determination of the acquired Houghton and Fluidcare
 
trademarks
and tradename intangible assets as of the closing of the
 
Combination on August 1, 2019, and the 2019 annual impairment testing date
of October 1, the Company’s
 
2019 annual impairment assessment concluded that
 
the $242.0 million carrying value of acquired
Houghton and Fluidcare trademarks and tradename intangible
 
assets generally approximated fair value, with excess fair
 
value of less
than 5%.
 
Because of the previously concluded relatively narrow gap
 
between its fair value and its carrying value, the Company
concluded in the first quarter of 2020 that the expected
 
current year impact from COVID-19 on the Company’s
 
net sales represented a
triggering event.
 
As a result of the conclusion, the Company completed an interim
 
quantitative indefinite-lived intangible asset
impairment assessment as of March 31, 2020.
 
The determination of estimated fair value of the Houghton
 
and Fluidcare trademarks
 
and tradename intangible assets was based
on a relief from royalty valuation method which requires
 
management’s judgment
 
and often involves the use of significant estimates
and assumptions, including assumptions with respect to
 
the WACC
 
and royalty rates, as well as revenue growth rates
 
and terminal
growth rates.
 
In completing the interim quantitative impairment assessment as of March
 
31, 2020, the Company used a WACC
assumption of approximately 10% as well as current year
 
forecasted net sales and management’s
 
estimates with respect to future net
sales growth
 
rates specific to legacy Houghton’s
 
net sales.
 
As a result of an increase in the WACC
 
assumption as of March 31, 2020,
compared to the prior year fourth quarter annual impairment
 
assessment, and the significant decline in current year projected
 
legacy
Houghton net sales due to the impact of COVID-19,
 
the Company concluded that the estimated fair values of these intangible
 
assets
were less than their carrying values and that an
 
impairment charge to write down their carrying values
 
to their estimated fair values
was warranted.
 
This resulted in a first quarter of 2020 non-cash impairment
 
charge of $38.0 million for these indefinite-lived
intangible assets, primarily related to the Houghton trademarks
 
and tradename.
 
The book value of these assets as of December 31,
2020 was $204.0 million.
 
The Company’s consolidated
 
goodwill at December 31, 2020 and 2019 was $631.2
 
million and $607.2 million, respectively.
 
The
Company completed its annual impairment assessment over
 
goodwill during the fourth quarter of 2020, and no impairment
 
charges
were warranted.
 
Furthermore, the estimated fair value of each of the Company’s
 
reporting units substantially exceeded their carrying
value, with none of the Company’s
 
reporting units at risk for failing the goodwill impairment test.
 
The Company used a WACC
assumption for each of its reporting units of approximately
 
9.5%, and this assumption would have had to increase
 
by approximately
59%, or 6 percentage points, before any of the Company’s
 
reporting units would be considered potentially impaired.
 
Separately,
 
the
Company’s assumption
 
of future and projected EBITDA margins by reporting
 
unit would have had to decrease by more than
approximately 75%
 
before any of the Company’s
 
reporting units would be considered potentially impaired.
 
The Company’s
consolidated indefinite-lived intangible assets at December
 
31, 2020 and 2019 were $205.1 million and $243.1 million,
 
respectively.
 
The Company completed its annual indefinite lived
 
intangible asset impairment assessment during the fourth quarter
 
of 2020, and
determined that no impairment charge was
 
warranted.
 
The Company’s impairment assessment
 
concluded that the $204.0 million
carrying value of acquired Houghton and Fluidcare
 
trademarks and tradename intangible assets exceeded fair value
 
by approximately
18%.
 
See Note 16 of Notes to Consolidated Financial Statements in
 
Item 8 of this Report.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
29
Pension and Postretirement benefits:
 
The Company provides certain defined benefit pension
 
and other postretirement benefits
to current employees, former employees and retirees.
 
Independent actuaries, in accordance with U.S. GAAP,
 
perform the required
valuations to determine benefit expense and, if necessary,
 
non-cash charges to equity for additional minimum
 
pension liabilities.
 
Critical assumptions used in the actuarial valuation include
 
the weighted average discount rate, which is based on applicable
 
yield
curve data,
 
including the use of a split discount rate (spot-rate approach)
 
for the U.S. plans and certain foreign plans, rates of increase
in compensation levels, and expected long-term rates of
 
return on assets.
 
If different assumptions were used, additional
 
pension
expense or charges to equity might be required.
 
The Company had two noncontributory U.S. pension plan
 
s, one of which (the “Legacy Quaker U.S. Pension Plan”) had
 
a
November 30 year-end and a measurement date of December
 
31.
 
As previously disclosed, the Company began the process of
terminating the Legacy Quaker U.S. Pension Plan during
 
the fourth quarter of 2018.
 
During the third quarter of 2019, the Company
received a favorable termination determination letter
 
from the Internal Revenue Service (“I.R.S.”) and completed the
 
Legacy Quaker
U.S. Pension Plan termination during the first quarter
 
of 2020.
 
In order to terminate the Legacy Quaker U.S. Pension Plan
 
in
accordance with I.R.S. and Pension Benefit Guaranty Corporation
 
requirements, the Company was required to fully fund the Legacy
Quaker U.S. Pension Plan on a termination basis and
 
the amount necessary to do so was approximately $1.8 million, subject to
 
final
true up adjustments.
 
In the third quarter of 2020, the Company finalized the amount
 
of the liability and related annuity payments and
received a refund in premium of approximately $1.6
 
million.
 
In addition, the Company recorded a non-cash pension settlement
 
charge
at plan termination of approximately $22.7 million.
 
This settlement charge included the immediate recognition
 
into expense of the
related unrecognized losses within accumulated other
 
comprehensive income (loss) (“AOCI”) on the balance sheet
 
as of the plan
termination date.
 
The following table highlights the potential impact
 
on the Company’s pre
 
-tax earnings due to changes in assumptions with respect
to the Company’s defined
 
benefit pension and postretirement benefit plans, based on assets and
 
liabilities as of December 31, 2020:
1/2 Percentage Point Increase
1/2 Percentage Point Decrease
(dollars in millions)
Foreign
U.S.
Total
Foreign
U.S.
Total
Discount rate (1)
$
0.4
$
0.2
$
0.6
$
(0.4)
$
(0.2)
$
(0.6)
Expected rate of return on plan
assets (2)
0.9
0.2
1.1
(1.0)
(0.2)
(1.2)
(1)
 
The weighted-average discount rate used to determine
 
net periodic benefit costs for the year ended December 31, 2020 was
2.3%
 
for Foreign plans and 3.1% for
 
U.S. plans.
 
(2)
 
The weighted average expected rate of return on plan
 
assets used to determine net periodic benefit costs for the year ended
December 31, 2020 was 2.2% for Foreign plans and
 
6.5% for U.S. plans.
Restructuring and other related liabilities:
 
A restructuring related program may consist of charges
 
for employee severance,
rationalization of manufacturing facilities and other related
 
expenses.
 
To account for
 
such, the Company applies the Financial
Accounting Standards Board’s
 
guidance regarding exit or disposal cost obligations.
 
This guidance requires that a liability for a cost
associated with an exit or disposal activity be recognized
 
when the liability is incurred, is estimable, and payment is probable.
 
See
Note 7 of Notes to Consolidated Financial Statements in
 
Item 8 of this Report.
Recently Issued Accounting Standards
See Note 3 of Notes to the Consolidated Financial Statements in
 
Item 8 of this Report for a discussion regarding recently issued
accounting standards.
 
Liquidity and Capital Resources
At December 31, 2020, the Company had cash,
 
cash equivalents and restricted cash of $181.9 million.
 
Total cash, cash
equivalents and restricted cash was $143.6 million
 
at December 31, 2019.
 
The $38.3 million increase in cash, cash equivalents and
restricted cash was the net result of $178.4 million
 
of cash provided by operating activities and $6.6 million
 
of positive impacts due to
the effect of foreign currency translation on
 
cash, partially offset by $75.3 million of cash used in financing
 
activities and $71.4
million of cash used in investing activities.
 
Net cash flows provided by operating activities were $178.4
 
million in 2020 compared to $82.4 million in 2019.
 
The Company’s
current year net operating cash flow increase was largely
 
due to higher earnings from including a full year of Houghton
 
and Norman
Hay, lower net
 
cash outflows than in 2019 associated with restructuring and the Combination
 
and other acquisition-related expenses,
higher cash dividends received from its equity affiliated
 
companies year-over-year, and higher operating
 
cashflow from changes in
working capital.
 
The operating cashflow improvement due to working capital
 
changes includes benefits from changes in accounts
payable and accrued liabilities due to more favorable negotiated
 
vendor terms and other benefits from the Combination, impacts
 
due to
volume declines related to COVID-19, and lower
 
cash tax payments due to current year mix of earnings and deductibility of
 
one-time
expenses.
 
Net cash flows used in investing activities were $71.4
 
million in 2020 compared to $908.6 million in 2019.
 
This $837.2 million
decrease in cash outflows used in investing activities
 
was largely due to a decrease in payments related to
 
acquisitions as the prior year
$893.4 million outflow included the closing of the
 
Combination on August 1, 2019, as further described below,
 
compared to the
 
30
current year payments related to acquisitions
 
of $56.2 million that were mainly driven by the acquisition of Coral
 
for approximately
$53.1
 
million,
 
net of cash acquired, further described below,
 
and a post-closing adjustment related to Norman Hay of approximately
$3.2 million.
 
In addition, the Company had higher investments in property,
 
plant and equipment in the current year due to the
inclusion of a full year of both Houghton and Norman
 
Hay, including higher
 
expenditures related to integrating the companies during
2020.
 
These higher outflows were partially offset by approximately
 
$2.6 million of higher proceeds from disposition of assets in
2020, which was mainly driven by the sale of certain
 
assets as part of its Combination integration plan.
 
Net cash flows used in financing activities
 
were $75.3 million in 2020 compared to cash provided
 
in financing activities of $844.1
million in 2019.
 
The $919.4 million decrease in net cash flows from financing
 
activities was due primarily to $897.1 million of
additional term loan and revolving credit facility borrowings in
 
the prior year used to close the Combination compared
 
to $49.1
million of current year debt repayments in accordance with
 
its term loan agreements and other reductions in borrowings
 
under its
revolving credit facilities.
 
Also, as part of the Combination, the Company incurred and
 
paid debt issuance costs of approximately
$23.7 million in the prior year.
 
In addition, the Company paid $27.6 million of cash dividends
 
during 2020, a $5.7 million or 26%
increase in cash dividends compared to the prior year,
 
primarily due to the approximately 4.3 million shares issued at closing
 
of the
Combination, as well as both the current year and
 
prior year cash dividend per share increases.
 
Finally, during
 
2020, the Company
used $1.0 million to purchase the remaining noncontrolling
 
interest in one of its South African affiliates.
 
Prior to this buyout, this
South African affiliate made a distribution
 
to the prior noncontrolling affiliate shareholder of approximately
 
$0.8 million in 2020.
 
There were no similar noncontrolling interest activities in
 
2019.
 
On August 1, 2019, the Company completed the Combination,
 
whereby the Company acquired all of the issued and outstanding
shares of Houghton from Gulf Houghton Lubricants, Ltd.
 
in accordance with the Share Purchase Agreement dated
 
April 4, 2017.
 
The
final purchase consideration was comprised of:
 
(i) $170.8 million in cash; (ii) the issuance of approximately
 
4.3 million shares of
common stock of the Company with par value of $1.00,
 
comprising 24.5% of the common stock of the Company
 
at closing; and (iii)
the Company’s refinancing
 
of $702.6 million of Houghton’s
 
indebtedness at closing.
 
Cash acquired in the Combination was $75.8
million.
 
Prior to the Combination, the Company secured commitments
 
from certain banks for a new credit facility (as amended,
 
the
“Credit Facility”).
 
The Credit Facility is comprised of a $400.0 million multicurrency
 
revolver (the “Revolver”), a $600.0 million term loan (the
“U.S. Term Loan”),
 
each with the Company as borrower,
 
and a $150.0 million (as of August 1, 2019) Euro equivalent term
 
loan (the
“Euro Term Loan”
 
and together with the “U.S. Term
 
Loan”, the “Term
 
Loans”) with Quaker Chemical B.V.,
 
a Dutch subsidiary of the
Company as borrower, each
 
with a five-year term maturing in August 2024.
 
Subject to the consent of the administrative agent and
certain other conditions, the Company may designate
 
additional borrowers.
 
The maximum amount available under the Credit Facility
can be increased by up to $300.0 million at the Company’s
 
request if there are lenders who agree to accept additional commitments
and the Company has satisfied certain other conditions.
 
Borrowings under the Credit Facility bear interest at a base rate
 
or LIBOR
plus an applicable margin based upon the
 
Company’s consolidated net leverage
 
ratio.
 
There are LIBOR replacement provisions that
contemplate a further amendment if and when LIBOR ceases
 
to be reported.
 
The interest rate incurred on the outstanding borrowings
under the Credit Facility during 2020 was approximately
 
2.1%.
 
At December 31, 2020, the interest rate on the
 
outstanding
borrowings under the Credit Facility was approximately
 
1.9%.
 
In addition to paying interest on outstanding principal under
 
the Credit
Facility, the Company
 
is required to pay a commitment fee ranging from 0.2% to
 
0.3% depending on the Company’s
 
consolidated net
leverage ratio to the lenders under the Revolver in
 
respect of the unutilized commitments thereunder.
The Credit Facility is subject to certain financial and
 
other covenants.
 
The Company’s initial consolidated
 
net debt to
consolidated adjusted EBITDA ratio could not exceed
 
4.25 to 1, with step downs in the permitted ratio over the
 
term of the Credit
Facility.
 
As of December 31, 2020, the consolidated net debt to consolidated
 
adjusted EBITDA ratio may not exceed 4.00 to 1.
 
The
Company’s consolidated
 
adjusted EBITDA to interest expense ratio may not be less than
 
3.0 to 1 over the term of the agreement.
 
The
Credit Facility also prohibits
 
the payment of cash dividend if the Company is in default
 
or if the amount of the dividend paid annually
exceeds the greater of $50.0 million and 20% of consolidated
 
adjusted EBITDA unless the ratio of consolidated
 
net debt to
consolidated adjusted EBITDA is less than 2.0 to 1,
 
in which case there is no such limitation on amount.
 
As of December 31, 2020
and December 31, 2019, the Company was in compliance
 
with all of the Credit Facility covenants.
 
The Term Loans have
 
quarterly
principal amortization during their five-year terms,
 
with 5.0% amortization of the principal balance due in years 1 and
 
2, 7.5% in year
3, and 10.0% in years 4 and 5, with the remaining principal
 
amount due at maturity.
 
The Credit Facility is guaranteed by certain of the
Company’s domestic subsidiaries
 
and is secured by first priority liens on substantially all of
 
the assets of the Company and the
domestic subsidiary guarantors, subject to certain customary exclusions.
 
The obligations of the Dutch borrower are guaranteed only
by certain foreign subsidiaries on an unsecured basis.
The Credit Facility required the Company to fix its variable
 
interest rates on at least 20% of its total Term
 
Loans.
 
In order to
satisfy this requirement as well as to manage the
 
Company’s exposure to variable
 
interest rate risk associated with the Credit Facility,
in November 2019, the Company entered into $170.0
 
million notional amounts of three-year interest rate swaps at a base
 
rate of
1.64% plus an applicable margin as provided
 
in the Credit Facility, based on
 
the Company’s consolidated net
 
leverage ratio.
 
At the
time the Company entered into the swaps, and as
 
of December 31, 2020, the aggregate interest rate on the swaps,
 
including the fixed
base rate plus an applicable margin, was 3.1%.
 
 
 
31
The Company capitalized $23.7 million of certain third-party
 
debt issuance costs in connection with executing the
 
Credit Facility.
 
Approximately $15.5 million of the capitalized costs were attributed
 
to the Term Loans and
 
recorded as a direct reduction of long-
term debt on the Company’s
 
Consolidated Balance Sheet.
 
Approximately $8.3 million of the capitalized costs were
 
attributed to the
Revolver and recorded within other assets on the Company’s
 
Consolidated Balance Sheet.
 
These capitalized costs are being
amortized into interest expense over the five-year term
 
of the Credit Facility.
 
As of December 31, 2020, the Company had Credit Facility
 
borrowings outstanding of $887.1 million.
 
As of December 31, 2019,
the Company had Credit Facility borrowings outstandin
 
g
 
of $922.4 million.
 
The Company has unused capacity under the Revolver of
approximately $234 million, net of bank letters of
 
credit of approximately $6 million, as of December 31, 2020.
 
The Company’s other
debt obligations are primarily industrial development
 
bonds, bank lines of credit and municipality-related loans, which
 
totaled $12.1
million and $12.6 million as of December 31, 2020 and
 
2019, respectively.
 
Total unused capacity
 
under these arrangements as of
December 31, 2020 was approximately $40 million.
 
The Company’s total net debt
 
as of December 31, 2020 was $717.3 million.
The Company estimates that it realized full year cost synergies
 
in 2020 of approximately $58 million compared to
 
$7 million in
2019.
 
The Company continues to expect to realize Combination cost synergies
 
of approximately $75 million in 2021 and $80 million
in 2022.
The Company expects to continue to incur additional costs
 
and make associated cash payments to integrate Quaker
 
and Houghton
and continue realizing the Combination’s
 
total anticipated cost synergies.
 
The Company expects total cash payments, including those
pursuant to the QH Program, described below,
 
but excluding incremental capital expenditures related to
 
the Combination, will be in
the range of 1.3 times its total anticipated 2022 cost
 
synergies of $80 million.
 
A significant portion of these costs were already
incurred in 2019 and 2020, but the Company expects
 
to continue to incur such costs through 2021.
 
The Company incurred $30.3
million of total Combination, integration and other acquisition-related
 
expenses in 2020, including $0.8 million of accelerated
depreciation, a $0.6 million loss on the sale of held-for-sale
 
assets, and $0.8 million of other income related to an indemnification
asset, described in the Non-GAAP Measures section of this
 
Item below.
 
The Company had aggregate net cash outflows of
approximately $29.4 million related to the Combination,
 
integration and other acquisition-related expenses during
 
2020.
 
Comparatively,
 
in 2019, the Company incurred $38.0 million of total Combination,
 
integration and other acquisition-related expenses,
including $2.1 million of ticking fees as well as $0.6
 
million of accelerated depreciation, and aggregate net cash outflows related
 
to
these costs were approximately $52.4 million.
Quaker Houghton’s management
 
approved, and the Company initiated, a global restructuring
 
plan (the “QH Program”) in the
third quarter of 2019 as part of its planned cost synergies
 
associated with the Combination and recorded $26.7
 
million in restructuring
and related charges in 2019.
 
The Company recognized an additional $5.5 million of
 
restructuring and related charges in 2020 as
 
a
result of the QH Program.
 
The QH Program includes restructuring and associated severance costs to
 
reduce total headcount by
approximately 350 people globally and plans for the
 
closure of certain manufacturing and non-manufacturing
 
facilities.
 
In connection
with the plans for closure of certain manufacturing and
 
non-manufacturing facilities, the Company made a decision
 
to make available
for sale certain facilities during the second quarter of 2020.
 
During the fourth quarter of 2020, certain of these facilities were
 
sold and
the Company recognized a loss on disposal of $0.6 million
 
included within other expense, net on the Consolidated Statement
 
of
Income.
 
Additionally, certain
 
buildings and land with an aggregate book value of
 
approximately $10.0 million have been reclassified
to other current assets from property,
 
plant and equipment as of December 31, 2020.
 
The Company expects to receive amounts
 
in
excess of net book value for the properties held for sale.
 
The exact timing and total costs associated with the QH Program
 
will depend
on a number of factors and is subject to change;
 
however, the Company currently expects
 
reduction in headcount and site closures will
continue to occur into 2021 under the QH Program
 
and estimates that the anticipated cost synergies realized
 
under this program will
approximate one-times restructuring costs incurred.
 
The Company made cash payments related to the settlement
 
of restructuring
liabilities under the QH Program during 2020 of approximately
 
$15.7 million compared to $8.9 million in 2019.
 
As described above, in the first quarter of 2020, the
 
Company completed the termination of the Legacy Quaker U.S. Pension
 
Plan
and funded the plan on a termination basis with approximately
 
$1.8 million, subject to final true up adjustments.
 
In the third quarter
of 2020, the Company finalized the amount of liability and
 
related annuity payments and received a refund in premium
 
of $1.6
million.
 
In addition, the Company recorded a non-cash pension settlement charge
 
at plan termination of approximately $22.7 million
in the first quarter of 2020.
On December 22, 2020, the Company closed its acquisition
 
of Coral Chemical Company (“Coral”), a privately held,
 
U.S. based
provider of metal finishing fluid solutions.
 
The purchase price was $54.1 million,
 
on a cash-free and debt-free basis, subject to routine
and customary post-closing adjustments related to working
 
capital and net indebtedness levels.
 
The Company expects to finalize its
post-closing adjustments for the Coral acquisition in the first quarter
 
of 2021.
 
Cash paid for Coral in the fourth quarter of 2020 was
approximately $53.1 million, net of cash acquired.
 
In February 2021, the Company acquired certain assets related to
 
tin-plating
solutions primarily for steel end markets for approximately
 
$25 million.
As of December 31, 2020, the Company’s
 
gross liability for uncertain tax positions, including interest
 
and penalties, was $28.9
million.
 
The Company cannot determine a reliable estimate of the
 
timing of cash flows by period related to its uncertain tax position
liability.
 
However, should the entire liability
 
be paid, the amount of the payment may be reduced by up
 
to $7.5 million as a result of
offsetting benefits in other tax jurisdictions.
 
During the fourth quarter of 2020, one of the Company’s
 
subsidiaries received a notice of
inspection from a taxing authority in a country where certain
 
of its subsidiaries operate, which related to a non-income
 
(indirect) tax
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
32
that may be applicable to certain products the subsidiary
 
sells.
 
To date, the Company
 
has not received any assessment from the
authority related to potential liabilities that may be due
 
from the Company’s subsidiary.
 
Consequently there is substantial uncertainty
with respect to the Company’s
 
ultimate liability with respect to this indirect tax.
 
See Note 26 of Notes to Consolidated Financial
Statements in Item 8 of this Report.
The Company believes that its existing cash, anticipated
 
cash flows from operations and available additional liquidity
 
will be
sufficient to support its operating requirements
 
and fund its business objectives for at least the next twelve
 
months, including but not
limited to, payments of dividends to shareholders, costs related
 
to the Combination and integration, pension plan contributions,
 
capital
expenditures, other business opportunities (including
 
potential acquisitions) and other potential contingencies.
 
The Company’s
liquidity is affected by many factors, some
 
based on normal operations of our business and others related
 
to the impact of the
pandemic on our business and on global economic
 
conditions as well as industry uncertainties, which we cannot
 
predict.
 
We also
cannot predict economic conditions and industry downturns
 
or the timing, strength or duration of recoveries.
 
We may seek,
 
as we
believe appropriate, additional debt or equity financing
 
which would provide capital for corporate purposes, working
 
capital funding,
additional liquidity needs or to fund future growth opportunities, including
 
possible acquisitions and investments.
 
The timing and
amount of potential capital requirements cannot be
 
determined at this time and will depend on a number of factors,
 
including the
actual and projected demand for our products, specialty
 
chemical industry conditions, competitive factors, and the
 
condition of
financial markets, among others.
 
The following table summarizes the Company’s
 
contractual obligations as of December 31, 2020, and the effect
 
such obligations
are expected to have on its liquidity and cash flows in
 
future periods.
 
Pension and postretirement plan contributions beyond 2021
 
are
not determinable since the amount of any contribution
 
is heavily dependent on the future economic environment and investment
returns on pension trust assets.
 
The timing of payments related to other long-term liabilities which
 
consists primarily of deferred
compensation agreements and environmental reserves,
 
also cannot be readily determined due to their uncertainty.
 
Interest obligations
on the Company’s long-term
 
debt and capital leases assume the current debt levels will be outstanding
 
for the entire respective period
and apply the interest rates in effect as of
 
December 31, 2020.
 
Payments due by period
(dollars in thousands)
2026 and
Contractual Obligations
Total
2021
2022
2023
2024
2025
Beyond
Long-term debt
$
898,789
$
38,686
$
57,754
$
76,856
$
715,155
$
172
$
10,166
Interest obligations
52,997
14,514
13,703
12,583
10,444
526
1,227
Capital lease obligations
439
109
96
87
72
59
16
Operating leases
43,544
12,342
8,395
6,220
4,610
3,836
8,141
Purchase obligations
2,377
2,279
92
6
-
-
-
Transition tax
8,500
-
-
1,529
3,099
3,872
-
Pension and other postretirement plan
 
contributions
10,280
10,280
-
-
-
-
-
Other long-term liabilities (See Note 22 of
Notes to Consolidated Financial Statements)
12,494
-
-
-
-
-
12,494
Total contractual
 
cash obligations
$
1,029,420
$
78,210
$
80,040
$
97,281
$
733,380
$
8,465
$
32,044
Non-GAAP Measures
The information in this Form 10-K filing includes non-GAAP (unaudited)
 
financial information that includes EBITDA, adjusted
EBITDA, adjusted EBITDA margin, non-GAAP operating
 
income, non-GAAP operating margin, non-GAAP
 
net income and non-
GAAP earnings per diluted share.
 
The Company believes these non-GAAP financial measures provide
 
meaningful supplemental
information as they enhance a reader’s understanding
 
of the financial performance of the Company,
 
are indicative of future operating
performance of the Company,
 
and facilitate a comparison among fiscal periods, as the
 
non-GAAP financial measures exclude items
that are not considered indicative of future operating performance
 
or not considered core to the Company’s
 
operations.
 
Non-GAAP
results are presented for supplemental informational
 
purposes only and should not be considered a substitute for the
 
financial
information presented in accordance with GAAP.
 
The Company presents EBITDA which is calculated as net income
 
attributable to the Company before depreciation and
amortization, interest expense, net, and taxes on income
 
before equity in net income of associated companies.
 
The Company also
presents adjusted EBITDA which is calculated as EBITDA plus
 
or minus certain items that are not considered indicative
 
of future
operating performance or not considered core to the Company’s
 
operations.
 
In addition, the Company presents non-GAAP operating
income which is calculated as operating income plus or
 
minus certain items that are not considered indicative of future operating
performance or not considered core to the Company’s
 
operations.
 
Adjusted EBITDA margin and non-GAAP operating
 
margin are
calculated as the percentage of adjusted EBITDA and
 
non-GAAP operating income to consolidated net sales, respectively.
 
The
Company believes these non-GAAP measures provide
 
transparent and useful information and are widely used by analysts, investors,
and competitors in our industry as well as by management
 
in assessing the operating performance of the Company on
 
a consistent
basis.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
33
Additionally, the
 
Company presents non-GAAP net income and non-GAAP earnings
 
per diluted share as additional performance
measures.
 
Non-GAAP net income is calculated as adjusted EBITDA, defined
 
above, less depreciation and amortization, interest
expense, net, and taxes on income before equity in
 
net income of associated companies, in each case adjusted,
 
as applicable, for any
depreciation, amortization, interest or tax impacts resulting
 
from the non-core items identified in the reconciliation
 
of net income
attributable to the Company to adjusted EBITDA.
 
Non-GAAP earnings per diluted share is calculated as non
 
-GAAP net income per
diluted share as accounted for under the “two-class share
 
method.”
 
The Company believes that non-GAAP net income and non-
GAAP earnings per diluted share provide transparent
 
and useful information and are widely used by analysts, investors,
 
and
competitors in our industry as well as by management in
 
assessing the operating performance of the Company on a consistent
 
basis.
The following tables reconcile the Company’s
 
non-GAAP financial measures (unaudited) to their most
 
directly comparable
GAAP financial measures (dollars in thousands, unless otherwise
 
noted, except per share amounts):
 
Non-GAAP Operating Income and Margin Reconciliations
For the years ended December 31,
2020
2019
2018
Operating income
$
59,360
$
46,134
$
87,781
Fair value step up of inventory sold (a)
226
11,714
Houghton combination, integration and other
 
acquisition-related expenses (b)
30,446
35,945
16,661
Restructuring and related charges (c)
5,541
26,678
Customer bankruptcy costs (d)
463
1,073
Charges related to the settlement of a non-core
 
equipment sale (e)
384
Indefinite-lived intangible asset impairment (f)
38,000
Non-GAAP operating income
$
134,036
$
121,928
$
104,442
Non-GAAP operating margin (%) (o)
9.5%
10.8%
12.0%
 
EBITDA, Adjusted EBITDA, Adjusted EBITDA Margin and
Non-GAAP Net Income Reconciliations
For the years ended December 31,
2020
2019
2018
Net income attributable to Quaker Chemical Corporation
$
39,658
$
31,622
$
59,473
Depreciation and amortization (b)(m)
84,494
45,264
19,714
Interest expense, net (b)
26,603
16,976
4,041
Taxes on income
 
before equity in net income of associated companies (n)
(5,296)
2,084
25,050
EBITDA
145,459
95,946
108,278
Equity income in a captive insurance company (g)
(1,151)
(1,822)
(966)
Fair value step up of inventory sold (a)
226
11,714
Houghton combination, integration and other
 
acquisition-related expenses (b)
29,538
35,361
16,051
Restructuring and related charges (c)
5,541
26,678
Customer bankruptcy costs (d)
463
1,073
Charges related to the settlement of a non-core
 
equipment sale (e)
384
Indefinite-lived intangible asset impairment (f)
38,000
Pension and postretirement benefit costs, non-service components
 
(h)
21,592
2,805
2,285
Gain on changes in insurance settlement restrictions of an
 
inactive
 
subsidiary and related insurance insolvency recovery (i)
(18,144)
(60)
(90)
Gain on liquidation of an inactive legal entity (j)
(446)
Currency conversion impacts of hyper-inflationary economies (k)
450
1,033
664
Adjusted EBITDA
$
221,974
$
173,112
$
125,776
Adjusted EBITDA margin (%) (o)
15.7%
15.3%
14.5%
Adjusted EBITDA
$
221,974
$
173,112
$
125,776
Less: Depreciation and amortization - adjusted (b)
83,732
44,680
19,714
Less: Interest expense, net - adjusted (b)
26,603
14,896
593
Less: Taxes on income
 
before equity in net income
 
of associated companies - adjusted (l)(n)
26,488
24,825
22,978
Non-GAAP net income
$
85,151
$
88,711
$
82,491
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
34
Non-GAAP Earnings per Diluted Share Reconciliations
For the years ending December 31,
2020
2019
2018
GAAP earnings per diluted share attributable to
Quaker Chemical Corporation common shareholders
$
2.22
$
2.08
$
4.45
Equity income in a captive insurance company per diluted
 
share (g)
(0.07)
(0.12)
(0.07)
Fair value step up of
 
inventory sold per diluted share (a)
0.01
0.58
Houghton combination, integration and other
 
 
acquisition-related expenses per diluted share (b)
1.31
2.05
1.21
Restructuring and related charges per diluted
 
share (c)
0.23
1.34
Customer bankruptcy costs per diluted share (d)
0.02
0.05
Charges related to the settlement of a non-core
 
equipment
 
sale per diluted share (e)
0.02
Indefinite-lived intangible asset impairment per diluted
 
share (f)
1.65
Pension and postretirement benefit costs, non-service
 
 
components per diluted share (h)
0.79
0.14
0.13
Gain on changes in insurance settlement restrictions of an
 
inactive
 
 
subsidiary and related insurance insolvency recovery per diluted
 
share (i)
(0.78)
(0.00)
(0.01)
Gain on liquidation of an inactive legal entity per diluted
 
share (j)
(0.03)
Currency conversion impacts of hyper-inflationary economies
 
per diluted share (k)
0.02
0.07
0.06
Impact of certain discrete tax items per diluted share (l)
(0.62)
(0.38)
0.43
Non-GAAP earnings per diluted share (p)
$
4.78
$
5.83
$
6.17
(a)
 
Fair value step up of inventory sold relates to expenses associated
 
with selling inventory from acquired businesses which
 
was
adjusted to fair value as part of purchase accounting.
 
These increases to costs of goods sold (“COGS”) are not indicative
 
of the
future operating performance of the Company.
 
(b)
 
Houghton combination, integration and other acquisition-related
 
expenses include certain legal, financial, and other advisory
 
and
consultant costs incurred in connection with due diligence,
 
regulatory approvals and closing the Combination, as well as
integration planning and post-closing integration activities including
 
internal control readiness and remediation.
 
These cost also
include certain one-time labor costs associated with the Company’s
 
acquisition-related activities.
 
These costs are not indicative
of the future operating performance of the Company.
 
Approximately $1.5 million, $9.4 million and $5.1 million for
 
the years
ended December 31, 2020, 2019 and 2018, respectively,
 
of these pre-tax costs were considered non-deductible for the
 
purpose of
determining the Company’s
 
effective tax rate, and, therefore, taxes on income before
 
equity in net income of associated
companies - adjusted reflects the impact of these items.
 
During 2020 and 2019, the Company recorded $0.8 million
 
and $0.6
million, respectively,
 
of accelerated depreciation related to certain of the Company’s
 
facilities, which is included in the caption
“Houghton combination, integration and other acquisition
 
-related expenses” in the reconciliation of operating income
 
to non-
GAAP operating income and included in the caption
 
“Depreciation and amortization” in the reconciliation of net
 
income
attributable to the Company to EBITDA, but excluded from
 
the caption “Depreciation and amortization – adjusted” in the
reconciliation of adjusted EBITDA to non-GAAP net
 
income attributable to the Company.
 
During 2019 and 2018, the Company
incurred $2.1 million and $3.5 million, respectively,
 
of ticking fees to maintain the bank commitment related
 
to the Combination.
 
These interest costs are included in the caption “Interest expense,
 
net” in the reconciliation of net income attributable to
 
the
Company to EBITDA, but are excluded from the caption
 
“Interest expense, net – adjusted” in the reconciliation of adjusted
EBITDA to non-GAAP net income.
 
During 2020, the Company recorded $0.8 million of other income
 
related to an
indemnification asset.
 
During 2020 and 2018, the Company recorded a loss of
 
$0.6 million and a gain of $0.6 million,
respectively, on the
 
sale of held-for-sale assets related to the Combination.
 
Each of these items are included in the caption
“Houghton combination, integration and other acquisition
 
expenses” in the reconciliation of GAAP earnings per diluted
 
share
attributable to Quaker Chemical Corporation common shareholders
 
to Non-GAAP earnings per diluted share as well as the
reconciliation of Net Income attributable to Quaker Chemical Corporation
 
to Adjusted EBITDA and Non-GAAP net income See
Note 2 and Note 9 of Notes to Consolidated Financial Statements,
 
which appears in Item 8 of this Report.
(c)
 
Restructuring and related charges represent
 
the costs incurred by the Company associated with the QH restructuring
 
program
which was initiated in the third quarter of 2019 as part
 
of the Company’s plan
 
to realize cost synergies associated with the
Combination.
 
These costs are not indicative of the future operating performance
 
of the Company.
 
See Note 7 of Notes to
Consolidated Financial Statements, which appears in Item
 
8 of this Report.
 
(d)
 
Customer bankruptcy costs represent the cost associated
 
with a specific reserve for trade accounts receivable related
 
to a customer
who filed for bankruptcy protection.
 
These expenses are not indicative of the future operating
 
performance of the Company.
 
See
Note 13 of Notes to Consolidated Financial Statements, which
 
appears in Item 8 of this Report.
 
35
(e)
 
Charges related to the settlement of a non-core
 
equipment sale represent the pre-tax charge related to
 
a one-time, uncommon,
customer settlement associated with a prior sale of non
 
-core equipment.
 
These charges are not indicative of the future operating
performance of the Company.
(f)
 
Indefinite-lived intangible asset impairment represents the
 
non-cash charge taken to write down the value
 
of certain indefinite-
lived intangible assets associated with the Houghton
 
Combination.
 
The Company has no prior history of goodwill or intangible
asset impairments and this charge is not indicative
 
of the future operating performance of the Company.
 
See Note 16 of Notes to
Consolidated Financial Statements, which appears in Item
 
8 of this Report.
(g)
 
Equity income in a captive insurance company represents the
 
after-tax income attributable to the Company’s
 
interest in Primex,
Ltd. (“Primex”), a captive insurance company.
 
The Company holds a 32% investment in and has significant
 
influence over
Primex, and therefore accounts for this investment under
 
the equity method of accounting.
 
The income attributable to Primex is
not indicative of the future operating performance of the
 
Company and is not considered core to the Company’s
 
operations.
(h)
 
Pension and postretirement benefit costs, non-service components
 
represent the pre-tax, non-service components of the
Company’s pension and
 
postretirement net periodic benefit cost in each period.
 
These costs are not indicative of the future
operating performance of the Company.
 
The year ended December 31, 2020 includes a $22.7 million
 
settlement charge for the
Company’s termination
 
of the Legacy Quaker U.S. Pension Plan.
 
See Note 21 of Notes to Consolidated Financial Statements,
which appears in Item 8 of this Report.
(i)
 
Gain on changes in insurance settlement restrictions of an
 
inactive subsidiary and related insurance insolvency recovery
represents income associated with the gain on the termination
 
of restrictions on insurance settlement reserves and the cash
receipts from an insolvent insurance carrier for previously
 
submitted claims by an inactive subsidiary of the Company.
 
This other
income is not indicative of the future operating performance
 
of the Company.
 
See Notes 9 and 26 of Notes to Consolidated
Financial Statements, which appears in Item 8 of this Report.
(j)
 
Gain on liquidation of an inactive legal entity represents
 
the decrease in historical cumulative currency translation adjustments
associated with an inactive legal entity which was closed.
 
These cumulative currency translation adjustments were the result of
remeasuring the legal entity’s
 
monetary assets and liabilities to the applicable published
 
exchange rates and were a component of
accumulated other comprehensive loss, which was included
 
in total shareholder’s equity on the Company’s
 
Consolidated Balance
Sheet.
 
As required under U.S. GAAP,
 
when a legal entity is liquidated, any amount attributable to that
 
legal entity and
accumulated in the currency translation adjustment component
 
of equity is required to be removed from equity and reported
 
as
part of the gain or loss on liquidation of the legal entity
 
during the period in which the liquidation occurs.
 
This non-deductible
recognized gain is not indicative of the future operating
 
performance of the Company.
 
See Note 9 of Notes to Consolidated
Financial Statements, which appears in Item 8 of this Report.
(k)
 
Currency conversion impacts of hyper-inflationary economies represents
 
the foreign currency remeasurement impacts associated
with the Company’s affiliates
 
whose local economies are designated as hyper-inflationary
 
under U.S. GAAP.
 
An entity which
operates within an economy deemed to be hyper-inflationary
 
under U.S. GAAP is required to remeasure its monetary
 
assets and
liabilities to the applicable published exchange rates and
 
record the associated gains or losses resulting from the remeasurement
directly to the Consolidated Statements of Income.
 
Venezuela’s
 
economy has been considered hyper-inflationary
 
under U.S.
GAAP since 2010, while Argentina’s
 
economy has been considered hyper-inflationary beginning
 
July 1, 2018.
 
In addition, the
Company acquired an Argentine Houghton
 
subsidiary which also applies hyper-inflationary accounting.
 
During 2020 and 2019,
the Company incurred non-deductible, pre-tax charges
 
related to the Company’s Argentine
 
affiliates.
 
During 2018, the Company
incurred non-deductible, pre-tax charges related
 
to the Company’s Legacy
 
Quaker Argentine affiliate as well as after
 
-tax charges
related to the Company’s
 
Venezuela
 
joint venture.
 
The charges incurred related to the immediate recognition
 
of foreign currency
remeasurement in the Consolidated Statements of
 
Income associated with these entities are not indicative of the
 
future operating
performance of the Company.
 
See Notes 1, 9 and 17 of Notes to Consolidated Financial
 
Statements, which appears in Item 8 of
this Report.
 
(l)
 
The impacts of certain discrete tax items included the impact of
 
changes in the valuation allowance for foreign tax credits
acquired with the Combination, changes in withholding
 
tax rates and the associated impact on previously accrued
 
for distributions
at certain of the Company’s
 
Asia/Pacific subsidiaries, additional reserves for uncertain
 
tax positions related to tax audits at certain
of the Company’s EMEA
 
subsidiaries.
 
This line item also includes deferred tax benefits the Company
 
recorded in 2020 and 2019
related to intercompany intangible asset transfers and
 
the related amortization of these deferred tax benefits.
 
Additionally, the
2019 and 2018 amounts include certain transition tax adjustments
 
related to adjustments to adopt U.S. Tax
 
Reform.
 
See Note 10
of Notes to Consolidated Financial Statements, which appears
 
in Item 8 of this Report.
(m)
 
Depreciation and amortization for the years ended
 
December 31, 2020 and 2019 includes $1.2 million and $0.4 million,
respectively, of
 
amortization expense recorded within equity in net income of
 
associated companies in the Company’s
Consolidated Statements of Income, which is attributable
 
to the amortization of the fair value step up for the Company’s
 
50%
interest in a Houghton joint venture in Korea as a result
 
of required purchase accounting.
 
 
36
(n)
 
Taxes on income
 
before equity in net income of associated companies – adjusted
 
presents the impact of any current and deferred
income tax expense (benefit), as applicable, of
 
the reconciling items presented in the reconciliation of net income attributable
 
to
Quaker Chemical Corporation to adjusted EBITDA, and
 
was determined utilizing the applicable rates in the taxing jurisdictions
 
in
which these adjustments occurred, subject to deductibility.
 
Fair value step up of inventory sold described in (a) resulted
 
in
incremental taxes of less than $0.1 million and $2.9
 
million for 2020 and 2019, respectively.
 
Houghton combination,
 
integration
and other acquisition-related expenses described in
 
(b) resulted in incremental taxes of $6.9 million for 2020
 
,
 
$6.7 million for
2019, and $3.1 million for 2018.
 
Restructuring and related charges described in (c) resulted
 
in incremental taxes of $1.4 million
for 2020 and $6.2 million for 2019.
 
Customer bankruptcy costs described in (d) resulted in incremental
 
taxes of $0.1 million in
2020 and $0.3 million in 2019.
 
Charges related to the settlement of a non-core
 
equipment sale described in (e) resulted in
incremental taxes of $0.1 million for 2019.
 
Indefinite-lived intangible asset impairment described in (f) resulted
 
in incremental
taxes of $8.7 million for 2020.
 
Pension and postretirement benefit costs, non-service components
 
described in (h) resulted in
incremental taxes of $7.5 million for 2020, $0.7 million
 
for 2019, and $0.5 million for 2018.
 
Gain on changes in insurance
settlement restrictions of an inactive subsidiary and related
 
insurance insolvency recovery described in (i) resulted in a reduction
of taxes of $4.2 million in 2020 and less than $0.1
 
million in 2019 and 2018.
 
Gain on liquidation of an inactive legal entity
described in (k) resulted in a reduction of taxes of $0.1
 
million in 2018.
 
The impact of certain discrete items described in (m)
resulted in incremental taxes of $11.2
 
million for 2020, $5.7 million for 2019, and a reduction of taxes
 
of $5.8 million in 2018.
 
(o)
 
The Company calculates adjusted EBITDA margin
 
and non-GAAP operating margin as the percentage
 
of adjusted EBITDA and
non-GAAP operating income to consolidated net sales.
(p)
 
The Company calculates non-GAAP earnings per diluted share
 
as non-GAAP net income attributable to the Company
 
per
weighted average diluted shares outstanding using the “two-class share
 
method” to calculate such in each given period.
Off-Balance Sheet Arrangements
The Company had no material off-balance
 
sheet items, as defined under Item 303(a)(4) of Regulation S-K as of
 
December 31,
2020.
 
The Company’s only off
 
-balance sheet items outstanding as of December 31,
 
2020 represented approximately $10 million of
total bank letters of credit and guarantees.
 
The bank letters of credit and guarantees are not significant to
 
the Company’s liquidity or
capital resources.
 
See Note 20 of Notes to Consolidated Financial Statements in
 
Item 8 of this Report.
Operations
Consolidated Operations Review – Comparison of 2020
 
with 2019
 
Net sales were 1,417.7 million in 2020 compared to $1,133.5
 
million in 2019.
 
The net sales increase of 25% year-over-year
includes additional net sales from acquisitions, primarily
 
Houghton and Norman Hay,
 
of $408.6 million.
 
Excluding net sales related
to acquisitions, the Company’s
 
current year net sales would have declined approximately
 
11% which reflects a decrease in
 
sales
volumes of 9%, a negative impact from foreign currency
 
translation of 1% and a decrease from selling price and product
 
mix of 1%.
 
The primary driver of the volume decline in the current
 
year was the negative impact of COVID-19 on global production
 
levels.
COGS were $904.2 million in 2020 compared to $741.4
 
million in 2019.
 
The increase in COGS of 22% was primarily due to the
inclusion of a full year of Houghton and Norman Hay COGS and
 
$0.8 million of accelerated depreciation charges in
 
the current year,
partially offset by lower current year COGS on
 
the decline in net sales due to COVID-19 and prior year charges
 
of $11.7 million to
increase acquired inventory to its fair value, described
 
in the Non-GAAP Measures section of this Item above.
Gross profit in 2020 increased $121.3 million or 31%
 
from 2019 due primarily to additional gross profit from
 
Houghton and
Norman Hay.
 
The Company’s reported
 
gross margin in the current period
 
was 36.2% compared to 34.6% in 2019, which included the
inventory fair value step up described above.
 
Excluding one-time increases to COGS in both periods,
 
the Company estimates that its
gross margins for 2020 and 2019 would have
 
been 36.3% and 35.7%, respectively.
 
The estimated increase in gross margin year-over-
year was primarily due to lower COGS as a result of the Company’s
 
progress on Combination-related logistics, procurement and
manufacturing cost savings initiatives, partially offset
 
by the lower current year sales volumes on certain fixed
 
manufacturing costs.
SG&A in 2020 increased $96.9 million compared
 
to 2019 due primarily to additional SG&A from Houghton and Norman
 
Hay,
partially offset by the impact of COVID-19
 
cost savings actions, including lower travel expenses, and the
 
benefits of realized costs
savings associated with the Combination.
During 2020, the Company incurred $29.8 million
 
of Combination, integration and other acquisition-related
 
expenses, primarily
for professional fees related to Houghton integration
 
and other acquisition-related activities.
 
Comparatively,
 
the Company incurred
$35.5 million of similar expenses in the prior year,
 
primarily due to various professional fees related to integration
 
planning and
regulatory approval as well as professional fees associated
 
with closing the Combination.
 
See the Non-GAAP Measures section of
this Item, above.
The Company initiated a restructuring program during
 
the third quarter of 2019 as part of its global plan to realize cost
 
synergies
associated with the Combination.
 
The Company recorded additional restructuring and related charges
 
of $5.5 million during 2020
compared to $26.7 million during 2019 under this program.
 
See the Non-GAAP Measures section of this Item, above.
 
 
 
37
During the first quarter of 2020, the Company recorded
 
a $38.0 million non-cash impairment charge to write
 
down the value of
certain indefinite-lived intangible assets associated with the
 
Combination.
 
This non-cash impairment charge is related to certain
acquired Houghton trademarks and tradenames and
 
is primarily the result of the current year negative impacts of
 
COVID-19 on their
estimated fair values.
 
There were no additional impairment charges in the
 
remainder of 2020 or in the prior year.
 
See the Critical
Accounting Policies and Estimates section as well as the Non
 
-GAAP Measures section,
 
of this Item, above.
Operating income in 2020 was $59.4 million compared
 
to $46.1 million in 2019.
 
Excluding Combination, integration and other
acquisition-related expenses, restructuring and related
 
charges, the non-cash indefinite-lived intangible
 
asset impairment charge, and
other expenses that are not indicative of the Company’s
 
future operating performance,
 
the Company’s current year
 
non-GAAP
operating income of $134.0 million increased compared
 
to $121.9 million in the prior year, primarily
 
due to additional operating
income from Houghton and Norman Hay and
 
the benefits from costs savings initiatives related to the Combination
 
,
 
partially offset by
the current year negative impact due to COVID-19.
The Company’s other
 
expense, net, was $5.6 million in 2020 compared to $0.3 million in
 
2019.
 
The year-over-year increase in
other expense, net was primarily due to the first quarter
 
of 2020 non-cash settlement charge of $22.7 million
 
associated with the
termination of the Legacy Quaker U.S. Pension Plan,
 
partially offset by a fourth quarter of 2020 gain
 
of $18.1 million related to the
lapsing of restrictions over certain cash that was previously
 
designated solely for the settlement of asbestos claims at
 
an inactive
subsidiary of the Company,
 
which are both described in the Non-GAAP Measures section of this
 
Item, above.
 
Additionally, the
increase year-over-year in other expense,
 
net, includes higher foreign currency transaction losses in the current
 
year.
 
Interest expense, net, increased $9.6 million in 2020 compared
 
to 2019 primarily due to a full year of borrowings under the
Company’s Credit Facility
 
to finance the closing of the Combination on August 1,
 
2019, partially offset by lower overall interest rates
in the current year.
The Company’s effective
 
tax rates for 2020 and 2019 were a benefit of 19.5% and an expense of
 
7.2%, respectively.
 
The
Company’s current year
 
effective tax rate was impacted by the tax effect
 
of certain one-time tax charges and benefits in the
 
current
period, including deferred tax benefits related to an intercompany
 
intangible asset transfer, as well as changes in
 
the valuation
allowance for foreign tax credits acquired with the Combination,
 
additional charges for uncertain tax positions relating
 
to certain
foreign tax audits, and the tax impact of the Company’s
 
termination of its Legacy Quaker U.S. pension plan.
 
Comparatively, the prior
year effective tax rate was primarily impacted
 
by certain non-deductible costs associated with the Combination
 
as well as a prior year
deferred tax benefit related to a separate intercompany
 
intangible asset transfer.
 
Excluding the impact of all non-core items in each
year, described in the Non-GAAP measures
 
section of this Item, above, the Company estimates that its effective
 
tax rates for 2020 and
2019 were approximately 25% and 22%, respectively.
 
The year-over-year increase is driven primarily
 
by higher U.S. income taxes
resulting from a change in certain deductions and
 
the taxability of foreign earnings in the U.S., partially offset
 
by a change in the mix
of earnings.
 
The Company has experienced and expects to continue to experience
 
volatility in its effective tax rates due to several
factors, including the timing of tax audits and the expiration
 
of applicable statutes of limitations as they relate to uncertain
 
tax
positions, the unpredictability of the timing and
 
amount of certain incentives in various tax jurisdictions, valuation
 
allowances
necessary on certain of the Company’s
 
tax positions, the treatment of certain acquisition-related costs and
 
the timing and amount of
certain share-based compensation-related tax benefits,
 
among other factors.
Equity in net income of associated companies increased $2.3
 
million in 2020 compared to 2019, primarily due to additional
earnings from our 50% interest in a joint venture
 
in Korea partially offset by lower earnings as compared
 
to the prior year period from
the Company’s interest in
 
a captive insurance company.
 
See the Non-GAAP Measures section of this Item, above.
Net income attributable to noncontrolling interest was $0.1
 
million in 2020 compared to $0.3 million in 2019
 
primarily a result of
the first quarter of 2020 acquisition of the remaining
 
ownership interest in one of the Company’s
 
South African affiliates.
 
Foreign exchange negatively impacted the Company’s
 
2020 results by approximately $0.38 per diluted share, primarily
 
due to
higher foreign exchange transaction losses year-over-year
 
and, to a lesser extent, an aggregate negative
 
impact from foreign currency
translation on earnings.
 
Consolidated Operations Review – Comparison of 2019
 
with 2018
 
Net sales were $1,133.5 million in 2019 compared to
 
$867.5 million in 2018.
 
The net sales increase of 31% year-over-year
includes additional net sales from Houghton and
 
Norman Hay of $319.4 million.
 
Excluding Houghton and Norman Hay net sales, the
Company’s 2019 net sales would
 
have declined 6% compared to the prior year,
 
reflecting a decrease in sales volumes of
approximately 3% and a negative impact from foreign
 
currency translation of 3%.
COGS in 2019 of $741.4 million increased approximately
 
$186.2 million or 34% from $555.2 million in 2018.
 
The increase in
COGS was primarily due to the inclusion of Houghton
 
and Norman Hay COGS, as well as the fair value inventory step
 
up and
accelerated depreciation charges described in
 
the Non-GAAP Measures section of this Item above, partially
 
offset by lower COGS on
the decline in Legacy Quaker net sales.
Gross profit in 2019 increased $79.8 million from 2018
 
due primarily to Houghton and Norman Hay net sales noted above.
 
The
Company’s reported
 
gross margin in 2019 was 34.6%, which includes
 
an aggregate $11.7 million of expense
 
associated with selling
Houghton and Norman Hay acquired inventory adjusted
 
to fair value as well as 2019 accelerated depreciation
 
charges, both of which
 
 
38
are described in the Non-GAAP Measures section of this
 
Item above.
 
Excluding these one-time increases to COGS, the Company
estimates that its gross margin would have been
 
approximately 35.7% in 2019 compared to 36.0% in 2018.
 
The decrease in gross
margin year-over-year
 
was primarily the result of price and product mix attributed
 
to lower Houghton gross margin compared to
Legacy Quaker.
 
SG&A in 2019 increased $76.0 million compared to 2018 driven
 
by additional Houghton and Norman Hay SG&A as
well as charges related to the settlement of a
 
non-core equipment sale and certain customer bankruptcy costs, both
 
of which are
described in the Non-GAAP Measures section of this Item
 
above, partially offset by lower SG&A due to
 
foreign currency translation,
the impact of the year-over-year base
 
sales decline noted above on direct selling costs, and the benefits
 
of realized cost savings
associated with the Combination.
 
During 2019, the Company incurred $35.5 million
 
of Combination and other acquisition-related expenses,
 
primarily for legal,
financial, and other advisory and consultant expenses for
 
integration planning and regulatory approvals, fees associated
 
with the
closing of the Combination and costs associated with various integration
 
activities.
 
Comparatively, the Company
 
incurred $16.7
million of expenses in 2018, primarily due to various professional
 
fees related to integration planning and regulatory approval.
 
See
the Non-GAAP Measures section of this Item above.
The Company initiated a restructuring program during
 
the third quarter of 2019 as part of its global
 
plan to realize cost synergies
associated with the Combination.
 
The Company expects reductions in headcount and site closures to occur
 
over the next two years
under this program.
 
The Company recorded restructuring expense during 2019 of $26.7
 
million related to this program.
 
There were
no similar restructuring expenses recorded during the prior
 
year.
 
See the Non-GAAP Measures section of this Item, above.
Operating income in 2019 was $46.1 million compared
 
to $87.8 million in 2018.
 
Excluding the Combination and other
acquisition-related charges, restructuring
 
expenses and other non-core items, described in the Non-GAAP Measures
 
section of this
Item, above, the Company’s
 
2019 non-GAAP operating income increased to $121.9 million
 
compared to $104.4 million in 2018,
primarily due to additional net sales and operating income
 
from Houghton and Norman Hay.
The Company had other expense, net, of $0.3 million
 
in 2019 compared to $0.6 million in 2018.
 
The decrease in other expense,
net, was primarily driven by foreign currency transaction
 
gains in 2019 compared to foreign currency transaction
 
losses in 2018.
 
The
Company’s 2019 and
 
2018 foreign currency transaction gains and losses included
 
both recurring transactional activity as well as
foreign currency transaction losses of approximately $1.0
 
million and $0.4 million, respectively,
 
related to the Company’s Argentine
subsidiaries and, in 2018, a foreign currency transaction
 
gain of approximately $0.4 million related to the liquidation
 
of an inactive
legal entity, both
 
of which are described in the Non-GAAP measures section of
 
this Item, above.
 
In addition, the Company had an
increase in receipts of local municipality-related grants in
 
one of the Company’s regions year
 
-over-year, partially offset
 
by an increase
in pension and postretirement benefit costs, non-service
 
components, in 2019 compared to 2018.
 
Lastly, in 2018, the
 
Company
recorded a gain of $0.6 million for the sale of a
 
held-for-sale asset.
Interest expense, net, increased $12.9 million in 2019
 
compared to 2018, primarily as a result of additional borrowings
 
under the
Company’s Credit Facility
 
to finance the closing of the Combination on August 1,
 
2019.
The Company’s effective
 
tax rates for 2019 and 2018 were 7.2% and 30.1%, respectively.
 
The Company’s low 2019
 
effective tax
rate was primarily driven by a one-time deferred tax
 
benefit related to an intercompany intangible asset transfer,
 
described in the Non-
GAAP measures section of this Item, above.
 
Comparatively, the Company’s
 
higher 2018 effective tax rate was largel
 
y
 
driven by
combination-related expenses incurred, certain of which
 
were non-deductible for the purpose of determining the
 
Company’s effective
tax rate, as well as tax charges related to an
 
adjustment to the Company’s
 
initial estimate of the impact from U.S. Tax
 
Reform.
 
Excluding the impact of these and all other non-core items
 
in each period, described in the Non-GAAP Measures section
 
of this Item,
above, the Company estimates that its effective tax
 
rates would have been approximately 22% in each year.
Equity in net income of associated companies increased $3.3 million
 
in 2019 compared to 2018, primarily due to additional
earnings from the Company’s
 
50% interest in a Houghton joint venture in Korea and
 
higher earnings from the Company’s
 
interest in a
captive insurance company.
Net income attributable to noncontrolling interest was relatively
 
consistent in both 2019 and 2018.
Foreign exchange negatively impacted the Company’s
 
2019 earnings by approximately 2% or $0.09 per diluted share, as the
negative impact from foreign currency translation
 
of approximately 3% due to the strengthening of the U.S.
 
dollar in 2019 was
partially offset by higher 2019 foreign exchange
 
transaction gains.
 
Reportable Segments Review – Comparison of 2020
 
with 2019
The Company’s reportable
 
segments reflect the structure of the Company’s
 
internal organization, the method by which the
Company’s resources are
 
allocated and the manner by which the chief operating decision
 
maker assesses the Company’s
 
performance.
 
During the third quarter of 2019 and in connection with the
 
Combination, the Company reorganized its executive
 
management team to
align with its new business structure which reflects the method
 
by which the Company assesses its performance and allocates its
resources.
 
The Company’s current
 
reportable segment structure includes four segments: (i) Americas;
 
(ii) EMEA; (iii) Asia/Pacific;
and (iv) Global Specialty Businesses.
 
The three geographic segments are composed of
 
the net sales and operations in each respective
region, excluding net sales and operations managed globally
 
by the Global Specialty Businesses segment, which includes the
Company’s container,
 
metal finishing, mining, offshore, specialty coatings,
 
specialty grease and Norman Hay businesses.
 
 
39
Segment operating earnings for each of the Company’s
 
reportable segments are comprised of the segment’s
 
net sales less directly
related COGS and SG&A.
 
Operating expenses not directly attributable to the net sales of
 
each respective segment are not included in
segment operating earnings, such as certain corporate
 
and administrative costs, Combination,
 
integration and other acquisition-related
expenses, Restructuring and related charges
 
,
 
and COGS related to acquired inventory sold, which is adjusted
 
to fair value as part of
purchase accounting.
 
Other items not specifically identified with the Company’s
 
reportable segments include interest expense, net
and other expense, net.
 
Certain immaterial reclassifications within the segment disclosures for
 
the years ended December 31, 2019
have been made to conform with the Company’s
 
current customer industry segmentation and reflected in the prior
 
year comparisons
below.
Americas
Americas represented approximately 32% of the Company’s
 
consolidated net sales in 2020.
 
The segment’s net sales were $450.2
million, an increase of $58.0 million or 15% compared
 
to 2019.
 
The increase in net sales reflects additional net sales from
acquisitions of $120.4 million, primarily a result of
 
the inclusion of seven additional months of Houghton net sales, as the
Combination closed on August 1 in the prior year.
 
Excluding net sales from acquisitions, the segment’s
 
net sales decreased
 
year-over-
year by approximately 16% due to lower volumes of 12%
 
and a negative impact of foreign currency translation of 4%.
 
The current
year volume decline was driven by the economic slowdown
 
that began in late March and continued throughout 2020
 
due to the
impacts of COVID-19.
 
The foreign exchange impact was primarily due to the weakening
 
of the Brazilian real and the Mexican peso
against the U.S. dollar, as these exchange
 
rates averaged 5.10 and 21.34, respectively,
 
in 2020 compared to 3.94 and 19.24,
respectively in 2019.
 
This segment’s operating earnings
 
were $96.4 million, an increase of $18.1 million or 23% compared
 
to 2019.
 
The increase in segment operating earnings reflects the
 
inclusion of a full year of Houghton net sales, noted,
 
above, and the impacts on
gross margins and SG&A due to the Combination’s
 
cost synergies and costs savings actions related to COVID-19
 
year-over-year,
partially offset by the impact of COVID-19
 
on current year sales volumes and higher COGS and SG&A due
 
to seven additional
months of Houghton in the current year.
EMEA
EMEA represented approximately 27% of the Company’s
 
consolidated net sales in 2020.
 
The segment’s net
 
sales were $383.2
million, an increase of $97.6 million or 34% compared
 
to 2019.
 
The increase in net sales reflects additional net sales from
acquisitions of $117.9 million, primarily
 
a result of the inclusion of seven additional months of Houghton net
 
sales, as the
Combination closed on August 1 in the prior year.
 
Excluding net sales from acquisitions, the segment’s
 
net sales decreased
 
year-over-
year by approximately 7% due to lower volumes of
 
10%, partially offset by a positive impact of foreign
 
currency translation of 2%
and increases in selling price and product mix of 1%.
 
The current year volume decline was driven by the economic slowdown
 
that
began in late March and continued throughout 2020
 
due to the impacts of COVID-19.
 
The foreign exchange impact was primarily
due to the strengthening of the euro against the U.S. dollar
 
as this exchange rate averaged 1.14 in 2020 compared to 1.12
 
in 2019.
 
This segment’s operating
 
earnings were $69.2 million, an increase of $22.1
 
million or 47% compared to 2019. The increase in
segment operating earnings reflects the inclusion of
 
a full year of Houghton net sales, noted, above, and the impacts on
 
gross margins
and SG&A due to the Combination’s
 
cost synergies and costs savings actions related
 
to COVID-19 year-over-year,
 
partially offset by
the impact of COVID-19 on current year sales volumes
 
and higher COGS and SG&A due to seven additional months of
 
Houghton in
the current year.
Asia/Pacific
Asia/Pacific represented approximately 22% of the
 
Company’s consolidated net
 
sales in 2020.
 
The segment’s net sales were
$315.3 million,
 
an increase of $67.5 million or 27% compared to 2019.
 
The increase in net sales reflects the inclusion of seven
additional months of Houghton net sales of $79.7 million,
 
as the Combination closed on August 1 in the prior year.
 
Excluding
Houghton net sales, the segment’s
 
net sales decreased
 
by approximately 5% year-over-year was due to
 
lower volumes of 3% and
decreases in selling price and product mix of 3% partially offset
 
by the positive impact of foreign currency translation
 
of 1%.
 
The
current year volume decline was driven by the economic
 
slowdown that began in the first quarter in China and in late March
throughout the rest of the region due to the impacts of
 
COVID-19.
 
The foreign exchange impact was primarily due to the
strengthening of the Chinese renminbi against the U.S. dollar.
 
While this exchange rate averaged
 
6.90 in each of 2020 and 2019,
respectively, post
 
the closing of the Combination, this exchange rate strengthened
 
in the last 5 months of 2020 to average 6.72
compared to 7.06 in the last 5 months of 2019, partially offset
 
by the weakening of the Indian rupee against the U.S.
 
dollar as this
exchange rate averaged
 
73.95 in 2020 compared to 70.35 in 2019.
 
This segment’s operating earnings
 
were $88.4 million, an increase
of $20.8 million or 31% compared to 2019.
 
The increase in segment operating earnings reflects the inclusion
 
of incremental
Houghton net sales, noted, above, and the impacts on
 
gross margins and SG&A due to the Combination’s
 
cost synergies and costs
savings actions related to COVID-19 year-over-year,
 
partially offset by the impact of COVID-19 on current
 
year sales volumes and
higher COGS and SG&A due to seven additional months
 
of Houghton in the current year.
Global Specialty Businesses
Global Specialty Businesses represented approximately
 
19% of the Company’s consoli
 
dated net sales in 2020.
 
The segment’s net
sales were $269.0 million, an increase of $61.1 million
 
or 29%
 
compared to 2019.
 
The increase in net sales reflects the inclusion of
seven additional months of Houghton net sales and nine
 
additional months of Norman Hay net sales, totaling $90.6
 
million, as the
Combination closed on August 1 and the Norman Hay
 
acquisition closed on October 1 in the prior year.
 
Excluding Houghton and
 
 
40
Norman Hay net sales, the segment’s
 
net sales decreased by approximately 14%
 
year-over-year due to lower volumes of 7%,
decreases in selling price and product mix of 5% and a negative
 
impact from foreign currency translation of 2%.
 
The current year
volume decline was primarily due to a decrease in
 
the Company’s specialty coatings
 
business driven by Boeing’s
 
decision to
temporarily stop production of the 737 Max aircraft and
 
volume declines due to the economic slowdown resulting
 
from COVID-19.
 
Partially offsetting these volume declines,
 
and contributing to the decrease in selling price and product mix
 
,
 
were higher shipments of
a lower priced product in the Company’s
 
mining business compared to the prior year.
 
The foreign exchange impact was primarily due
to the weakening of the Brazilian real against the U.S.
 
dollar described in the Americas section, above.
 
This segment’s operating
earnings were $79.7 million, an increase of $20.8
 
million or 35%
 
compared to 2019.
 
The increase in segment operating earnings
reflects the inclusion of incremental Houghton and Norman
 
Hay net sales, noted above, coupled with an increase in
 
gross margin due
to the Company’s progress
 
on Combination-related logistics, procurement and manufacturing
 
cost savings initiatives, partially offset
by higher SG&A, including seven additional months of
 
Houghton and nine additional months of Norman Hay SG&A in the current
year.
Reportable Segments Review – Comparison of 2019
 
with 2018
Americas
Americas represented approximately 35% of the Company’s
 
consolidated net sales in 2019.
 
The segment’s net sales were $392.1
million, an increase of $94.5 million or 32% compared
 
to 2018.
 
The increase in net sales reflects the inclusion of Houghton
 
net sales
of $110.1 million.
 
Excluding Houghton net sales, the segment’s
 
net sales decrease year-over-year of 5% was due
 
primarily to lower
volumes of 6% and a negative impact from foreign
 
currency translation of 1% partially offset by a positive impact
 
from selling price
and product mix of 2%.
 
The decline in volumes compared to 2018 was driven by compounding
 
conditions of weak automotive and
steel markets, a generally weaker overall industrial environment
 
in the region and some customer inventory corrections.
 
The
segment’s operating earnings
 
were $78.3 million, an increase of $15.6 million or 25%
 
compared to 2018.
 
The increase in segment
operating earnings reflects the inclusion of Houghton
 
net sales, partially offset by a lower gross margin
 
due to price and product mix,
including lower Houghton gross margins compared
 
to Legacy Quaker and higher SG&A, including Houghton
 
SG&A.
EMEA
EMEA represented approximately 25% of the Company’s
 
consolidated net sales in 2019.
 
The segment’s net
 
sales were $285.6
million, an increase of $68.6 million or 32% compared
 
to 2018.
 
The increase in net sales reflects the inclusion of Houghton
 
net sales
of $92.5 million.
 
Excluding Houghton net sales, the segment’s
 
net sales decrease year-over-year of 11%
 
was due to a negative impact
of foreign currency translation of 5%, lower volumes of
 
approximately 5% and a decrease from selling price and product
 
mix of 1%.
 
The foreign exchange impact was primarily due to the
 
weakening of the euro against the U.S. dollar as this exchange rate averaged
1.12 in 2019 compared to 1.18 in 2018.
 
The decline in volumes compared to 2018 was driven by a weak
 
automotive market and the
challenging overall industrial environment in the region,
 
as well as a decrease in volume associated with a specific piece
 
of business
which the Company stopped selling during the second
 
half of 2018 primarily due to its limited profitability.
 
This segment’s operating
earnings were $47.0 million, an increase of $10.9
 
million or 30% compared to 2018.
 
The increase in segment operating earnings
reflects the inclusion of Houghton net sales and
 
a slightly higher gross margin, partially offset by
 
higher SG&A, including Houghton
SG&A.
Asia/Pacific
Asia/Pacific represented approximately 22% of the
 
Company’s consolidated net
 
sales in 2019.
 
The segment’s net sales were
$247.8 million, an increase of $55.3 million or 29%
 
compared to 2018.
 
The increase in net sales reflects the inclusion of Houghton
net sales of $67.4 million.
 
Excluding Houghton net sales, the segment’s
 
net sales decreased 6% year-over-year due
 
primarily to the
negative impact of foreign currency translation of 3% and
 
lower volumes of approximately 3%.
 
The foreign exchange impact was
primarily due to the weakening of the Chinese renminbi
 
and India rupee against the U.S. dollar as these exchange rates
 
averaged 6.90
and 70.3, respectively,
 
in 2019 compared to 6.60 and 68.18, respectively,
 
in 2018.
 
The decline in volumes was driven by weak
automotive and steel markets and the challenging overall
 
industrial environment in the region.
 
This segment’s operating earnings
were $67.5 million, an increase of $13.8 million or 26%
 
compared to 2018.
 
The increase in segment operating earnings reflects the
inclusion of Houghton net sales, and relatively consistent gross margins,
 
partially offset by higher SG&A, including
 
Houghton SG&A.
Global Specialty Businesses
Global Specialty Businesses represented approximately
 
18% of the Company’s consolidated
 
net sales in 2019.
 
The segment’s net
sales were $208.0 million, an increase of $47.5 million
 
or 30% compared to 2018.
 
The increase in net sales reflects the inclusion of
Houghton and Norman Hay net sales of $49.4 million.
 
Excluding Houghton and Norman Hay net sales, the segment’s
 
net sales
decreased 1% year-over-year driven
 
by a decline in selling price and product mix of 5% and
 
a negative impact from foreign currency
translation of less than 1% partially offset by
 
an increase in volume of 4%.
 
This segment’s operating earnings
 
were $58.9 million, an
increase of approximately $15.9 million or 37% compared
 
to 2018.
 
The increase in segment operating earnings reflects the inclusion
of Houghton and Norman Hay net sales, and relatively
 
consistent gross margins, partially offset by
 
higher SG&A, including Houghton
and Norman Hay.
 
41
Environmental Clean-up Activities
The Company is involved in environmental clean-up
 
activities in connection with an existing plant location and former
 
waste
disposal sites.
 
This includes certain soil and groundwater contamination
 
the Company identified in 1992 at AC Products, Inc.
(“ACP”), a wholly owned subsidiary.
 
In voluntary coordination with the Santa Ana California Regional
 
Water Quality
 
Board, ACP
has been remediating the contamination.
 
In 2007, ACP agreed to operate two groundwater treatment systems,
 
so as to hydraulically
contain groundwater contamination emanating from ACP’s
 
site until such time as the concentrations of contaminants
 
are below the
current Federal maximum contaminant level for four
 
consecutive quarterly sampling events.
 
In 2014, ACP ceased operation at one of
its two groundwater treatment systems, as it had met the above
 
condition for closure.
 
In 2020, the Santa Ana Regional Water
 
Quality
Control Board asked that ACP conduct some additional
 
indoor and outdoor soil vapor testing on and near the ACP site to
 
confirm that
ACP continues to meet the applicable local standards
 
and ACP has begun the testing program.
 
As of December 31, 2020, ACP
believes it is close to meeting the conditions for closure of the
 
remaining groundwater treatment system, but continues to
 
operate this
system while in discussions with the relevant authorities.
 
As of December 31, 2020, the Company believes that the range of
 
potential-
known liabilities associated with the balance of the
 
ACP water remediation program is approximately $0.1 million to
 
$1.0 million.
 
The low and high ends of the range are based on the
 
length of operation of the treatment system as determined
 
by groundwater
modeling.
 
 
As a result of the closing of the Combination on August
 
1, 2019, the Company is party to environmental matters related
 
to certain
Houghton domestic and foreign properties currently or previously
 
owned.
 
Houghton’s Sao Paulo, Brazil site
 
was required under
Brazilian environmental, health and safety regulations to
 
perform an environmental assessment as part of a permit renewal process.
 
Initial investigations
 
identified soil and ground water contamination in select areas
 
of the site.
 
The site has conducted a multi-year soil
and groundwater investigation and corresponding
 
risk assessments based on the result of the investigations.
 
In 2017, the site had to
submit a new 5-year permit renewal request and was asked
 
to complete additional investigations to further delineate
 
the site based on
review of the technical data by the local regulatory agency,
 
Companhia Ambiental do Estado de São Paulo (“CETESB”).
 
Based on
review of the updated investigation data, CETESB issued a Technical
 
Opinion regarding the investigation and remedial actions taken
to date.
 
The site developed an action plan and submitted it to CETESB in 2018
 
based on CETESB requirements.
 
The site
intervention plan primarily requires the site, among
 
other actions, to conduct periodic monitoring for methane in
 
soil vapors, source
zone delineation, groundwater plume delineation, bedrock
 
aquifer assessment, update the human health risk assessment, develop
 
a
current site conceptual model and conduct a remedial feasibility
 
study and provide a revised intervention plan.
 
In December 2019, the
site submitted a report on the activities completed including
 
the revised site conceptual model and results of the remedial feasibility
study and recommended remedial strategy for the site.
 
Other Houghton environmental matters include participation in
 
certain
payments in connection with four currently active environmental
 
consent orders related to certain hazardous waste cleanup
 
activities
under the U.S. Federal Superfund statute.
 
Houghton has been designated a potentially responsible party (“PRP”)
 
by the
Environmental Protection Agency along with other PRPs depending
 
on the site, and has other obligations to perform cleanup
 
activities
at certain other foreign subsidiaries.
 
These environmental matters primarily require the
 
Company to perform long-term monitoring as
well as operating and maintenance at each of the applicable
 
sites.
 
The Company continually evaluates its obligations related
 
to such matters and, based on historical costs incurred and projected
costs to be incurred over the next 28 years, has estimated the present
 
value range of costs for all of the Houghton environmental
matters, on a discounted basis, to be between approximately
 
$5.5 million and $6.5 million as of December 31,
 
2020, for which $6.0
million is accrued within other accrued liabilities and
 
other non-current liabilities on the Company’s
 
Consolidated Balance Sheet as of
December 31, 2020.
 
Comparatively, as of
 
December 31, 2019, the Company had $6.6 million accrued
 
with respect to these matters.
The Company believes, although there can be no assurance
 
regarding the outcome of other unrelated environmental matters, that
it has made adequate accruals for costs associated with other
 
environmental problems of which it is aware.
 
Approximately $0.1
million and $0.2 million were accrued as of December
 
31, 2020 and 2019, respectively,
 
to provide for such anticipated future
environmental assessments and remediation costs.
Notwithstanding the foregoing, the Company cannot be
 
certain that future liabilities in the form of remediation expenses and
damages will not exceed amounts reserved.
 
See Note 26 of Notes to Consolidated Financial Statements in Item
 
8 of this Report
General
See Item 7A of this Report, below,
 
for further discussion of certain quantitative and qualitative
 
disclosures about market risk.
 
Item 7A.
 
Quantitative and Qualitative Disclosures About Market Risk.
Quaker Houghton is exposed to the impact of interest
 
rates, foreign currency fluctuations, changes in commodity prices,
 
and
credit risk.
 
The current economic environment associated with COVID-19 has led
 
to significant volatility and uncertainty with each
of these market risks.
 
See Item 1A. “Risk Factors.” of this Report for additional
 
discussions of the current and potential risks
associated with the COVID-19 pandemic.
 
Except as otherwise disclosed below,
 
the market risks discussed below did not change
materially from December 31, 2019.
 
42
Interest Rate Risk.
 
The Company’s exposure
 
to changes in interest rates relates primarily to its borrowings
 
under the Credit
Facility as of December 31, 2020 and 2019.
 
Borrowings under the Credit Facility bear interest at a base rate
 
or LIBOR plus an
applicable margin based upon the Company’s
 
consolidated net leverage ratio.
 
As a result of the variable interest rates applicable
under the Credit Facility,
 
if interest rates rise significantly,
 
the cost of debt to the Company could increase as
 
well.
 
This could have an
adverse effect on the Company,
 
depending on the extent of the Company’s
 
borrowings outstanding throughout a given year.
 
As of
December 31, 2020, the Company had outstanding borrowings
 
under the Credit Facility of approximately $887.1 million.
 
The
variable interest rate incurred on the outstanding
 
borrowings under the Credit Facility during the year ended
 
December 31, 2020 was
approximately 2.2%.
 
If interest rates had changed by 10% during 2020, the Company’s
 
interest expense for the period ended
December 31, 2020 on its credit facilities, including the
 
Credit Facility borrowings outstanding post-closing of the Combination,
would have correspondingly increased or decreased
 
by approximately $0.8 million.
 
The Credit Facility required the Company to fix its variable
 
interest rates on at least 20% of its total Term
 
Loans.
 
In order to
satisfy this requirement as well as to manage the
 
Company’s exposure to variable
 
interest rate risk associated with the Credit Facility,
in November 2019, the Company entered into $170.0
 
million notional amounts of three-year interest rate swaps at a base
 
rate of
1.64% plus an applicable margin as provided
 
in the Credit Facility, based on
 
the Company’s consolidated net
 
leverage ratio.
 
At the
time the Company entered into the swaps and as of December
 
31, 2020, the aggregate interest rate on the swaps, including
 
the fixed
base rate plus an applicable margin, was 3.1%.
 
These interest rate swaps are designated and qualify as cash flow
 
hedges.
 
The
Company has previously used derivative financial instruments
 
primarily for the purpose of hedging exposures to fluctuations
 
in
interest rates.
 
Foreign Exchange Risk
.
 
A significant portion of the Company’s
 
revenues and earnings are generated by its foreign operations.
 
These foreign operations also represent a significant portion
 
of Quaker Houghton’s assets and
 
liabilities.
 
Generally, all of these
foreign operations use the local currency as their functional
 
currency.
 
Accordingly, Quaker Houghton’s
 
financial results are affected
by foreign currency fluctuations, particularly between the
 
U.S. dollar and the euro, the British pound sterling, the Brazilian real,
 
the
Mexican peso, the Chinese renminbi and the Indian
 
rupee.
 
Quaker Houghton’s results
 
can be materially affected depending on the
volatility and magnitude of foreign exchange rate
 
changes.
 
If the euro, the British pound sterling, the Brazilian real,
 
the Mexican
peso, the Chinese renminbi and the Indian rupee had
 
all weakened or strengthened by 10% against the U.S. dollar,
 
the Company’s
2020 revenues and pre-tax earnings would have correspondingly
 
decreased or increased by approximately $78.9 million and
 
$7.4
million, respectively.
The Company generally does not use financial instruments
 
that expose it to significant risk involving foreign currency
transactions.
 
However, the size of its non-U.S. activities
 
has a significant impact on reported operating results and
 
the attendant net
assets.
 
During the past three years, sales by its non-U.S.
 
subsidiaries accounted for approximately 60% to 70% of
 
its consolidated net
sales.
 
In addition, the Company occasionally sources inventory
 
among its worldwide operations.
 
This practice can give rise to
foreign exchange risk resulting from the varying cost of
 
inventory to the receiving location, as well as from the revaluation
 
of
intercompany balances.
 
The Company primarily mitigates this risk through local sourcing
 
efforts.
Commodity Price Risk
.
 
Many of the raw materials used by Quaker Houghton
 
are derivatives of commodity chemicals, which can
experience significant price volatility,
 
and therefore Quaker Houghton’s
 
earnings can be materially affected by market changes
 
in raw
material prices.
 
At times, the Company has entered into fixed-price purchase
 
contracts to manage this risk.
 
These contracts provide
protection to Quaker Houghton if the prices for the contracted
 
raw materials rise; however, in certain
 
circumstances, the Company
may not realize the benefit if such prices decline.
 
A gross margin change of one percentage point,
 
would correspondingly
 
have
increased or decreased the Company’s
 
pre-tax earnings by approximately $14.2 million.
Credit Risk
.
 
Quaker Houghton establishes allowances for doubtful
 
accounts for estimated losses resulting from the inability of its
customers to make required payments.
 
If the financial condition of Quaker Houghton’s
 
customers were to deteriorate, resulting in an
impairment of their ability to make payments, additional allowances
 
might be required.
 
Downturns in the overall economic climate
may also exacerbate specific customer financial issues.
 
A significant portion of the Company’s
 
revenues are derived from sales to
customers in the steel and automotive industries, including
 
some of our larger customers, where bankruptcies
 
have occurred in the past
and where companies have experienced past financial
 
difficulties.
 
Though infrequent, when a bankruptcy occurs, Quaker Houghton
must judge the amount of proceeds, if any,
 
that may ultimately be received through the bankruptcy or
 
liquidation process.
 
In addition,
as part of its terms of trade, Quaker Houghton may custom
 
manufacture products for certain large customers
 
and/or may ship product
on a consignment basis.
 
These practices may increase the Company’s
 
exposure should a bankruptcy occur and may require a write-
down or disposal of certain inventory due to its estimated obsolescence
 
or limited marketability as well as of accounts receivable.
 
Customer returns of products or disputes may also result in
 
similar issues related to the realizability of recorded
 
accounts receivable or
returned inventory.
 
The Company recorded expense to its provision for doubtful
 
accounts by $3.6 million, $1.9 million and $0.5
million for the years ended December 31, 2020, 2019
 
and 2018, respectively.
 
A change of 10% to the expense recorded to the
Company’s provision
 
would have increased or decreased the Company’s
 
pre-tax earnings by $0.4 million, $0.2 million and $0.1
million for the years ended December 31, 2020, 2019
 
and 2018, respectively.
 
 
43
Item 8.
 
Financial Statements and Supplementary Data.
QUAKER CHEMICAL CORPORATION
INDEX TO CONSOLIDATED
 
FINANCIAL STATEMENTS
 
 
 
 
Page
Financial Statements:
 
 
 
44
 
47
48
 
49
 
50
 
51
52
 
44
Report of Independent Registered Public Accounting
 
Firm
 
To
 
the Board of Directors and Shareholders of Quaker Chemical Corporation
 
Opinions on the Financial Statements and Internal Control over
 
Financial Reporting
We have audited
 
the accompanying consolidated balance sheets of Quaker
 
Chemical Corporation and its subsidiaries (the
“Company”) as of December 31, 2020 and 2019, and the
 
related consolidated statements of income, of comprehensive
 
income, of
changes in equity and of cash flows for each of the three
 
years in the period ended December 31, 2020, including
 
the related notes
(collectively referred to as the “consolidated financial statements”).
 
We also have
 
audited the Company's internal control over
financial reporting as of December 31, 2020, based on criteria
 
established in Internal Control - Integrated Framework
 
(2013) issued by
the Committee of Sponsoring Organizations
 
of the Treadway Commission (COSO).
 
In our opinion, the consolidated financial statements referred
 
to above present fairly,
 
in all material respects, the financial position of
the Company as of December 31, 2020 and 2019, and the
 
results of its operations and its cash flows for each of the three
 
years in the
period ended December 31, 2020 in conformity with accounting
 
principles generally accepted in the United States of America.
 
Also
in our opinion, the Company did not maintain, in all material
 
respects, effective internal control over financial
 
reporting as of
December 31, 2020, based on criteria established in
Internal Control - Integrated Framework
(2013) issued by the COSO because
material weaknesses in internal control over financial
 
reporting existed as of that date as the Company did not design
 
and maintain
effective controls (i) in response to the risks of
 
material misstatement and (ii) over the review of pricing,
 
quantity and customer data to
verify that revenue recognized was complete and
 
accurate.
A material weakness is a deficiency,
 
or a combination of deficiencies, in internal control over financial
 
reporting, such that there is a
reasonable possibility that a material misstatement of the
 
annual or interim financial statements will not be prevented
 
or detected on a
timely basis.
 
The material
 
weaknesses referred to above are described in Management’s
 
Report on Internal Control over Financial
Reporting appearing under Item 9A.
 
We considered
 
these material weaknesses in determining the nature, timing,
 
and extent of audit
tests applied in our audit of the 2020 consolidated financial
 
statements, and our opinion regarding the effectiveness
 
of the Company’s
internal control over financial reporting does not affect
 
our opinion on those consolidated financial statements.
Change in Accounting Principle
As discussed in Note 6 to the consolidated financial statements,
 
the Company changed the manner in which
 
it accounts for leases in
2019.
 
Basis for Opinions
The Company's management is responsible for
 
these consolidated financial statements, for maintaining effective
 
internal control over
financial reporting, and for its assessment of the effectiveness
 
of internal control over financial reporting, included
 
in management's
report referred to above.
 
Our responsibility is to express opinions on the Company’s
 
consolidated financial statements and on the
Company's internal control over financial reporting based
 
on our audits.
 
We are a public
 
accounting firm registered with the Public
Company Accounting Oversight Board (United States) (PCAOB) and
 
are required to be independent with respect to the Company in
accordance with the U.S. federal securities laws and the
 
applicable rules and regulations of the Securities and
 
Exchange Commission
and the PCAOB.
We conducted
 
our audits in accordance with the standards of the PCAOB.
 
Those standards require that we plan and perform
 
the
audits to obtain reasonable assurance about whether
 
the consolidated financial statements are free of material misstatement,
 
whether
due to error or fraud, and whether effective
 
internal control over financial reporting was maintained in all material
 
respects.
Our audits of the consolidated financial statements included
 
performing procedures to assess the risks of material misstatement
 
of the
consolidated financial statements, whether due to error
 
or fraud, and performing procedures that respond to those
 
risks. Such
procedures included examining, on a test basis, evidence
 
regarding the amounts and disclosures in the consolidated
 
financial
statements.
 
Our audits also included evaluating the accounting
 
principles used and significant estimates made by management, as well
as evaluating the overall presentation of the consolidated
 
financial statements.
 
Our audit of internal control over financial reporting
included obtaining an understanding of internal control over financial
 
reporting, assessing the risk that a material weakness exists, and
testing and evaluating the design and operating effectiveness
 
of internal control based on the assessed risk.
 
Our audits also included
performing such other procedures as we considered necessary
 
in the circumstances.
 
We believe that our
 
audits provide a reasonable
basis for our opinions.
 
 
45
As described in Management’s
 
Report on Internal Control over Financial Reporting, management
 
has excluded Tel
 
Nordic ApS and
Coral Chemical Company from its assessment of internal
 
control over financial reporting as of December 31, 2020,
 
because they were
acquired by the Company in purchase business combinations during
 
2020.
 
These excluded entities are wholly owned subsidiaries,
whose total assets represent less than 1% and approximately 2%,
 
respectively,
 
and whose total revenues each represent less than 1%,
of the related consolidated financial statement amounts
 
as of and for the year ended December 31, 2020.
Definition and Limitations of Internal Control over Financial
 
Reporting
A company’s internal
 
control over financial reporting is a process designed to provide
 
reasonable assurance regarding the reliability of
financial reporting and the preparation of financial statements
 
for external purposes in accordance with generally
 
accepted accounting
principles.
 
A company’s internal control
 
over financial reporting includes those policies and procedures
 
that (i) pertain to the
maintenance of records that, in reasonable detail, accurately
 
and fairly reflect the transactions and dispositions of the
 
assets of the
company; (ii) provide reasonable assurance that transactions are
 
recorded as necessary to permit preparation of financial statements
 
in
accordance with generally accepted accounting principles,
 
and that receipts and expenditures of the company are being
 
made only in
accordance with authorizations of management and directors
 
of the company; and (iii) provide reasonable assurance
 
regarding
prevention or timely detection of unauthorized acquisition,
 
use, or disposition of the company’s
 
assets that could have a material effect
on the financial statements.
Because of its inherent limitations, internal control
 
over financial reporting may not prevent or detect misstatements.
 
Also, projections
of any evaluation of effectiveness to future
 
periods are subject to the risk that controls may become
 
inadequate because of changes in
conditions, or that the degree of compliance with the
 
policies or procedures may deteriorate.
 
Critical Audit Matters
The critical audit matter communicated below is a matter
 
arising from the current period audit of the consolidated financial
 
statements
that was communicated or required to be communicated
 
to the audit committee and that (i) relates to accounts or disclosures that
 
are
material to the consolidated financial statements and (ii)
 
involved our especially challenging, subjective, or complex judgments.
 
The
communication of critical audit matters does not alter
 
in any way our opinion on the consolidated financial statements,
 
taken as a whole,
and we are not, by communicating the critical audit
 
matter below, providing
 
a separate opinion on the critical audit matter or on the
accounts or disclosures to which it relates.
Houghton Trademarks and
 
Tradename Impairment Assessments
As described in Note 16 to the consolidated financial
 
statements, the Company’s consolidated
 
Other intangible assets, net balance was
$1,081.4
 
million as of December 31, 2020, and the indefinite-lived
 
intangible asset was $205.1 million, which substantially relates to
the Houghton trademarks and tradename.
 
Management completes its annual indefinite-lived intangible
 
asset impairment test during
the fourth quarter of each year, or
 
more frequently if triggering events indicate a potential impairment.
 
An impairment exists when it
is determined that it is more likely than not that the indefinite
 
-lived intangible asset carrying value exceeds its fair value and
 
is not
recoverable.
 
In the first quarter of 2020, as a result of the impact of COVID-19
 
driving a decrease in projected legacy Houghton net
sales in the current year and the impact of the current year
 
decline on projected future legacy Houghton net sales as well as an
 
increase
in the weighted average cost of capital (“WACC”)
 
assumption utilized in the quantitative impairment
 
assessment, the Company
concluded that the estimated fair value of the Houghton
 
trademarks and tradename intangible asset was less than its carrying
 
value.
 
As a result, an impairment charge of $38.0
 
million, primarily related to the Houghton trademarks and tradename,
 
was recorded in the
first quarter of 2020. The Company completed its annual
 
impairment assessment during the fourth quarter of 2020
 
for the Houghton
trademarks and tradename and concluded no impairment charge
 
was warranted.
 
The determination of estimated fair value of the
Houghton trademarks and tradename is based on a relief
 
from royalty valuation method which requires management’s
 
judgment and
often involves the use of significant estimates and assumptions
 
with respect to the WACC
 
and royalty rates, as well as revenue growth
rates and terminal growth rates.
The principal considerations for our determination that
 
performing procedures relating to the Houghton trademarks
 
and tradename
impairment assessments is a critical audit matter are
 
(i) the significant judgment by management when determining
 
the fair value
measurement of the Houghton trademarks and tradename;
 
(ii) a high degree of auditor judgment, subjectivity,
 
and effort in performing
procedures and evaluating
 
management’s significant
 
assumptions related to the WACC,
 
royalty rates, revenue growth rates and
terminal growth rates; and (iii) the audit effort
 
involved the use of professionals with specialized skill and knowledge.
 
 
 
46
Addressing the matter involved performing procedures and
 
evaluating audit evidence in connection with forming our overall opinion
on the consolidated financial statements.
 
These procedures included testing the effectiveness of controls
 
relating to management’s
indefinite-lived intangible assets impairment assessments, including
 
controls over the valuation of the Houghton trademarks and
tradename.
 
These procedures also included, among others (i) testing management’s
 
process for determining the fair value estimate;
(ii) evaluating the appropriateness of the relief from
 
royalty valuation method; (iii) testing the completeness
 
and accuracy of
underlying data used in the estimate; and (iv) evaluating
 
the reasonableness of significant assumptions related to
 
the WACC,
 
royalty
rates, revenue growth rates and terminal growth rates.
 
Evaluating management’s
 
assumptions related to the royalty rates, revenue
growth rates and terminal growth rates involved evaluating
 
whether the assumptions used by management were
 
reasonable
considering (i) the current and past performance of the
 
legacy Houghton business; (ii) the consistency with external
 
market and
industry data; and (iii) whether these assumptions were consistent with
 
evidence obtained in other areas of the audit.
 
Professionals
with specialized skill and knowledge were used to
 
assist in evaluating the appropriateness of the relief from
 
royalty valuation method
and evaluating the reasonableness
 
of royalty rates and the WACC.
/s/PricewaterhouseCoopers LLP
Philadelphia, Pennsylvania
March 1, 2021
We have served
 
as the Company’s auditor since
 
at least 1972. We
 
have not been able to determine the specific year we began
 
serving
as auditor of the Company.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
47
 
QUAKER CHEMICAL CORPORATION
CONSOLIDATED STATEMENTS
 
OF INCOME
(
Dollars in thousands, except per share data
)
 
Year
 
Ended December 31,
 
2020
2019
2018
Net sales
$
1,417,677
$
1,133,503
$
867,520
Cost of goods sold (excluding amortization expense -
 
See Note 16)
 
904,234
741,386
555,206
Gross profit
513,443
392,117
312,314
Selling, general and administrative expenses
 
380,752
283,828
207,872
Indefinite-lived intangible asset impairment
38,000
Restructuring and related charges
 
5,541
26,678
Combination, integration and other acquisition-related
 
expenses
 
29,790
35,477
16,661
Operating income
 
59,360
46,134
87,781
Other expense, net
 
(5,618)
(254)
(642)
Interest expense, net
(26,603)
(16,976)
(4,041)
Income before taxes and equity in net income of associated companies
 
27,139
28,904
83,098
Taxes on income
 
before equity in net income of associated companies
(5,296)
2,084
25,050
Income before equity in net income of associated companies
32,435
26,820
58,048
Equity in net income of associated companies
7,352
5,064
1,763
Net income
39,787
31,884
59,811
Less: Net income attributable to noncontrolling intere
 
st
129
262
338
Net income attributable to Quaker Chemical Corporation
$
39,658
$
31,622
$
59,473
Per share data:
 
 
 
Net income attributable to Quaker Chemical Corporatio
 
n
 
common
 
shareholders – basic
$
2.23
$
2.08
$
4.46
Net income attributable to Quaker Chemical Corporation
 
common
 
shareholders – diluted
$
2.22
$
2.08
$
4.45
 
 
The accompanying notes are an integral
 
part of these consolidated financial statements.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
48
 
QUAKER CHEMICAL CORPORATION
CONSOLIDATED STATEMENTS
 
OF COMPREHENSIVE INCOME
(
Dollars in thousands
)
 
Year
 
Ended December 31,
2020
2019
2018
Net income
$
39,787
$
31,884
$
59,811
Other comprehensive income (loss), net of tax
Currency translation adjustments
41,601
4,779
(17,519)
Defined benefit retirement plans
Net gain (loss) arising during the period, other
8,827
(6,289)
1,119
Amortization of actuarial loss
2,308
2,458
2,507
Amortization of prior service gain
(69)
(151)
(84)
Current period change in fair value of derivatives
(3,278)
(320)
Unrealized gain (loss) on available-for-sale securities
2,091
2,093
(1,728)
Other comprehensive income (loss)
51,480
2,570
(15,705)
Comprehensive income
91,267
34,454
44,106
Less: Comprehensive income attributable to noncontrolling
 
interest
(37)
(287)
(248)
Comprehensive income attributable to Quaker Chemical Corporation
$
91,230
$
34,167
$
43,858
 
 
The accompanying notes are an integral
 
part of these consolidated financial statements.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
49
 
QUAKER CHEMICAL CORPORATION
CONSOLIDATED BALANCE
 
SHEETS
(
Dollars in thousands, except par value and share amounts
)
 
 
December 31,
2020
2019
 
ASSETS
Current assets
Cash and cash equivalents
$
181,833
$
123,524
Accounts receivable, net
 
372,974
375,982
Inventories, net
 
187,764
174,950
Prepaid expenses and other current assets
 
50,156
41,516
Total current
 
assets
 
792,727
 
715,972
Property, plant and
 
equipment, net
 
203,883
213,469
Right of use lease assets
38,507
42,905
Goodwill
631,212
607,205
Other intangible assets, net
 
1,081,358
1,121,765
Investments in associated companies
 
95,785
93,822
Deferred tax assets
 
16,566
14,745
Other non-current assets
 
31,796
40,433
Total assets
$
2,891,834
$
2,850,316
 
 
 
LIABILITIES AND EQUITY
 
 
Current liabilities
 
 
Short-term borrowings and current portion of long-term debt
$
38,967
$
38,332
Accounts payable
 
191,821
 
164,101
Dividends payable
7,051
6,828
Accrued compensation
 
43,300
 
45,620
Accrued restructuring
8,248
18,043
Accrued pension and postretirement benefits
1,466
3,405
Other accrued liabilities
 
92,107
 
83,605
Total current
 
liabilities
 
382,960
 
359,934
Long-term debt
 
849,068
 
882,437
Long-term lease liabilities
27,070
31,273
Deferred tax liabilities
192,763
211,094
Non-current accrued pension and postretirement benefits
63,890
56,828
Other non-current liabilities
 
55,169
 
66,384
Total liabilities
 
1,570,920
 
1,607,950
Commitments and contingencies (Note 26)
Equity
 
 
Common stock, $
1.00
 
par value; authorized
30,000,000
 
shares; issued and outstanding
 
 
2020 –
17,850,616
 
shares; 2019
 
17,735,162
 
shares
17,851
17,735
Capital in excess of par value
 
905,171
 
888,218
Retained earnings
 
423,940
 
412,979
Accumulated other comprehensive loss
 
(26,598)
 
(78,170)
Total Quaker
 
shareholders’ equity
 
1,320,364
 
1,240,762
Noncontrolling interest
 
550
1,604
Total equity
1,320,914
1,242,366
Total liabilities and
 
equity
$
2,891,834
$
2,850,316
 
 
The accompanying notes are an integral
 
part of these consolidated financial statements.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
50
 
QUAKER CHEMICAL CORPORATION
CONSOLIDATED STATEMENTS
 
OF CASH FLOWS
(
Dollars in thousands
)
Year Ended
 
December 31,
 
2020
2019
2018
Cash flows from operating activities
 
 
 
 
 
 
Net income
 
$
39,787
$
31,884
$
59,811
Adjustments to reconcile net income to net cash provided by operating activities:
Amortization of debt issuance costs
4,749
1,979
70
Depreciation and amortization
 
83,246
44,895
19,714
Equity in undistributed earnings of associated companies, net of dividends
 
4,862
(2,115)
2,784
Acquisition-related fair value adjustments related to inventory
229
11,714
Deferred income taxes
(38,281)
(24,242)
8,197
Uncertain tax positions (non-deferred portion)
1,075
958
(89)
Non-current income taxes payable
856
(8,181)
Deferred compensation and other, net
(471)
(6,789)
2,914
Share-based compensation
 
10,996
4,861
3,724
Loss (gain) on disposal of property, plant, equipment and other assets
 
871
(58)
(657)
Insurance settlement realized
 
(1,035)
(822)
(1,055)
Indefinite-lived intangible asset impairment
38,000
Gain on inactive subsidiary litigation and settlement reserve
(18,144)
Combination and other acquisition-related expenses, net of payments
860
(14,414)
2,727
Restructuring and related charges
5,541
26,678
Pension and other postretirement benefits
 
16,535
46
(1,392)
Increase (decrease) in cash from changes in current assets and current
 
 
liabilities, net of acquisitions:
Accounts receivable
 
17,170
19,926
(2,822)
Inventories
 
(3,854)
10,844
(10,548)
Prepaid expenses and other current assets
 
927
(4,640)
(1,540)
Change in restructuring liabilities
(15,745)
(8,899)
Accounts payable and accrued liabilities
 
22,308
(8,915)
190
Estimated taxes on income
8,763
(1,373)
4,932
 
Net cash provided by operating activities
 
178,389
 
82,374
 
78,779
Cash flows from investing activities
 
 
 
Investments in property, plant and equipment
 
(17,901)
(15,545)
(12,886)
Payments related to acquisitions, net of cash acquired
 
(56,230)
(893,412)
(500)
Proceeds from disposition of assets
2,702
103
866
Insurance settlement interest earned
 
44
222
162
 
Net cash used in investing activities
 
(71,385)
 
(908,632)
 
(12,358)
Cash flows from financing activities
 
 
 
Payments of long-term debt
(37,615)
Proceeds from term loan debt
 
750,000
(Repayments) borrowings on revolving credit facilities, net
 
(11,485)
147,135
(21,120)
Repayments on other debt, net
 
(661)
(8,798)
(5,671)
Financing-related debt issuance costs
(23,747)
Dividends paid
 
(27,563)
(21,830)
(19,319)
Stock options exercised, other
 
3,867
1,370
82
Purchase of noncontrolling interest in affiliates
(1,047)
Distributions to noncontrolling affiliate shareholders
(751)
(877)
 
Net cash (used in) provided by financing activities
 
(75,255)
 
844,130
 
(46,905)
Effect of foreign exchange rate changes on cash
 
6,591
1,258
(6,141)
Net increase in cash, cash equivalents and restricted cash
 
38,340
19,130
13,375
Cash, cash equivalents and restricted cash at the beginning of the period
 
143,555
124,425
111,050
Cash, cash equivalents and restricted cash at the end of the period
$
181,895
$
143,555
$
124,425
Supplemental cash flow disclosures:
Cash paid during the year for:
Income taxes, net of refunds
$
20,253
$
15,499
$
19,617
Interest
23,653
19,553
2,417
Non-cash activities:
Change in accrued purchases of property, plant and equipment, net
$
(1,376)
$
1,978
$
281
 
The accompanying notes are an integral
 
part of these consolidated financial statements.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
51
 
QUAKER CHEMICAL CORPORATION
CONSOLIDATED STATEMENTS
 
OF CHANGES IN EQUITY
(
Dollars in thousands, except per share amounts
)
 
Accumulated
Capital in
other
Common
excess of
Retained
comprehensive
Noncontrolling
stock
par value
earnings
loss
interest
Total
Balance as of December 31, 2017
$
13,308
93,528
365,936
(65,100)
1,946
$
409,618
Cumulative effect of an accounting change
(754)
(754)
Balance as of January 1, 2018
13,308
93,528
365,182
(65,100)
1,946
408,864
Net income
59,473
338
59,811
Amounts reported in other comprehensive loss
(15,615)
(90)
(15,705)
Dividends declared ($
1.465
 
per share)
(19,530)
(19,530)
Distributions to noncontrolling affiliate
 
shareholders
(877)
(877)
Shares issued upon exercise of stock options
 
and other
9
(432)
(423)
Shares issued for employee stock purchase plan
3
502
505
Share-based compensation plans
18
3,706
3,724
Balance as of December 31, 2018
13,338
97,304
405,125
(80,715)
1,317
436,369
Cumulative effect of an accounting change
(44)
(44)
Balance as of January 1, 2019
13,338
97,304
405,081
(80,715)
1,317
436,325
Net income
31,622
262
31,884
Amounts reported in other comprehensive income
2,545
25
2,570
Dividends declared ($
1.525
 
per share)
(23,724)
(23,724)
Shares issued related to the Combination
4,329
784,751
789,080
Shares issued upon exercise of stock options
 
and other
23
871
894
Shares issued for employee stock purchase plan
3
473
476
Share-based compensation plans
42
4,819
4,861
Balance as of December 31, 2019
17,735
888,218
412,979
(78,170)
1,604
1,242,366
Cumulative effect of an accounting change
(911)
(911)
Balance as of January 1, 2020
17,735
888,218
412,068
(78,170)
1,604
1,241,455
Net income
39,658
129
39,787
Amounts reported in other comprehensive income
51,572
(92)
51,480
Dividends declared ($
1.560
0 per share)
(27,786)
(27,786)
Acquisition of noncontrolling interest
(707)
(340)
(1,047)
Distributions to noncontrolling affiliate
 
shareholders
(751)
(751)
Shares issued upon exercise of stock options
 
and other
66
6,714
6,780
Share-based compensation plans
50
10,946
10,996
Balance as of December 31, 2020
$
17,851
$
905,171
$
423,940
$
(26,598)
$
550
$
1,320,914
 
 
 
The accompanying notes are an integral part of these consolidated financial statements.
QUAKER CHEMICAL CORPORATION
NOTES TO CONSOLIDATED
 
FINANCIAL STATEMENTS
(
Dollars in thousands, except share and per share amounts,
 
unless otherwise stated
)
 
52
Note 1 – Significant Accounting Policies
As used in these Notes to Consolidated Financial Statements,
 
the terms “Quaker”, “Quaker Houghton”, the “Company”, “we”,
and “our” refer to Quaker Chemical Corporation (doing
 
business as Quaker Houghton), its subsidiaries, and associated companies,
unless the context otherwise requires.
 
As used in these Notes to Consolidated Financial Statements, the
 
term Legacy Quaker refers to
the Company prior to the closing of its combination with
 
Houghton International, Inc. (“Houghton”) (herein referred
 
to as the
“Combination”).
 
Principles of consolidation:
All majority-owned subsidiaries are included in the
 
Company’s consolidated financial
 
statements,
with appropriate elimination of intercompany balances and
 
transactions.
 
Investments in associated companies (less than majority-
owned and in which the Company has significant
 
influence) are accounted for under the equity method.
 
The Company’s share of net
income or losses in these investments in associated companies
 
is included in the Consolidated Statements
 
of Income.
 
The Company
periodically reviews these investments for impairments
 
and, if necessary, would adjust
 
these investments to their fair value when a
decline in market value or other impairment indicators are
 
deemed to be other than temporary.
 
See Note 17 of Notes to Consolidated
Financial Statements.
 
The Company is not the primary beneficiary of any
 
variable interest entities (“VIEs”) and therefore the
Company’s consolidated
 
financial statements do not include the accounts of any VIEs.
Translation of
 
foreign currency:
Assets and liabilities of non-U.S. subsidiaries and associated comp
 
anies are translated into
U.S. dollars at the respective rates of exchange prevailing
 
at the end of the year.
 
Income and expense accounts are translated at
average exchange rates prevailing during the year.
 
Translation adjustments resulting
 
from this process are recorded directly in equity
as accumulated other comprehensive (loss) income
 
(“AOCI”) and will be included as income or expense only upon
 
sale or liquidation
of the underlying entity or asset.
 
Generally, all of the
 
Company’s non-U.S. subsidiaries
 
use their local currency as their functional
currency.
Cash and cash equivalents:
The Company invests temporary and excess funds in money market securities and financial
instruments having maturities within 90 days. The Company considers all highly liquid investments with original maturities of three
months or less to be cash equivalents.
 
The Company has not experienced losses from the aforementioned
 
investments.
 
Inventories:
Inventories are valued at the lower of cost or net realizable
 
value, and are valued using the first-in, first-out method.
 
See Note 14 of Notes to Consolidated Financial Statements.
 
Long-lived assets:
Property, plant and
 
equipment (“PP&E”) are stated at gross cost, less accumulated depreciation.
 
Depreciation
is computed using the straight-line method on an individual
 
asset basis over the following estimated useful lives: building
 
s
 
and
improvements,
10
 
to
45
 
years; and machinery and equipment,
1
 
to
15
 
years.
 
The carrying values of long-lived assets are evaluated
whenever changes in circumstances or current events indicate
 
the carrying amount of such assets may not be recoverable.
 
An estimate
of undiscounted cash flows produced by the asset, or the
 
appropriate group of assets, is compared with the carrying value to
 
determine
whether an impairment exists.
 
If necessary, the Company
 
recognizes an impairment loss for the difference between
 
the carrying
amount of the assets and their estimated fair value.
 
Fair value is based on current and anticipated future cash flows.
 
Upon sale or
other dispositions of long-lived assets, the applicable amounts of
 
asset cost and accumulated depreciation are removed from
 
the
accounts and the net amount, less proceeds from
 
disposals, is recorded in the Consolidated Statements of Income.
 
Expenditures for
renewals or improvements that increase the estimated useful
 
life or capacity of the assets are capitalized, whereas
 
expenditures for
repairs and maintenance are expensed when incurred.
 
See Notes 9 and 15 of Notes to Consolidated Financial
 
Statements.
 
Capitalized software:
The Company capitalizes certain costs in connection with developing
 
or obtaining software for internal
use, depending on the associated project.
 
These costs are amortized over a period of
3
 
to
5
 
years once the assets are ready for their
intended use.
 
In connection with the implementations and upgrades to
 
the Company’s global transaction,
 
consolidation and other
related systems, approximately
$2.3
 
million and
$2.6
 
million of net costs were capitalized in PP&E on the
 
Company’s Consolidated
Balance Sheets at December 31, 2020 and 2019, respectively.
 
Goodwill and other intangible assets:
The Company records goodwill, definite-lived intangible
 
assets and indefinite-lived
intangible assets at fair value at the date of acquisition.
 
Goodwill and indefinite-lived intangible assets are not amortized
 
but tested for
impairment at least annually.
 
These tests will be performed more frequently if triggering
 
events indicate potential impairment.
Definite-lived intangible assets are amortized on a straight
 
-line basis over their estimated useful lives, generally for periods ranging
from
4
 
to
20
 
years.
 
The Company continually evaluates the reasonableness of
 
the useful lives of these assets, consistent with the
discussion of long-lived assets, above.
 
See Note 16 of Notes to Consolidated Financial Statements.
QUAKER CHEMICAL CORPORATION
NOTES TO CONSOLIDATED
 
FINANCIAL STATEMENTS
 
- Continued
(
Dollars in thousands, except share and per share amounts,
 
unless otherwise stated
)
 
53
Revenue recognition:
The Company applies the Financial Accounting Standards
 
Board’s (“FASB’s”)
 
guidance on revenue
recognition which requires the Company to recognize
 
revenue in an amount that reflects the consideration to which
 
the Company
expects to be entitled in exchange for goods or services
 
transferred to its customers.
 
To do this, the Company
 
applies the five-step
model in the FASB’s
 
guidance, which requires the Company to: (i) identify
 
the contract with a customer; (ii) identify the performance
obligations in the contract; (iii) determine the transaction
 
price; (iv) allocate the transaction price to the performance
 
obligations in the
contract; and (v) recognize revenue when, or as,
 
the Company satisfies a performance obligation.
 
See Note 5 of Notes to Consolidated
Financial Statements.
 
Accounts receivable and allowance for doubtful
 
accounts:
Trade accounts receivable subject the Company
 
to credit risk.
 
Trade accounts receivable are recorded
 
at the invoiced amount and generally do not bear interest.
 
The allowance for doubtful
accounts is the Company’s
 
best estimate of the amount of expected credit losses with its existing
 
accounts receivable.
 
The Company
adopted ASU 2016-13,
Financial Instruments - Credit Losses (Topic
 
326): Measurement of Credit
 
Losses on Financial Instruments
on
a modified retrospective basis, effective January
 
1, 2020.
 
See Note 3 of Notes to the Consolidated Financial Statements.
The Company recognizes an allowance for credit losses, which
 
represents the portion of the receivable that the Company does
 
not
expect to collect over its contractual life, considering
 
past events and reasonable and supportable forecasts of
 
future economic
conditions.
 
The Company’s allowance for
 
credit losses on its trade accounts receivable is based on specific
 
collectability facts and
circumstances for each outstanding receivable and customer,
 
the aging of outstanding receivables, and the associated
 
collection risk
the Company estimates for certain past due aging categories,
 
and also, the general risk to all outstanding accounts receivable
 
based on
historical amounts determined to be uncollectible.
 
The Company does not have any off-balance-sheet credit
 
exposure related to its
customers.
 
See Note 13 of Notes to Consolidated Financial Statements.
 
Research and development costs
 
Research and development costs are expensed as incurred
 
and are included in selling, general
and administrative expenses (“SG&A”).
 
Research and development expenses were
$40.0
 
million,
$32.1
 
million and
$24.5
 
million for
the years ended December 31, 2020, 2019 and 2018,
 
respectively.
 
Environmental liabilities and expenditures:
Accruals for environmental matters are recorded
 
when it is probable that a liability
has been incurred and the amount of the liability can
 
be reasonably estimated.
 
If there is a range of estimated liability and no amount
in that range is considered more probable than another,
 
then the Company records the lowest amount in the range in accordance
 
with
generally accepted accounting principles in the United
 
States (“U.S. GAAP”).
 
Environmental costs and remediation costs are
capitalized if the costs extend the life, increase the
 
capacity or improve safety or efficiency of the property
 
from the date acquired or
constructed, and/or mitigate or prevent contamination
 
in the future.
 
See Note 26 of Notes to Consolidated Financial Statements.
 
Asset retirement obligations:
The Company follows the FASB’s
 
guidance regarding asset retirement obligations,
 
which
addresses the accounting and reporting for obligations
 
associated with the retirement of tangible long-lived assets and the associated
retirement costs.
 
Also, the Company follows the FASB’s
 
guidance for conditional asset retirement obligations
 
(“CARO”), which
relates to legal obligations to perform an asset retirement
 
activity in which the timing and (or) method of settlement are
 
conditional on
a future event that may or may not be within the control
 
of the entity.
 
In accordance with this guidance, the Company records a
liability when there is enough information regarding the
 
timing of the CARO to perform a probability-weighted discounted cash
 
flow
analysis.
 
As of December 31, 2020 and 2019, the Company
 
had limited exposure to such obligations and had immaterial
 
liabilities
recorded for such on its Consolidated Balance Sheets.
 
Pension and o
ther postretirement benefits:
The Company maintains various noncontributory retirement
 
plans, covering a
portion of its employees in the U.S. and certain other
 
countries, including the Netherlands, the United Kingdom
 
(“U.K.”), Mexico,
Sweden, Germany and France.
 
These retirement plans are subject to the provisions of FASB’s
 
guidance regarding employers’
accounting for defined benefit pension plans.
 
The plans of the remaining non-U.S. subsidiaries are, for
 
the most part, either fully
insured or integrated with the local governments’ plans and
 
are not subject to the provisions of the guidance.
 
The guidance requires
that employers recognize on a prospective basis the
 
funded status of their defined benefit pension and other
 
postretirement plans on
their consolidated balance sheet and, also, recognize
 
as a component of AOCI, net of tax, the gains or losses and prior
 
service costs or
credits that arise during the period but are not recognized
 
as components of net periodic benefit cost.
 
In addition, the guidance
requires that an employer recognize a settlement charge
 
in their consolidated statement of income when certain events occur,
including plan termination or the settlement of certain
 
plan liabilities.
 
A settlement charge represents the immediate
 
recognition into
expense of a portion of the unrecognized loss within AOCI on
 
the balance sheet in proportion to the share of the projected benefit
obligation that was settled.
 
The Company’s Legacy
 
Quaker U.S. pension plan year ends on November 30 and the
 
measurement date is
December 31.
 
The measurement date for the Company’s
 
other postretirement benefits plan is December 31.
 
 
QUAKER CHEMICAL CORPORATION
NOTES TO CONSOLIDATED
 
FINANCIAL STATEMENTS
 
- Continued
(
Dollars in thousands, except share and per share amounts,
 
unless otherwise stated
)
 
54
The Company’s global
 
pension investment policies are designed to ensure that
 
pension assets are invested in a manner consistent
with meeting the future benefit obligations of the pension
 
plans and maintaining compliance with various laws and regulations
including the Employee Retirement Income Security
 
Act of 1974.
 
The Company establishes strategic asset allocation percentage
targets and benchmarks for significant asset classes
 
with the aim of achieving a prudent balance between
 
return and risk.
 
The
Company’s investment
 
horizon is generally long term, and, accordingly,
 
the target asset allocations encompass a long-term
perspective of capital markets, expected risk and return
 
and perceived future economic conditions while also considering
 
the profile of
plan liabilities.
 
To the extent
 
feasible, the short-term investment portfolio is managed
 
to match the short-term obligations, the
intermediate portfolio duration is matched to reduce
 
the risk of volatility in intermediate plan distributions, and the
 
total return
portfolio is managed to maximize the long-term real
 
growth of plan assets.
 
The critical investment principles of diversification,
assessment of risk and targeting the optimal expected
 
returns for given levels of risk are applied.
 
The Company’s investment
guidelines prohibit the use of securities such as letter stock and
 
other unregistered securities, commodities or commodity contracts,
short sales, margin transactions, private placements
 
(unless specifically addressed by addendum), or any derivatives, options or
 
futures
for the purpose of portfolio leveraging.
 
The target asset allocation is reviewed periodically
 
and is determined based on a long-term projection of capital market
 
outcomes,
inflation rates, fixed income yields, returns, volatilities and
 
correlation relationships.
 
The interaction between plan assets and benefit
obligations is periodically studied to assist in establishing such
 
strategic asset allocation targets.
 
Asset performance is monitored with
an overall expectation that plan assets will meet or exceed
 
benchmark performance over rolling five-year periods.
 
The Company’s
pension committee, as authorized by the Company’s
 
Board of Directors, has discretion to manage the assets within
 
established asset
allocation ranges approved by senior management of the
 
Company.
 
See Note 21 of Notes to Consolidated Financial Statements.
 
Comprehensive income (loss):
The Company presents other comprehensive income (loss) in its Statements
 
of Comprehensive
Income.
 
The Company follows the FASB’s
 
guidance regarding the disclosure of reclassifications from
 
AOCI which requires the
disclosure of significant amounts reclassified from each
 
component of AOCI, the related tax amounts and the income
 
statement line
items affected by such reclassifications.
 
See Note 23 of Notes to Consolidated Financial Statements.
 
Income taxes and uncertain tax positions:
The provision for income taxes is determined using the asset and
 
liability approach
of accounting for income taxes.
 
Under this approach, deferred taxes represent the future tax consequences
 
expected to occur when the
reported amounts of assets and liabilities are recovered
 
or paid.
 
The provision for income taxes represents income taxes paid
 
or
payable for the current year and the change in deferred taxes
 
during the year.
 
Deferred taxes result from differences between the
financial and tax bases of the Company’s
 
assets and liabilities and are adjusted for changes in tax rates and
 
tax laws when changes are
enacted.
 
Valuation
 
allowances are recorded to reduce deferred tax assets when it is more
 
likely than not that a tax benefit will not be
realized.
 
The FASB’s
 
guidance regarding accounting for uncertainty in income
 
taxes prescribes the recognition threshold and
measurement attributes for financial statement recognition
 
and measurement of tax positions taken or expected to be
 
taken on a tax
return.
 
The guidance further requires the determination of whether
 
the benefits of tax positions are probable or more likely than not
sustained upon audit based upon the technical merits of
 
the tax position.
 
For tax positions that are determined to be more likely than
not sustained upon audit, a company recognizes the largest
 
amount of benefit that is greater than
50
% likely of being realized upon
ultimate settlement in the financial statements.
 
For tax positions that are not determined to be more likely
 
than not sustained upon
audit, a company does not recognize any portion of the
 
benefit in the financial statements.
 
Additionally, the Company
 
monitors and
adjusts for derecognition, classification, and penalties and
 
interest in interim periods, with appropriate disclosure and
 
transition
thereto.
 
Also, the amount of interest expense and income related to uncertain
 
tax positions is computed by applying the applicable
statutory rate of interest to the difference
 
between the tax position recognized, including timing differences,
 
and the amount previously
taken or expected to be taken in a tax return.
 
The Company recognizes
 
interest and/or penalties related to income tax matters in
income tax expense.
 
Finally, when applicable,
 
the Company nets its liability for unrecognized tax benefits
 
against deferred tax assets
related to net operating losses or other tax credit carryforwards
 
that would apply if the uncertain tax position were settled
 
for the
presumed amount at the balance sheet date.
 
Pursuant to the Tax
 
Cuts and Jobs Act (“U.S. Tax
 
Reform”), specifically the one-time tax on deemed repatriation
 
(the “Transition
Tax”),
 
the Company has provided for U.S. income tax on its undistributed
 
earnings of non-U.S. subsidiaries, however,
 
the Company is
subject to and will incur other taxes, such as withholding taxes and
 
dividend distribution taxes, if these undistributed earnings were
ultimately remitted to the U.S.
 
The Company currently intends to reinvest its future undistributed
 
earnings of non-U.S. subsidiaries to
support working capital needs and certain other growth
 
initiatives of those subsidiaries.
 
However, in certain cases the Company
 
has
and may in the future change its indefinite reinvestment
 
assertion for any or all of these undistributed earnings.
 
In this case, the
Company would estimate and record a tax liability and
 
corresponding tax expense for the amount of non-U.S.
 
income taxes it would
incur to ultimately remit these earnings to the U.S.
 
See Note 10 of Notes to Consolidated Financial Statements.
 
QUAKER CHEMICAL CORPORATION
NOTES TO CONSOLIDATED
 
FINANCIAL STATEMENTS
 
- Continued
(
Dollars in thousands, except share and per share amounts,
 
unless otherwise stated
)
 
55
Derivatives:
The Company is exposed to the impact of changes in interest rates,
 
foreign currency fluctuations, changes in
commodity prices and credit risk.
 
The Company utilizes interest rate swap agreements to enhance
 
its ability to manage risk, including
exposure to variability in interest payments associated with its variable
 
rate debt.
 
Derivative instruments are entered into for periods
consistent with the related underlying exposures and do not
 
constitute positions independent of those exposures.
 
As of December 31,
2020 and 2019,
 
the Company had certain interest rate swap agreements that
 
were designated as cash flow hedges.
 
Interest rate swaps
are entered into with a limited number of counterparties,
 
each of which allows for net settlement of all contracts through
 
a single
payment in a single currency in the event of a default
 
on or termination of any one contract.
 
The Company records these instruments
on a net basis within the Consolidated Balance Sheets.
 
The effective portion of the change in fair value
 
of the agreement is recorded
in AOCI and will be recognized in the Consolidated Statements
 
of Income when the hedge item affects earnings
 
or losses or it
becomes probable that the forecasted transaction will not occur.
 
See Note 25 of Notes to Consolidated Financial Statements.
 
Fair value measurements:
The Company utilizes the FASB’s
 
guidance regarding fair value measurements,
 
which establishes a
common definition for fair value to be applied to guidance
 
requiring use of fair value, establishes a framework for
 
measuring fair
value and expands disclosure about such fair value measurements.
 
Specifically, the guidance
 
utilizes a fair value hierarchy that
prioritizes the inputs to valuation techniques used to measure fair
 
value into three broad levels.
 
See Notes 21 and 24 of Notes to
Consolidated Financial Statements.
 
The following is a brief description of those three levels:
Level 1: Observable inputs such as quoted prices (unadjusted)
 
in active markets for identical assets or liabilities.
Level 2: Inputs other than quoted prices that are observable
 
for the asset or liability,
 
either directly or indirectly.
 
These
include quoted prices for similar assets or liabilities in active
 
markets and quoted prices for identical or similar assets or
liabilities in markets that are not active.
Level 3: Unobservable inputs that reflect the reporting entity's own assumptions.
Share-based compensation:
The Company applies the FASB’s
 
guidance regarding share-based payments, which
 
requires the
recognition of the fair value of share-based compensation
 
as a component of expense.
 
The Company has a long-term incentive
program (“LTIP”)
 
for key employees which provides for the granting of options
 
to purchase stock at prices not less than its market
value on the date of the grant.
 
Most options become exercisable within
three years
 
after the date of the grant for a period of time
determined by the Company,
 
but not to exceed
seven years
 
from the date of grant.
 
Restricted stock awards and restricted stock units
issued under the LTIP
 
program are subject to time vesting generally over a
one
 
to
three-year
 
period.
 
In addition, as part of the
Company’s Annual Incentive
 
Plan, nonvested shares may be issued to key employees,
 
which generally would vest over a
two
 
to
five
-
year period.
 
In addition, while the FASB’s
 
guidance permits the Company to make an accounting
 
policy election to account for forfeitures as
they occur for service condition aspects of certain share-based
 
awards, the Company has decided not to elect this accounting
 
policy
and instead has elected to continue utilizing a forfeiture
 
rate assumption.
 
Based on historical experience, the Company has assumed a
forfeiture rate of
13
% on certain of its nonvested stock awards.
 
The Company will record additional expense if the actual forfeiture
rate is lower than estimated and will record a recovery
 
of prior expense if the actual forfeiture is higher than
 
estimated.
 
The Company also issues performance-dependent
 
stock awards as a component of its LTIP.
 
The fair value of the performance-
dependent stock awards is based on their grant-date market
 
value adjusted for the likelihood of attaining certain pre
 
-determined
performance goals and is calculated by utilizing a Monte Carlo
 
Simulation model.
 
Compensation expense is recognized on a straight-
line basis over the vesting period, generally
three years
.
See Note 8 of the Notes to Consolidated Financial Statements.
 
Earnings per share:
The Company follows the FASB’s
 
guidance regarding the calculation of earnings per
 
share for nonvested
stock awards with rights to non-forfeitable dividends.
 
The guidance requires nonvested stock awards with rights to
 
non-forfeitable
dividends to be included as part of the basic weighted
 
average share calculation under the two-class method.
 
See Note 11 of Notes to
Consolidated Financial Statements.
 
Segments:
The Company’s reportable
 
segments reflect the structure of the Company’s
 
internal organization, the method by
which the Company’s resources
 
are allocated and the manner by which the Company
 
and the chief operating decision maker assess its
performance
.
 
See Note 4 of Notes to Consolidated Financial Statements.
 
Hyper-inflationary accounting:
Economies that have a cumulative three-year rate of inflation
 
exceeding
100
% are considered
hyper-inflationary in accordance with U.S. GAAP.
 
A legal entity that operates within an economy deemed
 
to be hyper-inflationary is
required to remeasure its monetary assets and liabilities to the
 
applicable published exchange rates and record the associated gains
 
or
losses resulting from the remeasurement directly to the Consolidated
 
Statements of Income.
QUAKER CHEMICAL CORPORATION
NOTES TO CONSOLIDATED
 
FINANCIAL STATEMENTS
 
- Continued
(
Dollars in thousands, except share and per share amounts,
 
unless otherwise stated
)
 
56
Venezuela’s
 
economy has been considered hyper-inflationary
 
under U.S. GAAP since 2010.
 
The Company has a
50
% equity
interest in a Venezuelan
 
affiliate, Kelko Quaker Chemical, S.A (“Kelko Venezuela”).
 
Due to heightened foreign exchange controls
and restrictions currently present within Venezuela,
 
during the third quarter of 2018 the Company concluded
 
that it no longer had
significant influence over this affiliate.
 
Prior to this determination, the Company historically accounted
 
for this affiliate under the
equity method.
 
As of December 31, 2020 and 2019, the Company had
no
 
remaining carrying value for its investment in Kelko
Venezuela.
 
See Note 17 of Notes to Consolidated Financial Statements.
Based on various indices or index compilations currently
 
being used to monitor inflation in Argentina as well as
 
recent economic
instability, effective
 
July 1, 2018, Argentina’s
 
economy was considered hyper-inflationary under U.S. GAAP.
 
As a result, the
Company began applying hyper-inflationary
 
accounting with respect to the Company's wholly owned
 
Argentine subsidiary beginning
July 1, 2018.
 
In addition, Houghton has an Argentine subsidiary to
 
which hyper-inflationary accounting also is applied.
 
As of, and
for the year ended December 31, 2020, the Company's Argentine
 
subsidiaries represented less than
1
% of the Company’s consolidated
total assets and net sales, respectively.
 
During the years ended December 31, 2020, 2019 and 2018, the Company recorded $0.4
million, $1.0 million, and $0.7 million, respectively, of remeasurement losses associated with the applicable currency conversions
related to Venezuela and Argentina.
 
Business combinations:
The Company accounts for business combinations under
 
the acquisition method of accounting.
 
This
method requires the recording of acquired assets, including
 
separately identifiable intangible assets and assumed liabilities at their
respective acquisition date estimated fair values.
 
Any excess of the purchase price over the estimated fair value
 
of the identifiable net
assets acquired is recorded as goodwill.
 
The determination of the estimated fair value of assets acquired and
 
liabilities assumed
requires significant estimates and assumptions.
 
Based on the assessment of additional information during the measurement
 
period,
which may be up to one year from the acquisition date,
 
the Company may record adjustments to the estimated fair value of assets
acquired and liabilities assumed.
 
See Note 2 of Notes to Consolidated Financial Statements.
 
Restructuring activities:
Restructuring programs consist of employee severance,
 
rationalization of manufacturing or other
facilities and other related items.
 
To account for
 
such programs,
 
the Company applies FASB’s
 
guidance regarding exit or disposal
cost obligations.
 
This guidance requires that a liability for a cost associated with an
 
exit or disposal activity be recognized when the
liability is incurred, is estimable, and payment is probable.
 
See Note 7 of Notes to Consolidated Financial Statements.
 
Reclassifications:
Certain information has been reclassified to conform
 
to the current year presentation.
Accounting estimates:
The preparation of financial statements in conformity
 
with generally accepted accounting principles
requires management to make estimates and assumptions that
 
affect the reported amounts of assets, liabilities
 
and disclosure of
contingencies at the date of the financial statements and
 
the reported amounts of net sales and expenses during the reporting
 
period.
 
Actual results could differ from such estimates.
Note 2 – Business Combinations
 
Houghton
On
August 1, 2019
, the Company completed the Combination, whereby the Company
 
acquired all of the issued and outstanding
shares of Houghton from Gulf Houghton Lubricants, Ltd.
 
and certain other selling shareholders in exchange for a combination
 
of cash
and shares of the Company’s
 
common stock in accordance with the Share Purchase Agreement
 
dated April 4, 2017.
 
Houghton is a
leading global provider of specialty chemicals and technical
 
services for metalworking and other industrial applications.
 
The
Company believes that combining the Legacy Quaker
 
and Houghton products and service offerings allows Quaker
 
Houghton to better
serve its customers in its various end markets.
 
The Combination was subject to certain regulatory
 
and shareholder approvals.
 
At a shareholder meeting held during 2017, the
Company’s shareholders
 
approved the issuance of new shares of the Company’s
 
common stock at closing of the Combination.
 
Also
in 2017, the Company received regulatory approvals for
 
the Combination from China and Australia.
 
The Company received
regulatory approvals from the European Commission
 
(“EC”) during the second quarter of 2019 and the U.S. Federal
 
Trade
Commission (“FTC”) in July 2019.
 
The approvals from the FTC and the EC required the concurrent
 
divestiture of certain steel and
aluminum related product lines of Houghton, which
 
were sold by Houghton on August 1, 2019 for approximately
 
$
37
 
million in cash.
 
The final remedy agreed with the EC and the FTC was consistent
 
with the Company’s
 
previous expectation that the total divested
product lines would be approximately
3
% of the combined company’s
 
net sales.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
QUAKER CHEMICAL CORPORATION
NOTES TO CONSOLIDATED
 
FINANCIAL STATEMENTS
 
- Continued
(
Dollars in thousands, except share and per share amounts,
 
unless otherwise stated
)
 
57
The following table summarizes the fair value of consideration
 
transferred in the Combination:
Cash transferred to Houghton shareholders (a)
$
170,829
Cash paid to extinguish Houghton debt obligations
702,556
Fair value of common stock issued as consideration (b)
789,080
Total fair value
 
of consideration transferred
$
1,662,465
(a)
 
A portion is held in escrow by a third party,
 
subject to indemnification rights that lapse upon the achievement
 
of certain
milestones.
(b)
 
Amount was determined based on approximately
4.3
 
million shares, comprising
24.5
% of the common stock of the Company
immediately after the closing, and the closing price per
 
share of Quaker Chemical Corporation common stock
 
of $
182.27
 
on
August 1, 2019.
The Company accounted for the Combination under the
 
acquisition method of accounting.
 
This method requires the recording of
acquired assets, including separately identifiable
 
intangible assets, at their fair value on the acquisition date.
 
Any excess of the
purchase price over the estimated fair value of
 
the identifiable net assets acquired is recorded as goodwill.
 
The determination of the
estimated fair value of assets acquired, including indefinite
 
and definite-lived intangible assets, requires management’s
 
judgment and
often involves the use of significant estimates and assumptions,
 
including assumptions with respect to future cash inflows and
outflows, discount rates, customer attrition rates, royalty
 
rates, asset lives and market multiples, among other items.
 
Fair values were
determined by management using a variety of methodologies
 
and resources, including external independent valuation
 
experts.
 
The
valuation methods included physical appraisals, discounted
 
cash flow analyses, excess earnings, relief from
 
royalty, and other
appropriate valuation techniques to determine the fair value
 
of assets acquired and liabilities assumed.
The following table presents the final estimated fair
 
values of Houghton net assets acquired:
Measurement
August 1,
Period
August 1, 2019
2019 (1)
Adjustments
(as adjusted)
Cash and cash equivalents
$
75,821
$
$
75,821
Accounts receivable
178,922
178,922
Inventories
95,193
95,193
Prepaid expenses and other assets
10,652
666
11,318
Property, plant and
 
equipment
115,529
(66)
115,463
Right of use lease assets
10,673
10,673
Investments in associated companies
66,447
66,447
Other non-current assets
4,710
1,553
6,263
Intangible assets
1,028,400
1,028,400
Goodwill
494,915
4,625
499,540
Total assets purchased
2,081,262
6,778
2,088,040
Short-term borrowings, not refinanced at closing
9,297
9,297
Accounts
 
payable, accrued expenses and other accrued liabilities
150,078
1,127
151,205
Deferred tax liabilities
205,082
4,098
209,180
Long-term lease liabilities
6,607
6,607
Other non-current liabilities
47,733
1,553
49,286
Total liabilities assumed
418,797
6,778
425,575
Total consideration
 
paid for Houghton
1,662,465
1,662,465
Less: cash acquired
75,821
75,821
Less: fair value of common stock issued as consideration
789,080
789,080
Net cash paid for Houghton
$
797,564
$
$
797,564
(1) As previously disclosed in the Company’s
 
2019 Form 10-K.
During 2020, the allocation of the purchase price for
 
the Combination was finalized and the
one-year
 
measurement period has
ended.
 
Houghton assets acquired and liabilities assumed were assigned to
 
each of the Company’s reportable
 
segments on a specific
identification or allocated basis, as applicable.
 
Prior to finalizing the purchase price allocation, certain measurement
 
period
adjustments were recorded during 2020 related primarily
 
to increasing the valuation allowances against the deferred
 
tax assets
associated with foreign tax credits acquired as part of
 
the Combination as additional information became available and
 
was used to
 
 
 
 
 
 
 
 
 
 
 
QUAKER CHEMICAL CORPORATION
NOTES TO CONSOLIDATED
 
FINANCIAL STATEMENTS
 
- Continued
(
Dollars in thousands, except share and per share amounts,
 
unless otherwise stated
)
 
58
update the Company’s initial
 
estimates of expenses allocated to foreign source income
 
and expected creditable foreign taxes.
 
In
addition, measurement period adjustments included
 
the recognition of additional other non-current assets and other non-current
liabilities based on additional information obtained regarding
 
certain tax audits and associated rights to indemnification,
 
and certain
non-income tax liabilities payable upon closing of the
 
Combination in certain countries.
 
The Company allocated $
1,028.4
 
million of the purchase price to intangible assets, including certain
 
measurement period
adjustments, comprised of $
242.0
 
million of trademarks and tradename, to which management has
 
assigned indefinite lives; $
677.3
million of customer relationships, to be amortized over
15
 
to
18
 
years; and $
109.1
 
million of existing product technology,
 
to be
amortized over
20
 
years.
 
In addition, the Company recorded $
499.5
 
million of goodwill, including measurement period adjustments,
related to expected value not allocated to other acquired
 
assets, none of which will be tax deductible.
 
See Note 16 of Notes to
Consolidated Financial Statements.
 
Factors contributing to the purchase price that resulted in
 
goodwill included the acquisition of
management, business processes and personnel that
 
will allow Quaker Houghton to better serve its customers.
 
The expanded portfolio
is expected to generate significant cross-selling opportunities and
 
allow further expansion into certain emerging
 
growth markets.
 
 
Commencing August 1, 2019, the Company’s
 
Consolidated Statements of Income included the results of
 
Houghton.
 
Net sales of
Houghton subsequent to closing of the Combination and included
 
in the Company’s Consolidated
 
Statements of Income for the year
ended December 31, 2019 were $
299.8
 
million.
 
The following unaudited pro forma consolidated financial information
 
has been
prepared as if the Combination had taken place
 
on January 1, 2018.
 
The unaudited pro forma results include certain adjustments to
each company’s historical
 
actual results, including: (i) additional depreciation and amort
 
ization expense based on the initial estimates
of fair value step up and estimated useful lives of depreciable
 
fixed assets, definite-lived intangible assets and investment in
 
associated
companies acquired; (ii) adoption of required accounting
 
guidance and alignment of related accounting policies, (iii)
 
elimination of
transactions between Legacy Quaker and Houghton;
 
(iv) elimination of results associated with the divested product
 
lines; (v)
adjustment to interest expense, net, to reflect the impact
 
of the financing and capital structure of the combined Company;
 
and (vi)
adjustment for certain Combination,
 
integration and other acquisition-related costs to reflect such costs as
 
if they were incurred in the
period immediately following the pro-forma closing
 
of the Combination on January 1, 2018.
 
The adjustments described in (vi)
include an expense recorded in costs of goods sold (“COGS”)
 
associated with selling inventory acquired in the Combination which
was adjusted to fair value as part of purchase accounting,
 
restructuring expense incurred associated with the Company’s
 
global
restructuring program initiated post-closing of the Combination
 
and certain other integration costs incurred post-closing included
 
in
combination and other acquisition-related expenses.
 
These costs have been presented in the unaudited pro forma
 
table below as these
costs on a pro forma basis were incurred during the year
 
ended December 31, 2018.
 
Unaudited pro forma results are not necessarily
indicative of the results that would have occurred if the
 
acquisition had occurred on the date indicated, or that may result in the
 
future
for various reasons, including the potential impact of revenue
 
and cost synergies on the business.
For the years ending
Unaudited Pro Forma
 
 
December 31,
(as if the Combination occurred on
 
January 1, 2018)
2019
2018
Net sales
$
1,562,427
$
1,654,588
Net income attributable to Quaker Chemical Corporation
94,537
35,337
Combination,
 
integration and other acquisition-related expenses have been
 
and are expected to continue to be significant.
 
The
Company incurred total costs of $
30.3
 
million, $
38.0
 
million and $
19.5
 
million for the years ended December 31, 2020, 2019 and
2018
 
related to the Combination,
 
integration and other acquisition-related activities.
 
These costs included certain legal, financial and
other advisory
 
and consultant costs related to due diligence, regulatory approvals
 
and closing the Combination,
 
as well as integration
planning and post-closing integration activities including
 
internal control readiness and remediation.
 
These costs also include interest
costs to maintain the bank commitment (“ticking fees”)
 
for the Combination during each of the years ended December
 
31, 2019 and
2018,
 
accelerated depreciation charges during the year
 
s
 
ended December 31, 2020 and 2019, a loss on the sale of a held-for-sale
 
asset
during the year ended December 31, 2020, and a gain
 
on the sale of a held-for-sale asset during the year ended
 
December 31, 2018.
 
As of December 31, 2020 and 2019, the Company
 
had current liabilities related to the Combination and other acquisition-related
activities of $
7.5
 
million and $
6.6
 
million, respectively,
 
primarily recorded within other accrued liabilities on its Consolidated
 
Balance
Sheets.
Norman Hay
In
October 2019
, the Company completed its acquisition of the operating divisions
 
of
Norman Hay plc
 
(“Norman Hay”), a private
U.K. company
 
that provides specialty chemicals, operating equipment, and
 
services to industrial end markets.
 
The acquisition adds
new technologies in automotive, original equipment
 
manufacturer (“OEM”), and aerospace, as well as engineering
 
expertise which is
expected to strengthen the Company’s
 
existing equipment solutions platform.
 
The acquired Norman Hay assets and liabilities were
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
QUAKER CHEMICAL CORPORATION
NOTES TO CONSOLIDATED
 
FINANCIAL STATEMENTS
 
- Continued
(
Dollars in thousands, except share and per share amounts,
 
unless otherwise stated
)
 
59
assigned to the Global Specialty Businesses reportable segment.
 
The original purchase price was
80.0
 
million GBP,
 
on a cash-free
and debt-free basis, subject to routine and customary
 
post-closing adjustments related to working capital and
 
net indebtedness levels.
The following table presents the final estimated fair
 
values of Norman Hay net assets acquired:
Measurement
October 1,
Period
October 1, 2019
2019 (1)
Adjustments
(as adjusted)
Cash and cash equivalents
$
18,981
$
$
18,981
Accounts receivable
15,471
15,471
Inventories
8,213
(49)
8,164
Prepaid expenses and other assets
4,203
138
4,341
Property, plant and
 
equipment
14,981
14,981
Right of use lease assets
10,608
10,608
Intangible assets
51,088
51,088
Goodwill
29,384
(82)
29,302
Total assets purchased
152,929
7
152,936
Long-term debt included current portions
485
485
Accounts payable, accrued expenses and other accrued
 
liabilities
13,488
(732)
12,756
Deferred tax liabilities
12,746
905
13,651
Long-term lease liabilities
8,594
8,594
Total liabilities assumed
35,313
173
35,486
Total consideration
 
paid for Norman Hay
117,616
(166)
117,450
Less: estimated purchase price settlement (2)
3,287
(3,287)
Less: cash acquired
18,981
18,981
Net cash paid for Norman Hay
$
95,348
$
3,121
$
98,469
(1) As previously disclosed in the Company’s
 
2019 Form 10-K.
(2) The Company finalized its post-closing adjustments for
 
the Norman Hay acquisition and paid approximately
2.5
 
million GBP
during the first quarter of 2020 to settle such adjustments.
During 2020, the allocation of the purchase price for
 
Norman Hay was finalized and the
one-year
 
measurement period has ended.
 
The Company allocated $
51.1
 
million of the purchase price to intangible assets, comprised
 
of $
36.9
 
million of customer relationships,
to be amortized over
13
 
to
17
 
years; $
7.5
 
million of existing product technology,
 
to be amortized over
20
 
years; $
6.3
 
million of
trademarks, to be amortized over
16
 
to
17
 
years; and $
0.4
 
million of non-compete agreements, to be amortized over
2
 
to
11
 
years.
 
In
addition, the Company recorded $
29.3
 
million of goodwill related to expected value not allocated to
 
other acquired assets, none of
which will be tax deductible.
 
Factors contributing to the purchase price that resulted
 
in goodwill included the acquisition of
management, business processes and personnel that
 
will allow Quaker Houghton to better serve its customers.
 
The results of operations of Norman Hay are included
 
in the Consolidated Statements of Income as of October 1, 2019.
 
Transaction expenses associated with
 
this acquisition are included in Combination,
 
integration and other acquisition-related expenses
in the Company’s Consolidated
 
Statements of Income.
 
Certain pro forma and other information is not presented, as the operations
 
of
Norman Hay are not considered material to the overall
 
operations of the Company for the periods presented.
Coral Chemical Company
In
December 2020
, the Company completed its acquisition of
Coral Chemical Company
 
(“Coral”), a privately held, U.S.-based
provider of metal finishing fluid solutions.
 
The acquisition provides
 
technical expertise and product solutions for pre-treatment,
metalworking and wastewater treatment applications
 
to the beverage cans and general industrial end markets.
 
The acquired Coral
assets and liabilities were assigned to the Americas and Global
 
Specialty Businesses reportable segments.
 
The original purchase price
was approximately $
54.1
 
million, subject to routine and customary post-closing adjustments related
 
to working capital and net
indebtedness levels.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
QUAKER CHEMICAL CORPORATION
NOTES TO CONSOLIDATED
 
FINANCIAL STATEMENTS
 
- Continued
(
Dollars in thousands, except share and per share amounts,
 
unless otherwise stated
)
 
60
The following table presents the preliminary estimated fair
 
values of Coral net assets acquired:
December 22,
2020
Cash and cash equivalents
$
958
Accounts receivable
8,473
Inventories
4,527
Prepaid expenses and other assets
181
Property, plant and
 
equipment
10,467
Intangible assets
30,300
Goodwill
2,814
Total assets purchased
57,720
Long-term debt included current portions
183
Accounts payable, accrued expenses and other accrued liabilities
3,482
Total liabilities assumed
3,665
Total consideration
 
paid for Coral
54,055
Less: cash acquired
958
Net cash paid for Coral
$
53,097
The Company allocated $
30.3
 
million of the purchase price to intangible assets, comprised
 
of $
22.0
 
million of customer
relationships, to be amortized over
21
 
to
24
 
years; $
4.7
 
million of existing product technology,
 
to be amortized over
14
 
to
15
 
years;
$
3.6
 
million of trademarks, to be amortized over
17
 
years.
 
In addition, the Company recorded $
2.8
 
million of goodwill related to
expected value not allocated to other acquired assets, none
 
of which will be tax deductible.
 
Factors contributing to the purchase price
that resulted in goodwill included the acquisition of
 
management, business processes and personnel that will
 
allow Quaker Houghton
to better serve its customers.
 
As of December 31, 2020, the allocation of the purchase
 
price for Coral has not been finalized and the
one-year
 
measurement
period has not ended.
 
Further adjustments may be necessary as a result of the
 
Company’s on-going assessment of
 
additional
information related to the fair value of assets acquired
 
and liabilities assumed.
 
The preliminary purchase price allocations are based
upon the valuation of assets and these estimates and assumptions
 
are subject to change as the Company obtains additional information
during the measurement period.
 
These assets pending finalization include fixed assets and intangible
 
assets which could also result in
adjustments to goodwill.
 
The results of operations of Coral subsequent to the
 
acquisition date are included in the Consolidated Statements of
 
Income as of
December 31, 2020.
 
Transaction expenses associated with this acquisition
 
are included in Combination,
 
integration and other
acquisition-related expenses in the Company’s
 
Consolidated Statements of Income.
 
Certain pro forma and other information is not
presented, as the operations of Coral are not considered
 
material to the overall operations of the Company for the
 
periods presented.
Other Acquisitions
In February 2021, the Company acquired certain assets related
 
to tin-plating solutions in the steel end market for approximately
$
25
 
million.
 
The results of operations of the acquired assets are not
 
included in the Consolidated Statements of Income, because the
date of closing was after December 31, 2020.
 
Transaction expenses associated with this acquisition
 
that were incurred during the year
ended December 31, 2020 are included in Combination,
 
integration and other acquisition-related expenses in the Company’s
Consolidated Statements of Income.
 
A preliminary purchase price allocation of assets acquired
 
and liabilities assumed has not been
presented as that information is not available as of
 
the date of these Consolidated Financial Statements.
In May 2020, the Company acquired Tel
 
Nordic ApS (“TEL”), a company that specializes in lubricants and engineering
 
primarily
in high pressure aluminum die casting for its Europe,
 
Middle East and Africa (“EMEA”) reportable segment.
 
Consideration paid was
in the form of a convertible promissory note in the amount
 
of
20.0
 
million DKK, or approximately $
2.9
 
million, which was
subsequently converted into shares of the Company’s
 
common stock.
 
An adjustment to the purchase price of approximately
0.4
million DKK, or less than $
0.1
 
million, was made as a result of finalizing a post-closing
 
settlement in the second quarter of 2020.
 
The
Company allocated approximately $
2.4
 
million of the purchase price to intangible assets to be amortized
 
over
17
 
years.
 
In addition,
the Company recorded approximately $
0.5
 
million of goodwill, related to expected value not allocated to
 
other acquired assets, none
of which will be tax deductible.
 
The allocation of the purchase price of TEL has not been
 
finalized and the one-year measurement
period has not ended.
 
Further adjustments may be necessary as a result of the
 
Company’s on-going assessment of
 
additional
information related to the fair value of assets acquired
 
and liabilities assumed.
 
QUAKER CHEMICAL CORPORATION
NOTES TO CONSOLIDATED
 
FINANCIAL STATEMENTS
 
- Continued
(
Dollars in thousands, except share and per share amounts,
 
unless otherwise stated
)
 
61
In March 2020, the Company acquired the remaining
49
% ownership interest in one of its South African affiliates,
 
Quaker
Chemical South Africa Limited (“QSA”) for
16.7
 
million ZAR, or approximately $
1.0
 
million, from its joint venture partner PQ
Holdings South Africa.
 
QSA is a part of the Company’s
 
EMEA reportable segment.
 
As this acquisition was a change in an existing
controlling ownership, the Company recorded $
0.7
 
million of excess purchase price over the carrying value of
 
the noncontrolling
interest in Capital in excess of par value.
 
 
In March 2018, the Company purchased certain formulations
 
and product technology for the mining industry for $
1.0
 
million.
 
The Company allocated the entire purchase price to intangible
 
assets representing formulations and product technology,
 
to be
amortized over
10
 
years.
 
In accordance with the terms of the applicable purchase agreement,
 
$
0.5
 
million of the purchase price was
paid at signing, and the remaining $
0.5
 
million of the purchase price was paid during the first quarter of 2019.
Note 3 – Recently Issued Accounting Standards
Recently Issued Accounting Standards
 
Adopted
The FASB issued
 
Account Standards Update (“ASU”)
 
2020-04,
Reference Rate Reform (Topic
 
848): Facilitation of the Effects of
Reference Rate Reform on Financial
 
Reporting
 
in March 2020.
 
The amendments provide temporary optional expedients and
exceptions for applying GAAP to contract modifications,
 
hedging relationships and other transactions to ease the potential
 
accounting
and financial reporting burden associated with transitioning
 
away from reference rates that are expected to be discontinued,
 
including
the London Interbank Offered Rate (“LIBOR”).
 
ASU 2020-04 is effective for the
 
Company as of March 12, 2020 and generally can
be applied through December 31, 2022.
 
As of December 31, 2020,
 
the expedients provided in ASU 2020-04 do not impact the
Company; however, the Company
 
will continue to monitor for potential impacts on its consolidated
 
financial statements.
The FASB issued
 
ASU 2018-15
, Customer’s
 
Accounting for Implementation Costs Incurred
 
in a Cloud Computing Arrangement
That Is a Service Contract
 
in August 2018 that clarifies the accounting for implementation
 
costs incurred in a cloud computing
arrangement under a service contract.
 
This guidance generally aligns the requirements for capitalizing
 
implementation costs incurred
in a hosting arrangement under a service contract with the
 
requirements for capitalizing implementation costs related
 
to internal-use
software.
 
The guidance within this accounting standard update is effective
 
for annual periods beginning after December 15, 2019 and
should be applied either retrospectively or prospec
 
tively to all implementation costs incurred after the date of
 
adoption.
 
Early
adoption was permitted.
 
The Company adopted this standard on a prospective basis, effective
 
January 1, 2020.
 
There was no
cumulative effect of adoption recorded within
 
retained earnings on January 1, 2020.
 
The FASB issued
 
ASU 2018-14,
Disclosure Framework — Changes to
 
the Disclosure Requirements
 
for Defined Benefit Plans
 
in
August 2018 that modifies certain disclosure requirements
 
for fair value measurements.
 
The guidance removes certain disclosure
requirements regarding transfers between levels of
 
the fair value hierarchy as well as certain disclosures related
 
to the valuation
processes for certain fair value measurements.
 
Further, the guidance added certain disclosure
 
requirements including unrealized gains
and losses and significant unobservable inputs used to
 
develop certain fair value measurements.
 
The guidance within this accounting
standard update is effective for annual and
 
interim periods beginning after December 15, 2019, and should
 
be applied prospectively in
the initial year of adoption or prospectively to all periods
 
presented, depending on the amended disclosure requirement.
 
Early
adoption was permitted.
 
The Company adopted this standard on a prospective basis, effective
 
January 1, 2020.
 
ASU 2018-14
addresses disclosures only and will not
 
have an impact on the Company’s
 
consolidated financial statements.
The FASB issued
 
ASU 2018-13, Fair Value
 
Measurement (Topic 820):
 
Disclosure Framework – Changes to the Disclosure
Requirements for Fair Value
 
Measurement in August 2018 that modifies certain disclosure
 
requirements for employers that sponsor
defined benefit pension or other postretirement plans.
 
The amendments in this ASU remove disclosures that are
 
no longer considered
cost beneficial, clarify the specific requirements of certain
 
disclosures, and add new disclosure requirements as relevant.
 
The
guidance within this accounting standard update
 
is effective for annual periods beginning after December
 
15, 2019, and should be
applied retrospectively to all periods presented.
 
The Company adopted this standard on a prospective basis, effective
 
January 1, 2020.
 
There was no cumulative effect of adoption
 
recorded within retained earnings on January 1, 2020.
The FASB issued
 
ASU 2016-13,
Financial Instruments - Credit Losses (Topic
 
326): Measurement of Credit
 
Losses on Financial
Instruments
in June 2016 related to the accounting for and disclosure of
 
credit losses.
 
The FASB subsequently
 
issued several
additional accounting standard updates which amended
 
and clarified the guidance, but did not materially change
 
the guidance or its
applicability to the Company.
 
This accounting guidance introduces a new model for
 
recognizing credit losses on financial
instruments, including customer accounts receivable,
 
based on an estimate of current expected credit losses.
 
The Company adopted
the guidance in this accounting standard update, including
 
all applicable subsequent updates to this accounting guidance, as required,
on a modified retrospective basis, effective January
 
1, 2020.
 
Adoption did not have a material impact to the Company’s
 
financial
statements as expected.
 
However, as a result of this adoption,
 
the Company recorded a cumulative effect of
 
accounting change that
QUAKER CHEMICAL CORPORATION
NOTES TO CONSOLIDATED
 
FINANCIAL STATEMENTS
 
- Continued
(
Dollars in thousands, except share and per share amounts,
 
unless otherwise stated
)
 
62
resulted in an increase to its allowance for doubtful
 
accounts of approximately $
1.1
 
million, a decrease to deferred tax liabilities of
$
0.2
 
million and a decrease to retained earnings of $
0.9
 
million.
 
In accordance with this guidance, the Company recognizes
 
an allowance for credit losses reflecting the net amount expected to
 
be
collected from its financial assets, primarily trade accounts
 
receivable.
 
This allowance represents the portion of the receivable that the
Company does not expect to collect over its contractual
 
life, considering past events and reasonable and supportable forecasts of
 
future
economic conditions.
 
The Company’s allowance for
 
credit losses on its trade accounts receivable is based on
 
specific collectability
facts and circumstances for each outstanding receivable and
 
customer, the aging of outstanding
 
receivables and the associated
collection risk the Company estimates for certain past due
 
aging categories, and also, the general risk to all outstanding accounts
receivable based on historical amounts determined to
 
be uncollectible.
 
See Note 13 of Notes to the Consolidated Financial
Statements.
Recently Issued Accounting Standards
 
Not Yet Adopted
The FASB
 
issued ASU 2020-01,
 
Investments – Equity Securities (To
 
pic 321), Investments – Equity Method and Joint Ventures
(Topic
 
323), and Derivatives and Hedging (Topic
 
815) –Clarifying the Interactions between Topic
 
321, Topic
 
323, and Topic
 
815
 
in
January 2020 clarifying the interaction among the
 
accounting standards related to equity securities, equity method investments,
 
and
certain derivatives.
 
The new guidance, among other things, states that a company
 
should consider observable transactions that require
a company to either apply or discontinue the equity method
 
of accounting, for the purposes of applying the fair value
 
measurement
alternative immediately before applying or upon discontinuing
 
the equity method.
 
The new guidance also addresses the measurement
of certain purchased options and forward contracts used
 
to acquire investments.
 
The guidance within this accounting standard update
is effective for annual and interim periods beginning
 
after December 15, 2020 and is to be applied prospectively.
 
Early adoption is
permitted.
 
The Company will adopt this standard, as required, on a prospective
 
basis, effective January 1, 2021, and does not expect
adoption to have an impact to its financial statements.
The FASB issued
 
ASU 2019-12
, Income Taxes
 
(Topic
 
740): Simplifying the Accounting for Income Taxes
 
in December 2019.
 
The guidance within this accounting standard update
 
removes certain exceptions, including the exception to the incremental
 
approach
for certain intra-period tax allocations, to the requirement
 
to recognize or not recognize certain deferred tax liabilities for
 
equity
method investments and foreign subsidiaries, and to the
 
general methodology for calculating income taxes in
 
an interim period when a
year-to-date loss exceeds the anticipated loss for
 
the year.
 
Further, the guidance simplifies the accounting
 
related to franchise taxes,
the step up in tax basis for goodwill, current and deferred
 
tax expense, and codification improvements for income taxes
 
related to
employee stock ownership plans.
 
The guidance is effective for annual and interim
 
periods beginning after December 15, 2020.
 
Early
adoption is permitted.
 
The Company will adopt this standard, as required, effective
 
January 1, 2021, and is currently evaluating its
implementation and any potential adoption impact.
Note 4 – Business Segments
The Company’s operating
 
segments, which are consistent with its reportable segments,
 
reflect the structure of the Company’s
internal organization, the method by which
 
the Company’s resources are allocated
 
and the manner by which the chief operating
decision
 
maker assess the Company’s
 
performance.
 
During the third quarter of 2019 and in connection with the
 
Combination, the
Company reorganized its executive management
 
team to align with its new business structure, which reflects the
 
method by which the
chief operating decision maker assesses the Company’s
 
performance and allocates its resources.
 
The Company’s current reportable
segment structure includes four segments: (i) Americas;
 
(ii) EMEA; (iii) Asia/Pacific; and (iv) Global Specialty Businesses.
 
The three
geographic segments are composed of the net sales and
 
operations in each respective region, excluding net sales and
 
operations
managed globally by the Global Specialty Businesses segment,
 
which includes the Company’s
 
container, metal finishing, mining,
offshore, specialty coatings, specialty grease and
 
Norman Hay businesses.
Although the Company changed its reportable segments in
 
the third quarter of 2019, the calculation of the reportable
 
segments’
measures of earnings remains otherwise generally
 
consistent with past practices.
 
Segment operating earnings for each of the
Company’s reportable
 
segments are comprised of the segment’s
 
net sales less directly related
 
COGS and SG&A.
 
Operating expenses
not directly attributable to the net sales of each respective
 
segment, such as certain corporate and administrative costs, Combination,
integration and other acquisition-related expenses, and Restructuring
 
and related charges, are not included in segment operating
earnings.
 
Other items not specifically identified with the Company’s
 
reportable segments include interest expense, net and other
expense, net.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
QUAKER CHEMICAL CORPORATION
NOTES TO CONSOLIDATED
 
FINANCIAL STATEMENTS
 
- Continued
(
Dollars in thousands, except share and per share amounts,
 
unless otherwise stated
)
 
63
The following tables present information about the performance
 
of the Company’s reportable segments
 
for the years ended
December 31, 2020, 2019 and 2018.
 
Certain immaterial reclassifications within the segment disclosures
 
for the years ended
December 31, 2019 and 2018 have been made to conform with
 
the Company’s current customer
 
industry segmentation.
2020
2019
2018
Net sales
 
 
 
 
 
 
 
 
Americas
$
450,161
$
392,121
$
297,601
EMEA
 
383,187
 
285,570
 
216,984
Asia/Pacific
315,299
247,839
192,502
Global Specialty Businesses
269,030
207,973
160,433
Total
 
net sales
$
1,417,677
$
1,133,503
$
867,520
 
2020
2019
2018
Segment operating earnings
Americas
$
96,379
$
78,297
$
62,686
EMEA
 
69,163
 
47,014
 
36,119
Asia/Pacific
88,356
67,512
53,739
Global Specialty Businesses
79,690
58,881
42,931
Total
 
segment operating earnings
333,588
251,704
195,475
Combination, integration and other acquisition-related
 
expenses
(29,790)
(35,477)
(16,661)
Restructuring and related charges
(5,541)
(26,678)
Fair value step up of inventory sold
(226)
(11,714)
Indefinite-lived intangible asset impairment
(38,000)
Non-operating and administrative expenses
(143,202)
(104,572)
(83,515)
Depreciation of corporate assets and amortization
(57,469)
(27,129)
(7,518)
Operating income
59,360
46,134
87,781
Other expense, net
(5,618)
(254)
(642)
Interest expense, net
(26,603)
(16,976)
(4,041)
Income before taxes and equity in net income
 
of
associated companies
$
27,139
$
28,904
$
83,098
The following tables present information regarding the
 
Company’s reportable segments’
 
assets and long-lived assets, including
certain identifiable assets as well as an allocation of
 
shared assets, of December 31, 2020, 2019 and 2018:
2020
2019
2018
Segment assets
Americas
$
969,551
$
926,122
$
180,037
EMEA
697,821
688,663
149,984
Asia/Pacific
713,004
685,476
205,424
Global Specialty Businesses
511,458
550,055
174,220
Total segment assets
$
2,891,834
$
2,850,316
$
709,665
 
2020
2019
2018
Segment long-lived assets
Americas
$
122,302
$
139,170
$
60,745
EMEA
69,344
56,108
23,383
Asia/Pacific
119,233
126,166
26,217
Global Specialty Businesses
59,091
69,184
26,949
Total segment long-lived
 
assets
$
369,970
$
390,628
$
137,294
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
QUAKER CHEMICAL CORPORATION
NOTES TO CONSOLIDATED
 
FINANCIAL STATEMENTS
 
- Continued
(
Dollars in thousands, except share and per share amounts,
 
unless otherwise stated
)
 
64
The following tables present information regarding the
 
Company’s reportable segments’
 
capital expenditures and depreciation for
identifiable assets for the years ended December 31,
 
2020, 2019 and 2018:
2020
2019
2018
Capital expenditures
Americas
$
6,451
$
6,404
$
3,401
EMEA
3,844
3,263
2,081
Asia/Pacific
5,688
3,857
6,059
Global Specialty Businesses
1,918
2,021
1,345
Total segment capital
 
expenditures
$
17,901
$
15,545
$
12,886
 
2020
2019
2018
Depreciation
Americas
$
12,322
$
7,500
$
4,225
EMEA
6,813
4,560
3,434
Asia/Pacific
4,672
3,458
2,552
Global Specialty Businesses
3,544
2,248
1,985
Total segment depreciation
$
27,351
$
17,766
$
12,196
During the years ended December 31, 2020, 2019 and 2018,
 
the Company had approximately
$963.2
 
million,
$719.8
 
million and
$534.6
 
million of net sales, respectively,
 
attributable to non-U.S. operations.
 
As of December 31, 2020, 2019 and 2018, the Company
had approximately
$176.6
 
million,
$174.4
 
million and
$60.8
 
million of long-lived assets, respectively,
 
attributable to non-U.S.
operations.
Inter-segment revenue for the years ended December
 
31, 2020, 2019 and 2018 was
$9.1
 
million,
$7.3
 
million and
$8.3
 
million for
Americas,
$22.0
 
million,
$20.3
 
million and
$21.9
 
million for EMEA,
$0.6
 
million,
$0.2
 
million and
$0.5
 
million for Asia/Pacific and
$4.7
 
million,
$5.4
 
million and
$5.3
 
million for Global Specialty Businesses, respectively.
 
However, all inter-segment
 
transactions
have been eliminated from each reportable operating
 
segment’s net sales and earnings
 
for all periods presented in the above tables.
Note 5 – Net Sales and Revenue Recognition
Business Description
The Company develops, produces, and markets a broad
 
range of formulated chemical specialty products and offers
 
chemical
management services (“Fluidcare”) for various heavy
 
industrial and manufacturing applications throughout its four
 
segments.
 
The
Combination increased the Company’s
 
addressable metalworking, metals and industrial end markets, including
 
steel, aluminum,
aerospace,
 
defense, transportation-OEM, transportation-components, offshore
 
sub-sea energy,
 
architectural aluminum, construction,
tube and pipe, can and container,
 
mining, specialty coatings and specialty greases.
 
The Combination also strengthened the product
portfolio of the combined Company.
 
The major product lines of Quaker Houghton include metal removal
 
fluids, cleaning fluids,
corrosion inhibitors, metal drawing and forming fluids, die
 
cast mold releases, heat treatment and quenchants, metal forging
 
fluids,
hydraulic fluids, specialty greases, offshore
 
sub-sea energy control fluids, rolling lubricants, rod
 
and wire drawing fluids and surface
treatment chemicals.
A substantial portion of the Company’s
 
sales worldwide are made directly through its own employees
 
and its Fluidcare programs,
with the balance being handled through distributors and
 
agents.
 
The Company’s employees typic
 
ally visit the plants of customers
regularly, work
 
on site, and, through training and experience, identify production
 
needs,
 
which can be resolved or otherwise addressed
either by adapting the Company’s
 
existing products or by applying new formulations developed
 
in its laboratories.
 
The specialty
chemical industry comprises many companies similar in
 
size to the Company,
 
as well as companies larger and smaller than Quaker
Houghton.
 
The offerings of many of the Company’s
 
competitors differ from those of Quaker Houghton;
 
some offer a broad portfolio
of fluids, including general lubricants, while others have
 
a more specialized product range.
 
All competitors provide different levels of
technical services to individual customers. Competition
 
in the industry is based primarily on the ability to provide products that meet
the needs of the customer, render
 
technical services and laboratory assistance to the customer and,
 
to a lesser extent, on price.
As part of the Company’s
 
Fluidcare business, certain third-party product sales to customers are
 
managed by the Company.
 
Where
the Company acts as a principal, revenues are recognized
 
on a gross reporting basis at the selling price negotiated with
 
its customers.
 
Where the Company acts as an agent, revenue is recognized on
 
a net reporting basis at the amount of the administrative fee earned
 
by
QUAKER CHEMICAL CORPORATION
NOTES TO CONSOLIDATED
 
FINANCIAL STATEMENTS
 
- Continued
(
Dollars in thousands, except share and per share amounts,
 
unless otherwise stated
)
 
65
the Company for ordering the goods.
 
In determining whether the Company is acting as a principal
 
or an agent in each arrangement,
the Company considers whether it is primarily responsible
 
for the obligation to provide the specified good, has inventory
 
risk before
the specified good has been transferred to the customer
 
and has discretion in establishing the prices for the specified
 
goods.
 
The
Company transferred third-party products under arrangements
 
resulting in net reporting of $
42.5
 
million, $
48.0
 
million and $
47.1
million for the years ended December 31, 2020,
 
2019 and 2018, respectively.
A significant portion of the Company’s
 
revenues are realized from the sale of process fluids and services
 
to manufacturers of
steel, aluminum, automobiles, aircraft, industrial equipment,
 
and durable goods, and, therefore, the Company is subject
 
to the same
business cycles as those experienced by these manufacturers and
 
their customers.
 
The Company’s financial performance
 
is generally
correlated to the volume of global production within the
 
industries it serves, rather than discretely related to the financial performance
of such industries.
 
Furthermore, steel and aluminum customers typically have
 
limited manufacturing locations compared to
metalworking customers and generally use higher
 
volumes of products at a single location.
 
During the year ended December 31,
2020,
 
the Company’s five largest
 
customers (each composed of multiple subsidiaries or
 
divisions with semiautonomous purchasing
authority) accounted for approximately
10
% of consolidated net sales, with its largest customer accounting
 
for approximately
3
% of
consolidated net sales.
Revenue Recognition Model
The Company applies the FASB’s
 
guidance on revenue recognition which requires the
 
Company to recognize revenue in an
amount that reflects the consideration to which the Company
 
expects to be entitled in exchange for goods or services transferred
 
to its
customers.
 
To do this, the Company
 
applies the five-step model in the FASB’s
 
guidance, which requires the Company to: (i) identify
the contract with a customer; (ii) identify the performance
 
obligations in the contract; (iii) determine the transaction price;
 
(iv) allocate
the transaction price to the performance obligations in the
 
contract; and (v) recognize revenue when, or as, the Company
 
satisfies a
performance obligation.
The Company identifies a contract with a customer when a
 
sales agreement indicates approval and commitment of the parties;
identifies the rights of the parties; identifies the payment
 
terms; has commercial substance; and it is probable that the
 
Company will
collect the consideration to which it will be entitled in
 
exchange for the goods or services that will be transferr
 
ed to the customer.
 
In
most instances, the Company’s
 
contract with a customer is the customer’s
 
purchase order.
 
For certain customers, the Company may
also enter into a sales agreement which outlines a
 
framework of terms and conditions which apply to all future
 
and subsequent
purchase orders for that customer.
 
In these situations, the Company’s
 
contract with the customer is both the sales agreement as well as
the specific customer purchase order.
 
Because the Company’s contract
 
with a customer is typically for a single transaction or
customer purchase order, the duration
 
of the contract is almost always one year or less.
 
As a result, the Company has elected to apply
certain practical expedients and omit certain disclosures of
 
remaining performance obligations for contracts that have an
 
initial term of
one year or less as permitted by the FASB.
The Company identifies a performance obligation in a
 
contract for each promised good or service that is separately identifiable
from other obligations in the contract and for which the
 
customer can benefit from the good or service either on its own or together
with other resources that are readily available to
 
the customer.
 
The Company determines the transaction price as the amount
 
of
consideration it expects to be entitled to in exchange
 
for fulfilling the performance obligations, including the
 
effects of any variable
consideration, significant financing elements, amounts
 
payable to the customer or noncash consideration.
 
For any contracts that have
more than one performance obligation, the Company
 
allocates the transaction price to each performance obligation
 
in an amount that
depicts the amount of consideration to which the Company
 
expects to be entitled in exchange for satisfying each performance
obligation.
In accordance with the last step of the FASB’s
 
guidance, the Company recognizes revenue when,
 
or as, it satisfies the
performance obligation in a contract by transferring control
 
of a promised good or providing the service to the customer.
 
The
Company recognizes revenue over time as the customer
 
receives and consumes the benefits provided by the Company’s
 
performance;
the Company’s performance
 
creates or enhances an asset that the customer controls as the
 
asset is created or enhanced; or the
Company’s performance
 
does not create an asset with an alternative use to the entity,
 
and the entity has an enforceable right to
payment, including a profit margin, for performance
 
completed to date.
 
For performance obligations not satisfied over time, the
Company determines the point in time at which a customer
 
obtains control of an asset and the Company satisfies a performance
obligation by considering when the Company has a right
 
to payment for the asset; the customer has legal title to the
 
asset; the
Company has transferred physical possession of the asset; the
 
customer has the significant risks and rewards of ownership
 
of the asset;
or the customer has accepted the asset.
QUAKER CHEMICAL CORPORATION
NOTES TO CONSOLIDATED
 
FINANCIAL STATEMENTS
 
- Continued
(
Dollars in thousands, except share and per share amounts,
 
unless otherwise stated
)
 
66
The Company typically satisfies its performance obligations
 
and recognizes revenue at a point in time for product
 
sales, generally
when products are shipped or delivered to the customer,
 
depending on the terms underlying each arrangement.
 
In circumstances
where the Company’s
 
products are on consignment, revenue is generally recognized
 
upon usage or consumption by the customer.
 
For
any Fluidcare or other services provided by the Company
 
to the customer, the Company typically satisfies its
 
performance obligations
and recognizes revenue over time, as the promised services
 
are performed.
 
The Company uses input methods to recognize revenue
over time related to these services, including labor costs
 
and time incurred.
 
The Company believes that these input methods represent
the most indicative measure of the Fluidcare or other service
 
work performed by the Company.
Other Considerations
The Company does not have standard payment terms for
 
all customers, however the Company’s
 
general payment terms require
customers to pay for products or services provided after
 
the performance obligation is satisfied.
 
The Company does not have
significant financing arrangements with its customers.
 
The Company does not have significant amounts of variable
 
consideration in
its contracts with customers and where applicable,
 
the Company’s estimates of variable
 
consideration are not constrained.
 
The
Company records certain third-party license fees in
 
other income (expense), net, in its Consolidated Statement
 
of Income, which
generally include sales-based royalties in exchange for
 
the license of intellectual property.
 
These license fees are recognized in
accordance with their agreed-upon terms and when performance
 
obligations are satisfied, which is generally when the
 
third party has a
subsequent sale.
Practical Expedients and Accounting Policy Elections
The Company has made certain accounting
 
policy elections and elected to use certain practical expedients as permitted
 
by the
FASB in applying
 
the guidance on revenue recognition.
 
The Company does not adjust the promised amount of consideration for
 
the
effects of a significant financing compon
 
ent as the Company expects, at contract inception, that the
 
period between when the
Company transfers a promised good or service to the
 
customer and when the customer pays for that good or service will be one
 
year or
less.
 
In addition, the Company expenses
 
costs to obtain a contract as incurred when the expected
 
period of benefit, and therefore the
amortization period, is one year or less.
 
In addition, the Company excludes from the measurement of
 
the transaction price all taxes
assessed by a governmental authority that are both imposed
 
on and concurrent with a specific revenue-producing
 
transaction and
collected by the entity from a customer,
 
including sales, use, value added, excise and various other taxes.
 
Lastly, the Company
 
has
elected to account for shipping and handling activities that
 
occur after the customer has obtained control of a good
 
as a fulfilment cost,
rather than an additional promised service.
Contract Assets and Liabilities
The Company recognizes a contract asset or receivable
 
on its Consolidated Balance Sheet when the Company performs
 
a service
or transfers a good in advance of receiving consideration.
 
A receivable is the Company’s
 
right to consideration that is unconditional
and only the passage of time is required before payment
 
of that consideration is due.
 
A contract asset is the Company’s right
 
to
consideration in exchange for goods
 
or services that the Company has transferred to a customer.
 
The Company had no material
contract assets recorded on its Consolidated Balance Sheets
 
as of December 31, 2020 and 2019.
 
A contract liability is recognized when the Company
 
receives consideration, or if it has the unconditional right
 
to receive
consideration, in advance of performance.
 
A contract liability is the Company’s
 
obligation to transfer goods or services to a customer
for which the Company has received consideration,
 
or a specified amount of consideration is due, from the customer.
 
The Company’s
contract liabilities primarily represent deferred revenue
 
recorded for customer payments received by the Company
 
prior to the
Company satisfying the associated performance obligation.
 
The Company acquired and recorded an immaterial
 
amount of deferred
revenue as of the respective opening balance sheet dates
 
related to the Combination and Norman Hay acquisition.
 
Deferred revenues
are presented within other accrued liabilities in the Company’s
 
Consolidated Balance Sheets.
 
The Company had approximately $
4.0
million and $
2.2
 
million of deferred revenue as of December 31, 2020 and 2019,
 
respectively.
 
During the years ended December 31,
2020 and 2019,
 
respectively, the Company satisfied
 
all of the associated performance obligations and recognized
 
into revenue the
advance payments received and recorded as of December
 
31, 2020, 2019 and 2018, respectively.
Disaggregated Revenue
The Company sells its various industrial process fluids,
 
its specialty chemicals and its technical expertise as a global
 
product
portfolio.
 
The Company generally manages and evaluates its performance
 
by segment first, and then by customer industry,
 
rather than
by individual product lines.
 
Also, net sales of each of the Company’s
 
major product lines are generally spread throughout all three
 
of
the Company’s geographic
 
regions, and in most cases, approximately proportionate
 
to the level of total sales in each region.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
QUAKER CHEMICAL CORPORATION
NOTES TO CONSOLIDATED
 
FINANCIAL STATEMENTS
 
- Continued
(
Dollars in thousands, except share and per share amounts,
 
unless otherwise stated
)
 
67
The following tables present disaggregated information
 
regarding the Company’s net
 
sales, first by major product lines that
represent more than 10% of the Company’s
 
consolidated net sales for any of the years ended December
 
31, 2020, 2019 and 2018,
 
and
followed then by a disaggregation of the Company’s
 
net sales by segment, geographic region, customer industry,
 
and timing of
revenue recognized for the years ended December 31, 2020,
 
2019 and 2018.
2020
2019
2018
Metal removal fluids
23.9
%
19.9
%
15.4
%
Rolling lubricants
21.8
%
21.9
%
25.5
%
Hydraulic fluids
13.3
%
13.0
%
13.0
%
 
Net sales for the year ending December 31, 2020
Consolidated
Americas
EMEA
Asia/Pacific
Total
Customer Industries
Metals
$
163,135
$
107,880
$
168,096
$
439,111
Metalworking and other
287,026
275,307
147,203
709,536
450,161
383,187
315,299
1,148,647
Global Specialty Businesses
154,796
68,164
46,070
269,030
$
604,957
$
451,351
$
361,369
$
1,417,677
Timing of Revenue Recognized
Product sales at a point in time
$
580,663
$
434,549
$
352,917
$
1,368,129
Services transferred over time
24,294
16,802
8,452
49,548
$
604,957
$
451,351
$
361,369
$
1,417,677
 
Net sales for the year ending December 31, 2019
Consolidated
Americas
EMEA
Asia/Pacific
Total
Customer Industries
Metals
$
171,784
$
100,605
$
141,870
$
414,259
Metalworking and other
220,337
184,965
105,969
511,271
392,121
285,570
247,839
925,530
Global Specialty Businesses
149,428
30,115
28,430
207,973
$
541,549
$
315,685
$
276,269
$
1,133,503
Timing of Revenue Recognized
Product sales at a point in time
$
525,802
$
310,274
$
269,228
$
1,105,304
Services transferred over time
15,747
5,411
7,041
28,199
$
541,549
$
315,685
$
276,269
$
1,133,503
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
QUAKER CHEMICAL CORPORATION
NOTES TO CONSOLIDATED
 
FINANCIAL STATEMENTS
 
- Continued
(
Dollars in thousands, except share and per share amounts,
 
unless otherwise stated
)
 
68
Net sales for the year ending December 31, 2018
Consolidated
Americas
EMEA
Asia/Pacific
Total
Customer Industries
Metals
$
164,263
$
101,028
$
120,627
$
385,918
Metalworking and other
133,338
115,956
71,875
321,169
297,601
216,984
192,502
707,087
Global Specialty Businesses
122,165
16,613
21,655
160,433
$
419,766
$
233,597
$
214,157
$
867,520
Timing of Revenue Recognized
Product sales at a point in time
$
408,402
$
233,372
$
206,112
$
847,886
Services transferred over time
11,364
225
8,045
19,634
$
419,766
$
233,597
$
214,157
$
867,520
Note 6 – Leases
As previously disclosed in the Company’s
 
2019 Form 10-K, during 2019, the Company adopted, as required,
 
an accounting
standard update regarding the accounting and disclosure
 
for leases which changed the manner in which it accounts for
 
leases effective
January 1, 2019.
 
The Company determines if an arrangement is a lease at its inception.
 
This determination generally depends on
whether the arrangement conveys the right to control the
 
use of an identified fixed asset explicitly or implicitly for a period
 
of time in
exchange for consideration.
 
Control of an underlying asset is conveyed if the Company
 
obtains the rights to direct the use of, and
obtains
 
substantially all of the economic benefits from the use of,
 
the underlying asset.
 
Lease expense for variable leases and short-
term leases is recognized when the obligation is incurred.
 
The Company has operating leases for certain facilities, vehicles
 
and machinery and equipment with remaining lease terms up
 
to
11
 
years.
 
In addition, the Company has certain land use leases with remaining
 
lease terms up to
95
 
years.
 
The lease term for all of the
Company’s leases includes
 
the non-cancellable period of the lease plus any additional periods
 
covered by an option to extend the lease
that the Company is reasonably certain it will exercise.
 
Operating leases are included in
right of use lease assets
, other current
liabilities and long-term
lease liabilities
 
on the Consolidated Balance Sheet.
 
Right of use lease assets and liabilities are recognized
 
at
each lease’s commencement
 
date based on the present value of its lease payments over its respective
 
lease term.
 
The Company uses
the stated borrowing rate for a lease when readily
 
determinable.
 
When a stated borrowing rate is not available in a lease agreement,
the Company uses its incremental borrowing rate
 
based on information available at the lease’s
 
commencement date to determine the
present value of its lease payments.
 
In determining the incremental borrowing rate used to present
 
value each of its leases, the
Company considers certain information including fully
 
secured borrowing rates readily available to the Company and its subsidiaries.
 
The Company has immaterial finance leases, which are
 
included in PP&E, current portion of long-term debt and long-term debt
 
on the
Consolidated Balance Sheet.
Operating lease expense is recognized on a straight-line
 
basis over the lease term.
 
Operating lease expense for the years ended
December 31, 2020 and 2019 was $
14.2
 
million and $
9.4
 
million, respectively.
 
Short-term lease expense for the years ended
December 31, 2020 and 2019 was $
1.3
 
million and $
1.5
 
million, respectively.
 
The Company has
no
 
material variable lease costs or
sublease income for the years ended December 31,
 
2020 and 2019.
 
Cash paid for operating leases during the years ended December
 
31, 2020 and 2019 was $
14.1
 
million and $
9.2
 
million,
respectively.
 
The Company recorded new right of use lease assets and associated lease liabilities
 
of $
6.9
 
million during the year
ended December 31, 2020.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
QUAKER CHEMICAL CORPORATION
NOTES TO CONSOLIDATED
 
FINANCIAL STATEMENTS
 
- Continued
(
Dollars in thousands, except share and per share amounts,
 
unless otherwise stated
)
 
69
Supplemental balance sheet information related to the Company’s
 
leases is as follows:
December 31,
December 31,
2020
2019
Right of use lease assets
$
38,507
$
42,905
Other accrued liabilities
10,901
11,177
Long-term lease liabilities
27,070
31,273
Total operating
 
lease liabilities
$
37,971
$
42,450
Weighted average
 
remaining lease term (years)
6.0
6.2
Weighted average
 
discount rate
4.20%
4.21%
Maturities of operating lease liabilities as of December
 
31, 2020 were as follows:
December 31,
2020
For the year ended December 31, 2021
$
12,342
For the year ended December 31, 2022
8,395
For the year ended December 31, 2023
6,220
For the year ended December 31, 2024
4,610
For the year ended December 31, 2025
3,836
For the year ended December 31, 2026 and beyond
8,141
Total lease payments
43,544
Less: imputed interest
(5,573)
Present value of lease liabilities
$
37,971
Note 7 – Restructuring and Related Activities
The Company’s management
 
approved a global restructuring plan (the “QH Program”)
 
as part of its plan to realize certain cost
synergies associated with the Combination
 
in the third quarter of 2019.
 
The QH Program includes restructuring and associated
severance costs to reduce total headcount by approximately
350
 
people globally, as well as plans
 
for the closure of certain
manufacturing and non-manufacturing facilities.
 
The exact timing and total costs associated with the QH Program
 
will depend on a
number of factors and is subject to change; however,
 
the Company currently expects reduction in headcount and
 
site closures to
continue to occur into 2021 under the QH Program
 
and estimates that anticipated cost synergies realized from
 
the QH Program will
approximate one-times the restructuring costs incurred.
 
Employee separation benefits will vary depending on local
 
regulations within
certain foreign countries and will include severance
 
and other benefits.
All costs incurred to date relate to severance costs to reduce
 
headcount as well as costs to close certain facilities and are
 
recorded
in restructuring and related charges in the
 
Company’s Consolidated Statements of
 
Income.
 
As described in Note 4 of Notes to
Consolidated Financial Statements, restructuring and
 
related charges are not included in the Company’s
 
calculation of reportable
segments’ measure of operating earnings and therefore
 
these costs are not reviewed by or recorded to reportable segments.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
QUAKER CHEMICAL CORPORATION
NOTES TO CONSOLIDATED
 
FINANCIAL STATEMENTS
 
- Continued
(
Dollars in thousands, except share and per share amounts,
 
unless otherwise stated
)
 
70
Activity in the Company’s
 
accrual for restructuring under the QH Program for the years ended
 
December 31, 2020 and 2019 is as
follows:
QH Program
Accrued restructuring as of December 31, 2018
$
-
Restructuring and related charges
26,678
Cash payments
(8,899)
Currency translation adjustments
264
Accrued restructuring as of December 31, 2019
18,043
Restructuring and related charges
5,541
Cash payments
(15,745)
Currency translation adjustments
409
Accrued restructuring as of December 31, 2020
$
8,248
In connection with the plans for closure of certain
 
manufacturing and non-manufacturing facilities, the Company
 
made a decision
to make available for sale certain facilities.
 
During the fourth quarter of 2020, certain of these facilities were
 
sold and the Company
recognized a loss on disposal of approximately $
0.6
 
million included within other expense, net on the Consolidated
 
Statement of
Income.
 
Additionally, certain
 
buildings and land with an aggregate book value of
 
approximately $
10.0
 
million continues to be held-
for-sale as of December 31, 2020 and are
 
recorded in other current assets on the Company’s
 
Consolidated Balance Sheet.
 
Note 8 – Share-Based Compensation
The Company recognized the following share-based compensation
 
expense in its Consolidated Statements
 
of Income for the years
ended December 31, 2020, 2019 and 2018:
 
2020
2019
2018
Stock options
$
1,491
$
1,448
$
1,053
Non-vested stock awards and restricted stock units
5,012
3,206
2,459
Non-elective and elective 401(k) matching contribution in
 
stock
3,112
Employee stock purchase plan
84
89
Director stock ownership plan
541
123
123
Performance stock units
840
Annual incentive plan (1)
Total share-based
 
compensation expense
$
10,996
$
4,861
$
3,724
(1) Refer to the section entitled
Annual Incentive Plan
 
below for additional information.
Share-based compensation expense is recorded in SG&A,
 
except for $
1.5
 
million, $
0.9
 
million and $
0.1
 
million during the years
ended December 31, 2020,
 
2019 and 2018,
 
respectively, recorded
 
within Combination,
 
integration and other acquisition-related
expenses.
 
The increase in total share-based compensation expense for
 
the year ended December 31, 2020 includes performance stock
units and non-elective and elective 401(k) matching
 
contributions in stock as components of share-based compensation
 
beginning in
2020, described further below.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
QUAKER CHEMICAL CORPORATION
NOTES TO CONSOLIDATED
 
FINANCIAL STATEMENTS
 
- Continued
(
Dollars in thousands, except share and per share amounts,
 
unless otherwise stated
)
 
71
Stock Options
 
Stock option activity under all plans is as follows:
Weighted
 
Weighted
Average
Average
Exercise
 
Remaining
Aggregate
Number of
Price
 
Contractual
Intrinsic
Options
(per option)
Term
 
(years)
Value
Options outstanding as of January 1, 2020
144,412
$
137.15
Options granted
49,115
136.64
Options exercised
(83,191)
128.42
Options outstanding as of December 31, 2020
110,336
$
143.51
5.2
$
12,015
Options expected to vest after December 31, 2020
92,890
$
144.86
5.6
$
9,990
Options exercisable as of December 31, 2020
17,446
$
136.32
3.4
$
2,025
The total intrinsic value of options exercised during the years ended
 
December 31, 2020, 2019 and 2018 was approximately
$6.5
 
million,
$2.5
 
million and
$2.0
 
million, respectively.
 
Intrinsic value is calculated as the difference between
 
the current market price of
the underlying security and the strike price of a related
 
option.
 
A summary of the Company’s
 
outstanding stock options as of December 31, 2020 is as follows:
Weighted
Average
Weighted
Weighted
Number
Remaining
Average
Number
Average
Range of
of Options
Contractual
Exercise Price
of Options
Exercise Price
Exercise Prices
Outstanding
Term
 
(years)
(per option)
Exercisable
(per option)
$
70.01
 
-
$
80.00
 
2,133
1.0
$
72.12
2,133
$
72.12
$
80.01
 
-
$
90.00
 
1,309
1.0
87.30
1,309
87.30
$
90.01
 
-
$
130.00
 
$
130.01
 
-
$
140.00
 
51,732
6.0
136.54
2,617
134.60
$
140.01
 
-
$
150.00
 
$
150.01
 
-
$
160.00
 
55,162
4.8
154.14
11,387
154.37
110,336
5.2
143.51
17,446
136.32
As of December 31, 2020, unrecognized compensation expense
 
related to options granted in 2020, 2019 and 2018 was
$1.2
million,
$0.3
 
million and less than
$0.1
 
million, respectively, to be
 
recognized over a weighted average period of
1.9
 
years.
The Company granted stock options under its LTIP
 
plan that are subject only to time vesting generally over a
 
three-year period
during 2020,
 
2019,
 
2018 and 2017.
 
For the purposes of determining the fair value of stock option
 
awards, the Company uses the
Black-Scholes option pricing model and the assumptions
 
set forth in the table below:
 
2020
2019
2018
2017
Number of stock options granted
49,115
51,610
35,842
42,477
Dividend yield
0.99
%
1.12
%
1.37
%
1.49
%
Expected volatility
31.57
%
26.29
%
24.73
%
25.52
%
Risk-free interest rate
0.36
%
1.52
%
2.54
%
1.67
%
Expected term (years)
4.0
4.0
4.0
4.0
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
QUAKER CHEMICAL CORPORATION
NOTES TO CONSOLIDATED
 
FINANCIAL STATEMENTS
 
- Continued
(
Dollars in thousands, except share and per share amounts,
 
unless otherwise stated
)
 
72
The fair value of these options is being amortized on a
 
straight-line basis over the respective vesting period of each award.
 
The
compensation expense recorded on each award during
 
the years ended December 31, 2020, 2019 and 2018, respectively,
 
is as follows:
 
2020
2019
2018
2020 Stock option awards
$
385
$
$
2019 Stock option awards
698
665
2018 Stock option awards
357
364
310
2017 Stock option awards
51
369
367
Restricted Stock Awards
Activity of non-vested restricted stock awards granted
 
under the Company’s LTIP
 
plan is shown below:
Number of
Weighted Average
 
Grant
 
Shares
Date Fair Value
 
(per share)
Nonvested awards, December 31, 2019
64,500
$
152.67
 
Granted
28,244
145.63
 
Vested
(19,195)
148.15
 
Forfeited
(1,781)
150.27
 
Nonvested awards, December 31, 2020
71,768
$
151.17
 
The fair value of the non-vested stock is based on the trading
 
price of the Company’s
 
common stock on the date of grant.
 
The
Company adjusts the grant date fair value for expected
 
forfeitures based on historical experience for similar
 
awards.
 
As of December
31, 2020, unrecognized compensation expense related to
 
these awards was
$4.7
 
million, to be recognized over a weighted average
remaining period of
1.6
 
years.
Restricted Stock Units
Activity of non-vested restricted stock units granted under
 
the Company’s LTIP
 
plan is shown below:
Number of
Weighted Average
 
Grant
 
Units
Date Fair Value
 
(per unit)
Nonvested awards, December 31, 2019
8,655
$
152.09
 
Granted
6,030
141.65
 
Vested
(1,791)
141.92
 
Forfeited
(2,049)
153.50
 
Nonvested awards, December 31, 2020
10,845
$
147.70
 
The fair value of the non-vested restricted stock units is based
 
on the trading price of the Company’s
 
common stock on the date of
grant.
 
The Company adjusts the grant date fair value for expected forfeitures
 
based on historical experience for similar awards.
 
As of
December 31, 2020, unrecognized compensation expense
 
related to these awards was
$0.8
 
million, to be recognized over a weighted
average remaining period of
2.0
 
years.
Performance Stock Units
In March 2020, the Company included performance
 
-dependent stock awards (“PSUs”) as a component of its LTIP,
 
which will be
settled in a certain number of shares subject to market
 
-based and time-based vesting conditions.
 
The number of fully vested shares
that may ultimately be issued as settlement for each
 
award may range from
0
% up to
200
% of the target award, subject to the
achievement of the Company’s
 
total shareholder return (“TSR”) relative to the performance
 
of the Company’s peer
 
group, the S&P
Midcap 400 Materials group.
 
The service period required for the PSUs is three years and
 
the TSR measurement period for the PSUs is
from January 1, 2020 through December 31, 2022.
 
Compensation expense for PSUs is measured based on
 
their grant date fair value and is recognized on a straight-line basis over
the three-year vesting period.
 
The grant-date fair value of the PSUs was estimated using a
 
Monte Carlo simulation on the grant date
and using the following assumptions: (i) a risk-free
 
rate of
0.28
%; (ii) an expected term of
3.0
 
years; and (iii) a three-year daily
historical volatility for each of the companies in the
 
peer group, including Quaker Houghton.
 
 
QUAKER CHEMICAL CORPORATION
NOTES TO CONSOLIDATED
 
FINANCIAL STATEMENTS
 
- Continued
(
Dollars in thousands, except share and per share amounts,
 
unless otherwise stated
)
 
73
As of December 31, 2020, the Company estimates that it will issue
 
approximately
20,000
 
fully vested shares as of the settlement
date of the award based on the conditions of the
 
PSUs and Company’s closing
 
stock price on December 31, 2020.
 
As of December
31, 2020, there was approximately $
2.5
 
million of total unrecognized compensation cost related to PSUs which
 
the Company expects
to recognize over a weighted-average period of
2.2
 
years.
Annual Incentive Plan
The Company maintains an Annual Incentive Plan
 
(“AIP”), which may be settled in cash or a certain number of
 
shares subject to
performance-based and time-based vesting conditions.
 
As previously disclosed within the Company’s
 
Form 10-Q for the first three
quarters of 2020, it was the Company’s
 
intention at that time to settle the 2020 AIP in shares, and
 
therefore, expense associated with
the AIP in 2020 was recorded as a component of share
 
-based compensation expense during the first nine months of 2020.
 
In the fourth quarter of 2020, the Company determined
 
that it would settle the current year AIP in cash.
 
Therefore, the share-
based compensation associated with the AIP during
 
the year ended December 31, 2020 was reclassified from a
 
component of share-
based compensation expense to incentive compensation.
 
This determination and conclusion had no impact on
 
the classification of
AIP expense within the Company’s
 
Consolidated Statement of Income for the year ended December
 
31, 2020 as both are a component
of SG&A.
 
As a result of the change, there was an immaterial impact
 
on the Company’s calculation
 
of diluted earnings per share for the year
ended December 31, 2020 as the Company no longer considers
 
the estimated number of shares related to a hypothetical
 
AIP
settlement in shares as a component of its diluted earnings
 
per share calculation.
 
In addition, there was no impact on the Company’s
 
Consolidated Balance Sheet as of December 31, 2020, as the
 
AIP was and
continues to be classified as a liability and included within
 
accrued compensation.
 
Similarly, there was a
 
reclassification on the
Company’s Consolidated
 
Statement of Cash Flow between lines within Net cash provided by
 
operating activities in the fourth quarter
of 2020.
 
The expected cash flow impact of the AIP settled in cash is presented
 
as a component of accounts payable and accrued
liabilities for the year ended December 31, 2020.
 
Defined Contribution Plan
 
The Company has a 401(k) plan with an employer
 
match covering a majority of its U.S. employees.
 
The Company matches
50
%
of the first
6
% of compensation that is contributed to the plan, with a maximum
 
matching contribution of
3
% of compensation.
 
Additionally, the
 
plan provides for non-elective nondiscretionary contributions
 
on behalf of participants who have completed one year
of service equal to
3
% of the eligible participant's compensation.
 
The Company’s matching contributions
 
and non-elective
contributions may be made in cash or in fully vested shares
 
of the Company’s common
 
stock.
 
Beginning in April 2020,
 
the Company
began matching both non-elective and elective 401(k)
 
contributions in fully vested shares of its common stock rather than
 
cash.
 
For
the year ended December 31, 2020, total contributions
 
were $
3.1
 
million.
Employee Stock Purchase Plan
In 2000, the Board adopted an Employee Stock Purchase
 
Plan (“ESPP”) whereby employees may purchase Company stock
through a payroll deduction plan.
 
Purchases were made from the plan and credited to each
 
participant’s account on
 
the last day of
each calendar month in which the organized
 
securities trading markets in the U.S. were open for business (the
 
“Investment Date”).
 
The purchase price of the stock was
85
% of the fair market value on the Investment Date.
 
The plan was compensatory,
 
and the
15
%
discount was expensed on the Investment Date.
 
All employees, including officers, were eligible to participate
 
in this plan.
 
A
participant could withdraw all uninvested payment
 
balances credited to a participant’s
 
account at any time.
 
An employee whose stock
ownership of the Company exceeds five percent of
 
the outstanding common stock was not eligible to participate in this plan.
 
Effective January 1, 2020, the Company
 
discontinued the ESPP.
2013 Director Stock Ownership Plan
In 2013, the Company adopted the 2013 Director Stock
 
Ownership Plan (the “Plan”), to encourage the Directors to increase their
investment in the Company,
 
which was approved at the Company’s
 
May 2013 shareholders’ meeting.
 
The Plan authorizes the
issuance of up to
75,000
 
shares of Quaker common stock in accordance with
 
the terms of the Plan in payment of all or a portion of the
annual cash retainer payable to each of the Company’s
 
non-employee directors in 2013 and subsequent years during
 
the term of the
Plan.
 
Under the Plan, each director who, on May 1
 
of the applicable calendar year, owns less than
400
% of the annual cash retainer
for the applicable calendar year,
 
divided by the average of the closing price of a share of
 
Quaker Common Stock as reported by the
composite tape of the New York
 
Stock Exchange for the previous calendar year (the “Threshold Amount”),
 
is required to receive
75
%
of the annual cash retainer in Quaker common stock and
25
% of the retainer in cash, unless the director elects to receive a
 
greater
percentage of Quaker common stock, up to
100
% of the annual cash retainer for the applicable year.
 
Each director who owns more
than the Threshold Amount may elect to receive
 
common stock in payment of a percentage (up to
100
%) of the annual cash retainer.
 
The annual retainer is $
0.1
 
million and the retainer payment date is June 1.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
QUAKER CHEMICAL CORPORATION
NOTES TO CONSOLIDATED
 
FINANCIAL STATEMENTS
 
- Continued
(
Dollars in thousands, except share and per share amounts,
 
unless otherwise stated
)
 
74
Note 9 – Other Expense, net
 
Other expense, net, for the years ended December 31, 2020,
 
2019 and 2018 are as follows:
2020
2019
2018
Income from third party license fees
$
999
$
1,035
$
862
Foreign exchange (losses) gains, net
(6,082)
223
(807)
(Loss) gain on fixed asset disposals, net
(871)
58
657
Non-income
 
tax refunds and other related credits
3,345
1,118
668
Pension and postretirement benefit costs, non-service components
(21,592)
(2,805)
(2,285)
Gain on changes in insurance settlement restrictions of an
 
inactive
 
subsidiary and related insurance insolvency recovery
18,144
60
90
Other
 
non-operating income, net
439
57
173
Total other
 
expense, net
$
(5,618)
$
(254)
$
(642)
Pension and postretirement benefit costs, non-service components
 
during the year ended December 31, 2020 include a
 
$
1.6
million refund in premium and a $
22.7
 
million non-cash settlement charge related to the
 
Legacy Quaker U.S. Pension Plan, as
described in Note 21 of Notes to Consolidated Financial Statements.
 
Gain on changes in insurance restrictions of an inactive
subsidiary and related insurance insolvency recovery relate
 
to the termination of restrictions over certain cash that was previously
designated solely to be used for settlement of asbestos
 
claims at an inactive subsidiary of the Company and
 
cash proceeds from an
insolvent insurance carrier with respect to previously
 
filed recovery claims.
 
See Note 12, Note 19 and Note 26 of Notes to
Consolidated Financial Statements.
 
Foreign exchange (losses) gains, net, during the years
 
ended December 31, 2020,
 
2019 and 2018,
include foreign currency transaction losses of approximately
 
$
0.4
 
million, $
1.0
 
million and $
0.4
 
million, respectively,
 
related to
hyper-inflationary accounting for the Company’s
 
Argentine subsidiaries, and specific to 2018,
 
a foreign currency transaction gain of
approximately $
0.4
 
million related to the liquidation of an inactive legal entity.
 
See Note 1 of Notes to Consolidated Financial
Statements.
 
(Loss) gain on fixed asset disposals, net, during the year
 
ended December 31, 2020 and 2018, included $
0.6
 
million loss
and a $
0.6
 
million gain, respectively,
 
on the sale of held-for-sale assets related to the Combination.
Note 10 – Taxes
 
on Income
 
On December 22, 2017, the U.S. government enacted
 
comprehensive tax legislation commonly referred to as U.S. Tax
 
Reform.
 
U.S. Tax Reform
 
implemented a new system of taxation for non-U.S. earnings which
 
eliminated U.S. federal income taxes on
dividends from certain foreign subsidiaries and imposed
 
a one-time transition tax on the deemed repatriation of undistributed
 
earnings
of certain foreign subsidiaries that is payable over eight
 
years.
 
Following numerous regulations, notices, and other formal
 
guidance published by the Internal Revenue Service (“I.R.S.”),
 
U.S.
Department of Treasury,
 
and various state taxing authorities, the Company has completed
 
its accounting for the transition tax and has
elected to pay its $
15.5
 
million transition tax in installments over eight years as permitted
 
under U.S. Tax
 
Reform.
 
As of December
31, 2020, $
7.0
 
million in installments have been paid with the remaining
 
$
8.5
 
million to be paid through installments in future years.
As of December 31, 2020, the Company has a deferred
 
tax liability of $
5.9
 
million on certain undistributed foreign earnings,
which primarily represents the Company’s
 
estimate of the non-U.S. income taxes the Company will incur
 
to ultimately remit certain
earnings to the U.S.
 
The Company’s reinvestment
 
assertions are further explained below.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
QUAKER CHEMICAL CORPORATION
NOTES TO CONSOLIDATED
 
FINANCIAL STATEMENTS
 
- Continued
(
Dollars in thousands, except share and per share amounts,
 
unless otherwise stated
)
 
75
Taxes on income
 
before equity in net income of associated companies for the
 
years ended December 31, 2020, 2019 and 2018 are
as follows:
2020
2019
2018
Current:
Federal
$
(1,359)
$
(239)
$
6,583
State
1,171
352
(1,844)
Foreign
33,173
26,213
12,114
32,985
26,326
16,853
Deferred:
Federal
(28,437)
(9,267)
7,859
State
(3,087)
(396)
(173)
Foreign
(6,757)
(14,579)
511
Total
$
(5,296)
$
2,084
$
25,050
The components of earnings before income taxes for the
 
years ended December 31, 2020, 2019 and 2018 are as follows:
2020
2019
2018
U.S.
$
(66,585)
$
(46,697)
$
27,387
Foreign
93,724
75,601
55,711
Total
$
27,139
$
28,904
$
83,098
Total deferred
 
tax assets and liabilities are composed of the following
 
as of December 31, 2020 and 2019:
2020
2019
Retirement benefits
$
15,237
$
15,142
Allowance for doubtful accounts
2,316
2,253
Insurance and litigation reserves
842
1,002
Performance incentives
5,914
7,213
Equity-based compensation
1,282
1,050
Prepaid expense
756
2,976
Insurance settlement
3,895
Operating loss carryforward
16,693
16,044
Foreign tax credit and other credits
24,873
34,384
Interest
16,812
11,479
Restructuring reserves
1,121
2,167
Right of use lease assets
9,346
10,015
Royalties and license fees
2,156
Inventory reserves
2,225
2,163
Research and development
7,974
2,580
Other
3,005
1,317
108,396
115,836
Valuation
 
allowance
(21,511)
(13,834)
Total deferred
 
tax assets, net
$
86,885
$
102,002
Depreciation
15,473
17,754
Foreign pension and other
1,807
1,269
Amortization and other
222,794
254,359
Lease liabilities
9,151
9,965
Outside basis in equity investment
7,938
6,776
Unremitted Earnings
5,919
8,228
Total deferred
 
tax liabilities
$
263,082
$
298,351
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
QUAKER CHEMICAL CORPORATION
NOTES TO CONSOLIDATED
 
FINANCIAL STATEMENTS
 
- Continued
(
Dollars in thousands, except share and per share amounts,
 
unless otherwise stated
)
 
76
The Company has $
11.3
 
million of deferred tax assets related to state net operating
 
losses.
 
A partial valuation allowance of $
8.0
million has been established against this amount resulting
 
in a net $
3.3
 
million expected future benefit.
 
Management analyzed the
expected impact of the reversal of existing taxable temporary
 
differences, considered expiration dates, analyzed
 
current state tax laws,
and determined that $
3.3
 
million of state net operating loss carryforwards will be
 
realized based on the reversal of deferred tax
liabilities.
 
These state net operating losses are subject to various
 
carryforward periods of
5
 
years to
20
 
years or an indefinite
carryforward period.
 
An additional $
1.0
 
million of valuation allowance was established for other net
 
state deferred tax assets.
The Company has $
5.4
 
million of deferred tax assets related to foreign net operating
 
loss carryforwards.
 
A partial valuation
allowance of $
1.7
 
million has been established against the $
5.4
 
million due to the expected expiration of these losses before
 
they are
able to be utilized.
 
These foreign net operating losses are subject to various carryforward
 
periods with the majority having an
indefinite carryforward period.
 
An additional partial valuation allowance of $
0.6
 
million has been established against certain other
foreign deferred tax assets.
In conjunction with the Combination, the Company
 
acquired foreign tax credit deferred tax assets of $
41.8
 
million expiring
between 2019 and 2028.
 
Foreign tax credits may be carried forward for
10
 
years.
 
As of December 31, 2019, the foreign tax credit
carry forward was $
33.7
 
million with an $
8.2
 
million valuation allowance recorded against the deferred
 
tax asset.
 
Management
analyzed the expected impact of the utilization of foreign
 
tax credits based on certain assumptions such as projected
 
U.S. taxable
income, overall domestic loss recapture, and annual limitations due
 
to the ownership change under the Internal Revenue
Code.
 
Consequently, as of
 
December 31, 2020, the foreign tax credit carry forward
 
was $
24.9
 
million with a $
10.2
 
million valuation
allowance reflecting the amount of credits that are not
 
expected to be utilized before expiration.
 
The Company also acquired disallowed interest deferred
 
tax assets of $
14.0
 
million as part of the Combination.
 
Disallowed
interest may be carried forward indefinitely.
 
Management analyzed the expected impact of the utilization
 
of disallowed interest
carryforwards based on projected US taxable income
 
and determined that the Company will utilize all expected future
 
benefits by
2022.
 
As of December 31, 2020, the Company had a net realizable disallowed
 
interest carryforward of $
15.7
 
million on its balance
sheet.
As of December 31, 2020, the Company had deferred tax
 
liabilities of $
222.8
 
million primarily related to the step-up in
intangibles resulting from the Combination and Norman
 
Hay acquisition.
 
As part of the Combination, the Company acquired a
50
% interest in the Korea Houghton Corporation joint venture and
 
has
recorded a $
7.9
 
million deferred tax liability for its outside basis difference.
The following are the changes in the Company’s
 
deferred tax asset valuation allowance for the years ended
 
December 31, 2020,
2019 and 2018:
Effect of
 
Balance at
Purchase
Additional
Allowance
Exchange
Balance
 
Beginning
Accounting
Valuation
Utilization
Rate
at End
of Period
Adjustments
Allowance
and Other
Changes
of Period
Valuation
 
Allowance
Year
 
ended December 31, 2020
$
13,834
$
7,148
$
2,738
$
(2,153)
$
(56)
$
21,511
Year
 
ended December 31, 2019
$
7,520
$
13,752
$
832
$
(8,227)
$
(43)
$
13,834
Year
 
ended December 31, 2018
$
7,401
$
$
650
$
(471)
$
(60)
$
7,520
The Company’s net deferred
 
tax assets and liabilities are classified in the Consolidated Balance
 
Sheets
 
as of December 31, 2020
and 2019 as follows:
2020
2019
Non-current deferred tax assets
$
16,566
$
14,745
Non-current deferred tax liabilities
192,763
211,094
Net deferred tax liability
$
(176,197)
$
(196,349)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
QUAKER CHEMICAL CORPORATION
NOTES TO CONSOLIDATED
 
FINANCIAL STATEMENTS
 
- Continued
(
Dollars in thousands, except share and per share amounts,
 
unless otherwise stated
)
 
77
The following is a reconciliation of income taxes at the Federal
 
statutory rate with income taxes recorded by the Company
 
for the
years ended December 31, 2020, 2019 and 2018:
2020
2019
2018
Income tax provision at the Federal statutory tax rate
$
5,699
$
6,070
$
17,458
Unremitted earnings
(2,308)
(4,383)
7,857
Tax law changes
 
/ reform
(1,059)
(416)
(3,118)
Sub part F / Global intangible low taxed income
5,140
574
2,095
Pension settlement
(2,247)
Foreign derived intangible income
(7,339)
(1,699)
(1,034)
Non-deductible acquisition expenses
131
1,743
1,019
Withholding taxes
7,809
8,621
1,161
Foreign tax credits
(4,699)
(3,787)
(1,911)
Share-based compensation
335
(540)
259
Foreign tax rate differential
596
920
1,081
Research and development credit
(475)
(306)
(230)
Uncertain tax positions
1,990
899
(79)
State income tax provisions, net
(2,245)
(117)
196
Non-deductible meals and entertainment
290
318
415
Intercompany transfer of intangible assets
(4,384)
(5,318)
Miscellaneous items, net
(2,530)
(495)
(119)
Taxes on income
 
before equity in net income of associated companies
$
(5,296)
$
2,084
$
25,050
Pursuant to U.S. Tax
 
Reform, the Company recorded a $
15.5
 
million transition tax liability for U.S. income taxes on the
undistributed earnings of non-U.S. subsidiaries.
 
However, the Company may also
 
be subject to other taxes, such as withholding taxes
and dividend distribution taxes, if these undistributed
 
earnings are ultimately remitted to the U.S.
 
As a result of the Combination,
additional third-party debt was incurred resulting in
 
the Company re-evaluating its global cash strategy in order
 
to meet its goal of
reducing leverage in upcoming years.
 
As of December 31, 2020, the Company has a deferred tax
 
liability $
5.9
 
million, which
primarily represents the estimate of the non-U.S.
 
taxes the Company will incur to ultimately remit these earnings to
 
the U.S.
 
It is the
Company’s current inten
 
tion to reinvest its additional undistributed earnings of non-U.S.
 
subsidiaries to support working capital needs
and certain other growth initiatives outside of the U.S.
 
The amount of such undistributed earnings at December 31, 2020 was
approximately $
322.6
 
million.
 
Any tax liability which might result from ultimate remittance
 
of these earnings is expected to be
substantially offset by foreign tax credits (subject
 
to certain limitations).
 
It is currently impractical to estimate any such incremental
tax expense.
As of December 31, 2020, the Company’s
 
cumulative liability for gross unrecognized tax benefits was $
22.2
 
million. The
Company had accrued approximately $
3.9
 
million for cumulative penalties and $
3.0
 
million for cumulative interest as of December
31, 2020.
 
As of December 31, 2019, the Company’s
 
cumulative liability for gross unrecognized tax benefits was $
19.1
 
million. The
Company had accrued approximately $
3.1
 
million for cumulative penalties and $
2.3
 
million for cumulative interest as of December
31, 2019.
The Company continues to recognize interest and penalties
 
associated with uncertain tax positions as a component of
 
tax expense
on income before equity in net income of associated companies
 
in its Consolidated Statements of Income.
 
The Company recognized
an expense of less than $
0.1
 
million for penalties and $
0.6
 
million for interest (net of expirations and settlements) in its Consolidated
Statement of Income for the year ended December 31,
 
2020, a credit of $
0.2
 
million for penalties and an expense of $
0.2
 
million for
interest (net of expirations and settlements) in its Consolidated
 
Statement of Income for the year ended December 31, 2019, and
 
a
credit of $
0.2
 
million for penalties and a credit of $
0.1
 
million for interest (net of expirations and settlements)
 
in its Consolidated
Statement of Income for the year ended December 31,
 
2018.
The Company estimates that during the year ending December
 
31, 2021, it will reduce its cumulative liability for gross
unrecognized tax benefits by approximately $
1.5
 
million due to the expiration of the statute of limitations with regard
 
to certain tax
positions.
 
This estimated reduction in the cumulative liability for unrecognized
 
tax benefits does not consider any increase in liability
for unrecognized tax benefits with regard to existing tax
 
positions or any increase in cumulative liability for unrecognized
 
tax benefits
with regard to new tax positions for the year ending December
 
31, 2021.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
QUAKER CHEMICAL CORPORATION
NOTES TO CONSOLIDATED
 
FINANCIAL STATEMENTS
 
- Continued
(
Dollars in thousands, except share and per share amounts,
 
unless otherwise stated
)
 
78
A reconciliation of the beginning and ending amounts
 
of unrecognized tax benefits for the years ended December
 
31, 2020, 2019
and 2018, respectively,
 
is as follows:
2020
2019
2018
Unrecognized tax benefits as of January 1
$
19,097
$
7,050
$
6,761
Increase (decrease) in unrecognized tax benefits taken
 
in prior periods
2,025
(28)
(183)
Increase in unrecognized tax benefits taken in current period
3,095
1,935
2,023
Decrease in unrecognized tax benefits due to lapse of statute of
 
limitations
(3,659)
(1,029)
(1,292)
Increase in unrecognized tax benefits due to acquisition
597
11,301
Increase (decrease) due to foreign exchange rates
997
(132)
(259)
Unrecognized tax benefits as of December
 
31
$
22,152
$
19,097
$
7,050
The amount of net unrecognized tax benefits above that, if
 
recognized, would impact the Company’s
 
tax expense and effective tax
rate is $
14.7
 
million, $
13.3
 
million and $
2.2
 
million for the years ended December 31, 2020, 2019
 
and 2018, respectively.
The Company and its subsidiaries are subject to U.S. Federal income
 
tax, as well as the income tax of various state and foreign
tax jurisdictions.
 
Tax years that remain
 
subject to examination by major tax jurisdictions include Italy
 
from
2006
, Brazil from
2011
,
Mexico, the Netherlands and China from
2015
, Spain, Germany and the United Kingdom from
2016
, Canada and the U.S. from
2017
,
India from fiscal year beginning April 1,
2018
 
and ending March 31, 2019, and various U.S. state tax jurisdictions
 
from
2011
.
As previously reported, the Italian tax authorities have
 
assessed additional tax due from the Company’s
 
subsidiary, Quaker Italia
S.r.l., relating to the tax
 
years 2007 through 2015. The Company filed for competent authority
 
relief from these assessments under the
Mutual Agreement Procedures (“MAP”) of the Organization
 
for Economic Co-Operation and Development for all
 
years except 2007.
In 2020, the respective tax authorities in Italy,
 
Spain, and Netherland reached agreement with respect to the
 
MAP proceedings, which
the Company has accepted. As a result, the Company has
 
recorded an estimated tax liability of $
0.9
 
million to finalize these
proceedings, net of refunds expected to be received from
 
the Spanish and Dutch tax authorities.
 
As of December 31, 2020, the
Company believes it has adequate reserves for uncertain
 
tax positions with respect to these and all other audits.
Houghton Italia, S.r.l
 
is also currently involved in a corporate income tax audit with the
 
Italian tax authorities covering tax years
2014 through 2018.
 
As of December 31, 2020, the Company has a $
5.8
 
million reserve for uncertain tax positions relating to matters
related to this audit.
 
Since this reserve relates to the tax periods prior to August 1,
 
2019, the tax liability was established through
purchase accounting related to the Combination.
 
The Company has also submitted an indemnification claim
 
against funds held in
escrow by Houghton’s former
 
owners and as a result, a corresponding $
5.8
 
million indemnification receivable has also been
established through purchase accounting.
Houghton Deutschland GmbH is also under audit by
 
the German tax authorities for tax years 2015-2017.
 
Based on preliminary
audit findings, primarily related to transfer pricing, the
 
Company has recorded a reserve for $
0.9
 
million as of December 31, 2020.
 
Of
this amount, $
0.8
 
million relates to tax periods prior to the Combination and
 
therefore the Company has submitted an indemnification
claim with Houghton’s
 
former owners for any tax liabilities arising pre-Combination.
 
As a result, a corresponding $
0.8
 
million
indemnification receivable has also been established
 
to offset the $
0.8
 
million tax liability.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
QUAKER CHEMICAL CORPORATION
NOTES TO CONSOLIDATED
 
FINANCIAL STATEMENTS
 
- Continued
(
Dollars in thousands, except share and per share amounts,
 
unless otherwise stated
)
 
79
Note 11 – Earnings Per Share
The following table summarizes earnings per share calculations
 
for the years ended December 31, 2020, 2019 and 2018:
2020
2019
2018
Basic earnings per common share
 
 
Net income attributable to Quaker Chemical Corporation
$
 
39,658
$
 
31,622
$
 
59,473
Less: income allocated to participating securities
 
(148)
 
(90)
 
(253)
Net income available to common shareholders
$
 
39,510
$
31,532
$
59,220
Basic weighted average common shares outstanding
17,719,792
15,126,928
13,268,047
Basic earnings per common share
$
2.23
$
2.08
$
4.46
Diluted earnings per common share
Net income attributable to Quaker Chemical Corporation
$
39,658
$
31,622
$
59,473
Less: income allocated to participating securities
(148)
(90)
(252)
Net income available to common shareholders
$
39,510
$
31,532
$
59,221
Basic weighted average common shares outstanding
17,719,792
15,126,928
13,268,047
Effect of dilutive securities
31,087
36,243
36,685
Diluted weighted
 
average common shares outstanding
17,750,879
15,163,171
13,304,732
Diluted earnings per common share
$
2.22
$
2.08
$
4.45
The Company’s calculation
 
of earnings per diluted share attributable to Quaker Chemical Corporation
 
common shareholders for
the year ended December 31, 2019 was impacted by the
 
variability of its reported earnings during the year and the approximately
4.3
million shares issued as a component of the consideration transferred
 
in the Combination, comprising
24.5
% of the common stock of
the Company immediately after the closing.
 
Certain stock options and restricted stock units are not included
 
in the diluted earnings
per share calculation because the effect would
 
have been anti-dilutive.
 
The calculated amount of anti-diluted shares not included were
945
 
in 2020,
108
 
in 2019 and
1,808
 
in 2018.
Note 12 – Restricted Cash
Prior to December 2020, the Company had restricted cash recorded in other assets related to proceeds from an inactive subsidiary
of the Company which previously executed separate settlement and release agreements with two of its insurance carriers for an
original total value of $35.0 million.
 
The proceeds of both settlements were restricted and could
 
only be used to pay claims and costs
of defense associated with the subsidiary’s
 
asbestos litigation.
 
The proceeds of the settlement and release agreements
 
were deposited
into interest bearing accounts which earned less then $
0.1
 
million and $
0.2
 
million in the years ended December 31, 2020 and 2019,
respectively, offset
 
by $
1.0
 
million and $
0.8
 
million of net payments during 2020 and 2019, respectively.
 
Due to the restricted nature
of the proceeds, a corresponding deferred credit was established
 
in other non-current liabilities for an equal and offsetting
 
amount.
 
During December 2020, the restrictions ended on these
 
previously received insurance settlements and the
 
Company transferred
the cash into an operating account.
 
In connection with the termination in restrictions, the Company
 
recognized an $
18.1
 
million gain
on its Consolidated Statement of Income in Other expense,
 
net, for the amount of previously restricted cash, net of the
 
estimated
liability to pay claims and associated with the inactive
 
subsidiary’s asbestos litigation as of
 
December 31, 2020.
 
See Notes 18, 22 and
26 of Notes to Consolidated Financial Statements.
The following table provides a reconciliation of cash,
 
cash equivalents and restricted cash as December 31, 2020, 2019,
 
2018 and
2017:
2020
2019
2018
2017
Cash and cash equivalents
$
181,833
$
123,524
$
104,147
$
89,879
Restricted cash included in other current assets
62
353
Restricted cash included in other assets
19,678
20,278
21,171
Cash, cash equivalents and restricted cash
$
181,895
$
143,555
$
124,425
$
111,050
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
QUAKER CHEMICAL CORPORATION
NOTES TO CONSOLIDATED
 
FINANCIAL STATEMENTS
 
- Continued
(
Dollars in thousands, except share and per share amounts,
 
unless otherwise stated
)
 
80
Note 13 – Accounts Receivable and Allowance for Doubtful Accounts
As of December 31, 2020 and 2019, the Company
 
had gross trade accounts receivable totaling
$386.1
 
million and
$387.7
 
million,
respectively.
 
The Company recognizes an allowance for credit losses, which
 
represents the portion of the receivable that the Company does
 
not
expect to collect over its contractual life, considering
 
past events and reasonable and supportable forecasts of
 
future economic
conditions.
 
The Company estimates credit losses for trade receivables by
 
aggregating similar customer types, because they tend to
share similar credit risk characteristics.
 
The Company’s allowance
 
for credit losses on its trade accounts receivable is based on
specific collectability facts and circumstances for each
 
outstanding receivable and customer, the
 
aging of outstanding receivables, and
the associated collection risk the Company estimates for certain
 
past due aging categories, and also, the general risk to all outstanding
accounts receivable based on historical amounts determined to
 
be uncollectible.
 
Trade and other receivables are written off
 
when
there is no reasonable expectation of recovery.
 
The following are changes in the allowance for doubtful
 
accounts during the years ended December 31, 2020, 2019 and 2018:
Exchange Rate
Balance at
Changes
Write-Offs
Changes
Balance
 
Beginning
to Costs and
Charged to
and Other
at End
of Period
Expenses
Allowance
Adjustments
of Period
Allowance for Doubtful Accounts
Year
 
ended December 31, 2020
$
11,716
$
3,582
$
(2,187)
$
34
$
13,145
Year
 
ended December 31, 2019
$
5,187
$
1,925
$
(322)
$
4,926
$
11,716
Year
 
ended December 31, 2018
$
5,457
$
493
$
(295)
$
(468)
$
5,187
Included in exchange rate changes and other adjustments for
 
the year ended December 31, 2019 are the allowance for
 
doubtful
accounts of $
5.0
 
million related to the acquired receivables in connection with
 
the Combination and Norman Hay acquisition.
 
See
Note 2 of Notes to Consolidated Financial Statements.
 
Included in exchange rate changes and other adjustments for
 
the year ended
December 31, 2018 is a reclassification of $
0.3
 
million to other assets related to certain customer receivables due
 
greater than a year.
Note 14 – Inventories
Inventories, net, as of December 31, 2020 and 2019 were
 
as follows:
2020
2019
Raw materials and supplies
$
86,148
$
82,058
Work in
 
process, finished goods and reserves
101,616
92,892
Total inventories,
 
net
$
187,764
$
174,950
Note 15 – Property,
 
Plant and Equipment
Property, plant and
 
equipment as of December 31, 2020 and 2019 were as follows:
2020
2019
Land
$
33,009
$
34,686
Building and improvements
135,595
130,462
Machinery and equipment
246,242
225,636
Construction in progress
8,407
8,050
Property, plant and
 
equipment, at cost
423,253
398,834
Less: accumulated depreciation
(219,370)
(185,365)
Total property,
 
plant and equipment, net
$
203,883
$
213,469
As of December 31, 2020, PP&E includes $
0.4
 
million of finance lease assets and future minimum lease payments.
 
In connection
with the plans for closure of certain facilities, certain buildings and land with an aggregate book value of approximately $10.0 million
continue to be held-for-sale as of December 31, 2020 and are recorded in other current assets on the Company’s Consolidated Balance
Sheet.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
QUAKER CHEMICAL CORPORATION
NOTES TO CONSOLIDATED
 
FINANCIAL STATEMENTS
 
- Continued
(
Dollars in thousands, except share and per share amounts,
 
unless otherwise stated
)
 
81
Note 16 – Goodwill and Other Intangible Assets
Changes in the carrying amount of goodwill for the
 
years ended December 31, 2020 and 2019 were as follows:
Global
Specialty
Americas
EMEA
Asia/Pacific
Businesses
Total
Balance as of December 31, 2018
$
28,464
$
17,423
$
13,149
$
24,297
 
$
83,333
Goodwill additions
188,494
114,167
130,091
91,545
524,297
Currency translation adjustments
 
(573)
1,428
(1,513)
233
(425)
Balance as of December 31, 2019
216,385
133,018
141,727
116,075
 
607,205
Goodwill additions
1,485
531
1,329
3,345
Currency translation and other
 
adjustments
(4,628)
6,613
16,363
2,314
20,662
Balance as of December 31, 2020
$
213,242
$
140,162
$
158,090
$
119,718
$
631,212
Other adjustments in the table above includes updates to
 
the Company’s allocation
 
of the Houghton purchase price and associated
goodwill to each of the Company’s
 
reportable segments during the year ended December 31, 2020,
 
including a $
2.6
 
million decrease
in the Americas, a $
1.4
 
million decrease in EMEA, a $
8.0
 
million increase in Asia/Pacific and a $
0.5
 
million increase in Global
Specialty Businesses.
 
Gross carrying amounts and accumulated amortization
 
for definite-lived intangible assets as of December 31, 2020 and
 
2019 were
as follows:
Gross Carrying
Accumulated
Amount
Amortization
2020
2019
2020
2019
Customer lists and rights to sell
$
839,551
$
792,362
 
$
99,806
 
$
49,932
Trademarks, formulations and product
 
technology
 
166,448
 
157,049
 
 
30,483
 
 
21,299
Other
 
6,372
 
 
6,261
 
 
5,824
 
 
5,776
Total definite
 
-lived intangible assets
$
1,012,371
 
$
955,672
 
$
136,113
 
$
77,007
The Company recorded $
55.9
 
million, $
26.7
 
million and $
7.3
 
million of amortization expense during the years ended December
31, 2020, 2019 and 2018, respectively.
 
Amortization is recorded within SG&A in the Company’s
 
Consolidated Statements of Income.
 
Estimated annual aggregate amortization expense for
 
the subsequent five years is as follows:
For the year ended December 31, 2021
$
58,752
For the year ended December 31, 2022
58,590
For the year ended December 31, 2023
58,361
For the year ended December 31, 2024
57,935
For the year ended December 31, 2025
57,263
The Company has four indefinite-lived intangible
 
assets totaling $
205.1
 
million as of December 31, 2020, including $
204.0
million of indefinite-lived intangible assets for trademarks and
 
tradename associated with the Combination.
 
Comparatively, the
Company had four indefinite-lived intangible assets for trademarks
 
and tradename totaling $
243.1
 
million as of December 31, 2019.
The Company completes its annual goodwill and indefinite
 
-lived intangible asset impairment test during the fourth
 
quarter of
each year, or more frequently if triggering
 
events indicate a possible impairment in one or more of its reporting
 
units.
 
The Company
completed its annual impairment assessment during the
 
fourth quarter of 2020 and concluded no impairment charge
 
was warranted.
 
The Company continually evaluates financial performance,
 
economic conditions and other relevant developments
 
in assessing if an
interim period impairment test for one or more of
 
its reporting units is necessary.
 
As of March 31, 2020, the Company evaluated the initial impact
 
of COVID-19 on the Company’s
 
operations, and the volatility
and uncertainty in the economic outlook as a result of
 
COVID-19 to determine if they indicated it was more likely
 
than not that the
carrying value of any of the Company’s
 
reporting units or indefinite-lived or long-lived assets was not recoverable.
 
The Company
concluded that the impact of COVID-19 did not represent
 
a triggering event as of March 31, 2020 with regards to the Company’s
reporting units or indefinite-lived and long-lived assets, except
 
for the Company’s Houghton
 
and Fluidcare trademarks
 
and tradename
indefinite-lived intangible assets.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
QUAKER CHEMICAL CORPORATION
NOTES TO CONSOLIDATED
 
FINANCIAL STATEMENTS
 
- Continued
(
Dollars in thousands, except share and per share amounts,
 
unless otherwise stated
)
 
82
The determination of estimated fair value of the Houghton
 
and Fluidcare trademarks and tradename indefinite-lived
 
assets was
based on a relief from royalty valuation method which
 
requires management’s
 
judgment and often involves the use of significant
estimates and assumptions, including assumptions with respect
 
to the weighted average cost of capital (“WACC”)
 
and royalty rates, as
well as revenue growth rates and terminal growth rates.
 
In the first quarter of 2020, as a result of the impact of
 
COVID-19 driving a
decrease in projected legacy Houghton net sales in the
 
current year and the impact of the current year decline on projected
 
future
legacy Houghton net sales as well as an increase in the WACC
 
assumption utilized in the quantitative impairment
 
assessment, the
Company concluded that the estimated fair values of
 
the Houghton and Fluidcare trademarks and tradename intangible
 
assets were
less than their carrying values.
 
As a result, an impairment charge of $
38.0
 
million, primarily related to the Houghton trademarks and
tradename, to write down the carrying values of these intangible
 
assets to their estimated fair values was recorded in the
 
first quarter
of 2020.
As of December 31, 2020, the Company continued to
 
evaluate the on-going impact of COVID-19 on the Company’s
 
operations,
and the volatility and uncertainty in the economic outlook
 
as a result of COVID-19, to determine if this indicated it was more
 
likely
than not that the carrying value of any of the Company’s
 
reporting units or indefinite-lived or long-lived intangible
 
assets were not
recoverable.
 
The Company concluded that the impact of COVID-19 did not represent
 
a triggering event as of December 31, 2020
with regards to any of the Company’s
 
reporting units or indefinite-lived and long-lived intangible
 
assets.
While the Company concluded that the impact of COVID-19
 
did not represent a triggering event as of December 31,
 
2020 for any
of its other long-lived or indefinite-lived assets or reporting
 
units, the Company will continue to evaluate the impact
 
of COVID-19 on
the Company’s current
 
and projected results.
 
If the current economic conditions worsen or projections of the
 
timeline for recovery are
significantly extended, then the Company may conclude
 
in the future that the impact from COVID-19 requires the need
 
to perform
further interim quantitative impairment tests, which could
 
result in additional impairment charges in the future.
 
Note 17 – Investments in Associated Companies
As of December 31, 2020, the Company held a
50
% investment in and had significant influence over Nippon
 
Quaker Chemical,
Ltd. (“Nippon Japan”), Kelko Quaker Chemical, S.A.
 
(“Kelko Panama”) and Houghton Korea acquired in 2019 in
 
connection with the
Combination, and held a
32
% investment in and had significant influence over Primex,
 
Ltd. (“Primex”).
 
See Note 2 of Notes to
Consolidated Financial Statements.
The carrying amount of the Company’s
 
equity investments as of December 31, 2020 was $
95.8
 
million, which includes
investments of $
68.3
 
million in Houghton Korea; $
19.4
 
million in Primex; $
7.8
 
million in Nippon Japan; and $
0.3
 
million in Kelko
Panama.
The Company also has a
50
% equity interest in Kelko Venezuela.
 
Due to heightened foreign exchange controls, deteriorating
economic circumstances and other restrictions in Venezuela,
 
during 2018 the Company concluded that it no longer
 
had significant
influence over this affiliate.
 
Prior to this determination, the Company historically accounted for
 
this affiliate under the equity method.
 
As of December 31, 2020 and 2019, the Company
 
had
no
 
remaining carrying value for its investment in Kelko Venezuela.
 
The following table is a summary of equity income in associated
 
companies by investment for the years ending December 31,
2020, 2019 and 2018:
Year
 
Ended December 31,
2020
2019
2018
Houghton Korea
$
5,241
$
2,337
$
Nippon Japan
853
850
713
Kelko Panama
107
55
222
Kelko Venezuela
(138)
Primex
1,151
1,822
966
Total equity
 
in net income of associated companies
$
7,352
$
5,064
$
1,763
As the Combination closed on August 1, 2019, the Company
 
included five months of equity income from Houghton
 
Korea in its
December 31, 2019 Consolidated Statement of Income.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
QUAKER CHEMICAL CORPORATION
NOTES TO CONSOLIDATED
 
FINANCIAL STATEMENTS
 
- Continued
(
Dollars in thousands, except share and per share amounts,
 
unless otherwise stated
)
 
83
Note 18 – Other Non-Current Assets
Other non-current assets as of December 31, 2020
 
and 2019 were as follows:
2020
2019
Uncertain tax positions
$
7,209
$
4,993
Pension assets
 
6,748
 
 
Debt issuance costs
5,919
7,571
Indemnification assets
7,615
4,006
Supplemental retirement income program
 
1,961
 
 
1,782
Restricted insurance settlement
 
19,678
Other
2,344
2,403
Total other
 
assets
$
31,796
 
$
40,433
During December 2020, the restrictions lapsed over certain
 
cash that was previously only designated to be used for settlement
 
of
asbestos claims at an inactive subsidiary of the Company.
 
As of December 31, 2020 and 2019, indemnification assets relates to
certain Houghton foreign subsidiaries for which the Company
 
expects it will incur additional tax amounts which are subject to
indemnification under the terms of the Combination
 
share and purchase agreement.
 
These indemnification assets have a
corresponding uncertain tax position recorded in
 
other non-current liabilities.
 
As of December 31, 2020, one of the Company’s
foreign pension plan’s
 
fair value of plan assets exceeded its gross benefit obligation
 
and was therefore over-funded, which is
represented by the line Pension assets in the table above.
 
See Notes 10, 12, 21 and 22 of Notes to Consolidated Financial
 
Statements.
 
Note 19 – Other Accrued Liabilities
Other accrued liabilities as of December 31, 2020 and
 
2019 were as follows:
2020
2019
Non-income taxes
$
26,080
$
21,176
Current income taxes payable
13,124
7,503
Professional fees, legal, and acquisition-related accruals
11,437
17,103
Short-term lease liabilities
10,901
11,177
Selling expenses and freight accruals
10,475
11,350
Customer advances and sales return reserves
6,380
5,554
Other
13,710
9,742
Total other
 
accrued liabilities
$
92,107
$
83,605
Note 20 – Debt
Debt as of December 31, 2020 and 2019 includes the
 
following:
As of December 31, 2020
As of December 31, 2019
Interest
Outstanding
 
Interest
Outstanding
 
Rate
Balance
Rate
Balance
Credit Facilities:
Revolver
1.65%
$
160,000
3.20%
$
171,169
U.S. Term Loan
1.65%
570,000
3.20%
600,000
EURO Term Loan
1.50%
157,062
1.50%
151,188
Industrial development bonds
5.26%
10,000
5.26%
10,000
Bank lines of credit and other debt obligations
Various
2,072
Various
2,608
Total debt
$
899,134
$
934,965
Less: debt issuance costs
(11,099)
(14,196)
Less: short-term and current portion of long-term debts
(38,967)
(38,332)
Total long
 
-term debt
$
849,068
$
882,437
QUAKER CHEMICAL CORPORATION
NOTES TO CONSOLIDATED
 
FINANCIAL STATEMENTS
 
- Continued
(
Dollars in thousands, except share and per share amounts,
 
unless otherwise stated
)
 
84
Credit facilities
The Company’s primary
 
credit facility (as amended, the “Credit Facility”) is comprised
 
of a $
400.0
 
million multicurrency
revolver (the “Revolver”), a $
600.0
 
million term loan (the “U.S. Term
 
Loan”), each with the Company as borrower,
 
and a $
150.0
million (as of August 1, 2019) Euro equivalent term loan (the
 
“EURO Term Loan”
 
and together with the “U.S. Term
 
Loan”, the
“Term Loans”
 
)
 
with Quaker Chemical B.V.,
 
a Dutch subsidiary of the Company as borrower,
 
each with a five-year term maturing in
August 2024.
 
Subject to the consent of the administrative agent and certain
 
other conditions, the Company may designate additional
borrowers.
 
The maximum amount available under the Credit Facility can be
 
increased by up to $
300.0
 
million at the Company’s
request if there are lenders who agree to accept additional
 
commitments and the Company has satisfied certain other
 
conditions.
 
Borrowings under the Credit Facility bear interest at a base
 
rate or LIBOR plus an applicable margin based upon
 
the Company’s
consolidated net leverage ratio.
 
There are LIBOR replacement provisions that contemplate a further
 
amendment if and when LIBOR
ceases to be reported.
 
The variable interest rate incurred on the outstanding borrowings under
 
the Credit Facility during the year
ended December 31, 2020 was approximately
2.2
%.
 
As of December 31, 2020, the variable interest rate on the outstanding
borrowings under the Credit Facility was approximately
1.6
%.
 
In addition to paying interest on outstanding principal under
 
the Credit
Facility, the Company
 
is required to pay a commitment fee ranging from
0.2
% to
0.3
% depending on the Company’s
 
consolidated net
leverage ratio to the lenders under the Revolver in
 
respect of the unutilized commitments thereunder.
 
The Company has unused
capacity under the Revolver of approximately $
234
 
million, net of bank letters of credit of approximately $
6
 
million, as of December
31, 2020.
 
Until closing of the Combination, the Company incurred ticking
 
fees to maintain the bank commitment, which began to
accrue on September 29, 2017.
 
Concurrent with the closing of the Combination and executing the
 
Credit Facility on August 1, 2019,
the Company paid approximately $
6.3
 
million of ticking fees.
The Credit Facility is subject to certain financial and
 
other covenants.
 
The Company’s initial consolidated net debt to
consolidated adjusted EBITDA ratio could not exceed 4.25 to 1, with step downs in the permitted ratio over the term of the Credit
Facility. As of December 31, 2020, the consolidated net debt to adjusted EBITDA may not exceed 4.00 to 1. The Company’s
consolidated adjusted EBITDA to interest expense ratio cannot be less than 3.0 to 1 over the term of the agreement. The Credit
Facility also prohibits the payment of cash dividends if the Company is in default or if the amount of the dividend paid annually
exceeds the greater of $50.0 million and 20% of consolidated adjusted EBITDA unless the ratio of consolidated net debt to
consolidated adjusted EBITDA is less than 2.0 to 1, in which case there is no such limitation on amount.
 
As of December 31, 2020
and December 31, 2019, the Company was in compliance with all of the Credit Facility covenants.
 
The Term Loans have
 
quarterly
principal amortization during their five-year terms,
 
with
5.0
% amortization of the principal balance due in years
 
1 and 2,
7.5
% in year
3, and
10.0
% in years 4 and 5, with the remaining principal amount due at
 
maturity.
 
During the year ended December 31, 2020, the
Company made four quarterly amortization payments
 
related to the Term Loans
 
totaling $
37.6
 
million.
 
The Credit Facility is
guaranteed by certain of the Company’s
 
domestic subsidiaries and is secured by first priority liens on substantially
 
all of the assets of
the Company and the domestic subsidiary guarantors,
 
subject to certain customary exclusions.
 
The obligations of the Dutch borrower
are guaranteed only by certain foreign subsidiaries on
 
an unsecured basis.
The Credit Facility required the Company to fix its variable
 
interest rates on at least 20% of its total Term
 
Loans.
 
In order to
satisfy this requirement as well as to manage the
 
Company’s exposure to variable
 
interest rate risk associated with the Credit Facility,
in November 2019, the Company entered into $
170.0
 
million notional amounts of three-year interest rate swaps at a base
 
rate of
1.64
% plus an applicable margin as provided in the Credit
 
Facility, based on the Company’s
 
consolidated net leverage ratio.
 
At the
time the Company entered into the swaps, and as
 
of December 31, 2020,
 
the aggregate interest rate on the swaps, including the fixed
base rate plus an applicable margin, was
3.1
%.
 
See Note 25 of Notes to Consolidated Financial Statements.
The Company capitalized $
23.7
 
million of certain third-party debt issuance costs in connection
 
with executing the Credit Facility.
 
Approximately $
15.5
 
million of the capitalized costs were attributed to the Term
 
Loans and recorded as a direct reduction of long-
term debt on the Company’s
 
Consolidated Balance Sheet.
 
Approximately $
8.3
 
million of the capitalized costs were attributed to the
Revolver and recorded within other assets on the Company’s
 
Consolidated Balance Sheet.
 
These capitalized costs are being
amortized into interest expense over the five-year term
 
of the Credit Facility.
 
As of December 31, 2020 and 2019,
 
the Company had
$
11.1
 
million and $
14.2
 
million, respectively,
 
of debt issuance costs recorded as a reduction of long-term
 
debt.
 
As of December 31,
2020 and 2019, the Company had $
5.9
 
million and $
7.6
 
million, respectively,
 
of debt issuance costs recorded within other assets.
 
Industrial development bonds
As of December 31, 2020 and 2019, the Company
 
had fixed rate, industrial development authority bonds totaling $
10.0
 
million in
principal amount due in
2028
.
 
These bonds have similar covenants to the Credit Facility noted
 
above.
The Company also had a $
5.0
 
million industrial development authority bond bearing
 
interest at a rate of
5.60
%, which matured
and was paid off during the fourth quarter of
2018
.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
QUAKER CHEMICAL CORPORATION
NOTES TO CONSOLIDATED
 
FINANCIAL STATEMENTS
 
- Continued
(
Dollars in thousands, except share and per share amounts,
 
unless otherwise stated
)
 
85
Bank lines of credit and other
 
debt obligations
The Company has certain unsecured bank lines of credit
 
and discounting facilities in certain foreign subsidiaries, which are
 
not
collateralized.
 
The Company’s other debt
 
obligations primarily consist of certain domestic and foreign
 
low interest rate or interest-
free municipality-related loans, local credit facilities of
 
certain foreign subsidiaries and capital lease obligations.
 
Total unused
capacity under these arrangements as of December
 
31, 2020 was approximately $
40
 
million.
In addition to the bank letters of credit described in
 
the “Credit facilities” subsection above, the Company’s
 
only other off-balance
sheet arrangements include certain financial and other
 
guarantees.
 
The Company’s total bank
 
letters of credit and guarantees
outstanding as of December 31, 2020 were approximately
 
$
10
 
million.
The Company incurred the following debt related expenses
 
included within Interest expense, net, in the Consolidated
 
Statements
of Income:
Year
 
Ended December 31,
2020
2019
2018
Interest expense
$
23,552
$
16,788
$
6,158
Amortization of debt issuance costs
4,749
1,979
70
Total
$
28,301
$
18,767
$
6,228
Based on the variable interest rates associated with the Credit
 
Facility, as of December
 
31, 2020 and 2019, the amounts at which
the Company’s total debt
 
were recorded are not materially different from
 
their fair market value.
At December 31, 2020, annual maturities on long-term
 
borrowings maturing in the next five fiscal years (excluding
 
the reduction
to long-term debt attributed to capitalized and unamortized
 
debt issuance costs) are as follows:
 
2021
$
38,795
2022
57,850
2023
76,943
2024
715,227
2025
231
Note 21 – Pension and Other Postretirement
 
Benefits
The following table shows the funded status of the Company’s
 
plans’ reconciled
 
with amounts reported in the Consolidated
Balance Sheets as of December 31, 2020 and 2019:
Other Post-
Pension Benefits
Retirement Benefits
2020
2019
2020
2019
Foreign
U.S.
Total
Foreign
U.S.
Total
U.S.
U.S.
Change in benefit obligation
Gross benefit obligation at beginning
of year
$
217,893
$
153,723
$
371,616
$
111,316
$
58,734
$
170,050
$
4,266
$
4,106
Service cost
4,340
491
4,831
3,507
434
3,941
5
6
Interest cost
3,416
2,923
6,339
3,046
3,313
6,359
77
143
Employee contributions
73
73
73
73
Effect of plan amendments
50
50
30
30
Curtailment gain
(2,324)
(2,324)
Plan settlements
(2,316)
(53,494)
(55,810)
(1,087)
(1,087)
Benefits paid
(5,087)
(6,138)
(11,225)
(3,832)
(6,034)
(9,866)
(250)
(384)
Plan expenses and premiums paid
(135)
(135)
(129)
(129)
Transfer in of business acquisition
85,658
86,414
172,072
Actuarial loss (gain)
16,834
12,414
29,248
13,616
10,862
24,478
(864)
395
Translation differences and
 
other
14,981
14,981
5,695
5,695
Gross benefit obligation at end of year
$
247,675
$
109,969
$
357,644
$
217,893
$
153,723
$
371,616
$
3,234
$
4,266
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
QUAKER CHEMICAL CORPORATION
NOTES TO CONSOLIDATED
 
FINANCIAL STATEMENTS
 
- Continued
(
Dollars in thousands, except share and per share amounts,
 
unless otherwise stated
)
 
86
Other Post-
Pension Benefits
Retirement Benefits
2020
2019
2020
2019
Foreign
U.S.
Total
Foreign
U.S.
Total
U.S.
U.S.
Change in plan assets
Fair value of plan assets at
 
beginning of year
$
195,099
$
120,550
$
315,649
$
94,826
$
49,415
$
144,241
$
$
Actual return on plan assets
20,367
10,759
31,126
13,458
10,663
24,121
Employer contributions
6,912
2,302
9,214
5,223
1,087
6,310
250
384
Employee contributions
73
73
73
73
Plan settlements
(2,316)
(53,494)
(55,810)
(1,087)
(1,087)
Benefits paid
(5,087)
(6,138)
(11,225)
(3,832)
(6,034)
(9,866)
(250)
(384)
Plan expenses and premiums paid
(135)
(498)
(633)
(129)
(500)
(629)
Transfer in of business acquisition
81,068
65,919
146,987
Translation differences
13,876
13,876
5,499
5,499
Fair value of plan assets at end of year
$
228,789
$
73,481
$
302,270
$
195,099
$
120,550
$
315,649
$
$
Net benefit obligation recognized
$
(18,886)
$
(36,488)
$
(55,374)
$
(22,794)
$
(33,173)
$
(55,967)
$
(3,234)
$
(4,266)
Amounts recognized in the balance
 
sheet consist of:
Non-current assets
$
6,748
$
$
6,748
$
$
$
$
$
Current liabilities
(568)
(612)
(1,180)
(359)
(2,620)
(2,979)
(286)
(426)
Non-current liabilities
(25,066)
(35,876)
(60,942)
(22,435)
(30,553)
(52,988)
(2,948)
(3,840)
Net benefit obligation recognized
$
(18,886)
$
(36,488)
$
(55,374)
$
(22,794)
$
(33,173)
$
(55,967)
$
(3,234)
$
(4,266)
Amounts not yet reflected in net
periodic benefit costs and included in
accumulated other comprehensive loss:
Prior service credit
(26)
50
24
1,271
1,271
Accumulated loss
(21,976)
(5,532)
(27,508)
(22,816)
(46,560)
(69,376)
124
(734)
AOCI
(22,002)
(5,482)
(27,484)
(21,545)
(46,560)
(68,105)
124
(734)
Cumulative employer contributions
(below) or in excess of
 
net periodic
benefit cost
3,116
(31,006)
(27,890)
(1,249)
13,387
12,138
(3,358)
(3,532)
Net benefit obligation recognized
$
(18,886)
$
(36,488)
$
(55,374)
$
(22,794)
$
(33,173)
$
(55,967)
$
(3,234)
$
(4,266)
The accumulated benefit obligation for all defined benefit
 
pension plans was
$344.4
 
million
($109.5
 
million U.S. and
$234.9
million Foreign) and
$366.0
 
million (
$152.9
 
million U.S. and approximately
$213.1
 
million Foreign) as of December 31, 2020 and
2019, respectively.
 
Information for pension plans with an accumulated benefit
 
obligation in excess of plan assets:
2020
2019
Foreign
U.S.
Total
Foreign
U.S.
Total
Projected benefit obligation
$
32,373
$
109,969
$
142,342
$
217,893
$
153,723
$
371,616
Accumulated benefit obligation
30,892
109,540
140,432
213,060
152,930
365,990
Fair value of plan assets
18,074
73,481
91,555
195,099
120,550
315,649
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
QUAKER CHEMICAL CORPORATION
NOTES TO CONSOLIDATED
 
FINANCIAL STATEMENTS
 
- Continued
(
Dollars in thousands, except share and per share amounts,
 
unless otherwise stated
)
 
87
Information for pension plans with a projected
 
benefit obligation in excess of plan assets:
2020
2019
Foreign
U.S.
Total
Foreign
U.S.
Total
Projected benefit obligation
$
32,373
$
109,969
$
142,342
$
217,893
$
153,723
$
371,616
Fair value of plan assets
18,074
73,481
91,555
195,099
120,550
315,649
Components of net periodic benefit costs – pension plans:
2020
2019
Foreign
U.S.
Total
Foreign
U.S.
Total
Service cost
$
4,340
$
491
$
4,831
$
3,507
$
434
$
3,941
Interest cost
3,416
2,923
6,339
3,046
3,313
6,359
Expected return on plan assets
(4,262)
(4,810)
(9,072)
(3,668)
(3,227)
(6,895)
Settlement loss
(88)
22,667
22,579
258
258
Curtailment charge
(1,155)
(1,155)
Actuarial loss amortization
886
2,110
2,996
757
2,348
3,105
Prior service (credit) cost
 
amortization
(167)
(167)
(165)
(165)
Net periodic benefit cost
$
2,970
$
23,381
$
26,351
$
3,735
$
2,868
$
6,603
 
2018
Foreign
U.S.
Total
Service cost
$
3,426
$
383
$
3,809
Interest cost
2,254
1,847
4,101
Expected return on plan assets
(2,228)
(2,803)
(5,031)
Settlement loss
2
2
Actuarial loss amortization
881
2,276
3,157
Prior service (credit) cost amortization
(175)
59
(116)
Net periodic benefit cost
$
4,160
$
1,762
$
5,922
Other changes recognized in other comprehensive
 
income – pension plans:
2020
2019
Foreign
U.S.
Total
Foreign
U.S.
Total
Net (gain) loss arising during
 
the period
$
(1,594)
$
1,536
$
(58)
$
3,826
$
3,926
$
7,752
Effect of plan amendment
Recognition of amortization in net
periodic benefit cost
Settlement (loss)
(39)
(22,667)
(22,706)
Prior service credit (cost)
1,325
50
1,375
196
196
Actuarial loss
(758)
3,967
3,209
(1,015)
(2,347)
(3,362)
Curtailment Recognition
(3)
(3)
Effect of exchange rates on amounts
included in AOCI
1,535
1,535
(61)
(61)
Total recognized
 
in other
 
comprehensive loss (income)
 
466
(17,114)
(16,648)
2,946
1,579
4,525
Total recognized
 
in net periodic
 
benefit cost and other
 
comprehensive loss (income)
 
$
3,436
$
6,267
$
9,703
$
6,681
$
4,447
$
11,128
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
QUAKER CHEMICAL CORPORATION
NOTES TO CONSOLIDATED
 
FINANCIAL STATEMENTS
 
- Continued
(
Dollars in thousands, except share and per share amounts,
 
unless otherwise stated
)
 
88
2018
Foreign
U.S.
Total
Net gain arising during period
$
(663)
$
453
$
(210)
Recognition of amortization in net periodic benefit
 
cost
Prior service credit (cost)
175
(59)
116
Actuarial loss
(883)
(2,276)
(3,159)
Effect of exchange rates on amounts included
 
in AOCI
(890)
(890)
Total recognized
 
in other comprehensive loss
(2,261)
(1,882)
(4,143)
Total recognized
 
in net periodic benefit cost and
 
other comprehensive loss
$
1,899
$
(120)
$
1,779
Components of net periodic benefit costs – other postretirement
 
plan:
2020
2019
2018
Service cost
$
5
$
6
$
7
Interest cost
77
143
130
Actuarial loss amortization
(5)
42
Net periodic benefit costs
$
77
$
149
$
179
Other changes recognized in other comprehensive
 
income – other postretirement benefit
 
plans:
2020
2019
2018
Net (gain) loss arising during period
$
(864)
$
395
$
(443)
Amortization of actuarial loss in net periodic
 
benefit costs
5
(42)
Total recognized
 
in other comprehensive (income)
loss
(859)
395
(485)
Total recognized
 
in net periodic benefit cost and
 
other comprehensive (income) loss
 
$
(782)
$
544
$
(306)
Weighted-average
 
assumptions used to determine benefit obligations as of December
 
31, 2020 and 2019:
Other Postretirement
Pension Benefits
Benefits
2020
2019
2020
2019
U.S. Plans:
Discount rate
2.19
%
3.06
%
2.05
%
2.98
%
Rate of compensation increase
6.00
%
6.00
%
N/A
N/A
Foreign
 
Plans:
Discount rate
1.79
%
1.83
%
N/A
N/A
Rate of compensation increase
2.74
%
2.58
%
N/A
N/A
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
QUAKER CHEMICAL CORPORATION
NOTES TO CONSOLIDATED
 
FINANCIAL STATEMENTS
 
- Continued
(
Dollars in thousands, except share and per share amounts,
 
unless otherwise stated
)
 
89
Weighted-average
 
assumptions used to determine net periodic benefit costs for the
 
years ended December 31, 2020 and
2019:
Other Postretirement
Pension Benefits
Benefits
2020
2019
2020
2019
U.S. Plans:
Discount rate
3.11
%
4.08
%
2.99
%
4.03
%
Expected long-term return on
plan assets
6.50
%
5.75
%
N/A
N/A
Rate of compensation increase
6.00
%
5.50
%
N/A
N/A
Foreign Plans:
Discount rate
2.30
%
2.30
%
N/A
N/A
Expected long-term return on
plan assets
2.20
%
3.13
%
N/A
N/A
Rate of compensation increase
2.79
%
2.87
%
N/A
N/A
The long-term rates of return on assets were selected from
 
within the reasonable range of rates determined by (a)
 
historical real
returns for the asset classes covered by the investment
 
policy and (b) projections of inflation over the long-term period
 
during which
benefits are payable to plan participants.
 
See Note 1 of Notes to Consolidated Financial Statements for
 
further information.
Assumed health care cost trend rates
 
as of December 31, 2020 and 2019:
 
2020
2019
Health care cost trend rate for next year
5.70
%
5.90
%
Rate to which the cost trend rate is assumed to decline (the
ultimate trend rate)
4.50
%
4.50
%
Year
 
that the rate reaches the ultimate trend rate
2037
2037
Plan Assets and Fair Value
The Company’s pension
 
plan target asset allocation and the weighted-average
 
asset allocations as of December 31, 2020 and 2019
by asset category were as follows:
Asset Category
Target
2020
2019
U.S. Plans
Equity securities
10
%
58
%
32
%
Debt securities
90
%
36
%
64
%
Other
0
%
6
%
4
%
Total
100
%
100
%
100
%
Foreign Plans
Equity securities
37
%
33
%
34
%
Debt securities
53
%
45
%
45
%
Other
10
%
22
%
21
%
Total
100
%
100
%
100
%
QUAKER CHEMICAL CORPORATION
NOTES TO CONSOLIDATED
 
FINANCIAL STATEMENTS
 
- Continued
(
Dollars in thousands, except share and per share amounts,
 
unless otherwise stated
)
 
90
As of December 31, 2020 and 2019, “Other” consisted principally
 
of cash and cash equivalents, and investments in real estate
funds.
 
The following is a description of the valuation methodologies
 
used for the investments measured at fair value, including
 
the
general classification of such instruments pursuant to
 
the valuation hierarchy,
 
where applicable:
Cash and Cash
 
Equivalents
Cash and
 
cash equivalents
 
consist of
 
cash and
 
money market
 
funds and
 
are classified
 
as Level
 
1 investments.
Commingled Funds
 
Investments
 
in the U.S.
 
pension plan
 
and foreign
 
pension plan
 
commingled
 
funds represent
 
pooled institutional
 
investments,
including
 
primarily
 
collective
 
investment
 
trusts.
 
These commingled funds are not available on an exchange or
 
in an active market
and these investments are valued using
 
their net
 
asset value
 
(“NAV”), which is generally
 
based on
 
the underlying
 
asset values
 
of the
investments
 
held in the
 
trusts.
 
As of December 31, 2020, the foreign pension plan commingled
 
funds included approximately
35
 
percent of investments in
equity securities,
51
 
percent of investments in fixed income securities, and
14
 
percent of other non-related investments, primarily
real estate.
 
Pooled Separate
 
Accounts
 
Investments
 
in the U.S.
 
pension plan
 
pooled separate
 
accounts
 
consist of
 
annuity contracts
 
and are
 
valued based
 
on the reported
unit value
 
at year
 
end.
 
Units of
 
the pooled
 
separate
 
account are
 
not traded
 
on an exchange
 
or in an
 
active market;
 
however, valuation
 
is
based on the
 
underlying
 
investments
 
of each pooled
 
separate
 
account and
 
are classified
 
as Level
 
2 investments.
 
As of December 31,
2020, the U.S. pension plan pooled separate accounts included approximately 61 percent of investments in equity securities and 39
percent of investments in fixed income securities.
Fixed Income
 
Government
 
Securities
Investments in foreign pension plans fixed income government
 
securities were valued using third party pricing services
which are based on a combination of quoted market
 
prices on an exchange in an active market as well as proprietary
 
pricing
models and
 
inputs using
 
observable
 
market data
 
and are classified
 
as Level
 
2 investments.
Insurance
 
Contract
 
Investments in the foreign pension plan insurance contract
 
are valued at the highest value available for the Company at year
end, either the reported cash surrender value of the contract
 
or the vested benefit obligation.
 
Both the cash surrender value and
the vested benefit obligation are determined based on unobservable
 
inputs, which are contractually or actuarially determined,
regarding returns, fees, the present value of the future cash
 
flows of the contract and benefit obligations.
 
The contract is classified
as a Level 3 investment.
Diversified
 
Equity Securities
 
- Registered
 
Investment
 
Companies
 
Investments
 
in the foreign
 
pension plans
 
diversified
 
equity securities
 
of registered
 
investment
 
companies
 
are based
 
upon the
quoted redemption
 
value of
 
shares in
 
the fund
 
owned by the
 
plan at year
 
end.
 
The shares
 
of the fund
 
are not available
 
on an exchange
or in an
 
active market;
 
however, the
 
fair value
 
is determined
 
based on
 
the underlying
 
investments
 
in the fund
 
as traded
 
on an exchange
in an active
 
market and
 
are classified
 
as Level
 
2 investments.
 
Fixed Income
 
– Foreign Registered
 
Investment
 
Companies
 
Investments
 
in the foreign
 
pension plans
 
fixed income
 
securities
 
of foreign
 
registered
 
investment
 
companies
 
are based
 
upon the
quoted redemption
 
value of
 
shares in
 
the fund
 
owned by the
 
plan at year
 
end.
 
The shares
 
of the fund
 
are not available
 
on an exchange
or in an
 
active market;
 
however, the
 
fair value
 
is determined
 
based on
 
the underlying
 
investments
 
in the fund
 
as traded
 
on an exchange
in an active
 
market and
 
are classified
 
as Level
 
2 investments.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
QUAKER CHEMICAL CORPORATION
NOTES TO CONSOLIDATED
 
FINANCIAL STATEMENTS
 
- Continued
(
Dollars in thousands, except share and per share amounts,
 
unless otherwise stated
)
 
91
Diversified Investment Fund - Registered
 
Investment Companies
Investments
 
in the foreign
 
pension plan
 
diversified
 
investment
 
fund of registered
 
investment
 
companies
 
are based
 
upon the quoted
redemption
 
value of
 
shares in
 
the fund
 
owned by
 
the plan
 
at year
 
end.
 
This fund
 
is not available
 
on an exchange
 
or in an
 
active market
and this investment
 
is valued
 
using its
 
NAV,
 
which is
 
generally
 
based on
 
the underlying
 
asset values
 
of the investments
 
held.
 
As of
December 31,
 
2020, the
 
diversified
 
investment
 
funds included
 
approximately
62
 
percent of
 
investments
 
in equity
 
securities,
19
 
percent
of investments
 
in fixed
 
income securities,
 
and
19
 
percent of
 
other alternative
 
investments.
Other – Alternative Investments
Investments
 
in the foreign
 
pension plans
 
include certain
 
other alternative
 
investments
 
such as
 
inflation
 
and interest
 
rate swaps.
 
These investments
 
are valued
 
based on
 
unobservable
 
inputs,
 
which are
 
contractually
 
or actuarially
 
determined,
 
regarding
 
returns, fees,
the present
 
value of
 
future cash
 
flows of the
 
contract and
 
benefit obligations.
 
These alternative
 
investments
 
are classified
 
as Level
 
3
investments.
Real Estate
 
The U.S. and foreign pension plans’ investment in real estate consists
 
of investments
 
in property funds.
 
The funds’
underlying investments consist of real property which
 
are valued using unobservable inputs.
 
These property
 
funds
 
are classified
as a Level 3 investment.
As of December 31, 2020 and 2019, the U.S. and foreign
 
plans’ investments measured at fair value on a recurring
 
basis were as
follows:
Fair Value
 
Measurements at December 31, 2020
Total
Using Fair Value
 
Hierarchy
U.S. Pension Assets
Fair Value
Level 1
Level 2
Level 3
Pooled separate accounts
$
69,385
$
$
69,385
$
Real estate
4,096
4,096
Subtotal U.S. pension plan assets in fair value hierarch
 
y
$
73,481
$
$
69,385
$
4,096
Total U.S. pension
 
plan assets
$
73,481
Foreign Pension Assets
Cash and cash equivalents
$
634
$
634
$
$
Insurance contract
112,920
112,920
Diversified equity securities - registered investment companies
8,851
8,851
Fixed income – foreign registered investment companies
3,711
3,711
Fixed income government securities
37,579
37,579
Real estate
5,679
5,679
Other - alternative investments
10,638
10,638
Sub-total of foreign pension assets in fair value hierarchy
$
180,012
$
634
$
50,141
$
129,237
Commingled funds measured at NAV
2,368
Diversified investment fund -
 
registered investment
companies measured at NAV
46,409
Total foreign pension
 
assets
$
228,789
Total pension
 
assets in fair value hierarchy
$
253,493
$
634
$
119,526
$
133,333
Total pension
 
assets measured at NAV
48,777
Total pension
 
assets
$
302,270
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
QUAKER CHEMICAL CORPORATION
NOTES TO CONSOLIDATED
 
FINANCIAL STATEMENTS
 
- Continued
(
Dollars in thousands, except share and per share amounts,
 
unless otherwise stated
)
 
92
Fair Value
 
Measurements at December 31, 2019
Total
Using Fair Value
 
Hierarchy
U.S. Pension Assets
Fair Value
Level 1
Level 2
Level 3
Cash and cash equivalents
$
450
$
450
$
$
Pooled separate accounts
64,636
64,636
Real estate
4,060
4,060
Subtotal U.S. pension plan assets in fair value hierarch
 
y
$
69,146
$
450
$
64,636
$
4,060
Commingled funds measured at NAV
51,404
Total U.S. pension
 
plan assets
$
120,550
Foreign Pension Assets
Cash and cash equivalents
$
1,502
$
1,502
$
$
Insurance contract
92,657
92,657
Diversified equity securities - registered investment companies
8,604
8,604
Fixed income – foreign registered investment companies
3,021
3,021
Fixed income government securities
32,512
32,512
Real estate
5,521
5,521
Other - alternative investments
9,436
9,436
Sub-total of foreign pension assets in fair value hierarchy
$
153,253
$
1,502
$
44,137
$
107,614
Commingled funds measured at NAV
2,037
Diversified investment fund -
 
registered investment
companies measured at NAV
39,809
Total foreign pension
 
assets
$
195,099
Total pension
 
assets in fair value hierarchy
$
222,399
$
1,952
$
108,773
$
111,674
Total pension
 
assets measured at NAV
93,250
Total pension
 
assets
$
315,649
Certain investments that are measured at fair value using
 
the NAV
 
per share (or its equivalent) have not been classified in
 
the fair
value hierarchy.
 
The fair value amounts presented for these investments in the
 
preceding tables are intended to permit reconciliation
of the fair value hierarchies to the line items presented
 
in the statements of net assets available for benefits.
Changes in the fair value of the plans’ Level 3 investments
 
during the years ended December 31, 2020 and 2019
 
were as follows:
Insurance
Alternative
Contract
Real Estate
Investments
Total
Balance as of December 31, 2018
$
79,873
2,382
$
82,255
Purchases
3,762
1,029
4,791
Assets acquired in business combinations
129
7,058
8,914
16,101
Sales
(238)
(278)
(516)
Settlements
(1,730)
(1,730)
Unrealized (losses) gains
12,199
403
(960)
11,642
Currency translation adjustment
(1,576)
(24)
731
(869)
Balance as of December 31, 2019
92,657
9,581
9,436
111,674
Purchases
3,902
18
989
4,909
Settlements
(2,027)
(2,027)
Unrealized gains (losses)
8,917
(16)
(171)
8,730
Currency translation adjustment
9,471
192
384
10,047
Balance as of December 31, 2020
$
112,920
$
9,775
$
10,638
$
133,333
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
QUAKER CHEMICAL CORPORATION
NOTES TO CONSOLIDATED
 
FINANCIAL STATEMENTS
 
- Continued
(
Dollars in thousands, except share and per share amounts,
 
unless otherwise stated
)
 
93
In the fourth quarter of 2018, the Company began the
 
process of terminating its Legacy Quaker noncontributory U.S. pension
plan (“Legacy Quaker U.S. Pension Plan”).
 
During the third quarter of 2019, the Company received a favorable
 
termination
determination letter from the Internal Revenue Service
 
(“I.R.S.”) and completed the Legacy Quaker U.S. Pension Plan
 
termination
during the first quarter of 2020.
 
In order to terminate the Legacy Quaker U.S. Pension Plan
 
in accordance with I.R.S. and Pension
Benefit Guaranty Corporation requirements, the Company
 
was required to fully fund the Legacy Quaker U.S. Pension Plan
 
on a
termination basis and the amount necessary to do so
 
was approximately $
1.8
 
million, subject to final true up adjustments.
 
In the third
quarter of 2020, the Company finalized the amount
 
of the liability and related annuity payments and received
 
a refund in premium of
approximately $
1.6
 
million.
 
In addition, the Company recorded a non-cash pension settlement
 
charge at plan termination of
approximately $
22.7
 
million.
 
This settlement charge included the immediate
 
recognition into expense of the related unrecognized
losses within AOCI on the balance sheet as of the plan
 
termination date.
In connection with the Combination, the Company indirectly
 
acquired all of Houghton’s
 
defined benefit pension plans, which are
included in the tables set forth above.
 
The pension plans cover certain U.S. salaried and hourly
 
employees as well as certain
employees in the U.K., France and Germany.
 
The Houghton U.S. plans provide benefits based on an employee’s
 
years of service and
compensation received for the highest five consecutive
 
years of earnings.
 
The foreign plans provide benefits based on a formula of
years and service and a percentage of compensation
 
which varies among the various countries.
 
The Company contributes to a multiemployer defined
 
benefit pension plan under terms of a collective bargaining
 
union contract
(the Cleveland Bakers and Teamsters
 
Pension Fund, Employer Identification Number: 34-0904419
 
-001).
 
The expiration date of the
collective bargaining contract is
May 1, 2022
.
 
As of January 1, 2019, the last valuation date available for the multiemployer
 
plan,
total plan liabilities were approximately $
589
 
million.
 
As of December 31, 2019, the multiemployer pension plan
 
had total plan assets
of approximately $
364
 
million.
 
The Company’s contribution
 
rate to the multiemployer pension plan is specified in the
 
collective
bargaining union contract and contributions are
 
made to the plan based on its union employee payroll.
 
The Company contributed $
0.1
million during the year ended December 31, 2020.
 
The Employee Retirement Income Security Act of 1974,
 
as amended by the Multi-
Employer Pension Plan Amendments Act of 1980, imposes
 
certain contingent liabilities upon an employer who is a
 
contributor to a
multiemployer pension plan if the employer withdraws
 
from the plan or the plan is terminated or experiences a mass withdrawal.
 
While the Company may also have additional liabilities imposed
 
by law as a result of its participation in the multiemployer
 
defined
benefit pension plan, there is
no
 
liability as of December 31, 2020.
 
The Pension Protection Act of 2006 (the “PPA”)
 
also added special funding and operational rules generally
 
applicable to plan
years beginning after 2007 for multiemployer plans with
 
certain classifications based on a multitude of factors (including,
 
for
example, the plan’s funded
 
percentage, cash flow position and whether the plan is projected
 
to experience a minimum funding
deficiency).
 
The plan to which the Company contributes is in “critical” status.
 
Plans in the “critical” status classification must adopt
measures to improve their funded status through a
 
funding improvement or rehabilitation plan which may require additional
contributions from employers (which may take the form
 
of a surcharge on benefit contributions) and/or
 
modifications to retiree
benefits.
 
The amount of additional funds that the Company may be obligated
 
to contribute to the plan in the future cannot be
estimated as such amounts will be likely based on
 
future levels of work that require the specific use of those
 
union employees covered
by the plan, and the amount of that future work and
 
the number of affected employees that may be
 
needed is not reasonably estimable.
 
Cash Flows
Contributions
The Company expects to make minimum cash contributions
 
of approximately
$10.0
 
million to its pension plans (approximately
$5.9
 
million U.S. and
$4.1
 
million Foreign) and approximately
$0.3
 
million to its other postretirement benefit plan in 2021.
Estimated Future Benefit Payments
Excluding any impact related to the PPA
 
noted above, the following benefit payments, which reflect
 
expected future service, as
appropriate, are expected to be paid:
Other Post-
Pension Benefits
Retirement
Foreign
U.S.
Total
Benefits
2021
$
6,658
$
5,923
$
12,581
$
286
2022
6,939
5,298
12,237
278
2023
7,024
6,072
13,096
265
2024
6,745
6,234
12,979
245
2025
7,394
6,228
13,622
226
2025 to 2029
42,522
30,443
72,965
923
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
QUAKER CHEMICAL CORPORATION
NOTES TO CONSOLIDATED
 
FINANCIAL STATEMENTS
 
- Continued
(
Dollars in thousands, except share and per share amounts,
 
unless otherwise stated
)
 
94
The Company maintains a plan under which supplemental
 
retirement benefits are provided to certain officers.
 
Benefits payable
under the plan are based on a combination of years of
 
service and existing postretirement benefits.
 
Included in total pension costs are
charges of $
2.5
 
million, $
1.8
 
million and $
1.6
 
million for the years ended December 31, 2020, 2019 and 2018,
 
respectively,
representing the annual accrued benefits under this
 
plan.
Defined Contribution Plan
The Company has a 401(k) plan with an employer
 
match covering a majority of its U.S. employees.
 
The plan allows for and the
Company previously paid a nonelective contribution
 
on behalf of participants who have completed one year
 
of service equal to 3% of
the eligible participants’ compensation in the form
 
of Company common stock.
 
During 2019 and 2018, the Company made both non-
elective and elective 401(k) matching contributions
 
in cash, rather than stock.
 
Beginning in April 2020, the Company began matching
both non-elective and elective 401(k) contributions in
 
fully vested shared
 
of the Company’s common
 
stock rather than cash.
 
See Note
8 of Notes to Consolidated Financial Statements.
 
Total Company
 
contributions were $
5.7
 
million, $
4.0
 
million and $
3.1
 
million for
the years ended December 31, 2020, 2019 and 2018,
 
respectively.
 
Note 22 – Other Non-Current Liabilities
Other non-current liabilities as of December 31, 2020
 
and 2019 were as follows:
 
2020
2019
Inactive subsidiary litigation and settlement reserve
$
542
 
$
19,678
Non-current income taxes payable
8,500
8,500
Uncertain tax positions (includes interest and penalties)
 
28,961
 
 
24,609
Fair value of interest rate swaps
 
4,672
 
 
415
Environmental reserves
4,610
5,259
Deferred and other long-term compensation
6,257
6,625
Other
1,627
1,298
Total other
 
non-current liabilities
$
55,169
 
$
66,384
The line item Inactive subsidiary litigation and settlement
 
reserve in the table above was previously titled Restricted insurance
settlement and has been updated in the current year
 
related to the December 2020 termination of restrictions on
 
the previously
restricted amounts, as described in Note 12 of Notes to
 
Consolidated Financial Statements.
Note 23 – Equity and Accumulated Other Comprehensive
 
Loss
 
The Company has
30,000,000
 
shares of common stock authorized with a par value
 
of $
1
, and
17,850,616
 
and
17,735,162
 
shares
issued and outstanding as of December 31, 2020
 
and 2019, respectively.
 
The change in shares issued and outstanding during 2020
was primarily related to
49,906
 
shares issued for share-based compensation plans and
65,548
 
shares issued for the exercise of stock
options and other share activity.
 
The Company is authorized to issue
10,000,000
 
shares of preferred stock with $
1
 
par value, subject to approval by the Board of
Directors.
 
The Board of Directors may designate one or more series of preferred
 
stock and the number of shares, rights, preferences,
and limitations of each series.
 
As of December 31, 2020, no preferred stock had been issued.
The Company has a share repurchase program that was approved
 
by its Board of Directors in 2015 for the repurchase of up to
$
100.0
 
million of Quaker Chemical Corporation common stock.
 
The Company has not repurchased any shares under the program
 
for
the years ended December 31, 2020, 2019 and 2018.
 
As of December 31, 2020, there was approximately $
86.9
 
million of common
stock remaining to be purchased under this share repurchase
 
program.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
QUAKER CHEMICAL CORPORATION
NOTES TO CONSOLIDATED
 
FINANCIAL STATEMENTS
 
- Continued
(
Dollars in thousands, except share and per share amounts,
 
unless otherwise stated
)
 
95
The following table shows the reclassifications from and
 
resulting balances of AOCI for the years ended December
 
31, 2020,
2019 and 2018:
Defined
Unrealized
Gain (Loss) in
Currency
Benefit
Translation
Pension
Available-for
 
-
Derivative
Adjustments
Plans
Sale Securities
Instruments
Total
Balance as of December 31, 2017
$
(31,893)
$
(34,093)
$
886
$
$
(65,100)
Other comprehensive (loss) income before
 
reclassifications
(17,429)
1,543
(2,622)
(18,508)
Amounts reclassified from AOCI
3,085
435
3,520
Related tax amounts
(1,086)
459
(627)
Balance as of December 31, 2018
(49,322)
(30,551)
(842)
(80,715)
Other comprehensive income (loss) before
 
reclassifications
4,754
(8,088)
2,951
(415)
(798)
Amounts reclassified from AOCI
3,169
(301)
2,868
Related tax amounts
937
(557)
95
475
Balance as of December 31, 2019
(44,568)
(34,533)
1,251
(320)
(78,170)
Other comprehensive income (loss) before
 
reclassifications
41,693
(6,617)
2,848
(4,257)
33,667
Amounts reclassified from AOCI
24,141
(202)
23,939
Related tax amounts
(6,458)
(555)
979
(6,034)
Balance as of December 31, 2020
$
(2,875)
$
(23,467)
$
3,342
$
(3,598)
$
(26,598)
All reclassifications related to unrealized gain (loss) in
 
available-for-sale securities relate to the Company’s
 
equity interest in a
captive insurance company and are recorded in equity
 
in net income of associated companies.
 
The amounts reported in other
comprehensive income for non-controlling interest are
 
related to currency translation adjustments.
Note 24 – Fair Value
 
Measures
 
The Company has valued its company-owned life insurance
 
policies at fair value.
 
These assets are subject to fair value
measurement as follows:
Fair Value
 
Measurements at December 31, 2020
Total
Using Fair Value
 
Hierarchy
Assets
Fair Value
Level 1
Level 2
Level 3
Company-owned life insurance
 
$
1,961
$
$
1,961
$
Total
$
1,961
$
$
1,961
$
 
Fair Value
 
Measurements at December 31, 2019
Total
Using Fair Value
 
Hierarchy
Assets
Fair Value
Level 1
Level 2
Level 3
Company-owned life insurance
 
$
1,782
$
$
1,782
$
Total
$
1,782
$
$
1,782
$
The fair values of Company-owned life insurance assets are based
 
on quotes for like instruments with similar credit ratings and
terms.
 
The Company did not hold any Level 3 investments as of December
 
31, 2020 or 2019,
 
respectively, so
 
related disclosures have
not been included.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
QUAKER CHEMICAL CORPORATION
NOTES TO CONSOLIDATED
 
FINANCIAL STATEMENTS
 
- Continued
(
Dollars in thousands, except share and per share amounts,
 
unless otherwise stated
)
 
96
Note 25 – Hedging Activities
In order to satisfy certain requirements of the Credit
 
Facility as well as to manage the Company’s
 
exposure to variable interest
rate risk associated with the Credit Facility,
 
in November 2019, the Company entered into $
170.0
 
million notional amounts of three-
year interest rate swaps.
 
See Note 20 of Notes to Consolidated Financial Statements.
 
These interest rate swaps are designated as cash
flow hedges and, as such, the contracts are marked-to-market
 
at each reporting date and any unrealized gains or losses are included
 
in
AOCI to the extent effective and reclassified
 
to interest expense in the period during which the transaction
 
effects earnings or it
becomes probable that the forecasted transaction will not occur.
 
The Company did not utilize derivatives designated as cash flow
hedges during the year ended December 31, 2018.
The balance sheet classification and fair values of the
 
Company’s derivative instruments,
 
which are Level 2 measurements, are as
follows:
Fair Value
Consolidated Balance Sheet
December 31,
Location
2020
2019
Derivatives designated as cash flow hedges:
Interest rate swaps
Other non-current liabilities
$
4,672
$
415
$
4,672
$
415
The following table presents the net unrealized loss deferred to
 
AOCI:
December 31,
2020
2019
Derivatives designated as cash flow hedges:
Interest rate swaps
AOCI
$
3,598
$
320
$
3,598
$
320
The following table presents the net loss reclassified from
 
AOCI to earnings:
For the Years
 
Ended
December 31,
2020
2019
2018
Amount and location of (expense) income reclassified
 
from AOCI into (expense) income (Effective Portion)
Interest expense, net
$
(1,754)
$
29
$
Interest rate swaps are entered into with a limited number
 
of counterparties, each of which allows for net settlement
 
of all
contracts through a single payment in a single currency
 
in the event of a default on or termination of any one
 
contract.
 
As such, in
accordance with the Company’s
 
accounting policy,
 
these derivative instruments are recorded on a net basis within
 
the Consolidated
Balance Sheets.
Note 26 – Commitments and Contingencies
In 1992, the Company identified certain soil and groundwater
 
contamination at AC Products, Inc. (“ACP”), a wholly
 
owned
subsidiary.
 
In voluntary coordination with the Santa Ana California Regional
 
Water Quality Board,
 
ACP has been remediating the
contamination, the principal contaminant of which
 
is perchloroethylene (“PERC”).
 
In 2004, the Orange County Water
 
District
(“OCWD”) filed a civil complaint against ACP and other
 
parties seeking to recover compensatory and other damages
 
related to the
investigation and remediation of the contamination in the
 
groundwater.
 
Pursuant to a settlement agreement with OCWD, ACP agreed,
among other things, to operate the two groundwater treatment
 
systems to hydraulically contain groundwater contamination
 
emanating
from ACP’s site until the concentrations
 
of PERC released by ACP fell below the current Federal maximum
 
contaminant level for
four consecutive quarterly sampling events.
 
In 2014, ACP ceased operation at one of its two groundwater
 
treatment systems, as it had
met the above condition for closure.
 
In 2020, the Santa Ana Regional Water
 
Quality Control Board asked that ACP conduct some
additional indoor and outdoor soil vapor testing on and
 
near the ACP site to confirm that ACP continues to meet the applicable
 
local
standards and ACP has begun the testing program.
 
As of December 31, 2020,
 
ACP believes it is close to meeting the conditions
 
for
closure of the remaining groundwater treatment system
 
but continues to operate this system while in discussions with the
 
relevant
authorities.
 
QUAKER CHEMICAL CORPORATION
NOTES TO CONSOLIDATED
 
FINANCIAL STATEMENTS
 
- Continued
(
Dollars in thousands, except share and per share amounts,
 
unless otherwise stated
)
 
97
As of December 31, 2020, the Company believes that
 
the range of potential-known liabilities associated with the balance
 
of ACP
water remediation program is approximately $
0.1
 
million to $
1.0
 
million.
 
The low and high ends of the range are based on the length
of operation of the treatment system as determined
 
by groundwater modeling.
 
Costs of operation include the operation and
maintenance of the extraction well, groundwater monitoring
 
and program management.
 
An inactive subsidiary of the Company that was acquired
 
in 1978 sold certain products containing asbestos, primarily on an
installed basis, and is among the defendants in numerous
 
lawsuits alleging injury due to exposure to asbestos.
 
The subsidiary
discontinued operations in 1991 and has no remaining
 
assets other than proceeds received from insurance settlements.
 
To date, the
overwhelming majority of these claims have been
 
disposed of without payment and there have been no adverse judgments
 
against the
subsidiary.
 
Based on a continued analysis of the existing and anticipated
 
future claims against this subsidiary,
 
it is currently projected
that the subsidiary’s total
 
liability over the next 50 years for these claims is approximately
 
$
0.5
 
million (excluding costs of defense).
 
Although the Company has also been named as a defendant
 
in certain of these cases, no claims have been actively pursued
 
against the
Company, and
 
the Company has not contributed to the defense or settlement of any
 
of these cases pursued against the subsidiary.
 
These cases were handled by the subsidiary’s
 
primary and excess insurers who had agreed in 1997 to
 
pay all defense costs and be
responsible for all damages assessed against the subsidiary arising
 
out of existing and future asbestos claims up to the aggregate
 
limits
of their policies.
 
A significant portion of this primary insurance coverage was provided
 
by an insurer that is insolvent, and the other
primary insurers asserted that the aggregate limits of their
 
policies had been exhausted.
 
The subsidiary challenged the applicability of
these limits to the claims being brought against the subsidiary.
 
In response, two of the three carriers entered into separate settlement
and release agreements with the subsidiary in 2005 and
 
2007 for $
15.0
 
million and $
20.0
 
million, respectively.
 
The proceeds of both settlements were restricted and could
 
only be used to pay claims and costs of defense associated with
 
the
subsidiary’s asbestos litigation.
 
In 2007, the subsidiary and the remaining primary insurance
 
carrier entered into a Claim Handling
and Funding Agreement, under which the carrier is paying
27
% of defense and indemnity costs incurred by or on behalf
 
of the
subsidiary in connection with asbestos bodily injury
 
claims.
 
The agreement continues until terminated and can only
 
be terminated by
either party by providing a minimum of two years prior
 
written notice.
 
As of December 31, 2020,
 
no notice of termination has been
given under this agreement.
 
At the end of the term of the agreement, the subsidiary
 
may choose to again pursue its claim against this insurer regarding
 
the
application of the policy limits.
 
The Company believes that, if the coverage issues under the primary
 
policies with the remaining
carrier are resolved adversely to the subsidiary and all
 
settlement proceeds were used, the subsidiary may have limited
 
additional
coverage from a state guarantee fund established following
 
the insolvency of one of the subsidiary’s
 
primary insurers.
 
Nevertheless,
liabilities in respect of claims may exceed the assets and coverage
 
available to the subsidiary.
If the subsidiary’s assets and
 
insurance coverage were to be exhausted, claimants of the
 
subsidiary may actively pursue claims
against the Company because of the parent-subsidiary relationship.
 
The Company does not believe that such claims would have merit
or that the Company would be held to have liability for any
 
unsatisfied obligations of the subsidiary as a result of such
 
claims.
 
After
evaluating the nature of the claims filed against the subsidiary
 
and the small number of such claims that have resulted in any
 
payment,
the potential availability of additional insurance
 
coverage at the subsidiary level, the additional availability of the
 
Company’s own
insurance and the Company’s
 
strong defenses to claims that it should be held responsible
 
for the subsidiary’s obligati
 
ons because of
the parent-subsidiary relationship, the Company believes
 
it is not probable that the Company will incur losses.
 
The Company has
been successful to date having any claims naming it
 
dismissed during initial proceedings.
 
Since the Company may be in this stage of
litigation for some time, it is not possible to estimate additional
 
losses or range of loss, if any.
 
As a result of the closing of the Combination on August
 
1, 2019, the Company is party to environmental matters related
 
to certain
Houghton domestic and foreign properties currently or previously
 
owned, described below.
 
These environmental matters primarily
require the Company to perform long-term monitoring
 
as well as operating and maintenance at each of the applicable
 
sites.
 
The
Company continually evaluates its obligations related to such
 
matters, and based on historical costs incurred and projected
 
costs to be
incurred over the next 28 years, has estimated the present
 
value range of costs for all of the Houghton environmental
 
matters, on a
discounted basis, to be between approximately $
5.5
 
million and $
6.5
 
million as of December 31, 2020, for which $
6.0
 
million is
accrued within other accrued liabilities and other non-current
 
liabilities on the Company’s
 
Consolidated Balance Sheet as of
December 31, 2020.
 
Comparatively, as of
 
December 31, 2019, the Company had $
6.6
 
million accrued for with respect to these
matters.
Houghton’s Sao Paulo,
 
Brazil site was required under Brazilian environmental, health
 
and safety regulations to perform an
environmental assessment as part of a permit renewal
 
process.
 
Initial investigations identified soil and ground
 
water contamination in
select areas of the site.
 
The site has conducted a multi-year soil and groundwater
 
investigation and corresponding risk assessments
based on the result of the investigations.
 
In 2017, the site had to submit a new 5-year permit renewal request
 
and was asked to
complete additional investigations to further delineate
 
the site based on review of the technical data by the local regulatory
 
agency,
Companhia Ambiental do Estado de São Paulo (“CETESB”).
 
Based on review of the updated investigation data, CETESB issued
 
a
QUAKER CHEMICAL CORPORATION
NOTES TO CONSOLIDATED
 
FINANCIAL STATEMENTS
 
- Continued
(
Dollars in thousands, except share and per share amounts,
 
unless otherwise stated
)
 
98
Technical Opinion
 
regarding the investigation and remedial actions taken to
 
date.
 
The site developed an action plan and submitted it
to CETESB in 2018 based on CETESB requirements.
 
The site intervention plan primarily requires the site, amongst other
 
actions, to
conduct periodic monitoring for methane in soil vapors,
 
source zone delineation, groundwater plume delineation,
 
bedrock aquifer
assessment, update the human health risk assessment, develop
 
a current site conceptual model and conduct a remedial feasibility study
and provide a revised intervention plan.
 
In December 2019, the site submitted a report on the activities completed
 
including the revised site conceptual model and results
of the remedial feasibility study and recommended remedial
 
strategy for the site.
 
Other Houghton environmental matters include
participation in certain payments in connection with four
 
currently active environmental consent orders related to
 
certain hazardous
waste cleanup activities under the U.S. Federal Superfund
 
statute.
 
Houghton has been designated a potentially responsible party
(“PRP”) by the Environmental Protection Agency along
 
with other PRPs depending on the site, and has other obligations
 
to perform
cleanup activities at certain other foreign subsidiaries.
 
These environmental matters primarily require the Company
 
to perform long-
term monitoring as well as operating and maintenance
 
at each of the applicable sites.
 
The Company believes, although there can be no assurance
 
regarding the outcome of other unrelated environmental matters, that
it has made adequate accruals for costs associated with other
 
environmental problems of which it is aware.
 
Approximately $
0.1
million and $
0.2
 
million were accrued as of December 31, 2020 and 2019, respectively,
 
to provide for such anticipated future
environmental assessments and remediation costs.
During the fourth quarter of 2020, one of the Company’s
 
subsidiaries received a notice of inspection from a taxing authority
 
in a
country where certain of its subsidiaries operate which
 
related to a non-income (indirect) tax that may be applicable to
 
certain products
the subsidiary sells.
 
To date, the Company
 
has not received any assessment from the authority related
 
to potential liabilities that may
be due from the Company’s
 
subsidiary.
 
Consequently, there is substantial uncertainty
 
with respect to the Company’s
 
ultimate liability
with respect to this indirect tax, as the application of
 
this tax in its given
 
market is ambiguous and interpreted differently among
 
other
peer companies and taxing authorities.
 
The Company, with
 
assistance from independent experts, has performed an
 
evaluation of the
applicability of this indirect tax to the Company’s
 
subsidiaries in this country.
 
Information available to the Company at this time is
only sufficient to establish a range of probable
 
liability, and no amount
 
within the range is considered a better estimate than another.
 
Based on this evaluation, the Company recorded a liability
 
of $
1.5
 
million in other accrued liabilities, which reflects the low end
 
of the
range of probable indirect tax owed, including interest
 
and taking into account applicable statutes of limitations.
 
Because these
amounts in part relate to a Houghton entity acquired
 
in the Combination and for periods prior to the Combination, the
 
Company has
submitted an indemnification claim with Houghton’s
 
former owners related to this potential indirect tax liability.
 
The Company
recorded a receivable in other assets for approximately $
1.1
 
million, which reflects the amount of the $
1.5
 
million recorded liability
for which the Company anticipates being indemnified.
 
The impact of this indirect tax, net of the recorded indemnification
 
asset, was
approximately $
0.4
 
million and was recorded as a component of SG&A during
 
the fourth quarter of 2020.
 
As noted, the Company
believes there is substantial uncertainty with respect to
 
its ultimate liability given the ambiguous application of this indirect tax.
 
At
this time, the Company’s
 
best estimate of a potential range for possible assessments, including
 
additional amounts that may be
assessed under these indirect tax laws, would be approximately
 
$
0.4
 
million to $
34
 
million, which is net of approximately $
9
 
million
of estimated income tax deductions and approximately $
22
 
million of applicable rights to indemnification from Houghton’s
 
former
owners.
The Company is party to other litigation which management
 
currently believes will not have a material adverse
 
effect on the
Company’s results of
 
operations, cash flows or financial condition. In addition,
 
the Company has an immaterial amount of contractual
purchase obligations.
 
Note 27 – COVID-19 Global Pandemic
In early 2020, a global outbreak of COVID-19 occurred
 
initially in China and then across all locations where the Company does
business, and which continued throughout the rest of the
 
year.
 
In March 2020, the World
 
Health Organization formally identified the
COVID-19 outbreak as a pandemic.
 
In an effort to halt the outbreak of COVID-19,
 
the governments of impacted countries, including
but not limited to the U.S., the European Union, and
 
China, have taken various actions to reduce its spread, including
 
travel
restrictions, shutdowns of businesses deemed nonessential,
 
and stay-at-home or similar orders.
 
This outbreak and associated
measures to reduce its spread have caused significant disruptions
 
to the operations of the Company and its suppliers and customers.
 
The disruptions and negative impact to the Company
 
include significant volume declines and lower net sales initially at its China
subsidiaries in the first quarter of 2020 and beginning
 
in late March continued throughout the rest of 2020 at almost
 
all of its other
sites as the global economy slowed significantly in response
 
to the pandemic.
 
Management continues to monitor the impact that the
COVID-19 pandemic is having on the Company,
 
the overall specialty chemical industry,
 
and the economies and markets in which the
Company operates.
Further, management continues to
 
evaluate how COVID-19-related circumstances, such as remote
 
work arrangements, have
affected financial reporting processes, internal control
 
over financial reporting, and disclosure controls and procedures.
 
While the
circumstances have presented and are expected to continue
 
to present challenges, at this time, management does not believe
 
that
QUAKER CHEMICAL CORPORATION
NOTES TO CONSOLIDATED
 
FINANCIAL STATEMENTS
 
- Continued
(
Dollars in thousands, except share and per share amounts,
 
unless otherwise stated
)
 
99
COVID-19 has had a material impact on financial reporting
 
processes, internal control over financial reporting,
 
and disclosure
controls and procedures.
 
The full extent of the COVID-19 pandemic related
 
business and travel restrictions and changes to business and
 
consumer
behavior intended to reduce its spread are uncertain as of
 
the date of this Report as COVID-19 and the responses of governmental
authorities continue to evolve globally.
 
The Company cannot reasonably estimate the magnitude of the effects
 
these conditions will
have on the Company’s
 
operations in the future as they are subject to significant uncertainties relating
 
to the ultimate geographic
spread of the virus, the incidence and severity of
 
the symptoms, the duration or resurgence of the outbreak,
 
the length of the travel
restrictions and business closures imposed by governments
 
of impacted countries, and the economic response by governments
 
of
impacted countries.
 
To the extent
 
that the Company’s customers and
 
suppliers continue to be significantly and adversely impacted by
 
COVID-19, this
could reduce the availability,
 
or result in delays, of materials or supplies to or from
 
the Company, which in
 
turn could significantly
interrupt the Company’s
 
business operations.
 
Such impacts could grow and become more significant to the
 
Company’s operations
and the Company’s liquidity
 
or financial position.
 
Therefore, given the speed and frequency of continuously
 
evolving developments
with respect to this pandemic, the Company cannot reasonably
 
estimate the magnitude or the full extent to which COVID-19
 
may
impact the Company’s results
 
of operations, liquidity or financial position.
 
100
Item 9.
 
Changes in and Disagreements With Accountants on
 
Accounting and Financial Disclosure.
 
Not Applicable.
 
Item 9A.
 
Controls and Procedures.
 
Conclusion Regarding the Effectiveness of Disclosure
 
Controls and Procedures
As required by Rule 13a-15(b) under the Securities Exchange
 
Act of 1934, as amended (the “Exchange Act”), our management,
including our principal executive officer
 
and principal financial officer,
 
has evaluated the effectiveness of our disclosure controls
 
and
procedures (as defined in Rule 13a-15(e) under the Exchange Act)
 
as of the end of the period covered by this report.
 
Based on that
evaluation, our principal executive officer and
 
our principal financial officer have concluded that,
 
as of the end of the period covered
by this Report, our disclosure controls and procedures
 
(as defined in Rule 13a-15(e) under the Exchange Act) were
 
not effective as of
December 31, 2020 because of the material weaknesses in
 
our internal control over financial reporting, as described
 
below.
Notwithstanding these material weaknesses, the Company
 
has concluded that the audited consolidated financial statements
included in this Report present fairly,
 
in all material respects, the financial position of the Company
 
as of December 31, 2020 and
2019, and the results of its operations and its cash flows
 
and changes in equity for each of the years in the three
 
-year period ended
December 31, 2020, in conformity with accounting
 
principles generally accepted in the United States.
Management’s Report on Internal
 
Control over Financial Reporting
Management is responsible for establishing and maintaining
 
adequate internal control over financial reporting as such term
 
is
defined in Rule 13a-15(f) under the Exchange Act.
 
Internal control over financial reporting is a process designed
 
to provide
reasonable assurance regarding the reliability of financial
 
reporting and the preparation
 
of financial statements for external purposes in
accordance with generally accepted accounting principles.
Because of its inherent limitations, internal control
 
over financial reporting may not prevent or detect misstatements.
 
Also,
projections of any evaluation of effectiveness
 
to future periods are subject to the risk that controls may
 
become inadequate because of
changes in conditions or that the degree of compliance
 
with the policies or procedures may deteriorate.
Our management, with the participation of our principal
 
executive officer and principal financial officer,
 
assessed the
effectiveness of the Company’s
 
internal control over financial reporting as of December
 
31, 2020.
 
In making this assessment, our
management used the criteria set forth by the Committee
 
of Sponsoring Organizations of the Treadway
 
Commission in Internal
Control—Integrated Framework (2013) (the “COSO framework”).
 
A material weakness is a deficiency,
 
or combination of
deficiencies, in internal control over financial reporting,
 
such that there is a reasonable possibility that a material misstatement
 
of
annual or interim financial statements will not be prevented
 
or detected on a timely basis.
 
We identified
 
certain deficiencies in our
application
 
of the principles associated with the COSO framework that
 
management concluded constituted a material weakness.
 
We
did not design and maintain effective controls in
 
response to the risks of material misstatement.
 
Specifically, changes
 
to existing
controls or the implementation of new controls were not
 
sufficient to respond to changes to the risks of material
 
misstatement in
financial reporting as a result of becoming a larger,
 
more complex global organization due to the Combination.
 
This material
weakness also contributed to an additional material weakness as we did
 
not design and maintain effective controls
 
over the review of
pricing, quantity and customer data to verify that revenue
 
recognized was complete and accurate.
 
These material weaknesses did not
result in material misstatements to the interim or annual
 
consolidated financial statements.
 
However, these material weaknesses could
result in misstatements to our account balances and disclosures
 
that could result in a material misstatement to the interim
 
or annual
consolidated financial statements that would not be
 
prevented or detected.
 
Therefore, management concluded that the Company’s
internal control over financial reporting was not effective
 
as of December 31, 2020.
Management has excluded the internal controls of Tel
 
Nordic ApS and Coral Chemical Company from our assessment of internal
control over financial reporting as of December 31, 2020,
 
because these entities were acquired by the Company in
 
purchase business
combinations in May 2020 and December 2020, respectively.
 
These excluded entities are wholly owned subsidiaries, whose
 
total
assets represent less than 1% and approximately 2%,
 
respectively, and whose
 
total revenues each represent less than 1%, of the related
consolidated financial statement amounts as of and
 
for the year ended December 31, 2020.
The effectiveness of the Company’s
 
internal control over financial reporting as of December 31,
 
2020 has been audited by
PricewaterhouseCoopers LLP,
 
an independent registered public accounting firm, as
 
stated in its report which is included in “Item 8.
Financial Statements and Supplementary Data.”
Progress on Remediation of
 
Material Weaknesses
The aforementioned material weaknesses, as well as the remediated
 
business combination material weakness discussed below,
were previously disclosed in
“Item 9A. Controls and Procedures.”
in the Company’s 2019
 
Form 10-K.
 
The Company and its Board
of Directors are committed to maintaining a strong
 
internal control environment.
 
Since identifying the material weaknesses, the
Company has dedicated a significant amount of time
 
and resources to remediate all of the previously identified material
 
weaknesses as
quickly and effectively as possible.
 
In 2020, the Company dedicated multiple internal resources
 
and supplemented those internal
resources with various third-party specialists to assist with the
 
formalization of a robust and detailed remediation
 
plan.
 
In undertaking
 
101
remediation activities, the Company has hired additional
 
personnel dedicated to financial and information technology
 
compliance to
further supplement its internal resources.
 
In addition, the Company has established a global network
 
of personnel to assist local
management in understanding control performance and
 
documentation requirements.
 
In order to sustain this network, the Company
conducts periodic trainings and hosts discussions to address
 
questions on a current basis.
 
However,
 
the impact of COVID-19,
including travel restrictions and remote work arrangements
 
required the Company to adapt and make changes to its internal
 
controls
integration plans as well as its remediation plans, and
 
has presented and is expected to continue to present challenges
 
with regards to
the timing of the Company’s
 
remediation and integration plan activities.
 
In addition, the Company was executing its plan of
remediation in the current year while also integrating
 
its past Houghton and Norman Hay acquisitions into the Company’s
 
control
framework.
 
Remediation of Business Combination Material Weakness
 
Through these efforts described above, the
 
Company was able to implement its plan to remediate the previously
 
identified
material weakness concerning the reliability of data used
 
to support the reasonableness of certain assumptions in the accounting
 
for
business combinations, including updating the Company’s
 
design and documentation as well as implementing changes to
 
certain
internal controls to specifically address this control deficiency.
 
The Company was able to document, test and evaluate the updated
internal controls in the given year so as to successfully
 
remediate this material weakness as of December 31, 2020.
 
Management’s
 
Remediation Initiatives for the Risk Assessment and Revenue
 
– Price and Quantity Material Weaknesses
Despite the challenges brought on by COVID-19 and
 
driven by the Company’s
 
priority of creating a long-term sustainable control
structure to ensure stability for a Company that has more
 
than doubled in size since August 2019, the Company did
 
make substantial
strides towards remediating the underlying causes of the
 
previously disclosed material weaknesses in our risk assessment process
 
and
within our revenue process in the current year,
 
as further discussed below.
Risk Assessment –
Specific to the material weakness in our risk assessment process
 
that was previously disclosed in
“Item 9A.
Controls and Procedures.”
in the Company’s 2019
 
Form 10-K , we previously determined that our risk assessment process
 
was not
designed adequately to respond to changes to the
 
risks of material misstatement to financial reporting.
 
In order to remediate this
material weakness, we have designed and implemented
 
an improved risk assessment process, including identifying
 
and assessing
those risks attendant to the significant changes within the
 
Company as a result of becoming a larger,
 
more complex global
organization due to the Combination.
 
During 2020, a full review was performed of our processes and controls
 
across significant
locations in order to identify and address potential design
 
gaps.
 
In addition to individual transactional-level control enhancements,
this review resulted in (i) an enhanced financial statement
 
risk assessment, (ii) the standardization of existing legal entity and
 
newly
implemented segment quarterly analytics and quarterly
 
closing packages completed by key financial reporting
 
personnel, (iii) a global
account reconciliation review program and (iv) enhancements
 
to our quarterly identification and reassessment of new and
 
existing
business and information technology risks that could
 
affect our financial reporting.
 
Monitoring is also performed through our
enhanced quarterly controls certification process, whereby
 
changes in business or information technology processes or control
 
owners
are identified and addressed timely.
 
Although we have implemented and tested the additional controls
 
as noted in our remediation
plan and found them to be effective, this material
 
weakness will not be considered remediated as of December
 
31, 2020 due to the
Revenue – Price and Quantity material weakness, discussed
 
below.
 
Once the Revenue – Price and Quantity material weakness is
remediated, we expect the Risk Assessment material weakness will also
 
be remediated.
 
Revenue – Price and Quantity –
Specific to the material weakness in our revenue process that
 
was previously disclosed in
“Item 9A.
Controls and Procedures.”
in the Company’s 2019
 
Form 10-K, we did not design and maintain effective
 
controls over the review of
pricing, quantity and customer data to verify that revenue
 
recognized was complete and accurate.
 
In order to remediate this material
weakness, the Company has made significant progress in
 
its redesign of certain aspects of its revenue process and
 
related controls
during 2020.
 
As of the date of this report on Form 10-K, the Company has identified
 
and agreed upon design enhancements and
requirements for each revenue sub-process.
 
The design includes enhancements to entity-level and
 
transactional-level manual controls
as well as IT general and application controls and the
 
Company is in the process of implementing these design changes
 
both centrally
and locally.
 
However, because the additional
 
controls had not been implemented and tested as of December
 
31, 2020, this material
weakness is not yet remediated.
 
This existing material weakness will not be considered remediated
 
until the applicable remedial
controls operate for a sufficient period of
 
time and management has concluded, through testing, that the controls
 
are operating
effectively.
 
Given the significant resources the Company has dedicated
 
to remediation of its material weaknesses, the Company is committed
to remediation and expects that in 2021 it will successfully implement
 
the enhanced design of its revenue processes and have a
sufficient operational effectiveness period
 
to evidence material weakness remediation over its price and
 
quantity material weakness
and, concurrently,
 
evidence material weakness remediation over its risk assessment material
 
weakness in 2021 as well.
 
 
Changes in Internal Control Over Financial
 
Reporting
As required by Rule 13a-15(d) under the Exchange Act,
 
our management, including our principal executive officer
 
and principal
financial officer, has
 
evaluated our internal control over financial reporting to
 
determine whether any changes to our internal control
over financial reporting occurred during the fourth quarter
 
of the year ended December 31, 2020 that have materially affected,
 
or are
 
102
reasonably likely to materially affect, our
 
internal control over financial reporting.
 
Based on that evaluation, there were no changes
that have materially affected, or are reasonably
 
likely to materially affect, our internal control over financial
 
reporting during the
fourth quarter of the year ended December 31, 2020.
Item 9B.
 
Other Information.
 
As previously reported by the Company on February 25,
 
2021, Michael F.
 
Barry on February 24, 2021 informed the Board of
Directors of the Company (the “Board”) that he plans to
 
retire as President and Chief Executive Officer
 
of Quaker Houghton on
December 31, 2021.
 
Mr. Barry,
 
who has been nominated for re-election as a director at
 
the 2021 annual meeting of the Company’s
shareholders, is expected to serve his full three-year term
 
as a director and will retain the role of Chairman of the Board following
 
his
retirement.
 
The Board is committed to a strong, orderly process and transition
 
with a comprehensive search that will include internal
and external candidates.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
103
PART
 
III
Item 10.
 
Directors, Executive Officers and Corporate Governance.
 
Incorporated by reference is (i) the information
 
beginning with and including the caption “Proposal 1—Election
 
of Directors and
Nominee Biographies” in Quaker Houghton’s
 
definitive Proxy Statement relating to the 2021 Annual
 
Meeting of Shareholders, to be
filed with the Securities and Exchange Commission no
 
later than 120 days after the close of its fiscal year ended
 
December 31, 2020
(the “2021 Proxy Statement”) to, but not including,
 
the sub-caption “Governance Committee Procedures for Selecting
 
Director
Nominees,” (ii) the information appearing in Item 4(a)
 
of this Report, (iii) the information in the 2021 Proxy Statement
 
beginning with
and including the caption, “Delinquent Section 16(a)
 
Reports” to, but not including, the caption “Certain Relationships
 
and Related
Transactions,” (iv) the information in
 
the 2021 Proxy Statement beginning with and including the
 
sub-caption “Code of Conduct” to,
but not including, the caption “Compensation Committee
 
Interlocks and Insider Participation,” and (v) the information
 
in the 2021
Proxy Statement beginning with and including the
 
sub-caption “Shareholder Nominations and Recommendations”
 
to, but not
including, the sub-caption “Board Oversight
 
of Risk.”
 
Information about our Executive Officers is included
 
in Item 4(a) of this
Report.
Item 11.
 
Executive Compensation.
Incorporated by reference is (i) the information
 
in the 2021 Proxy Statement beginning with and including the caption
“Compensation Committee Interlocks and Insider Participation”
 
to, but not including the caption “Stock Ownership of
 
Certain
Beneficial Owners and Management.”
Item 12.
 
Security Ownership of Certain Beneficial Owners and Management
 
and Related Stockholder Matters.
 
Incorporated by reference is the information in the 2021
 
Proxy Statement beginning with and including the caption
 
“Stock
Ownership of Certain Beneficial Owners and Management”
 
to, but not including, the caption “Delinquent Section 16(a)
 
Reports.”
Equity Compensation Plans
 
The following table sets forth certain information
 
relating to the Company’s equity
 
compensation plans as of December 31, 2020.
 
Each number of securities reflected in the table is a reference
 
to shares of Quaker common stock.
Equity Compensation Plan Information
Number of securities
 
Number of securities
remaining available for
 
to be issued upon
 
Weighted-average
 
future issuance under
 
exercise of
exercise price of
equity compensation plans
outstanding options,
outstanding options,
 
(excluding securities
Plan Category
warrants and rights
warrants and rights
reflected in column (a))
(a)
(b)
(c)
Equity compensation plans approved
 
by security holders
110,336
 
$
143.51
 
650,060
 
(1)
Equity compensation plans not approved
 
by security holders
Total
110,336
 
$
143.51
 
650,060
 
(1)
 
(1)
As of December 31, 2020, 304,900 of these shares were
 
available for issuance as restricted stock awards under
 
the Company’s
2001 Global Annual Incentive Plan, 283,508 shares were
 
available for issuance upon the exercise of stock options and/or as
restricted stock awards and/or restricted stock unit awards
 
under the Company’s 2016
 
Long-Term Performance
 
Incentive Plan, and
61,652 shares were available for issuance under the
 
2013 Director Stock Ownership Plan.
Item 13.
 
Certain Relationships and Related Transact
 
ions, and Director Independence.
 
Incorporated by reference is (i) the information
 
in the 2021 Proxy Statement beginning with and including the caption
 
“Certain
Relationships and Related Party Transactions”
 
to, but not including, the caption “Proposal 2 — Ratification of
 
Appointment of
Independent Registered Public Accounting Firm,” (ii)
 
the information in the 2021 Proxy Statement beginning with
 
and including the
sub-caption “Director Independence” to, but not including,
 
the sub-caption “Governance Committee Procedures for Selecting
 
Director
Nominees,” and (iii) the information in the 2021 Proxy
 
Statement beginning with and including the caption “Meetings
 
and
Committees of the Board” to, but not including, the
 
caption “Compensation Committee Interlocks and Insider Participation.”
Item 14.
 
Principal Accountant Fees and Services.
 
Incorporated by reference is the information in the 2021
 
Proxy Statement beginning with and including the sub-caption
 
“Audit
Fees” to, but not including, the statement recommending
 
a vote for ratification of the appointment of PricewaterhouseCoopers
 
LLP as
the Company’s independent
 
registered public accounting firm for the year ending December
 
31, 2021.
 
 
104
PART
 
IV
 
 
Item 15.
 
Exhibits and Financial Statement Schedules.
(a)
 
Exhibits and Financial Statement Schedules
1.
 
Financial Statements and Supplementary Data
 
 
 
 
 
Page
Financial Statements:
 
 
 
 
44
 
47
48
 
49
 
50
 
 
51
 
52
2.
 
Financial Statement Schedules
All schedules are omitted because they are not applicable
 
or the required information is shown in the financial statements or
 
notes
thereto.
 
Financial statements of 50% or less owned companies have been
 
omitted because none of the companies meets the criteria
requiring inclusion of such statements.
 
3. Exhibits - filed pursuant to,
 
and numbered in accordance with Item 601
 
of Regulation S-K (all of which are under
Commission File number 001-12019, except as otherwise noted):
 
2.1 —
3.1 —
3.2 —
4.1 —
4.2 —
4.3 —
10.1 —
10.2 —
10.3 —
10.4 —
 
 
105
10.5 —
10.6 —
10.7 —
10.8 —
10.9 —
10.10 —
 
10.11 —
 
10.12 —
 
10.13 —
10.14 —
.†
10.15 —
.†
10.16 —
.†
10.17 —
.†
10.18 —
 
 
10.19 —
10.20 —
10.21 —
10.22 —
 
106
10.23 —
10.24 —
10.25 —
 
10.26 —
 
10.27 —
10.28 —
10.29 —
10.30 —
10.31 —
10.32 —
10.33 —
10.34 —
 
***
10.35 —
10.36 —
10.37 —
10.38 —
10.39 —
10.40 —
10.41 —
 
107
21 —
23 —
31.1 —
31.2 —
32.1 —
32.2 —
101.INS —
Inline XBRL Instance Document*
101.SCH —
Inline XBRL Taxonomy
 
Extension Schema Document*
101.CAL —
Inline XBRL Taxonomy
 
Calculation Linkbase
 
Document*
101.DEF —
Inline XBRL Taxonomy
 
Definition Linkbase Document*
101.LAB —
Inline XBRL Taxonomy
 
Label Linkbase Document*
101.PRE —
Inline XBRL Taxonomy
 
Presentation Linkbase Document*
104 —
Cover Page Interactive Data File (formatted as Inline XBRL and
 
contained in Exhibit 101.INS) *
* Filed herewith.
** Furnished herewith.
*** Certain exhibits and schedules have been omitted,
 
and the Company agrees to furnish supplementally to
 
the Securities and
Exchange commission a copy of any omitted exhibits and
 
schedules upon request.
† Management contract or compensatory plan
 
Item 16.
Form 10-K Summary.
 
The Company has elected not to include a Form 10-K summary
 
under this Item 16.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
108
SIGNATURES
 
Pursuant to the requirements of Section
 
13 or 15(d) of the Securities Exchange Act of 1934, the
 
Registrant has duly
caused this Report to be signed on its behalf by the undersigned,
 
thereunto duly authorized.
 
 
 
 
 
QUAKER CHEMICAL CORPORATION
Registrant
 
 
By:
/s/
 
MICHAEL F. BARRY
 
 
 
Michael F.
 
Barry
Chairman of the Board, Chief Executive Officer and
President
 
 
Date: March 1, 2021
 
Pursuant to the requirements of the
 
Securities Exchange Act of 1934, this Report has been signed below
 
by the following
persons on behalf of the Registrant and in the capacities and
 
on the dates indicated.
 
Signatures
Capacity
Date
/s/
 
MICHAEL F. BARRY
Principal Executive Officer and
March 1, 2021
Michael F. Barry
 
Director
Chairman of the Board, Chief Executive Officer and President
/s/
 
MARY DEAN HALL
Principal Financial Officer
March 1, 2021
Mary Dean Hall
Senior Vice President, Chief Financial Officer and Treasurer
 
/s/
 
SHANE W. HOSTETTER
Principal Accounting Officer
March 1, 2021
Shane W. Hostetter
Vice President, Finance and Chief Accounting Officer
/s/
 
DONALD R. CALDWELL
Director
March 1, 2021
Donald R. Caldwell
/s/
 
CHARLOTTE C. DECKER
Director
March 1, 2021
Charlotte C. Decker
/s/
 
MARK A. DOUGLAS
Director
March 1, 2021
Mark A. Douglas
/s/
 
JEFFRY D. FRISBY
Director
March 1, 2021
Jeffry D. Frisby
/s/
 
WILLIAM H. OSBORNE
Director
March 1, 2021
William H. Osborne
/s/
 
ROBERT H. ROCK
Director
March 1, 2021
Robert H. Rock
/s/
 
FAY
 
WEST
Director
March 1, 2021
Fay West
/s/
 
SANJAY HINDUJA
Director
March 1, 2021
Sanjay Hinduja
/s/
 
RAMASWAMI SESHASAYEE
Director
March 1, 2021
Ramaswami Seshasayee
/s/
 
MICHAEL SHANNON
Director
March 1, 2021
Michael Shannon
 
exhibit21
 
 
 
 
1
EXHIBIT 21
 
SUBSIDIARIES AND AFFILIATES
 
OF THE REGISTRANT
Jurisdiction of
 
Percentage of Voting
 
Securities Owned
Name
Incorporation
Directly or Indirectly by Quaker
*
Quaker Chemical, S.A.
Argentina
100%
*
Houghton Argentina S.A.
Argentina
100%
+*
Quaker Australia Holdings Pty.
 
Limited
Australia
100%
*
Quaker Chemical (Australasia) Pty.
 
Limited
Australia
100%
+*
Houghton Australia Pty.
 
Ltd.
Australia
100%
*
Surface Technology
 
Australia
Australia
100%
**
Primex, Ltd.
Barbados
33%
+*
Quaker Chemical Participacoes, Ltda.
Brazil
100%
*
Quaker Chemical Industria e Comercio Ltda.
Brazil
100%
*
Quaker Chemical Operacoes, Ltda.
Brazil
100%
*
Ultraseal Asia Limited
British Virgin Islands
100%
*
Quaker Chemical Canada Limited
Canada
100%
+*
Quaker Chemical Canada Holdings, Inc.
Canada
100%
*
Quaker Houghton Canada Inc. (formerly Lubricor,
Inc.)
Canada
100%
*
Houghton Canada Inc.
Canada
100%
+*
Global Houghton Ltd.
Cayman Islands
100%
*
Quaker Chemical (China) Co. Ltd.
China
100%
*
Quaker Shanghai Trading Company
 
Limited
China
100%
+*
Quaker Chemical Investment Management (Shanghai)
Co., Ltd.
China
100%
*
Wuhan Quaker Technology
 
Co., Ltd
China
60%
*
Houghton (Shanghai) Specialty Industrial Fluids Co.,
Ltd
China
100%
*
DA Stuart Shanghai Co
China
100%
*
Ultraseal Chongqing Limited
China
100%
*
Ultraseal Machinery Dongguan Ltd
China
100%
*
Ultraseal Shanghai Limited
China
100%
*
Houghton CZ s.r.o
Czech Republic
100%
+*
Quaker Denmark ApS
Denmark
100%
*
Houghton Denmark AS
Denmark
100%
*
Tel Nordic ApS
Denmark
100%
*
Houghton S.A.S.
France
100%
*
SIFCO Concepts Sarl
France
100%
*
Quaker Chemical Services EURL
France
100%
*
Engineered Custom Lubricants GmbH
Germany
100%
*
Houghton Deutschland GmbH
Germany
100%
*
Ultraseal Germany GmbH
Germany
100%
*
Internationale Metall Impragnier GmbH
Germany
100%
*
Maldaner GmbH
Germany
100%
*
Sterr & Eder Industrieservice GmbH
Germany
100%
*
Quaker Chemical Limited
Hong Kong
100%
*
Houghton Magyarország Kft
 
Hungary
100%
*
Quaker Chemical India Private Limited
India
100%
*
DA Stuart India Private Limited
India
100%
*
Ultraseal India Private Ltd
India
30%
 
 
 
 
2
EXHIBIT 21
 
SUBSIDIARIES AND AFFILIATES
 
OF THE REGISTRANT,
continued
Jurisdiction of
 
Percentage of Voting
 
Securities Owned
Name
Incorporation
Directly or Indirectly by Quaker
*
Quaker Italia S.r.l.
Italy
100%
*
Quaker Chemical S.r.l.
Italy
100%
*
Houghton Italia S.p.A.
Italy
100%
*
Houghton Japan Co., Ltd.
Japan
100%
**
Nippon Quaker Chemical, Ltd.
Japan
50%
*
Houghton Oil (Malaysia) Sdn, Bhd.
Malaysia
100%
+*
Quaker Houghton (Finco) Ltd.
Malta
100%
+*
Quaker Houghton Ltd.
Malta
100%
+*
Quaker Houghton Holdings Ltd.
Malta
100%
+*
Quaker Hougton Investments Limited
Malta
100%
*
Tecniquimia
 
Mexicana S.A. de C.V.
Mexico
100%
*
Unitek Servicios De Asesoria Especializad S.A de C.V.
Mexico
100%
*
Houghton Mexico S.A. de C.V.
Mexico
100%
*
Lubricor Mexicana S.A. de C.V.
Mexico
100%
+*
Quaker Chemical Europe B.V.
Netherlands
100%
*
Quaker Chemical B.V.
Netherlands
100%
+*
Quaker Russia B.V.
 
(formerly KWR Holdings B.V.)
Netherlands
100%
+*
Quaker China Holdings B.V.
Netherlands
100%
+*
Houghton Europe BV
Netherlands
100%
*
Houghton Benelux BV
Netherlands
100%
+*
QH Europe BV
Netherlands
100%
*
Quaker Sales Europe, BV
Netherlands
100%
**
Kelko Quaker Chemical, S.A.
Panama
50%
*
Houghton Polska Sp. Zo.o.
Poland
100%
+*
Quaker Chemical Holdings South Africa (Pty) Limited
Republic of South Africa
100%
*
Quaker Chemical South Africa (Pty.)
 
Limited
Republic of South Africa
100%
*
Houghton Romania S.R.L.
Romania
100%
+*
GHI Asia Pacific Pte. Ltd.
Singapore
100%
*
Houghton Singapore
Singapore
100%
**
Korea Houghton Corporation
South Korea
50%
*
Quaker Chemical, S.A.
Spain
100%
*
Verkol
 
S.A.U.
Spain
100%
+*
Quaker Spain Holding, SLU
Spain
100%
*
Houghton Iberica S.A.
 
Spain
100%
*
Binol AB
Sweden
100%
*
Houghton Sverige AB
Sweden
100%
*
SIFCO Concepts Sweden
Sweden
100%
*
Houghton Taiwan
 
Co. Limited
Taiwan
100%
*
Quaker (Thailand) Ltd.
Thailand
100%
*
Quaker Houghton Thailand (formerly Thai Houghton
1993 Co., Ltd)
Thailand
100%
*
Houghton Kimya Sanayi AS
Turkey
100%
 
 
 
 
3
EXHIBIT 21
 
SUBSIDIARIES AND AFFILIATES
 
OF THE REGISTRANT,
continued
Jurisdiction of
 
Percentage of Voting
 
Securities Owned
Name
Incorporation
Directly or Indirectly by Quaker
*
Quaker Chemical Corporation
U.S.A.
100%
+*
SB Decking, Inc. (formerly Selby,
 
Battersby & Co.)
U.S.A.
100%
*
AC Products, Inc.
U.S.A.
100%
*
Epmar Corporation
U.S.A.
100%
*
Summit Lubricants, Inc.
U.S.A.
100%
*
ECLI Products, LLC
U.S.A.
100%
+*
EFHCO, LLC
U.S.A.
100%
+*
GH Holdings Inc.
U.S.A.
100%
+*
Houghton Technical
 
Corp.
U.S.A.
100%
*
SIFCO Applied Surface Concepts, LLC
U.S.A.
100%
*
Quaker Houghton PA,
 
Inc. (formerly Houghton
International)
U.S.A.
100%
*
Ultraseal USA Inc.
U.S.A.
100%
+*
Wallover Enterprises,
 
Inc.
U.S.A.
100%
*
Wallover Oil Company
 
Incorporated
U.S.A.
100%
*
Wallover Oil Hamilton
 
Inc.
U.S.A.
100%
+*
Quaker International Holdings, LLC
U.S.A.
100%
+*
MIH Acquisition Company,
 
LLC
U.S.A.
100%
*
Coral Chemical Company,
 
LLC
U.S.A.
100%
*
Houghton Ukraine ToV
Ukraine
100%
*
Quaker Chemical Limited
United Kingdom
100%
+*
GHGL London Ltd.
United Kingdom
100%
+*
GHG Lubricants Holdings Limited
United Kingdom
100%
+*
Houghton Holdings Limited
United Kingdom
100%
*
Houghton Limited (formerly Houghton plc)
United Kingdom
100%
+*
Applied Surface Concepts Holdings Ltd.
 
United Kingdom
100%
*
Norman Hay Engineering Ltd.
 
United Kingdom
100%
*
SIFCO Applied Surface Concepts (UK) Ltd
United Kingdom
100%
*
Surface Technology
 
Holdings Ltd.
 
United Kingdom
100%
*
Surface Technology
 
(Leeds) Ltd
United Kingdom
100%
*
Surface Technology
 
Aberdeen Ltd
United Kingdom
100%
*
Surface Technology
 
(East Kilbride) Ltd.
United Kingdom
100%
*
Surface Technology
 
(Coventry) Ltd
United Kingdom
100%
*
Ultraseal International Group Ltd
United Kingdom
100%
*
MX Systems International Ltd
United Kingdom
100%
+*
Quaker Houghton International LP
United Kingdom
100%
+*
Quaker Houghton Holdings Limited
United Kingdom
100%
+*
QH Holdings Limited
United Kingdom
100%
+*
QH Chemical Limited
United Kingdom
100%
+*
QH International Limited
United Kingdom
100%
+*
Quaker Specialty Chemicals (UK) Limited
United Kingdom
100%
*
Quaker Houghton Support Deutschland
United Kingdom
100%
Kelko Quaker Chemical, S.A.
Venezuela
50%
+
A non-operating company
*
Included in the consolidated financial statements
**
Accounted for in the consolidated financial statements under
 
the equity method
 
exhibit23
 
1
EXHIBIT 23
 
CONSENT OF INDEPENDENT REGISTERED PUBLIC
 
ACCOUNTING FIRM
 
We hereby
 
consent to the incorporation by reference in the Registration Statements
 
on Forms
 
S-3 (Registration Nos. 333-155607, 333-
233530, 333-233956 and 333-238508) and on Forms
 
S-8 (Registration Nos. 033-54158, 333-58676, 333-115713,
 
333-159513, 333-
174145, 333-208188, 333-188594 and 333-211238)
 
of Quaker Chemical Corporation of our report dated March
 
1, 2021 relating to the
financial statements and the effectiveness of
 
internal control over financial reporting, which appears in this Form
 
10-K.
 
/s/ PricewaterhouseCoopers LLP
Philadelphia, Pennsylvania
March 1, 2021
exhibit311
 
 
1
 
EXHIBIT 31.1
 
CERTIFICATION
 
OF CHIEF EXECUTIVE OFFICER OF THE COMPANY
 
PURSUANT TO RULE 13a-14(a) OF THE
SECURITIES EXCHANGE ACT OF 1934
 
I, Michael F.
 
Barry, certify that:
 
1.
 
I have reviewed this Annual Report on Form 10-K of Quaker
 
Chemical Corporation;
2.
 
Based on my knowledge, this report does not contain
 
any untrue statement of a material fact or omit to state a material
 
fact
necessary to make the statements made, in light of the circumstances
 
under which such statements were made, not
misleading with respect to the period covered by this report;
 
3.
 
Based on my knowledge, the financial statements, and
 
other financial information included in this report, fairly
 
present in
all material respects the financial condition, results of operations
 
and cash flows of the registrant as of, and for,
 
the periods
presented in this report;
 
4.
 
The registrant’s other certifying
 
officer and I are responsible for establishing and maintaining
 
disclosure controls and
procedures (as defined in Exchange Act Rules 13a-15(e) and
 
15d-15(e)) and internal control over financial reporting
 
(as
defined in Exchange Act Rules 13a-15(f) and 15d-15(f))
 
for the registrant and have:
 
(a)
 
Designed such disclosure controls and procedures, or caused such
 
disclosure controls and procedures to be designed
under our supervision, to ensure that material information
 
relating to the registrant, including its consolidated
subsidiaries, is made known to us by others within those entities,
 
particularly during the period in which this report is
being prepared;
 
(b)
 
Designed such internal control over financial reporting,
 
or caused such internal control over financial reporting
 
to be
designed under our supervision, to provide reasonable
 
assurance regarding the reliability of financial reporting and the
preparation of financial statements for external purposes in
 
accordance with generally accepted accounting principles;
 
(c)
 
Evaluated the effectiveness of the registrant’s
 
disclosure controls and procedures and presented in this report
 
our
conclusions about the effectiveness of the disclosure
 
controls and procedures, as of the end of the period covered
 
by
this report based on such evaluation; and
 
(d)
 
Disclosed in this report any change in the registrant’s
 
internal control over financial reporting that occurred during
 
the
registrant’s most recent
 
fiscal quarter (the registrant’s fourth
 
fiscal quarter in the case of an annual report) that has
materially affected, or is reasonably likely
 
to materially affect, the registrant’s
 
internal control over financial reporting;
and
 
5.
 
The registrant’s other certifying
 
officer and I have disclosed, based on our most recent
 
evaluation of internal control over
financial reporting, to the registrant’s
 
auditors and the audit committee of the registrant’s
 
board of directors (or persons
performing the equivalent functions):
 
(a)
 
All significant deficiencies and material weaknesses in the
 
design or operation of internal control over financial
reporting which are reasonably likely to adversely affect
 
the registrant’s ability to record,
 
process, summarize and
report financial information; and
 
(b)
 
Any fraud, whether or not material, that involves management
 
or other employees who have a significant role in the
registrant’s internal control
 
over financial reporting.
 
 
 
Date: March 1, 2021
 
 
/s/
 
MICHAEL F. BARRY
 
Michael F.
 
Barry
Chief Executive Officer
 
exhibit312
 
 
1
EXHIBIT 31.2
 
CERTIFICATION
 
OF CHIEF FINANCIAL OFFICER OF THE COMPANY
 
PURSUANT TO RULE 13a-14(a) OF THE
SECURITIES EXCHANGE ACT OF 1934
 
I, Mary Dean Hall, certify that:
 
1.
 
I have reviewed this Annual Report on Form 10-K of Quaker
 
Chemical Corporation;
2.
 
Based on my knowledge, this report does not contain
 
any untrue statement of a material fact or omit to state a material
 
fact
necessary to make the statements made, in light of the circumstances
 
under which such statements were made, not
misleading with respect to the period covered by this report;
 
3.
 
Based on my knowledge, the financial statements, and
 
other financial information included in this report, fairly
 
present in
all material respects the financial condition, results of operations
 
and cash flows of the registrant as of, and for,
 
the periods
presented in this report;
 
4.
 
The registrant’s other certifying
 
officer and I are responsible for establishing and maintaining
 
disclosure controls and
procedures (as defined in Exchange Act Rules 13a-15(e) and
 
15d-15(e)) and internal control over financial reporting
 
(as
defined in Exchange Act Rules 13a-15(f) and 15d-15(f))
 
for the registrant and have:
 
(a)
 
Designed such disclosure controls and procedures, or caused such
 
disclosure controls and procedures to be designed
under our supervision, to ensure that material information
 
relating to the registrant, including its consolidated
subsidiaries, is made known to us by others within those entities,
 
particularly during the period in which this report is
being prepared;
 
(b)
 
Designed such internal control over financial reporting,
 
or caused such internal control over financial reporting
 
to be
designed under our supervision, to provide reasonable
 
assurance regarding the reliability of financial reporting and the
preparation of financial statements for external purposes in
 
accordance with generally accepted accounting principles;
 
(c)
 
Evaluated the effectiveness of the registrant’s
 
disclosure controls and procedures and presented in this report
 
our
conclusions about the effectiveness of the disclosure
 
controls and procedures, as of the end of the period covered
 
by
this report based on such evaluation; and
 
(d)
 
Disclosed in this report any change in the registrant’s
 
internal control over financial reporting that occurred during
 
the
registrant’s most recent
 
fiscal quarter (the registrant’s fourth
 
fiscal quarter in the case of an annual report) that has
materially affected, or is reasonably likely
 
to materially affect, the registrant’s
 
internal control over financial reporting;
and
 
5.
 
The registrant’s other certifying
 
officer and I have disclosed, based on our most recent
 
evaluation of internal control over
financial reporting, to the registrant’s
 
auditors and the audit committee of the registrant’s
 
board of directors (or persons
performing the equivalent functions):
 
(a)
 
All significant deficiencies and material weaknesses in the
 
design or operation of internal control over financial
reporting which are reasonably likely to adversely affect
 
the registrant’s ability to record,
 
process, summarize and
report financial information; and
 
(b)
 
Any fraud, whether or not material, that involves management
 
or other employees who have a significant role in the
registrant’s internal control
 
over financial reporting.
 
 
 
Date: March 1, 2021
 
 
/s/
 
MARY DEAN HALL
 
Mary Dean Hall
Chief Financial Officer
 
exhibit321
 
 
1
EXHIBIT 32.1
 
CERTIFICATION
 
PURSUANT TO 18 U.S.C. SECTION 1350
 
The undersigned hereby certifies that the Form 10-K Annual
 
Report of Quaker Chemical Corporation (the “Company”)
 
for the
annual period ended December 31, 2020 filed with the Securities and
 
Exchange Commission (the “Report”) fully complies with the
requirements of Section 13(a) or 15(d) of the Securities Exchange
 
Act of 1934 and that the information contained in the Report fairly
presents, in all material respects, the financial condition
 
and results of operations of the Company.
 
Dated: March 1, 2021
 
 
/s/
 
MICHAEL F. BARRY
 
Michael F.
 
Barry
Chief Executive Officer of Quaker Chemical Corporation
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
exhibit322
 
 
1
EXHIBIT 32.2
 
CERTIFICATION
 
PURSUANT TO 18 U.S.C. SECTION 1350
 
The undersigned hereby certifies that the Form 10-K Annual
 
Report of Quaker Chemical Corporation (the “Company”)
 
for the
annual period ended December 31, 2020 filed with the Securities and
 
Exchange Commission (the “Report”) fully complies with the
requirements of Section 13(a) or 15(d) of the Securities Exchange
 
Act of 1934 and that the information contained in the Report fairly
presents, in all material respects, the financial condition
 
and results of operations of the Company.
 
Dated: March 1, 2021
 
 
/s/
 
MARY DEAN HALL
Mary Dean Hall
Chief Financial Officer of Quaker Chemical Corporation